31.07.2013 Views

U.S and Trans-Border Securities Regulation

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

U.S <strong>and</strong> <strong>Trans</strong>-<strong>Border</strong><br />

<strong>Securities</strong> <strong>Regulation</strong><br />

Boston University School of Law<br />

Executive LL.M. - International Business Law<br />

July/August 2013<br />

Michael Krebs<br />

JD, Boston University School of Law 1985<br />

Senior Partner, Nutter, McClennen & Fish, LLP, Boston, MA<br />

Tel. 617.439.2288 email: mkrebs@nutter.com<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Course Objective<br />

General survey of primary U.S. securities laws <strong>and</strong> the domestic<br />

<strong>and</strong> trans-border business contexts in which they are relevant.<br />

Particular emphasis will be placed on<br />

<strong>Securities</strong> Act of 1933 (the “<strong>Securities</strong> Act”)<br />

<strong>Securities</strong> Exchange Act of 1934 (the “Exchange Act”),<br />

Role of the <strong>Securities</strong> Exchange Commission (the “SEC”),<br />

Impact of the Sarbanes-Oxley Act of 2002,<br />

Impact of 2010 Dodd-Frank Act<br />

Impact of 2012 JOBS Act<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


U.S <strong>and</strong> <strong>Trans</strong>-<strong>Border</strong><br />

<strong>Securities</strong> <strong>Regulation</strong><br />

Boston University School of Law<br />

Executive LL.M. in International Business Law<br />

Session 1 – July 22, 2013<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Session 1 Agenda<br />

Overarching concepts<br />

<strong>Securities</strong> Act overview<br />

Definition of a “security”<br />

<strong>Securities</strong> exempt from §5<br />

registration requirements<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Overarching concepts<br />

1) “Issuer” or “Registrant”<br />

2) “Interstate commerce”<br />

3) “Materiality”<br />

4) “GAAP” (vs. “IFRS”)<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


“Issuer” <strong>and</strong> “Registrant”<br />

“Issuer” is the company or other<br />

entity that issues securities<br />

“Registrant” is an issuer that has<br />

filed a registration statement with<br />

the SEC (pronounced “S-É-C”)<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Interstate Commerce<br />

Within U.S.?<br />

In offshore transactions?<br />

Reg. S<br />

F 3 or “F-cubed”<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Interstate Commerce (cont’d)<br />

Underlying the Federal securities laws is the concept that the<br />

U.S. Congress may regulate securities matters only to the<br />

extent that they involve “interstate commerce.”<br />

For example, the registration requirement under Section 5 of<br />

the <strong>Securities</strong> Act is predicated on<br />

[making] use of any means or instruments of transportation or<br />

communication in interstate commerce or of the mails to sell<br />

such security . . . or [carrying or causing] to be carried through<br />

the mails or in interstate commerce, by any means or<br />

instruments of transportation, any such security for the<br />

purpose of sale or for delivery after sale.<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Interstate Commerce (cont’d)<br />

Similarly, the anti-fraud provisions in Section 17 of<br />

the <strong>Securities</strong> Act <strong>and</strong> in Section 10(b) of the<br />

Exchange Act require an interstate commerce<br />

nexus.<br />

Liability under Section 10(b), for example, is<br />

predicated on the<br />

“use of any means or instrumentality of interstate<br />

commerce or of the mails, or of any facility of any<br />

national securities exchange. . . .”<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Interstate Commerce (cont’d)<br />

Reg. S (<strong>Securities</strong> Act Rules 901-905)<br />

Rule 901:<br />

For the purposes only of section 5 of the Act , the<br />

terms offer, offer to sell, sell, sale, <strong>and</strong> offer to buy<br />

shall be deemed to include offers <strong>and</strong> sales that<br />

occur within the United States <strong>and</strong> shall be deemed<br />

not to include offers <strong>and</strong> sales that occur outside the<br />

United States.<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Interstate Commerce (cont’d)<br />

Reg. S (<strong>Securities</strong> Act Rules 901-905)<br />

Rule 902(h):<br />

Definition of “offshore transaction”<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Interstate Commerce (cont’d)<br />

F 3 or “F-cubed”<br />

Issuer is foreign<br />

Plaintiffs are foreign<br />

Fraudulent purchase or sale of securities<br />

occurred in foreign country<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Interstate Commerce (cont’d)<br />

F3 or “F-cubed” (cont’d)<br />

In the 2010 Morrison v. National Australian Bank<br />

decision, the Supreme Court reasoned:<br />

It is a rare case of prohibited extraterritorial application<br />

that lacks all contact with United States territory. The<br />

Exchange Act’s focus is not on the place where the<br />

deception originated, but on purchases <strong>and</strong> sales of<br />

securities in the United States. Section 10(b) applies<br />

only to transactions in securities listed on domestic<br />

exchanges <strong>and</strong> domestic transactions in other<br />

securities” [emphasis added]<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Materiality<br />

An omitted fact will be deemed material if the fact<br />

“would have assumed actual significance in the<br />

deliberations of the reasonable shareholder. Put<br />

another way, there must be a substantial likelihood<br />

that the disclosure of the omitted fact would have<br />

been viewed by the reasonable investor as having<br />

significantly altered the "total mix" of<br />

information made available.”<br />

TSC v. Northway (1976)<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Materiality (cont’d)<br />

Basic v. Levinson (1988)<br />

Claim based upon misleading statement<br />

regarding ongoing merger discussions.<br />

Supreme Court adopts<br />

magnitude/probability test for materiality.<br />

Court endorsed “no comment” protocol.<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Materiality (cont’d)<br />

Matrixx Initiatives v. Siracusano (2011)<br />

Matrixx, a drug company, argued that “adverse<br />

event reports that do not reveal a statistically<br />

significant increased risk of adverse events from<br />

product use are [never] material information.”<br />

The Supreme Court declined to adopt the<br />

categorical statistical significance test.<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Materiality (cont’d)<br />

Matrixx Initiatives (2011) (cont’d)<br />

“The mere existence of reports of adverse events—which says<br />

nothing in <strong>and</strong> of itself about whether the drug is causing the<br />

adverse events—will not satisfy [the 10b-5 pleading st<strong>and</strong>ard].<br />

Something more is needed, but that something more is not<br />

limited to statistical significance <strong>and</strong> can come from the<br />

source, content, <strong>and</strong> context of the reports. This contextual<br />

inquiry may reveal in some cases that reasonable investors<br />

would have viewed reports of adverse events as material<br />

even though the reports did not provide statistically<br />

significant evidence of a causal link” [emphasis added]<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


GAAP (vs. IFRS)<br />

GAAP – “Generally Accepted Accounting<br />

Principles”<br />

As interpreted by SEC <strong>and</strong> FASB<br />

(Financial Accounting St<strong>and</strong>ards Board)<br />

Extremely important to issuer SEC filings<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


GAAP (vs. IFRS)<br />

IFRS – “International Financial Reporting St<strong>and</strong>ards”<br />

In 2008, SEC proposed a “roadmap” for the potential use in SEC<br />

filings of financial statements prepared in accordance IFRS.<br />

In 2010, SEC requested public comment on three specific topics<br />

related to its ongoing consideration of incorporating IFRS into<br />

financial reporting system for U.S. issuers known as<br />

“convergence”.<br />

November 2011 SEC released a staff study titled “A Comparison<br />

of U.S. GAAP <strong>and</strong> IFRS”<br />

July 13, 2012, the staff of the SEC's Office of the Chief<br />

Accountant published its final report (the “2013 Staff report") on<br />

its IFRS Work Plan.<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


IFRS – Continued<br />

GAAP (vs. IFRS)<br />

The 2013 Staff report does not include a final policy decision, or<br />

even a recommendation, as to whether IFRS should be<br />

incorporated into the US financial reporting system, or how such<br />

incorporation should occur.<br />

The 2013 Staff report indicates that IFRS is generally perceived<br />

to be of high quality. However, it notes that there are areas where<br />

gaps remain, <strong>and</strong> inconsistencies exist in the application of IFRS<br />

globally.<br />

The Staff also believes that improvements can be made to the<br />

IFRS interpretative process <strong>and</strong> the enforcement <strong>and</strong><br />

coordination activities of regulators across territories.<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


<strong>Securities</strong> Act Overview<br />

How would you describe the<br />

<strong>Securities</strong> Act to a foreign<br />

colleague who is unfamiliar with<br />

U.S. securities laws?<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


<strong>Securities</strong> Act Overview<br />

(cont’d)<br />

Core Principles:<br />

1. Each <strong>and</strong> every offer <strong>and</strong> sale of a<br />

security – whether by an issuer or by a<br />

previous purchaser of that security – must<br />

be registered with the SEC, unless either<br />

the security or the particular transaction<br />

(i.e., an “offer” <strong>and</strong> “sale”) specifically is<br />

exempt by statute or regulation from<br />

registration.<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


<strong>Securities</strong> Act Overview<br />

(cont’d)<br />

Core Principles:<br />

2. If a transaction is to be registered with the<br />

SEC, the issuer – <strong>and</strong> ONLY the issuer –<br />

must file the registration statement with the<br />

SEC.<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


<strong>Securities</strong> Act Overview<br />

(cont’d)<br />

Core Principles:<br />

3. If a transaction is registered with the SEC,<br />

the issuer has an affirmative obligation to<br />

disclose in the registration statement all<br />

information regarding the issuer <strong>and</strong> the<br />

security that is “material” to that investment<br />

decision.<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


<strong>Securities</strong> Act Overview<br />

(cont’d)<br />

More specifically:<br />

<strong>Securities</strong> Act primarily regulates<br />

“distributions” (i.e., public offerings) of<br />

securities by an “issuer”<br />

Also applies to offers <strong>and</strong> sales that are<br />

not public offerings<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


<strong>Securities</strong> Act Overview<br />

(cont’d)<br />

Establishes “prospectus” <strong>and</strong> “registration<br />

statement” as key disclosure documents<br />

Prospectus, which is a subpart of the registration<br />

statement, includes material information regarding<br />

Issuer's properties <strong>and</strong> business;<br />

Security offered for sale;<br />

Issuer’s management <strong>and</strong> principal shareholders;<br />

Issuer’s financial statements, as audited <strong>and</strong><br />

“certified” by issuer’s independent accountants; <strong>and</strong><br />

Material risks associated with issuer <strong>and</strong> security<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


<strong>Securities</strong> Act Overview<br />

(cont’d)<br />

<strong>Securities</strong> Act imposes accountability<br />

through administrative, civil <strong>and</strong> potentially<br />

criminal liability for:<br />

Failure to register sale of securities<br />

when required<br />

Materially false or misleading<br />

statements in a registration<br />

statement or prospectus<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Key Provisions of the<br />

<strong>Securities</strong> Act of 1933<br />

Section 5 – Registration requirements<br />

Section 2 – Definition of “security”<br />

Section 3 – <strong>Securities</strong> exempt from Section 2<br />

definition<br />

Section 4 – <strong>Trans</strong>actions exempt from Section 5<br />

registration<br />

Sections 11, 12, 17 <strong>and</strong> 24 – Civil/Criminal<br />

Liability<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Section 5<br />

§5(c) It is unlawful … to offer to sell or<br />

offer to buy … any “security,”<br />

unless a registration statement has<br />

been filed as to such security.<br />

§5(a) It is unlawful to sell a “security,”<br />

unless a registration statement is<br />

“in effect” as to such security.<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved.


Section 2(a)(1)<br />

§2(a)(1) - "security" means any [promissory]<br />

note, stock… bond… evidence of<br />

indebtedness … investment contract… any<br />

put, call, … option, on any security… or, in<br />

general, any interest or instrument commonly<br />

known as a "security”… or warrant or right to<br />

subscribe to or purchase … any of the<br />

foregoing.<br />

(c) 2005-2010 Michael K. Krebs. All<br />

Rights Reserved.


Stocks<br />

Key Components of §2(a)(1)<br />

Promissory Notes/Bonds<br />

Options<br />

Index or Group of <strong>Securities</strong><br />

“Investment Contracts”<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Section 3(a)<br />

§3(a) contains a lengthy list of securities not<br />

covered by the definition in §2(a)(1) <strong>and</strong><br />

therefore not covered by the provisions of the<br />

<strong>Securities</strong> Act (except the anti-fraud<br />

provisions of §17).<br />

(c) 2005-2010 Michael K. Krebs. All<br />

Rights Reserved.


Section 4<br />

§4 exempts some transactions from the §5<br />

registration requirements, including:<br />

§4(a)(1) – <strong>Trans</strong>actions by a person other than an Issuer,<br />

Underwriter, or Dealer.<br />

§4(a)(2) – <strong>Trans</strong>actions by an issuer not involving a<br />

“public offering” – the so-called “private placement”<br />

exemption<br />

Portions of §3(a) also exempt certain transactions from the<br />

§5 registration requirements. See, e.g., §3(a)(9); §3(a)(10);<br />

§3(a)(11)<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Civil <strong>and</strong> Criminal Liabilities<br />

§11 – Creates civil liability for false or misleading registration<br />

statements <strong>and</strong> provides for the award of damages<br />

§12 – Allows rescission of an offer or sale in violation of §5 or<br />

through the use of a materially false or misleading<br />

prospectus<br />

§17 – Makes it unlawful for any person to make fraudulent<br />

offer or sale of a security (applies even to exempt<br />

securities)<br />

§24 – Provides criminal fines <strong>and</strong> prison terms for securities<br />

law violations<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


What is a “Security”?<br />

Very broadly defined. Includes:<br />

Equity investments, such as common or preferred stock,<br />

issued by a business enterprise, whether organized as a<br />

corporation, limited liability company, or limited<br />

partnership (LLCs <strong>and</strong> LPs – but not corporations –<br />

analyzed under “investment contract” test)<br />

Often includes debt instruments, such as a bond or<br />

promissory note issued by a business enterprise or by a<br />

state, municipality or quasi-governmental entity, <strong>and</strong><br />

Includes interests in a pool of stocks or bonds, such as<br />

shares of a mutual fund<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


What is a “Security”?<br />

Promissory Notes<br />

When is a promissory note not<br />

considered a security for purposes<br />

of the <strong>Securities</strong> Act?<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Section 2(a) of the ’33 Act<br />

§2(a) – DEFINITIONS.—When used in this<br />

title [i.e., the <strong>Securities</strong> Act], unless<br />

the context otherwise requires—<br />

(1) The term "security" means any note…<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Promissory Notes<br />

Section 2(a)(1) defines a “security” to<br />

include “any note”<br />

Interpretative issue:<br />

Does “any” mean “every”?<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Promissory Notes<br />

Many extensions of credit do not have the<br />

typical attributes of an investment so . . .<br />

“the context otherwise requires” that<br />

some promissory notes not be treated as a<br />

security for purposes of the <strong>Securities</strong> Act.<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


“Unless the context otherwise<br />

requires…”<br />

Provides an important basis for judicial discretion<br />

concerning the proper scope of the securities laws:<br />

Is every promissory “note” really a security?<br />

What “profit sharing agreements” are securities?<br />

Are general partnership interests securities? Limited<br />

partnership interests? Limited liability companies?<br />

Should distinctions be drawn between the stock of<br />

publicly held <strong>and</strong> that of a closely held corporation<br />

(i.e., one the is not publicly traded)?<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Reves v. Ernst & Young,<br />

494 U.S. 56 (1990)<br />

Supreme Court establishes the “family<br />

resemblance” test for determining whether or not a<br />

promissory note is a security.<br />

Every note is presumed to be a security, unless it<br />

falls into a category of instruments that are not<br />

securities.<br />

Notes used in consumer lending, notes secured by a<br />

mortgage on a home, <strong>and</strong> short-term notes secured<br />

by the assignment of accounts receivable are in the<br />

“family” of nonsecurities.<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


What is a “Security”?<br />

Loan Participation Interests<br />

Could a loan participation interest<br />

be considered a security for<br />

purposes of the <strong>Securities</strong> Act?<br />

[Consider Module 2 Discussion Question]<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


What is a “Security”?<br />

Loan Participation Interests<br />

Promissory notes to several lender banks<br />

“It is well-settled that certificates<br />

evidencing loans by commercial banks to<br />

their customers for use in the customers'<br />

current operations are not securities.”<br />

Security Pacific Bank (2 nd Cir. 1992)<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


What is a “Security”?<br />

Loan Participation Interests<br />

“However, . . . a [loan] participation might in<br />

some circumstances be considered a security even<br />

where the instrument itself is not . . . .”<br />

Who are the participants?<br />

What are the purposes of the purchasers or<br />

participants?<br />

What are the promotional bases used in<br />

marketing the loan notes?<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


What is a “Security”?<br />

Loan Participation Interests<br />

“While banks are subjected to risks of<br />

misinformation, their ability to verify<br />

representations <strong>and</strong> take supervisory <strong>and</strong><br />

corrective actions places them in a<br />

significantly different posture than the<br />

investors sought to be protected through the<br />

securities acts.”<br />

Western Bank & Trust v. Kotz, 532 F.2d 1252<br />

(9th Cir. 1976) quoted approvingly in Security<br />

Pacific Bank dissent.<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


What is a “Security”?<br />

Loan Participation Interests<br />

“Potential purchasers were not presented<br />

with one loan <strong>and</strong> asked if they wanted to<br />

participate in it, but were solicited, often on<br />

a daily basis, <strong>and</strong> offered a range of<br />

investment options involving different<br />

issuers with different maturities <strong>and</strong> interest<br />

rates.”<br />

Security Pacific Bank dissent<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


What is a “Security”?<br />

Loan Participation Interests<br />

Has any court adopted the arguments<br />

made in the Security Pacific Bank<br />

dissent?<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


What is a “Security”?<br />

Loan Participation Interests<br />

Pollack v. Laidlaw Holdings, 27 F.3d 808 (2d Cir. 1994)<br />

The 2 nd Circuit reversed District’s Court’s dismissal, concluding that under the<br />

Reves factors the mortgage participations purchased <strong>and</strong> sold by Laidlaw<br />

Holdings were "securities" under federal securities law.<br />

In examining the Reves factors, the Court took particular interest in<br />

distinguishing BancoEspanol. The Laidlaw court found that the defendant was<br />

raising funds for its general business activities of making <strong>and</strong> servicing<br />

mortgages. The court also explained that the marketing scheme in<br />

BancoEspanol was more analogous to a group of highly sophisticated<br />

commercial entities engaging in short-term commercial financing arrangements<br />

than to the securities markets. In Laidlaw, by contrast, the trial court found that<br />

the purchasers of these mortgage instruments were unsophisticated, passive<br />

investors who had simply placed their money in discretionary accounts with<br />

instructions to make conservative investments.<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


What is a “Security”?<br />

Loan Participation Interests<br />

In April 1997 the federal banking regulators issued an<br />

“Interagency Statement on Sales of 100% Loan<br />

Participations.”<br />

Citing Banco Espanol, the regulators emphasized that<br />

the court cautioned that the holding was specific to the<br />

facts of the case <strong>and</strong> that even if an underlying<br />

instrument is not a security, the manner in which<br />

participations in that instrument are used, pooled or<br />

marketed might establish that such participations are<br />

securities.<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


What is a “Security”?<br />

Investment Contracts<br />

What is an “investment contract”<br />

for purposes of the <strong>Securities</strong> Act?<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Howey Test for Investment<br />

Contracts as a “Security”<br />

In Howey, the Supreme Court defined an<br />

“investment contract” as any transaction in<br />

which<br />

1) a person invests money,<br />

2) in a common enterprise, <strong>and</strong><br />

3) is led to expect profits,<br />

4) solely from the efforts of others.<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Howey Test – Up Close<br />

1. Investment: The investment, which can be cash or noncash<br />

consideration, is expected to produce income or profit; the investor is not<br />

buying a consumable commodity or service.<br />

2. Commonality: Multiple investors have interrelated interests in a<br />

common scheme – horizontal commonality. For some courts, it is<br />

sufficient to have vertical commonality – a single investor has a common<br />

interest with the manager of his investment.<br />

3. Profits: The expected return must come from earnings of the enterprise,<br />

not merely additional contributions, <strong>and</strong> this return must be the principal<br />

motivation for the investment.<br />

4. Efforts of others: Investor’s efforts in the common enterprise may<br />

contribute to profits, but the efforts of the managers must be predominant;<br />

the investors must be mostly passive.<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Howey Test – Applied:<br />

SEC v. ETS Payphones et al.<br />

What did the 11 th Circuit rule <strong>and</strong> why?<br />

Do you agree with the decision?<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Howey Test – Applied:<br />

SEC v. ETS Payphones et al.<br />

11 th Circuit ruled that contractual payphone<br />

arrangement was NOT a security, because:<br />

Howey test requires that an investment contract<br />

either provide for capital appreciation or a<br />

participation in earnings, <strong>and</strong> thus excludes<br />

schemes offering a fixed rate of return.<br />

Howey’s requirement that return on investment be<br />

"derived solely from the efforts of others" was not<br />

satisfied when purchasers had a contractual<br />

entitlement to return.<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Howey Test – Applied:<br />

SEC v. Edwards<br />

What does SEC v. Edwards teach us<br />

about the “investment contract” test?<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Howey Test – Applied:<br />

SEC v. Edwards<br />

In 2004, Supreme Court unanimously reversed the 11 th Circuit,<br />

ruling that the contractual arrangement of the ETS Payphones<br />

structure was a “security,” because<br />

The term “profits" is used in Howey in the sense of<br />

income or return, <strong>and</strong> includes dividends, other periodic<br />

payments, or increased value of investment, <strong>and</strong><br />

Howey test does not distinguish between a promise of<br />

fixed return <strong>and</strong> promise of variable return. That investors<br />

have bargained for fixed return on investment does not<br />

mean the return is not also expected to come “solely from<br />

efforts of others.”<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


The Reves Test compared to the Howey<br />

Test<br />

Reves<br />

1. Motivation of seller <strong>and</strong><br />

buyer.<br />

2. Plan of distribution.<br />

3. Reasonable expectations<br />

of investing public.<br />

4. Other factors reduce risk.<br />

(c) 2005-2010 Michael K. Krebs. All<br />

Rights Reserved.<br />

Howey<br />

1. Investment of Money<br />

2. In a Common<br />

Enterprise<br />

3. With an expectation<br />

of profit from the<br />

efforts of others


Howey vs. Reves<br />

The two tests can be viewed as two ends of<br />

the same filter. Howey allows items into the<br />

“security” box, while Reves allows items not<br />

to be characterized as securities <strong>and</strong> therefore<br />

to pass out of the “security” box.<br />

For public policy reasons, the Howey filter is<br />

the more porous filter, allowing more in than<br />

the Reves filter allows out.<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Partnership <strong>and</strong> LLC Interests<br />

Involves a particular application of the Howey test:<br />

Investor’s efforts in common enterprise may contribute to<br />

profits, but efforts of the managers must be predominant.<br />

Courts will look at the totality of circumstances<br />

surrounding the transaction, <strong>and</strong> not simply accept a literal<br />

reading of the written agreement between the parties.<br />

Courts will look at actual involvement contemplated by<br />

parties, evidence of such involvement (or lack of<br />

involvement), <strong>and</strong> anything else that can be gleaned from<br />

factual circumstances surrounding the investment.<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Partnership <strong>and</strong> LLC Interests<br />

Interests of general partners typically are<br />

not securities, but interests of limited<br />

partners typically are.<br />

Interests in LLCs may be securities<br />

depending on circumstances.<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


What is a “Security”?<br />

Common Stock<br />

Under what circumstances, if any, is<br />

common stock not considered a<br />

security for purposes of the<br />

<strong>Securities</strong> Act?<br />

Why not analyze common stock as<br />

an LLC interest?<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Stock in Closely Held<br />

Businesses<br />

The Supreme Court has emphasized that<br />

definition of a security must reflect “economic<br />

reality.”<br />

In some instances, transactions in corporate<br />

stock involve – in “economic reality” – the<br />

transfer of small business assets from one<br />

owner/manager to another owner/manager,<br />

neither of whom is expecting profits “solely<br />

from the efforts of others.”<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Stock in Closely Held<br />

Businesses<br />

Prior to 1985, under the “sale of business” doctrine, lower<br />

courts looked to the Howey test’s emphasis on<br />

management to conclude that sale of a majority equity<br />

interest passes complete control to purchaser, who should<br />

be viewed as an entrepreneur, not an investor.<br />

L<strong>and</strong>reth Timber Co. v. L<strong>and</strong>reth, 471 U.S. 681 (1985),<br />

resolved the issue with a literal interpretation of Section<br />

2. In a sale of “stock,” the Supreme Court refused to<br />

consider the “economic substance” of the transaction or to<br />

assume that federal securities laws apply only to passive<br />

investors.<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Compare Reves with L<strong>and</strong>reth<br />

Why did the Supreme Court in the subsequent<br />

Reves decision not take a literal approach?<br />

Why did the Supreme Court in L<strong>and</strong>reth not rely on<br />

introductory clause (i.e., “unless the context<br />

otherwise requires”)?<br />

Is the Supreme Court’s treatment of bank<br />

certificates of deposit consistent with L<strong>and</strong>reth?<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Guarantees as <strong>Securities</strong><br />

§2(a)1- “The term "security" “means …<br />

any…guarantee of…any of the foregoing”<br />

Guarantors are treated as issuers only if<br />

guarantees are incorporated into securities being<br />

distributed to investors.<br />

In other words, if guarantee <strong>and</strong> security are<br />

“bundled,” then guarantor is an issuer of a<br />

security.<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Swap Agreements<br />

Note that prior to the 2010 Dodd-Frank Act, the<br />

definition of "security" in section 2(a)(1) did not<br />

include either of the following:<br />

any non-security-based swap agreement (as<br />

defined in the Gramm-Leach-Bliley Act); or<br />

any security-based swap agreement (as defined in<br />

the Gramm-Leach-Bliley Act).<br />

The Dodd-Frank Act completely changed the scheme<br />

for the regulation of swaps.<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Dodd-Frank Act<br />

(July 2010)<br />

Changes to <strong>Securities</strong> Act include<br />

Adding “security-based swap” to definition of<br />

“security”<br />

Providing that any offer or sale of a securitybased<br />

swap by or on behalf of an issuer of the<br />

referenced securities constitutes a contract for<br />

the sale or offer of the sale of the referenced<br />

securities, <strong>and</strong> subjects the security-based swap<br />

to registration requirements of <strong>Securities</strong> Act<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


<strong>Securities</strong> exempt from §5<br />

registration requirements<br />

§3(a) of the <strong>Securities</strong> Act<br />

Creates exemptions for certain<br />

instruments that, based upon a strict<br />

reading of §2(a)(1), would<br />

otherwise be considered securities<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


<strong>Securities</strong> exempt from §5<br />

registration requirements<br />

Examples?<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Government <strong>Securities</strong> §3(a)2<br />

“Any security issued or guaranteed by the United States<br />

or … by any State of the United States, or by any<br />

political subdivision of a State…, or by any public<br />

instrumentality of one or more States . . . .”<br />

Federal government<br />

State governments<br />

“Political subdivision” (e.g., a city)<br />

“Public instrumentality” (e.g., public agency, such as<br />

a regional water authority or a turnpike authority)<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Government <strong>Securities</strong> §3(a)2<br />

Important Caveat - §17(c)<br />

SEC. 17. FRAUDULENT INTERSTATE TRANSACTIONS<br />

(a) It shall be unlawful for any person in the offer or<br />

sale of any securities . . . by the use of any means or instruments of . . .<br />

interstate commerce or by use of the mails, directly or indirectly—<br />

(1) to employ any device, scheme, or artifice to defraud, or<br />

(2) to obtain money or property by means of any untrue statement<br />

of a material fact or any omission to state a material fact<br />

necessary in order to make the statements made, in light of the<br />

circumstances under which they were made, not misleading;<br />

* * *<br />

(c) The exemptions provided in section 3 shall not apply to the<br />

provisions of this section.<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Government <strong>Securities</strong> §3(a)2<br />

Important Caveat – Rule 10b-5<br />

Recent SEC Enforcement Action<br />

On May 6, 2013, the SEC charged the City of Harrisburg, PA with securities fraud for its<br />

misleading public statements when its financial condition was deteriorating <strong>and</strong> financial<br />

information available to municipal bond investors was either incomplete or outdated.<br />

In a related SEC “Report of Investigation”, the SEC notes that public officials should be<br />

mindful that their written or oral public statements may affect the “total mix of<br />

information available to investors” <strong>and</strong> that this could result in anti-fraud liability under<br />

the federal securities laws for the public officials making such statements if they are<br />

materially misleading or omit material information.<br />

The report said that public officials should consider adopting policies <strong>and</strong> procedures that<br />

are reasonably designed to result in accurate, timely, <strong>and</strong> complete public disclosures;<br />

identifying those persons involved in the disclosure process; evaluating other public<br />

disclosures including financial information made by the municipal issuer; <strong>and</strong> assuring<br />

that responsible individuals receive adequate training about their obligations under the<br />

federal securities laws.<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Commercial Paper -- §3(a)3<br />

“Any note, draft, bill of exchange, or banker's<br />

acceptance which arises out of a current<br />

transaction or the proceeds of which have<br />

been or are to be used for current transactions,<br />

<strong>and</strong> which has a maturity at the time of<br />

issuance of not exceeding nine months,<br />

exclusive of days of grace, or any renewal<br />

thereof the maturity of which is likewise<br />

limited.” (Emphasis added.)<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Exempt Bank <strong>Securities</strong><br />

§3(a)2 “any security issued or guaranteed by<br />

any bank”<br />

§3(a)5 “Any security issued… by a savings <strong>and</strong><br />

loan association, cooperative bank, or<br />

similar institution, which is<br />

supervised <strong>and</strong> examined by State or<br />

Federal authority having supervision over<br />

any such institution…”<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Exempt Bank <strong>Securities</strong> (cont’d)<br />

Two important caveats:<br />

1. Federal or state bank regulators may<br />

impose requirements similar to ’33<br />

Act.<br />

2. Exemption does not apply to securities<br />

issued by a bank holding company,<br />

savings <strong>and</strong> loan holding company,<br />

etc.<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Session 1 – What is a Security<br />

for Purposes of the <strong>Securities</strong> Act?<br />

Study Problem 1.1<br />

Pennypincher <strong>and</strong> 14 of her closest (but not very wealthy) friends from all over<br />

New Engl<strong>and</strong> want to organize a commercial bank under Massachusetts law.<br />

Pennypincher <strong>and</strong> her friends do not want to bear all the risk of forming the new<br />

bank.<br />

Instead, they recruit 10 wealthy friends to share the expenses, including the cost<br />

of preparing regulatory applications for FDIC <strong>and</strong> Massachusetts approvals.<br />

Together they will contribute $1 million.<br />

If <strong>and</strong> when the bank opens for business, the bank will exchange common stock<br />

for the $1 million at a price per share equal to 90% of the price paid in the $10<br />

million offering. If the bank does not open, the balance of the $1 million, if<br />

any, remaining after expenses will be returned.<br />

Would the $1 million investment in connection with the bank’s organization be<br />

subject to §5 of the <strong>Securities</strong> Act?<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Limits on Bank <strong>Securities</strong><br />

Exemption<br />

Important: §3(a)2 <strong>and</strong> §3(a)5 do not<br />

apply to the pre-organization<br />

investment in Study Problem 1.1<br />

because investment is not contingent<br />

upon receipt of regulatory approvals<br />

<strong>and</strong> commencement of a banking<br />

business<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


U.S <strong>and</strong> <strong>Trans</strong>-<strong>Border</strong><br />

<strong>Securities</strong> <strong>Regulation</strong><br />

Boston University School of Law<br />

Executive LL.M. in International Business Law<br />

Session 2 – June 26, 2012<br />

(c) 2012 Michael K. Krebs<br />

All Rights Reserved


Private Placements §4(2), §3(b)<br />

Session 2 Agenda<br />

• <strong>Regulation</strong> D – primarily Rules 506 <strong>and</strong> 504<br />

• Accredited investor test – Rule 501(a)<br />

• General conditions – Rule 502<br />

“Crowdfunding”<br />

Equity awards to employees of privately held companies –<br />

Rule 701<br />

Exchange offers – §3(a)(9)<br />

Intrastate offerings – §3(a)(11), Rule 147<br />

Reg. S<br />

(c) 2012 Michael K. Krebs<br />

All Rights Reserved


But first, some context<br />

When does an “offer” occur?<br />

What is a “sale” of a security?<br />

What are the implications of<br />

registering a sale of a security<br />

with the SEC?<br />

(c) 2012 Michael K. Krebs<br />

All Rights Reserved


Basic Principle Underlying<br />

the <strong>Securities</strong> Act of 1933<br />

Unless an exemption is available,<br />

Each <strong>and</strong> every offer or sale of a security<br />

must be registered with the SEC, <strong>and</strong><br />

In the registration statement (which<br />

includes the prospectus), all information<br />

material to that investment decision must<br />

be disclosed.<br />

(c) 2012 Michael K. Krebs<br />

All Rights Reserved


What is an “offer”?<br />

2(a)(3) –"offer to sell", "offer for sale", or<br />

"offer"<br />

Includes every attempt or offer to dispose of, or<br />

solicitation of an offer to buy, a security or<br />

interest in a security, for value.<br />

Exception: “preliminary negotiations or<br />

agreements between an issuer . . . <strong>and</strong> any<br />

underwriter . . . .”<br />

(c) 2012 Michael K. Krebs<br />

All Rights Reserved


What is a “sale”?<br />

§ 2(a)(3) –"sale" or "sell"<br />

Every contract of sale or disposition of<br />

a security or interest in a security, for<br />

value.<br />

(c) 2012 Michael K. Krebs<br />

All Rights Reserved


What is a “sale”?<br />

Special Situations – Rule 145<br />

Mergers, Sale of Assets, Reclassifications of <strong>Securities</strong><br />

Original SEC “no sale” theory<br />

Superseded by Rule 145: an offer, offer to sell, offer for<br />

sale, or sale occurs when there is submitted to<br />

security holders for a vote or consent a plan or<br />

agreement pursuant to which such holders are required<br />

to make an investment decision, whether to accept a<br />

new or different security in exchange for their existing<br />

security<br />

(c) 2012 Michael K. Krebs<br />

All Rights Reserved


What is a “sale”?<br />

Special Situations – Spin Offs<br />

Policy Consideration:<br />

Legitimate dividend vs. problematic distribution<br />

Legal Issue:<br />

Is disposition “for value” within the meaning of §2(a)(3)?<br />

SEC position is that lack of monetary consideration for<br />

the shares does not mean that the disposition was not for<br />

value.<br />

(c) 2012 Michael K. Krebs<br />

All Rights Reserved


Considerations:<br />

What is a “sale”?<br />

Spin Offs (cont’d)<br />

Legitimate business purpose?<br />

Adequacy of public information about the spun off<br />

securities <strong>and</strong> their issuer?<br />

Do parent shareholders provide consideration for the<br />

spun-off shares?<br />

Is spin-off pro-rata to the parent shareholders?<br />

If the parent spins-off “restricted securities,” has it held<br />

those securities for at least two years?<br />

(c) 2012 Michael K. Krebs<br />

All Rights Reserved


What is a “sale”?<br />

Special Situation – Free Stock<br />

Phenomenon of early Internet era<br />

Legal Issue: Similar to Spin Off<br />

SEC takes the position that a “gift” of stock is a sale “for<br />

value” when the purpose of the “gift” is to advance the<br />

donor's economic objectives rather than to make a gift for<br />

simple reasons of generosity.<br />

Attracting additional people to the web site.<br />

Increasing advertising revenue<br />

Generating general interest in the company <strong>and</strong> its br<strong>and</strong><br />

(c) 2012 Michael K. Krebs<br />

All Rights Reserved


Back to Basics . . .<br />

Unless an exemption is available,<br />

Each <strong>and</strong> every offer or sale of a security<br />

must be registered with the SEC, <strong>and</strong><br />

In the registration statement (which<br />

includes the prospectus), all information<br />

material to that investment decision must be<br />

disclosed.<br />

(c) 2005-2010 Michael K. Krebs. All<br />

Rights Reserved.


Implications of SEC<br />

registration?<br />

What are the implications of<br />

registering a sale of a security<br />

with the SEC, especially an<br />

IPO?<br />

(c) 2012 Michael K. Krebs<br />

All Rights Reserved


What does “registration” entail?<br />

1. Preparation of registration statement<br />

For companies that are not WKSIs or other<br />

publicly traded companies, registration will<br />

entail<br />

Significant expense (typically >$500,000)<br />

Significant delay (typically > four months)<br />

Public disclosures that may benefit<br />

competitors<br />

(c) 2012 Michael K. Krebs<br />

All Rights Reserved


Lessons from Facebook IPO<br />

1. Preparation of registration statement<br />

Example of delay (not atypical)<br />

Facebook probably began working on<br />

IPO in late 2011<br />

Facebook first filed with SEC on<br />

February 1, 2012<br />

Facebook completed IPO on May 17,<br />

2012<br />

(c) 2012 Michael K. Krebs<br />

All Rights Reserved


What does “registration”<br />

entail? (cont’d)<br />

1. Preparation of registration statement<br />

2. Potential ’33 Act Liability<br />

Potential strict liability for issuer for<br />

materially false or misleading<br />

registration statement<br />

Potential liability for directors <strong>and</strong><br />

certain executive officers<br />

(c) 2012 Michael K. Krebs<br />

All Rights Reserved


Lessons from Facebook IPO<br />

2. Potential ’33 Act Liability<br />

Example of litigation (atypical)<br />

According to media reports, various civil<br />

lawsuits have been filed against Facebook,<br />

Mark Zuckerberg <strong>and</strong> underwriters<br />

At least one such lawsuit alleges that the<br />

defendants concealed a weakened growth<br />

forecast prior to the IPO<br />

(c) 2012 Michael K. Krebs<br />

All Rights Reserved


What does “registration”<br />

entail? (cont’d)<br />

1. Preparation of registration statement<br />

2. Potential ’33 Act Liability<br />

3. Subsequent ’34 Act Reporting<br />

Audited annual financial statements<br />

Audit of internal controls (for larger<br />

companies)<br />

Quarterly <strong>and</strong> periodic reporting<br />

(c) 2012 Michael K. Krebs<br />

All Rights Reserved


Exempt <strong>Trans</strong>actions<br />

How do “start-ups” <strong>and</strong> other small<br />

companies raise capital if they wish to<br />

avoid the time <strong>and</strong> expense of an IPO?<br />

Do mature companies raise capital other<br />

than in a registered public offering?<br />

(To be discussed in subsequent session)<br />

(c) 2012 Michael K. Krebs<br />

All Rights Reserved


Basic Principle Underlying the<br />

<strong>Securities</strong> Act of 1933<br />

“Unless an exemption is available, . . .”<br />

Some exemptions focus on the type of<br />

security being offered – Refer to Session 1<br />

Other exemptions focus on the nature of the<br />

transaction in which the offer <strong>and</strong> sale is to<br />

occur.<br />

(c) 2012 Michael K. Krebs<br />

All Rights Reserved


Exempt <strong>Trans</strong>actions<br />

Private placements –<br />

(c) 2012 Michael K. Krebs<br />

All Rights Reserved<br />

4(2) <strong>and</strong> Rule 506;<br />

Certain small offerings – 3(b), 4(6) (<strong>and</strong><br />

Rules 504 <strong>and</strong> 505), Reg. CE, Rule 701;<br />

Intrastate offerings –<br />

Exchanges by the issuer –<br />

Fairness Hearings –<br />

<br />

3(a)(11) <strong>and</strong> Rule 147;<br />

3(a)(10);<br />

3(a)(9);<br />

4(1) <strong>and</strong> Rule 144 – IUD (i.e., sales not by an<br />

Issuer, Underwriter or Dealer)<br />

Reg. S


Rule 506<br />

Exempt <strong>Trans</strong>actions<br />

JOBS Act Changes<br />

More flexibility in communicating<br />

regarding private placement<br />

“Crowdfunding”<br />

<strong>Regulation</strong>s not issued yet<br />

(c) 2012 Michael K. Krebs<br />

All Rights Reserved


Our Focus in Session 2<br />

Private placements –<br />

(c) 2012 Michael K. Krebs<br />

All Rights Reserved<br />

4(2) <strong>and</strong> Rule 506<br />

Certain small offerings – 3(b), 4(6) (<strong>and</strong> Rules 504<br />

<strong>and</strong> 505), “crowdfunding” <strong>and</strong> Reg. CE, Rule 701<br />

Intrastate offerings –<br />

Exchanges by the issuer –<br />

Fairness Hearings –<br />

3(a)(11) <strong>and</strong> Rule 147<br />

3(a)(10)<br />

3(a)(9)<br />

Secondary trading – 4(1) <strong>and</strong> Rules 144 (i.e., sales not<br />

by an Issuer, Underwriter or Dealer) (this will be<br />

covered in a later Session)<br />

Reg. S (this will be covered in a later Session)


Exempt <strong>Trans</strong>actions –<br />

Key Principle #1<br />

<strong>Securities</strong> offered <strong>and</strong> sold in an exempt<br />

transaction do not thereby become exempt<br />

securities.<br />

For each <strong>and</strong> every subsequent “offer”/<br />

“sale” of those securities, seller must either<br />

register the offer/sale with SEC or then<br />

qualify for an exemption from registration.<br />

(c) 2012 Michael K. Krebs<br />

All Rights Reserved


Session 2 – Exempt <strong>Trans</strong>actions<br />

Funding Start-Ups<br />

Study Problem No. 2.1<br />

BeanTown Biosystems, Inc. sells 10,000 shares of common<br />

stock for $600,000 to the parents of the company’s four<br />

founders, who are recent graduates from BC, BU, Harvard<br />

<strong>and</strong> MIT, respectively.<br />

In total, four parents will own in total 40% of Biosystems<br />

immediately after the investment. Each founder will own<br />

15%.<br />

Must Biosystems register under 5 of the <strong>Securities</strong> Act the<br />

sale of stock to the founders’ parents?<br />

(c) 2012 Michael K. Krebs<br />

All Rights Reserved


Session 2 – Exempt <strong>Trans</strong>actions<br />

Funding Start-Ups<br />

Study Problem No. 2.2<br />

Two months after the parents’ investment, BeanTown<br />

Biosystems, Inc. files a patent for medical diagnostic<br />

device.<br />

Very Confident VC Investment Fund wants to invest<br />

$4.5 million cash in Biosystems in exchange for<br />

Series A preferred stock, representing a 40% equity<br />

interest in Biosystems after the investment.<br />

Must Biosystems register under 5 of the <strong>Securities</strong><br />

Act the sale of the Series A Preferred Stock to Very<br />

Confident?<br />

(c) 2012 Michael K. Krebs<br />

All Rights Reserved


4(2) –<br />

Private Placements<br />

transactions by an issuer not<br />

involving any public offering<br />

(c) 2012 Michael K. Krebs<br />

All Rights Reserved


Private Placements<br />

Interpretative issue:<br />

What is a “public offering”<br />

within the meaning of<br />

(c) 2012 Michael K. Krebs<br />

All Rights Reserved<br />

4(2)?


4(2) Analysis<br />

1953 Ralston Purina Supreme Court Decision:<br />

Burden is on the issuer<br />

Offeree must be able to fend for himself<br />

Access to the “kind of information which registration<br />

under 5 would disclose”<br />

1962 SEC Release No. 4,552:<br />

“Coming to Rest” – Restrictions on transfer<br />

Integration – Five factors<br />

(c) 2012 Michael K. Krebs<br />

All Rights Reserved


4(2) Analysis (cont’d)<br />

1975 ABA Position Paper:<br />

Offeree qualification (i.e., offeree must be able<br />

to fend for himself)<br />

Access to information material to investment<br />

decision<br />

Manner of offering (i.e., no public advertising)<br />

Safeguards against redistribution (i.e., “coming<br />

to rest”)<br />

(c) 2012 Michael K. Krebs<br />

All Rights Reserved


Private Placements –<br />

<strong>Regulation</strong> D<br />

1982 SEC Adopts Regulatory “Safe Harbor”<br />

<strong>Regulation</strong> D (Limited Offers)<br />

Rule 501 (Categories of accredited investors)<br />

Rule 502 (General conditions to be met)<br />

BUT remember JOBS Act<br />

Rule 506 (Sales without regard to offering size)<br />

Rule 505 (Offerings not exceeding $5 million)<br />

Rule 504 (Offerings not exceeding $1 million)<br />

(c) 2012 Michael K. Krebs<br />

All Rights Reserved


Private Placements –<br />

<strong>Regulation</strong> D<br />

General conditions to be met – Rule 502<br />

No integration problem – Rule 502(a)<br />

Required disclosure, if any, provided – Rule 502(b)<br />

No general solicitation or general advertising – Rule 502(c)<br />

But keep in mind JOBS Act Change (see next slide)<br />

Limitations on resale – Rule 502(d)<br />

Notice of sale – Rule 503<br />

Must file Form D with the SEC no later than 15 calendar days<br />

after the first sale of securities in the offering<br />

No disqualification – Rule 507<br />

(c) 2012 Michael K. Krebs<br />

All Rights Reserved


<strong>Regulation</strong> D –<br />

Important JOBS Act Change<br />

JOBS Act limits prohibition on general solicitation or<br />

general advertising – Rule 502(c)<br />

JOBS Act requires the SEC, not later than July 4, 2012, to<br />

revise <strong>Regulation</strong> D to provide that prohibitions against<br />

general solicitation or general advertising contained in<br />

Rule 502(c) shall not apply to offers <strong>and</strong> sales of securities<br />

made pursuant to Rule 506 provided that all purchasers<br />

of the securities are accredited investors.<br />

(c) 2012 Michael K. Krebs<br />

All Rights Reserved


Private Placements –<br />

<strong>Regulation</strong> D<br />

Accredited investor test – “Rules of Thumb”<br />

Entities:<br />

Total assets > $5 million <strong>and</strong> not formed for the<br />

purpose of the investment<br />

Individuals:<br />

Income for last two years – <strong>and</strong> expected income for<br />

current year – is > $200,000 ($300,000 married<br />

couple)<br />

Net worth – excluding equity in primary residence –<br />

> $1,000,000 (with or without spouse)<br />

(c) 2012 Michael K. Krebs<br />

All Rights Reserved


Private Placements –<br />

<strong>Regulation</strong> D<br />

How many investors may<br />

purchase securities in a Reg. D<br />

offering?<br />

(c) 2012 Michael K. Krebs<br />

All Rights Reserved


Private Placements –<br />

<strong>Regulation</strong> D<br />

Practice points in dealing with non-accredited<br />

investors<br />

Rules 506 <strong>and</strong> 505 seem to cap at 35 the number of<br />

investors in an offering<br />

But Rule 501(e), which has special counting rules,<br />

excludes accredited investors from that 35 investor<br />

limit<br />

Beware: the inclusion of even one non-accredited<br />

investor triggers the information disclosure rules<br />

for 506 <strong>and</strong> 505 offerings. Rule 502(b)(1).<br />

(c) 2012 Michael K. Krebs<br />

All Rights Reserved


Private Placements –<br />

“Crowdfunding” §4(6)<br />

JOBS Act added §4(6) to the <strong>Securities</strong> Act<br />

Exempts from registration securities sold by a closely held<br />

company raising up to $1 million within any given 12‐month<br />

period, provided that:<br />

1. The amount purchased by an investor in the transaction<br />

does not exceed the maximum investment amount (see<br />

subsequent slide);<br />

2. The transaction is conducted through a broker or “funding<br />

portal;” <strong>and</strong><br />

3. The private company provides certain descriptive<br />

information to the funding portal <strong>and</strong> the SEC.<br />

(c) 2012 Michael K. Krebs<br />

All Rights Reserved


“Crowdfunding” – Investor Cap<br />

During any 12-month period, the aggregate amount sold to any<br />

investor by an issuer, including in reliance on §4(6), may<br />

not exceed —<br />

(1) Greater of $2,000 or 5 percent of the annual income or net<br />

worth of such investor, as applicable, if either the annual<br />

income or the net worth of the investor is less than $100,000;<br />

<strong>and</strong><br />

(2) 10 percent of the annual income or net worth of such<br />

investor, as applicable, not to exceed a maximum aggregate<br />

amount sold of $100,000, if either the annual income or net<br />

worth of the investor is equal to or more than $100,000<br />

(c) 2012 Michael K. Krebs<br />

All Rights Reserved


Crowdfunding Portal<br />

A funding portal is defined as a crowdfunding intermediary that does<br />

not:<br />

1. offer investment advice or recommendations;<br />

2. solicit purchases, sales, or offers to buy securities offered or<br />

displayed on its website or portal;<br />

3. compensate employees, agents, or others persons for such<br />

solicitation or based on the sale of securities displayed or<br />

referenced on its website or portal;<br />

4. hold, manage, possess, or otherwise h<strong>and</strong>le investor funds or<br />

securities; or<br />

5. engage in such other activities as the SEC, by rule, determines<br />

appropriate.<br />

(c) 2012 Michael K. Krebs<br />

All Rights Reserved


Session 2 – Exempt <strong>Trans</strong>actions<br />

Funding Start-Ups<br />

Study Problem No. 2.1<br />

BeanTown Biosystems, Inc. sells 10,000 shares of common<br />

stock for $600,000 to the parents of the company’s four<br />

founders, who are recent graduates from BC, BU, Harvard<br />

<strong>and</strong> MIT, respectively.<br />

In total, four parents will own in total 40% of Biosystems<br />

immediately after the investment. Each founder will own<br />

15%.<br />

Must Biosystems register under 5 of the <strong>Securities</strong> Act<br />

the sale of stock to the founders’ parents?<br />

(c) 2012 Michael K. Krebs<br />

All Rights Reserved


Session 2 – Exempt <strong>Trans</strong>actions<br />

Funding Start-Ups<br />

Study Problem No. 2.1 – Analysis<br />

Biosystems’s sale of stock to founders’ parents would<br />

be exempt from registration.<br />

Rule 504 (< $1 million) or 4(2)<br />

Size <strong>and</strong> nature of investor group would likely not<br />

raise concern under 4(2)<br />

One would expect that the parents would have<br />

access to all material information<br />

Investor “sophistication” (or “purchaser<br />

representative”) not required under Rule 504<br />

(c) 2012 Michael K. Krebs<br />

All Rights Reserved


Session 2 – Exempt <strong>Trans</strong>actions<br />

Funding Start-Ups<br />

Study Problem No. 2.1 – Analysis (cont’d)<br />

Rule 504 (< $1 million) (relies on Section 3(b) of <strong>Securities</strong> Act)<br />

Biosystems does not fall within one of the categories of issuers that<br />

may not use Rule 504. Those excluded issuers include:<br />

Issuer subject to Exchange Act reporting requirements of section<br />

13 or 15(d);<br />

Investment companies; or<br />

Development stage company that either has no specific business<br />

plan or purpose or has indicated that its business plan is to engage<br />

in a merger or acquisition with an unidentified company or<br />

companies, or other entity or person<br />

Investor “sophistication” (or “purchaser representative”) not required<br />

under Rule 504<br />

Issuer not required to furnish specific information under Rule 504.<br />

See Rule 502(b)(1).<br />

(c) 2012 Michael K. Krebs<br />

All Rights Reserved


Session 2 – Exempt <strong>Trans</strong>actions<br />

Funding Start-Ups<br />

Study Problem No. 2.1 – Analysis (cont’d)<br />

Either<br />

4(2) or Rule 504 Require Resale Restrictions<br />

See, for example, Rule 502(d):<br />

The issuer shall exercise reasonable care to assure that purchasers of securities are not<br />

underwriters within the meaning of Section 2(a)(11), which reasonable care may be<br />

demonstrated by:<br />

Reasonable inquiry to determine if purchaser is acquiring securities for himself or<br />

for other persons [this usually is satisfied by an investor representation in<br />

purchase agreement; see sample purchase agreement];<br />

Written disclosure to each purchaser prior to sale that securities have not been<br />

registered under the Act <strong>and</strong>, therefore, cannot be resold unless they are registered<br />

under the Act or unless an exemption from registration is available [this usually is<br />

satisfied by an investor representation in purchase agreement whereby investor<br />

acknowledges that she underst<strong>and</strong>s these restrictions]; <strong>and</strong><br />

Placement of a legend on the certificate or other document that evidences securities,<br />

stating that securities have not been registered under the Act <strong>and</strong> setting forth or<br />

referring to restrictions on transferability <strong>and</strong> sale of the securities [see slide with<br />

sample restrictive legend].”<br />

(c) 2012 Michael K. Krebs<br />

All Rights Reserved


Sample Subscription<br />

Agreement<br />

In a private placement, the agreement whereby the investor<br />

agrees to purchase, <strong>and</strong> the issuer agrees to sell, the<br />

restricted securities sometimes is referred to as the<br />

“subscription agreement.”<br />

Excerpts from a model subscription agreement for a private<br />

placement by a limited liability company (LLC) is posted<br />

on the course Web site under the Session 2 reading<br />

materials.<br />

The highlighted sections are the investor representations<br />

intended to satisfy Rule 502(d).<br />

(c) 2012 Michael K. Krebs<br />

All Rights Reserved


Sample Restrictive Legend<br />

THE SHARES REPRESENTED BY THIS CERTIFICATE HAVE<br />

NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF<br />

1933, AS AMENDED, OR QUALIFIED UNDER ANY STATE<br />

SECURITIES LAWS. THE SECURITIES MAY NOT BE<br />

OFFERED, SOLD, TRANSFERRED OR OTHERWISE<br />

DISPOSED OF WITHOUT SUCH REGISTRATION OR THE<br />

DELIVERY TO THE CORPORATION OF WRITTEN NOTICE<br />

AND, IF REQUESTED BY THE CORPORATION, AN OPINION<br />

OF COUNSEL, REASONABLY SATISFACTORY TO THE<br />

CORPORATION, THAT AN EXEMPTION FROM<br />

REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS<br />

AMENDED, AND FROM QUALIFICATION UNDER SUCH<br />

STATE SECURITIES LAW IS THEN AVAILABLE.<br />

(c) 2012 Michael K. Krebs<br />

All Rights Reserved


Session 2 – Exempt <strong>Trans</strong>actions<br />

Funding Start-Ups<br />

Study Problem No. 2.2<br />

Two months after the parents’ investment, BeanTown<br />

Biosystems, Inc. files a patent for medical diagnostic<br />

device.<br />

Very Confident VC Investment Fund wants to invest<br />

$4.5 million cash in Biosystems in exchange for<br />

Series A preferred stock, representing a 40% equity<br />

interest in Biosystems after the investment.<br />

Must Biosystems register under 5 of the<br />

<strong>Securities</strong> Act the sale of the Series A Preferred<br />

Stock to Very Confident?<br />

(c) 2012 Michael K. Krebs<br />

All Rights Reserved


Session 2 – Exempt <strong>Trans</strong>actions<br />

Funding Start-Ups<br />

Study Problem No. 2.2 – Analysis<br />

Biosystems’s sale of stock to Very Confident VC Investment Fund<br />

would be exempt from registration.<br />

Rule 506 or Rule 505 (< $5 million) or<br />

4(2)<br />

Facts suggest investor is both “accredited” <strong>and</strong> “sophisticated”<br />

Such an investor would likely not raise a concern under 4(2)<br />

Also, Rules 505 <strong>and</strong> 506 could be used:<br />

Issuer not required to furnish specific information to<br />

accredited investor. See Rule 502(b)(1).<br />

Facts do not indicate any impermissible “general<br />

solicitation or general advertising.” See Rule 502(c).<br />

No integration with $600,000 investment by parents<br />

Either 4(2), Rule 505 or Rule 506 require resale restrictions<br />

(c) 2012 Michael K. Krebs<br />

All Rights Reserved


Excerpts from Sample Venture<br />

Capital Purchase Agreement<br />

In the venture capital context, the agreement whereby the<br />

investor agrees to purchase, <strong>and</strong> the issuer agrees to sell,<br />

the restricted securities is sometimes referred to as a “stock<br />

purchase agreement.”<br />

Excerpts from a model stock purchase agreement for an<br />

initial round of venture capital investment is posted on the<br />

course Web site under the Session 2 reading materials.<br />

The highlighted sections are the investor representations<br />

intended to satisfy Rule 502(d).<br />

(c) 2012 Michael K. Krebs<br />

All Rights Reserved


Session 2 – Exempt <strong>Trans</strong>actions<br />

Funding Start-Ups<br />

Study Problem No. 2.3<br />

Assume BeanTown Biosystems does not obtain funding from Very Confident.<br />

Five months after the parents invest $600,000, 28 friends of the Biosystems<br />

founders want to invest a total of $4.6 million in Biosystems common stock.<br />

Each of those friends is very knowledgeable about Biosystems’s technology, but<br />

only four have had significant financial success. None has had any prior<br />

involvement with Biosystems.<br />

Each of the four financially successful investors intends to invest $1,000,000;<br />

each of the other 24 investors plans to invest $25,000.<br />

Could Biosystems structure the investment to avoid registration under 5<br />

of the <strong>Securities</strong> Act? If so, how? Do you need additional information?<br />

What if another 10 friends of modest means want to invest $10,000 each as part<br />

of the same offering? What if one of the $1 million investors was identified<br />

by a “finder.”<br />

(c) 2012 Michael K. Krebs<br />

All Rights Reserved


Session 2 – Exempt <strong>Trans</strong>actions<br />

Funding Start-Ups<br />

Study Problem No. 2.3 – Analysis<br />

Biosystems could structure the investment to avoid registration under<br />

of the <strong>Securities</strong> Act, possibly with some changes.<br />

4(2) vs. Rule 506 vs. Rule 505<br />

Size <strong>and</strong> nature of investor group raises concern under<br />

Cannot have more than 35 non-accredited investors under either Rule 505 or Rule<br />

506<br />

For non-accredited investors, investor “sophistication” (or “purchaser<br />

representative”) required under 506(b)(2)(ii) . . . If not possible, consider Rule<br />

505<br />

BUT Rule 505 raises “integration” concerns with the parents’ investment five<br />

months earlier . . .<br />

ALSO substantial disclosure would be required because of non-accredited<br />

investors (Rule 502(b) for both Rules 505 <strong>and</strong> 506) . . . so consider whether<br />

burden is warranted for the $600,000 of incremental financing from nonaccredited<br />

investors<br />

Adding another 10 presumably non-accredited investors would preclude reliance<br />

on Rule 506.<br />

(c) 2012 Michael K. Krebs<br />

All Rights Reserved<br />

4(2)<br />

5


Session 2 – Exempt <strong>Trans</strong>actions<br />

Funding Start-Ups<br />

Study Problem No. 2.3 – Analysis (cont’d)<br />

Important: Biosystem’s reliance on Rule 506 would<br />

provide ancillary benefits under state securities laws<br />

(also known as “blue sky” laws) as a result of the<br />

National <strong>Securities</strong> Markets Improvement Act of 1996<br />

("NSMIA"), which amended Section 18 of the<br />

<strong>Securities</strong> Act. [See next slide re NSMIA]<br />

Adding another 10 investors would preclude reliance<br />

on Rule 506, if, as it seems they are non-accredited.<br />

Biosystems’s use of a finder could cause many<br />

complications [See subsequent slide]<br />

(c) 2012 Michael K. Krebs<br />

All Rights Reserved


Session 2 – Exempt <strong>Trans</strong>actions<br />

Funding Start-Ups<br />

A Few Words About NSMIA<br />

NSMIA, which is codified in Section 18 of the <strong>Securities</strong><br />

Act, creates a class of securities - referred to as "covered<br />

securities" - the offer <strong>and</strong> sale of which are no longer<br />

subject to state securities law registration requirements.<br />

Covered securities include: securities listed (or approved<br />

for listing) on the NYSE <strong>and</strong> NASDAQ; certain securities<br />

exempt under Section 3(a) of the Act (including<br />

government or municipal securities, bank securities <strong>and</strong><br />

commercial paper); <strong>and</strong> securities exempt from<br />

registration under the Act if sold in transactions<br />

complying with Rule 506 of <strong>Regulation</strong> D.<br />

(c) 2012 Michael K. Krebs<br />

All Rights Reserved


Session 2 – Exempt <strong>Trans</strong>actions<br />

Funding Start-Ups<br />

A Few More Words About NSMIA<br />

As a result of NSMIA, states may no longer require the registration<br />

of covered securities.<br />

States may, as permitted under NSMIA, require filings <strong>and</strong> the<br />

payment of fees for offers <strong>and</strong> sales in their state of covered<br />

securities other than those which are listed.<br />

Additionally, since NSMIA only preempts state securities<br />

registration requirements, broker-dealer <strong>and</strong> agent/salesperson<br />

registration requirements (applicable to individuals engaged in the<br />

offer <strong>and</strong> sale of covered securities) must still be examined to<br />

determine whether action is required to be taken in connection with a<br />

particular offering or transaction.<br />

Although NSMIA preempts state securities registration requirements,<br />

NSMIA preserves the right of the states to investigate <strong>and</strong> prosecute<br />

fraud.<br />

(c) 2012 Michael K. Krebs<br />

All Rights Reserved


Session 2 – Exempt <strong>Trans</strong>actions<br />

Funding Start-Ups<br />

A Few Words About “Finders”<br />

Finders, mergers <strong>and</strong> acquisitions advisors <strong>and</strong> institutional<br />

private placement practitioners often are collectively referred to<br />

as Private Placement Broker-Dealers (“PPBDs”).<br />

Many finders <strong>and</strong> other PPBDs are not registered with the SEC<br />

as “broker-dealers.”<br />

The SEC takes the position that a finder or other PPBD whose<br />

compensation for participation in the transaction depends upon<br />

the amount or outcome of the transaction – which the SEC<br />

refers to as “transaction-based compensation” – is acting as a<br />

broker <strong>and</strong> therefore should register as such.<br />

The SEC <strong>and</strong> the states frequently bring enforcement actions<br />

against unlicensed PPBDs.<br />

(c) 2012 Michael K. Krebs<br />

All Rights Reserved


Session 2 – Exempt <strong>Trans</strong>actions<br />

Funding Start-Ups<br />

A Few More Words About “Finders”<br />

Why should an issuer care if a PPBD is an unregistered broker?<br />

Issuers must disclose on Form D payments to brokers <strong>and</strong> finders.<br />

Under state law, payment of a commission to an unregistered broker<br />

may preclude a state exemption if Rule 506 is not used <strong>and</strong> therefore<br />

NSMIA preemption does not apply.<br />

Depending on the nature of the finder’s marketing efforts, the activities<br />

may constitute general solicitation.<br />

Commentators have argued that if an unregistered PPBD engaged in a<br />

sale of a security to an investor, that investor may be able to “void” or<br />

rescind the investment contract because Section 29(b) of the Exchange<br />

Act provides that contracts in violation of that Act are void.<br />

Good secondary source: Report <strong>and</strong> Recommendation of the Task Force on<br />

Private Placement Broker- Dealers, 60 Business Lawyer 959 (May 2005).<br />

(c) 2012 Michael K. Krebs<br />

All Rights Reserved


Session 2 – Exempt <strong>Trans</strong>actions<br />

Mergers Involving Emerging Companies<br />

Study Problem No. 2.4<br />

[Assume transaction in Problem 2.2 did occur but the transaction in Problem 2.3 did not.]<br />

Five months after Very Confident’s $4.5 million investment, Biosystems wants to acquire<br />

Great Genome Solutions, Inc. a biotech company located in northern California. Genome is 60<br />

percent controlled by two friends of Biosystems’s founders.<br />

Biosystems will acquire Genome by merging a newly formed Biosystems subsidiary with <strong>and</strong><br />

into Genome, resulting in Genome becoming a wholly owned subsidiary of Biosystems (this is<br />

a conventional merger structure known as a “reverse triangular merger”). Genome<br />

stockholders will receive only shares of Biosystems common stock (assuming none exercises<br />

appraisal rights under applicable state corporate law).<br />

In addition to Genome’s founders, it has 20 other stockholders, some of whom are employees<br />

<strong>and</strong> others are relatives of the founders. Aside from the founders, none of Genome’s<br />

stockholders is very sophisticated regarding corporate finance matters. The founders would<br />

enter into a customary voting agreement, agreeing to vote their shares in favor of the merger.<br />

Must Biosystems file a registration statement with the SEC in order to acquire Genome?<br />

Assume the acquisition is valued at $3.5 million? What if Genome is valued at $7.0<br />

million? What if Genome has 60 stockholders <strong>and</strong> most are not Genome employees?<br />

(c) 2012 Michael K. Krebs<br />

All Rights Reserved


Session 2 – Exempt <strong>Trans</strong>actions<br />

Mergers Involving Emerging Companies<br />

Study Problem No. 2.4 – Analysis<br />

Biosystems’s issuance of stock to Genome stockholders need<br />

not be registered under 5 of the <strong>Securities</strong> Act, because<br />

Biosystems’s common stock clearly is a “security” under<br />

the Act <strong>and</strong> is not an exempt security under 3(a).<br />

The merger will involve a “sale” of a security under the<br />

Act (since 1972).<br />

2(a)(3) – “Sale” includes every . . . disposition of a<br />

security for value”<br />

See Rule 145 – especially the Preliminary Note<br />

Voting agreement by control stockholders does not change<br />

analysis.<br />

(c) 2012 Michael K. Krebs<br />

All Rights Reserved


Session 2 – Exempt <strong>Trans</strong>actions<br />

Mergers Involving Emerging Companies<br />

Study Problem No. 2.4 – Analysis (Cont’d)<br />

Biosystems’s issuance of stock to Genome stockholders in the merger could qualify<br />

as an exempt transaction.<br />

4(2) vs. Rule 506 vs. Rule 505<br />

Size <strong>and</strong> nature of stockholder group raises concerns about relying solely on<br />

4(2)<br />

Merger will not raise “integration” concerns under Rule 505 with recent $4.5<br />

million Very Confident investment, because<br />

The two transactions were not part of a single plan of financing<br />

Biosystems received very different consideration in each (Genome stock<br />

vs. cash)<br />

<strong>Trans</strong>action would involve less than 35 non-accredited investors, so either<br />

Rule 505 or 506 is possible<br />

Investor “sophistication” (or purchaser representative) not required under 505<br />

but would be required under 506(b)(2)(ii)<br />

Rule 505 exemption therefore probably is the best alternative if acquisition is<br />

valued at $3.5 million<br />

(c) 2012 Michael K. Krebs<br />

All Rights Reserved


Session 2 – Exempt <strong>Trans</strong>actions<br />

Mergers Involving Emerging Companies<br />

Study Problem No. 2.4 – Analysis (Cont’d)<br />

If Genome is valued at $7.0 million?<br />

Biosystems would rely on Rule 506 (not Rule 505)<br />

Investor “sophistication” (or purchaser representative) is<br />

required under 506(b)(2)(ii)<br />

What if Genome has 60 stockholders <strong>and</strong> most are not<br />

Genome employees?<br />

Rule 506 available if not more than 35 non-accredited<br />

investors, <strong>and</strong><br />

Unsophisticated investors need a purchaser representative<br />

under 506(b)(2)(ii) or, alternatively, Biosystems might<br />

consider a 3(a)(10) “fairness hearing” in California<br />

© 2012 Michael K. Krebs<br />

All Rights Reserved


Fairness Hearings –<br />

3(a)(10)<br />

©2012 Michael K. Krebs<br />

All Rights Reserved<br />

3(a)(10)<br />

any security . . . issued in exchange for one or more<br />

bona fide outst<strong>and</strong>ing securities… after a hearing upon<br />

the fairness of such terms <strong>and</strong> conditions … by any<br />

court, or by any official or agency of the United States,<br />

or by any State or Territorial banking or insurance<br />

commission or other governmental authority expressly<br />

authorized by law to grant such approval<br />

Additional guidance provided in SEC Staff Legal<br />

Bulletin regarding 3(a)(10) (not required reading)


Session 2 – Exempt <strong>Trans</strong>actions<br />

Emerging Companies <strong>and</strong> Warrants<br />

Study Problem No. 2.5<br />

[Assume Genome acquisition occurred valued at $3.5 million]<br />

In the year following the Great Genome acquisition, BeanTown Biosystems’s<br />

business exp<strong>and</strong>s significantly, <strong>and</strong> it wants to borrow $1 million each from Very<br />

Confident <strong>and</strong> the two Genome founders.<br />

The promissory notes evidencing the borrowing will be secured by a lien on all of<br />

Biosystems’s No’s tangible <strong>and</strong> intangible assets <strong>and</strong> payable in three years or, if<br />

earlier, upon the completion of an IPO of Biosystems.<br />

Each lender will receive a warrant to purchase from Biosystems 100,000 shares of<br />

Biosystems common stock at a price per share of $10, which is 25% above the $8<br />

price at which Biosystems common stock was valued in the Genome acquisition.<br />

The warrant expires in ten years <strong>and</strong> is exercisable only after 12 months or upon the<br />

completion of an IPO, whichever is earlier. The warrant includes a customary “net<br />

exercise” provision.<br />

Are the notes securities? Are the warrants securities? Must Biosystems file a<br />

registration statement with the SEC in connection with this financing?<br />

(c) 2012 Michael K. Krebs<br />

All Rights Reserved


Session 2 – Exempt <strong>Trans</strong>actions<br />

Emerging Companies <strong>and</strong> Warrants<br />

Study Problem No. 2.5 – Analysis<br />

The notes are not securities. See 2(a)(1) <strong>and</strong> Reves v. Ernst & Young - “Unless the context<br />

otherwise requires” in preamble to § 2(a).<br />

Reves: family resemblance test.<br />

• Every “note” is presumed to be security unless it bears a strong resemblance (in terms<br />

of four factors) to one of the categories of instruments listed by the court that are not<br />

securities.<br />

• Plan of distribution is not to general public; note is secured by all-assets lien, reducing<br />

the risks to note holders; <strong>and</strong> therefore better view is that Very Confident <strong>and</strong><br />

Genome’s two founders thought they were making a commercial loan, not<br />

purchasing a security.<br />

• Short-term note secured by assets of a small business is an example cited in Reves of<br />

a promissory note that is not a security<br />

• Therefore, the Biosystems promissory notes are more analogous to category of loans<br />

issued to commercial banks in a conventional lending transactions <strong>and</strong> do not fall<br />

within statutory definition of "notes" that are "securities."<br />

©2012 Michael K. Krebs<br />

All Rights Reserved


Session 2 – Exempt <strong>Trans</strong>actions<br />

Emerging Companies <strong>and</strong> Warrants<br />

Study Problem No. 2.5 – Analysis (cont’d)<br />

The warrants clearly are securities.<br />

See § 2(a)(1): “warrant” to purchase stock is specifically<br />

identified as a security<br />

The offer <strong>and</strong> sale of the warrants likely is exempt under<br />

any of several exemptions, including Rule 506.<br />

Size <strong>and</strong> nature of warrant holder group may justify<br />

reliance solely on §4(2).<br />

Therefore, Biosystems does not have to file a registration<br />

statement in connection with the $3 million borrowing or the<br />

warrants.<br />

©2012 Michael K. Krebs<br />

All Rights Reserved


Session 2 – Exempt <strong>Trans</strong>actions<br />

Emerging Companies/Employee Stock Awards<br />

Study Problem No. 2.6<br />

[Assume Genome acquisition occurred ]<br />

BeanTown Biosystems’s main office is in Massachusetts <strong>and</strong><br />

some development work will take place in at the former<br />

Genome facility in California.<br />

Biosystems has 40 employees <strong>and</strong> would like to offer them<br />

stock options as an inducement for them to accept less cash<br />

compensation than they would earn at many other companies.<br />

None of the employees qualifies as an accredited investor.<br />

Must Biosystems register under §5 of the <strong>Securities</strong> Act the<br />

grant of the options? What about the sale of stock upon<br />

exercise of the options? What if Biosystems had not<br />

acquired Genome?<br />

© 2012 Michael K. Krebs<br />

All Rights Reserved


Intrastate Offerings –<br />

<strong>and</strong> Rule 147<br />

Resale restrictions<br />

©2012 Michael K. Krebs<br />

All Rights Reserved<br />

3(a)(11)<br />

For nine months after the offering is complete, purchasers may<br />

not resell securities to any non-resident of the state<br />

Offering size<br />

No maximum offering amount<br />

Pitfalls for the unwary<br />

Many<br />

Exemption not available if any purchaser, or any offeree!!, is<br />

not a resident of the state<br />

Restrictions on use of an underwriter not located in the state


Session 2 – Exempt <strong>Trans</strong>actions<br />

Emerging Companies/Employee Stock Awards<br />

Study Problem No. 2.6 – Analysis<br />

Biosystems will likely not be required to register under 5 of the<br />

<strong>Securities</strong> Act the offer or sale of the stock options to the employees.<br />

<br />

4(2) may be available BUT rather risky given size of group<br />

Rule 504 might be available<br />

<br />

3(a)(11)/Rule 147 not available if grants made to employees<br />

who live in California<br />

MOST IMPORTANT – Rule 701 will likely be available.<br />

Rule 701 will also exempt the issuance of Biosystems stock<br />

upon the exercise of the option.<br />

© 2012 Michael K. Krebs<br />

All Rights Reserved


Rule 701<br />

Rule 701 (Benefit Plans/Contracts Relating to<br />

Compensation)<br />

Only for issuers that do not file periodic reports with<br />

SEC under Exchange Act<br />

Must be a written compensatory benefit plan (or written<br />

compensation contract)<br />

Only for sales to insiders or near-insiders, such as<br />

directors, officers, employees, <strong>and</strong> consultants or other<br />

advisors<br />

BUT . . . aggregate annual sales limits . . . See Rule<br />

701(d)(2)<br />

©2012 Michael K. Krebs<br />

All Rights Reserved


Rule 701 (cont’d)<br />

Rule 701(d):<br />

No limit on offers<br />

Aggregate sales price during any consecutive 12month<br />

period must not exceed the greatest of the<br />

following:<br />

$1,000,000;<br />

15% of the total assets;<br />

15% of the outst<strong>and</strong>ing amount of the class of<br />

securities being offered.<br />

©2012 Michael K. Krebs<br />

All Rights Reserved


Rule 701 (cont’d)<br />

Value of options for 701 purposes is<br />

based upon option exercise price<br />

No integration with other offerings<br />

Limited disclosure required unless<br />

amount during any 12-month period<br />

exceeds $5 million<br />

©2012 Michael K. Krebs<br />

All Rights Reserved


Session 2 – Exempt <strong>Trans</strong>actions<br />

Google Pre-IPO Private Placements<br />

SEC Form S-1, Part II, Item 15. Recent Sales of Unregistered<br />

<strong>Securities</strong><br />

Furnish information required by Item 701 of <strong>Regulation</strong> S-K<br />

SEC Reg. S-K Item 701:<br />

Furnish the following information as to all securities sold by registrant<br />

within the past three years which were not registered under <strong>Securities</strong><br />

Act.<br />

Include sales of reacquired securities, as well as new issues, securities<br />

issued in exchange for property, services, or other securities<br />

Indicate the section of <strong>Securities</strong> Act or SEC rule under which<br />

exemption from registration was claimed <strong>and</strong> state briefly facts relied<br />

upon to make exemption available<br />

©2012 Michael K. Krebs<br />

All Rights Reserved


Session 2 – Private Placements<br />

Google Pre-IPO Private Placements<br />

Google April 2004 Form S-1, Part II, Item 15. Recent Sales of<br />

Unregistered <strong>Securities</strong>:<br />

The following sets forth information regarding securities sold by the<br />

registrant since January 1, 2001.<br />

1. In January 2001, Google sold 9,000 shares of Series C preferred stock<br />

for cash consideration of $21,083 to an accredited investor.<br />

* * *<br />

5. Since January 2001, the registrant has issued to directors, officers,<br />

employees <strong>and</strong> consultants options to purchase 63,230,957 shares of<br />

common stock with an aggregate exercise price of $118,292,482, <strong>and</strong><br />

has issued 42,013,513 shares of common stock for an aggregate<br />

purchase price of $27,123,241 upon exercise of such options.<br />

©2012 Michael K. Krebs<br />

All Rights Reserved


Session 2 – Private Placements<br />

Google Pre-IPO Private Placements<br />

Google April 2004 Form S-1, Part II, Item 15. Recent Sales of<br />

Unregistered <strong>Securities</strong>:<br />

“Except as noted below, the issuance of securities described above<br />

were deemed to be exempt from registration under the <strong>Securities</strong><br />

Act in reliance on Section 4(2) . . . as transactions by an issuer not<br />

involving any public offering. The recipients of securities in each<br />

such transaction represented their intention to acquire the securities<br />

for investment only <strong>and</strong> not with a view to or for sale in connection<br />

with any distribution thereof <strong>and</strong> appropriate legends were affixed<br />

to the share certificates <strong>and</strong> other instruments issued in such<br />

transactions. The sale of these securities were made without<br />

general solicitation or advertising.”<br />

©2012 Michael K. Krebs<br />

All Rights Reserved


Session 2 – Private Placements<br />

Google Pre-IPO Private Placements<br />

Google July 2004 Amendment No. 4 to Form S-1, Part II, Item 15.<br />

Recent Sales of Unregistered <strong>Securities</strong>:<br />

“The option grants <strong>and</strong> stock issuances described in paragraph 5 above include the issuance<br />

of 37,099,623 options <strong>and</strong> 23,702,819 shares of our common stock that may not have been<br />

exempt from registration or qualification requirements under federal or state securities laws,<br />

<strong>and</strong> we have not registered or qualified all of these shares under these laws. Consequently,<br />

certain of the options we granted <strong>and</strong> the shares issued upon exercise of these options may<br />

have been issued in violation of federal or state securities laws, or both, <strong>and</strong> may be subject<br />

to rescission. In order to address this issue, we intend to make a rescission offer soon after<br />

the effective date of this offering to all holders of any outst<strong>and</strong>ing options <strong>and</strong> shares<br />

subject to rescission, pursuant to which we will offer to repurchase these options <strong>and</strong> shares<br />

then outst<strong>and</strong>ing from the holder. If our rescission offer is accepted by all offerees, we<br />

could be required to make an aggregate payment to the holders of these options <strong>and</strong> shares<br />

of up to approximately $25.9 million, which includes statutory interest. There are no<br />

assurances that we will not be subject to penalties or fines relating to these issuances. We<br />

believe our anticipated rescission offer could provide us with additional meritorious<br />

defenses against any future claims relating to these shares.”<br />

©2012 Michael K. Krebs<br />

All Rights Reserved


Rule 701 <strong>and</strong> JOBS Act<br />

§501 of JOBS Act amended §12(g)(1)(A) of Exchange<br />

Act to increase “holder of record” threshold to<br />

2,000 persons, or<br />

500 persons who are not accredited investors<br />

BUT §502 of JOBS Act provides that employees who<br />

receive securities in an exempt offering, which would<br />

include a 701 offering, are excluded from both “holder of<br />

record” tests.<br />

If these provisions had been in effect, would Facebook<br />

have gone public?<br />

©2012 Michael K. Krebs<br />

All Rights Reserved


U.S <strong>and</strong> <strong>Trans</strong>-<strong>Border</strong><br />

<strong>Securities</strong> <strong>Regulation</strong><br />

Boston University School of Law<br />

Executive LL.M. - International Business Law<br />

June/July 2012<br />

Michael Krebs<br />

JD, Boston University School of Law 1985<br />

Senior Partner, Nutter, McClennen & Fish, LLP, Boston, MA<br />

Tel. 617.439.2288 email: mkrebs@nutter.com<br />

(c) 2012 Michael K. Krebs<br />

All Rights Reserved


U.S <strong>and</strong> <strong>Trans</strong>-<strong>Border</strong><br />

<strong>Securities</strong> <strong>Regulation</strong><br />

Boston University School of Law<br />

Executive LL.M. in International Business Law<br />

Session 3 – June 27, 2012<br />

(c) 2012 Michael K. Krebs<br />

All Rights Reserved


Session 3 Agenda<br />

Planning for an Initial Public Offering or IPO –<br />

Underst<strong>and</strong>ing the “gun jumping” rules<br />

What is a “WKSI”? How are the gun jumping rules different<br />

for a WKSI?<br />

What are the other categories of issuers under the <strong>Securities</strong><br />

Act? How are the gun jumping rules different for them?<br />

How does the JOBS Act change the gun jumping rules?<br />

Civil <strong>and</strong> Criminal Liability under the <strong>Securities</strong> Act<br />

(c) 2012 Michael K. Krebs<br />

All Rights Reserved


Basic Principles Underlying the<br />

<strong>Securities</strong> Act of 1933<br />

Unless an exemption is available,<br />

1. Every offer or sale of a security must be<br />

registered with the SEC under § 5 of the<br />

<strong>Securities</strong> Act, <strong>and</strong><br />

2. In the registration statement (which<br />

includes the prospectus), all information<br />

material to that investment decision must<br />

be disclosed.<br />

©2012 Michael K. Krebs<br />

All Rights Reserved


Planning for an IPO<br />

Restrictions on communications during<br />

“registration”?<br />

• When is a company deemed to be “in registration”?<br />

• What is an “offer”?<br />

• What is a “prospectus”?<br />

• What are the restrictions on company<br />

communications while it is in registration?<br />

(c) 2012 Michael K. Krebs<br />

All Rights Reserved


Section 5 Rubric<br />

Three distinct phases of “registration”<br />

Pre-Filing<br />

Waiting Period<br />

Post-Effective<br />

(c) 2012 Michael K. Krebs. All<br />

Rights Reserved.


Section 5 Rubric<br />

5(c) It is unlawful to offer to sell a “security” before a<br />

registration statement is on file with the SEC with<br />

respect to such transaction.<br />

5(b)(1) It is unlawful to make use of a prospectus relating to<br />

a transaction for which a registration statement has<br />

been filed unless the prospectus meets the<br />

requirements of 10(a).<br />

5(a) It is unlawful to sell a security unless a registration<br />

statement is “in effect” [i.e., has been declared<br />

effective] with respect to such transaction.<br />

©2012 Michael K. Krebs<br />

All Rights Reserved


What constitutes an “offer”?<br />

The “Gun Jumping” Doctrine<br />

But first, some context!<br />

(c) 2012 Michael K. Krebs<br />

All Rights Reserved


Session 3 – What Can Be Done During<br />

“Registration”?<br />

Study Problem 3.1<br />

Two years after its formation, BeanTown Biosystems’s prototype medical<br />

diagnostic device is receiving rave reviews in beta testing, <strong>and</strong> Biosystems<br />

launches a publicity campaign aimed at building market dem<strong>and</strong> for its product<br />

<strong>and</strong> begins planning for the construction of a $75 million manufacturing facility<br />

that would allow Biosystems to meet anticipated dem<strong>and</strong> for the diagnostic<br />

device <strong>and</strong> accelerate its ongoing research <strong>and</strong> development efforts.<br />

The Biosystems board approves the recommendation of the company’s four<br />

founders, Rachel, Monica, Phoebe <strong>and</strong> Emma, that should Biosystems should<br />

“go public” by selling $100 million of common stock in an underwritten<br />

offering <strong>and</strong> use the proceeds to fund its manufacturing facility, to accelerate<br />

R&D, <strong>and</strong> to provide additional working capital for raw material <strong>and</strong> inventory.<br />

Might the marketing campaign create problems under the <strong>Securities</strong> Act for the<br />

proposed public offering if the campaign began 25 days before the registration<br />

statement was filed? What if it began 45 days before?<br />

©2012 Michael K. Krebs<br />

All Rights Reserved


Session 3 – What Can Be Done During<br />

“Registration”?<br />

Study Problem 3.1 — Pre Dec. 1, ’05 Analysis<br />

Biosystems will likely be considered to be in the “pre-filing” stage of a<br />

“registration,” because its board has determined to sell securities in a<br />

registered offering (even though the facts do not indicate whether it has<br />

selected a lead underwriter), but it has not filed a registrations statement.<br />

So, Section 5(c) applies.<br />

Whether the marketing campaign constitutes an “offer” in violation of<br />

Section 5(c) depends upon how the campaign is conducted.<br />

Biosystems should not engage in conduct that conditions the market (i.e.,<br />

arouses public interest in the company or the securities of the company)<br />

by initiating publicity when in registration, but it may continue to<br />

advertise products <strong>and</strong> services.<br />

For pre-December 1, 2005 analysis, See <strong>Securities</strong> Act Release No. 5180<br />

(August 16, 1971).<br />

©2012 Michael K. Krebs<br />

All Rights Reserved


Session 3 – What Can Be Done During<br />

“Registration”?<br />

Study Problem 3.1 — Pre-Dec. 1 ’05 Analysis<br />

Ordinary <strong>and</strong> customary advertisements aimed at<br />

building market dem<strong>and</strong> for Biosystems’s product<br />

would not likely violate Section 5.<br />

By comparison, forward-looking valuation information<br />

– especially a prediction, projection, forecast, estimate<br />

or opinion concerning, among other things, sales <strong>and</strong><br />

earnings <strong>and</strong> value of Biosystem’s securities – may be<br />

considered to be conditioning the market, <strong>and</strong> therefore<br />

deemed to be an “offer” in violation of Section 5(c).<br />

© 2012 Michael K. Krebs<br />

All Rights Reserved


Session 3 –What Can Be Done During<br />

“Registration”?<br />

Study Problem 3.2<br />

Same facts as Study Problem 3.1.<br />

To coincide with the most important annual trade show in the medical device<br />

industry that will begin around the time Biosystems plans to file its IPO registration<br />

statement, Biosystems dramatically steps up its marketing campaign, extolling what<br />

it characterizes as the “revolutionary” virtues of the diagnostic device.<br />

Contemporaneously, the four founders give extensive interviews with various<br />

technology <strong>and</strong> business magazines covering the trade show.<br />

Might Biosystems’s trade show-related activity create problems under the <strong>Securities</strong><br />

Act for the proposed public offering if the trade show activity occurs after<br />

Biosystems chooses its lead underwriter but before it files its IPO registration<br />

statement?<br />

What if the interviews were given 35 days before Biosystems files its registration<br />

statement but published only 5 days before the registration statement was filed?<br />

What if the trade show occurred, or the interviews were published, after the<br />

registration statement was filed but before it was declared effective?<br />

© 2012 Michael K. Krebs<br />

All Rights Reserved


Session 3 – What Can Be Done During<br />

“Registration”?<br />

Study Problem 3.2 — Pre-Dec. 1, ’05 Analysis<br />

Whether the trade-show activity violates<br />

Section 5 depends upon how <strong>and</strong> when it is<br />

conducted.<br />

If trade-show activity occurred before S-1<br />

filing, Biosystems must be concerned about<br />

whether its activities may be conditioning the<br />

market for its IPO, <strong>and</strong> thus constitute a prefiling<br />

“offer” in violation of Section 5(c).<br />

©2012 Michael K. Krebs<br />

All Rights Reserved


Session 3 – What Can Be Done During<br />

“Registration”?<br />

Study Problem 3.2 — Pre-Dec. 1, ’05 Analysis<br />

As regards trade show appearances <strong>and</strong> interviews published<br />

after the registration statement is filed, Biosystems must consider<br />

whether any statement made or material distributed in<br />

connection with the trade show, including any article that results<br />

from the interviews, may be deemed to be a “prospectus.”<br />

See Rule 134 (for post-filing, non-prospectus<br />

communications)<br />

See Google Inc. August 18, 2004 Prospectus: “Risk Factors –<br />

Risks Related to Our Offering” (1st paragraph) (p. 21); <strong>and</strong><br />

See Excerpt from Lexar Media, Inc.'s August 18, 2000 Post<br />

Effective Amendment (Risk of Illegal Prospectus)<br />

©2012 Michael K. Krebs<br />

All Rights Reserved


Session 3 – What Can Be Done During<br />

“Registration”?<br />

Study Problem 3.2 — Pre-Dec. 1, ’05 Analysis<br />

Statements about future possibilities of the company<br />

may be deemed a prospectus that does not satisfy the<br />

requirements of Section 10.<br />

Important facts are that Biosystems<br />

“dramatically” increased its marketing campaign<br />

<strong>and</strong> characterized its product as “revolutionary”.<br />

©2012 Michael K. Krebs<br />

All Rights Reserved


Session 3 – What Can Be Done During Registration”?<br />

Study Problem 3.1<br />

(Applying 2005 Offering Reforms)<br />

Two years after its formation . . . Biosystems launches a publicity<br />

campaign aimed at building market dem<strong>and</strong> for its product <strong>and</strong><br />

begins planning for the construction of a $75 million<br />

manufacturing facility . . . .<br />

The Biosystems board approves the recommendation of the<br />

company’s four founders . . . that should Biosystems “go public”.<br />

. .<br />

Might the marketing campaign create problems under the<br />

<strong>Securities</strong> Act for the proposed public offering if the campaign<br />

began 25 days before the registration statement was filed? What<br />

if it began 45 days before?<br />

©2012 Michael K. Krebs<br />

All Rights Reserved


Session 3 – What Can Be Done During<br />

“Registration”?<br />

Study Problem 3.1 — Post Dec. 1, ’05 Analysis<br />

Effective December 1, 2005, the SEC’s “Offering Reform”<br />

<strong>Regulation</strong>s (the “2005 Offering Reforms”) provide a “safe<br />

harbor” regarding pre-registration publicity<br />

The 2005 Offering Reforms involve three main areas:<br />

Communications related to registered securities offerings;<br />

Registration <strong>and</strong> other procedures in the offering <strong>and</strong><br />

capital formation processes; <strong>and</strong><br />

Delivery of information to investors, including delivery<br />

through access <strong>and</strong> notice, <strong>and</strong> timeliness of that delivery.<br />

©2012 Michael K. Krebs<br />

All Rights Reserved


Session 3 – What Can Be Done During “Registration”?<br />

Study Problem 3.1 — Post Dec. 1, ’05 Analysis<br />

Under Rule 163A, communications of any type by all issuers<br />

more than 30 days prior to filing a registration statement are<br />

not considered prohibited “gun-jumping” offers but only if<br />

the communication does not reference a registered securities<br />

offering, <strong>and</strong><br />

reasonable steps are taken to prevent distribution or<br />

republication of the communication during the 30-day period<br />

prior to filing the registration statement.<br />

Such communications are excluded from the definition of “offer”<br />

for purposes of Section 5(c).<br />

NB. Rule 163A is a non-exclusive safe harbor.<br />

©2012 Michael K. Krebs<br />

All Rights Reserved


Session 3 – What Can Be Done During “Registration”?<br />

Study Problem 3.1 — Post Dec. 1, ’05 Analysis<br />

For example, an IPO issuer may participate in industry<br />

conferences <strong>and</strong> similar events held more than 30 days before<br />

filing of the registration statement without gun-jumping<br />

concerns, so long as no registered securities offering is<br />

discussed.<br />

BUT safe harbor is available only to issuer <strong>and</strong> persons acting<br />

on behalf of an issuer.<br />

Safe harbor is not available to underwriters or dealers. Thus, it<br />

is not available to assist underwriters or dealers in testing the<br />

waters for the offering.<br />

©2012 Michael K. Krebs<br />

All Rights Reserved


Session 3 – What Can Be Done During “Registration”?<br />

Study Problem 3.2<br />

(Applying 2005 Offering Reforms)<br />

To coincide with the most important annual trade show in the medical device industry<br />

that will begin around the time of the S-1 filing, BeanTown Biosystems dramatically<br />

steps up its marketing campaign, extolling what it characterizes as the “revolutionary”<br />

virtues of the diagnostic device, <strong>and</strong> the four founders give extensive interviews with<br />

various technology <strong>and</strong> business magazines covering the trade show.<br />

Might Biosystems’s trade show-related activity create problems under the <strong>Securities</strong><br />

Act for the proposed public offering if the trade show activity occurred after<br />

Biosystems chose its lead underwriter but before it filed its registration statement?<br />

What if the interviews were given 35 days before Biosystems files its registration<br />

statement but published only 5 days before the registration statement was filed?<br />

What if the trade show occurred, or the interviews were published, after the<br />

registration statement was filed but before it was declared effective?<br />

©2012 Michael K. Krebs<br />

All Rights Reserved


Session 3 – What Can Be Done During “Registration”?<br />

Study Problem 3.2 — Post Dec. 1, ’05 Analysis<br />

What if the interviews were given 35 days before<br />

Biosystems files its registration statement but published<br />

only 5 days before the registration statement was filed?<br />

Under 2005 Offering Reforms, during the 30 days<br />

before the registration statement is filed, the IPO issuer<br />

will be in a “quiet period.”<br />

However, as was the case prior to the 2005 Offering<br />

Reforms, the issuer is permitted to make a very limited<br />

announcement of its intention to conduct a registered<br />

offering of securities, without naming any underwriters.<br />

Rule 135.<br />

©2012 Michael K. Krebs<br />

All Rights Reserved


Session 3 – What Can Be Done During “Registration”?<br />

Study Problem 3.2 — Post Dec. 1, ’05 Analysis<br />

In addition, in reliance on the non-exclusive safe harbor under Rule 169,<br />

IPO issuers may continue publishing, during 30-day quiet period <strong>and</strong> at any<br />

other time during the offering, factual business information intended to<br />

be used by persons other than in their capacity as investors or potential<br />

investors.<br />

Fact that a customer or other person to whom a factual business<br />

communication is made may be a potential investor does not affect the<br />

availability of the safe harbor.<br />

The manner <strong>and</strong> timing of the communication must be similar to the<br />

issuer’s historic practice.<br />

The same issuer employees who have historically been responsible for<br />

providing information to customers <strong>and</strong> suppliers must make the<br />

communications for which safe harbor protection is sought.<br />

©2012 Michael K. Krebs<br />

All Rights Reserved


Session 3 – What Can Be Done During “Registration”?<br />

Study Problem 3.2 — Post Dec. 1, ’05 Analysis<br />

Even if the safe harbor in Rule 169 is not available, the issuer<br />

retains the ability available prior to the 2005 Reforms to rely on a<br />

facts <strong>and</strong> circumstances analysis in addressing the question of<br />

whether a communication is an offer.<br />

The safe harbor for factual business information excludes<br />

information released as part of the offering activities in the<br />

registered offering.<br />

For example, the safe harbor is not available for a copy of a<br />

prior press release that originally had been regularly released<br />

in accordance with the safe harbor but later is specifically<br />

provided to investors or potential investors as part of offering<br />

activities.<br />

©2012 Michael K. Krebs<br />

All Rights Reserved


Session 3 – What Can Be Done During “Registration”?<br />

Study Problem 3.3<br />

June 30, 2010 – Forbes Magazine reported:<br />

In January 2010, General Motors Vice Chairman Bob Lutz told Forbes that a<br />

2010 IPO was a possibility, but only after a laundry list of criteria were checked<br />

off, including turning a profit, generating solid cash flow <strong>and</strong> having a<br />

compelling story to tell investors.<br />

August 5, 2010 – Bloomberg Businessweek reported:<br />

The White House’s senior advisor to the Task Force on the Auto Industry said<br />

that he believed it was likely that General Motors would have an initial public<br />

offering sometime in 2010 . . . . [The U.S. government then owned a majority<br />

interest in GM.]<br />

Ron Bloom, speaking at an auto industry conference . . . said the U.S.<br />

government would unwind its stakes in the automakers “as soon as is<br />

practicable,” echoing a comment made by President Obama.<br />

Do the comments of Mr. Lutz or Mr. Bloom raise any issue under the <strong>Securities</strong> Act?<br />

©2012 Michael K. Krebs<br />

All Rights Reserved


Session 3 – What Can Be Done During<br />

“Registration”?<br />

Study Problem 3.4<br />

Same facts as Study Problem 3.3.<br />

On August 16, 2010 – Bloomberg reported:<br />

Wall Street banks led by JPMorgan Chase & Co. <strong>and</strong> Morgan Stanley st<strong>and</strong> to make<br />

a combined $120 million on General Motors Co.’s initial public offering. If it<br />

weren’t for Goldman Sachs Group Inc., they could have made four times as much.<br />

In a pitch to the U.S. Treasury in May, Goldman Sachs offered to accept a fee of<br />

0.75 percent, according to people with direct knowledge of the matter. That’s a<br />

fraction of the 3 percent banks typically charge on the largest IPOs <strong>and</strong> well below<br />

the 2 percent offered by Bank of America Corp. <strong>and</strong> other banks that presented to<br />

Treasury, said the people, speaking anonymously because the matter is private.<br />

GM filed the registration statement for its IPO on August 18, 2010.<br />

Does the reporting on the proposed underwriting terms for the expected GM IPO raise<br />

any issue under the <strong>Securities</strong> Act?<br />

©2012 Michael K. Krebs<br />

All Rights Reserved


Session 3 Agenda<br />

Planning for an Initial Public Offering or IPO –<br />

Underst<strong>and</strong>ing the “gun jumping” rules<br />

What is a “WKSI”? How are the gun jumping rules<br />

different for a WKSI?<br />

What are the other categories of issuers under the <strong>Securities</strong><br />

Act? How are the gun jumping rules different for them?<br />

How did the JOBS Act change the gun jumping rules?<br />

Civil <strong>and</strong> Criminal Liability under the <strong>Securities</strong> Act<br />

(c) 2012 Michael K. Krebs<br />

All Rights Reserved


How are the rules different<br />

for a WKSI?<br />

An extremely important aspect of the SEC’s<br />

2005 Offering Reforms was the introduction<br />

of special class of issuers designated:<br />

“Well known seasoned issuers” or “WKSIs”<br />

(c) 2012 Michael K. Krebs<br />

All Rights Reserved


How are the rules different<br />

for a WKSI?<br />

What is a “WKSI”? - See Rule 405<br />

Meets all requirements of General Instruction I.A.<br />

of Form S–3 or Form F–3 [see subsequent slide]<br />

<strong>and</strong> either:<br />

(1) As of a date within 60 days of “determination<br />

date,” has a worldwide market value of its<br />

outst<strong>and</strong>ing voting <strong>and</strong> non-voting common equity<br />

held by non-affiliates of $700 million or more; or<br />

(c) 2012 Michael K. Krebs<br />

All Rights Reserved


How are the rules different<br />

for a WKSI?<br />

What is a “WKSI”? - See Rule 405<br />

Alternative Test:<br />

(2) As of a date within 60 days of determination<br />

date, has issued in the last three years at least<br />

$1 billion aggregate principal amount of nonconvertible<br />

securities, other than common equity,<br />

in primary offerings for cash registered under the<br />

Act<br />

(c) 2012 Michael K. Krebs<br />

All Rights Reserved


WSKI S-3 Eligibility<br />

Why does S-3 eligibility matter?<br />

What is the public policy rationale for<br />

treating WKSIs differently?<br />

(c) 2012 Michael K. Krebs<br />

All Rights Reserved


WSKI S-3 Eligibility<br />

General Instruction I.A. of Form S–3 requires:<br />

1. Registrant is organized under laws of U.S. or any<br />

state, etc. <strong>and</strong> has its principal business operations in<br />

U.S. or its territories.<br />

2. Registrant has a class of securities registered pursuant<br />

to Section 12(b) of the Exchange Act or a class of<br />

equity securities registered pursuant to Section 12(g)<br />

of the Exchange Act or is required to file reports<br />

pursuant to Section 15(d) of the Exchange Act.<br />

(c) 2012 Michael K. Krebs<br />

All Rights Reserved


WSKI S-3 Eligibility (cont’d)<br />

3. Registrant has been subject to the requirements of Section<br />

12 or 15(d) of the Exchange Act <strong>and</strong> has filed all the<br />

material required to be filed pursuant to Section 13, 14 or<br />

15(d) for a period of at least twelve calendar months<br />

immediately preceding the filing of the registration<br />

statement.<br />

4. Registrant has filed in a timely manner all reports<br />

required to be filed during the twelve calendar months<br />

<strong>and</strong> any portion of a month immediately preceding<br />

filing of registration statement, other than certain 8-K<br />

filings.<br />

(c) 2012 Michael K. Krebs<br />

All Rights Reserved


WSKI S-3 Eligibility (cont’d)<br />

5. Neither the registrant nor any of its consolidated or<br />

unconsolidated subsidiaries has, since the end of the last<br />

fiscal year for which certified financial statements of the<br />

registrant <strong>and</strong> its consolidated subsidiaries were included<br />

in a report filed pursuant to Section 13(a) or 15(d) of the<br />

Exchange Act: (a) failed to pay any dividend or sinking<br />

fund installment on preferred stock; or (b) defaulted (i)<br />

on any installment or installments on indebtedness for<br />

borrowed money, or (ii) on any rental on one or more<br />

long term leases, which defaults in the aggregate are<br />

material to the financial position of the registrant.<br />

© 2012 Michael K. Krebs<br />

All Rights Reserved


How are the rules different<br />

for a WKSI?<br />

Section 5 framework for WKSIs<br />

WKSI may file “automatic shelf registration<br />

statement” on Form S–3 or Form F–3.<br />

Rule 405<br />

Automatic shelf registration statement is<br />

immediately effective upon filing with the<br />

SEC. Rule 462(e)<br />

(c) 2012 Michael K. Krebs<br />

All Rights Reserved


How are the rules different<br />

for a WKSI?<br />

Gun jumping rules do not apply to WKSIs!<br />

Rule 163:<br />

In an offering by or on behalf of WKSI that will be<br />

or is at the time intended to be registered under the<br />

<strong>Securities</strong> Act, an offer by or on behalf of such<br />

issuer is exempt from the prohibitions in § 5(c)<br />

on offers before a registration statement has been<br />

filed, provided conditions of Rule 163 are satisfied.<br />

(c) 2012 Michael K. Krebs<br />

All Rights Reserved


Session 3 Agenda<br />

Planning for an Initial Public Offering or IPO –<br />

Underst<strong>and</strong>ing the “gun jumping” rules<br />

What is a “WKSI”? How are the gun jumping rules different<br />

for a WKSI?<br />

What are the other categories of issuers under the<br />

<strong>Securities</strong> Act? How are the gun jumping rules<br />

different for them?<br />

How did the JOBS Act change the gun jumping rules?<br />

Civil <strong>and</strong> Criminal Liability under the <strong>Securities</strong> Act<br />

(c) 2012 Michael K. Krebs<br />

All Rights Reserved


Other Categories of Issuers<br />

under <strong>Securities</strong> Act<br />

Four basic categories of issuers (prior to JOBS Act):<br />

1. WKSIs<br />

2. Issuers that are not WKSIs but still file periodic reports<br />

(10-Ks, 10-Qs, 8-Ks) with the SEC under the Exchange<br />

Act, usually because the issuer previously conducted a<br />

public offering of securities or has securities listed on an<br />

exchange;<br />

3. Foreign private issuers (which may also qualify as<br />

WKSIs); <strong>and</strong><br />

4. Issuers that do not file periodic reports with the SEC.<br />

©2012 Michael K. Krebs<br />

All Rights Reserved


Another Category of Issuers –<br />

Emerging Growth Company<br />

JOBS Act adds a fifth over-arching category:<br />

The "emerging growth company" is able to take<br />

advantage of new scaled disclosure, governance <strong>and</strong><br />

accounting requirements.<br />

An "emerging growth company" (EGC) is an issuer<br />

that, for its most recently completed fiscal year, had<br />

total annual gross revenues of less than $1 billion.<br />

©2012 Michael K. Krebs<br />

All Rights Reserved


Emerging Growth Companies<br />

An issuer's status as an EGC will continue until the earliest of the<br />

following:<br />

The last day of the issuer's fiscal year during which its gross<br />

revenues ≥ $1 billion;<br />

The last day of the issuer's fiscal year following the fifth<br />

anniversary of its IPO;<br />

The date on which the issuer has, during the previous three-year<br />

period, issued > $1 billion in non-convertible debt; or<br />

The date on which the issuer is deemed to be a "large accelerated<br />

filer," which generally is comparable to a WKSI.<br />

©2012 Michael K. Krebs<br />

All Rights Reserved


How are gun jumping rules different for<br />

“reporting companies” that are not<br />

WKSIs?<br />

For non-WKSI reporting companies <strong>and</strong><br />

certain foreign private issuers:<br />

Rule 168 permits the regular release or<br />

dissemination of communications containing<br />

factual business information or forwardlooking<br />

information, if the other conditions of<br />

Rule 168 are satisfied.<br />

© 2012 Michael K. Krebs<br />

All Rights Reserved


What is a Foreign Private Issuer?<br />

A foreign issuer (other than a foreign government) except an issuer<br />

meeting the following conditions:<br />

(i) > 50 percent of the outst<strong>and</strong>ing voting securities of such issuer are<br />

directly or indirectly owned of record by residents of the United<br />

States; <strong>and</strong><br />

(ii) Any of the following:<br />

(A) Majority of issuer’s executive officers or directors are U.S.<br />

citizens or residents;<br />

(B) >50 percent of issuer’s assets are located in U.S.; or<br />

(C) The issuer’s business is administered principally in U.S..<br />

©2012 Michael K. Krebs<br />

All Rights Reserved


Other Categories of Issuers<br />

under <strong>Securities</strong> Act<br />

Effective in January 2008, the SEC amended<br />

the eligibility requirements for the use of Form<br />

S-3 <strong>and</strong> Form F-3 registration statements.<br />

Previously, an issuer could use S-3 only if it<br />

had a “float” of $75 million or more. (The<br />

term “float” means the aggregate market value<br />

of the voting <strong>and</strong> non-voting common equity<br />

held by non-affiliates of the issuer.)<br />

©2012 Michael K. Krebs<br />

All Rights Reserved


Other Categories of Issuers<br />

under <strong>Securities</strong> Act<br />

Current S-3 Eligibility: If Float ≥ $75 million<br />

If issuer has a “float” of $75 million or more<br />

<strong>and</strong> satisfies other S-3 eligibility criteria:<br />

Issuer can sell an unlimited amount of<br />

securities under an S-3 registration statement.<br />

©2012 Michael K. Krebs<br />

All Rights Reserved


Other Categories of Issuers<br />

under <strong>Securities</strong> Act<br />

Current S-3 Eligibility: If Float < $75 million<br />

If issuer has a “float” of less than $75 million, the issuer<br />

can use S-3 if the issuer:<br />

1. Satisfies the other S-3 eligibility criteria;<br />

2. Has a class of common equity securities listed on a<br />

national securities exchange; <strong>and</strong><br />

3. Does not sell more than the equivalent of one-third<br />

of its public float in primary offerings over any<br />

period of 12 calendar months.<br />

©2012 Michael K. Krebs<br />

All Rights Reserved


How are gun jumping rules different for<br />

EGCs after the JOBS Act?<br />

“Test the Waters” Communications<br />

During the quiet period, non-WKSIs that meet<br />

the criteria for EGCs may discuss a possible<br />

offering of securities to institutions that are<br />

accredited investors (which includes Qualified<br />

Institutional Buyers or “QIBs”).<br />

Communications may occur prior to or after<br />

filing a registration statement<br />

© 2012 Michael K. Krebs<br />

All Rights Reserved


EGCs – “Test the Waters” Communications<br />

The JOBS Act added Section 5(d):<br />

An ECG or any person authorized to act on behalf of<br />

an ECG may engage in oral or written<br />

communications with potential investors that are<br />

qualified institutional buyers or institutions that are<br />

accredited investors, to determine whether such<br />

investors might have an interest in a contemplated<br />

securities offering, either prior to or following the date<br />

of filing of a registration statement, subject to the<br />

requirement of Section 5(b)(2).<br />

© 2012 Michael K. Krebs<br />

All Rights Reserved


Session 3 – What Can Be Done During “Registration”?<br />

Overview of Restrictions on Communications<br />

The following is a summary of the restrictions on<br />

communications while an issuer is “in registration:”<br />

1. Well-known seasoned issuers (“WKSIs”) are permitted to<br />

engage at any time in oral <strong>and</strong> written communications,<br />

including use at any time of a free writing prospectus,<br />

subject to enumerated conditions (including, in specified<br />

cases, filing with SEC).<br />

2. All reporting issuers are permitted, at any time, to continue<br />

to publish regularly released factual business information<br />

<strong>and</strong> forward-looking information under Rule 168.<br />

©2012 Michael K. Krebs<br />

All Rights Reserved


Session 3 – What Can Be Done During “Registration”?<br />

Overview of Restrictions on Communications<br />

3. Non-reporting issuers are permitted, at any time, to<br />

continue to publish regularly released factual business<br />

information that is intended for use by persons other than<br />

in their capacity as investors or potential investors under<br />

new Rule 169.<br />

4. ECGs are permitted to engage in “test the water”<br />

communications with QIBs <strong>and</strong> institutional accredited<br />

investors per new §5(d)<br />

©2012 Michael K. Krebs<br />

All Rights Reserved


Session 3 – What Can Be Done During “Registration”?<br />

Overview of Restrictions on Communications<br />

5. Other communications by non-WKSI issuers (i.e.,<br />

communications not sanctioned by new §5(d) ) made<br />

more than 30 days before filing a registration statement<br />

are not prohibited offers so long as they do not reference<br />

a securities offering that is or will be the subject of a<br />

registration statement.<br />

6. All issuers <strong>and</strong> offering participants are permitted to use<br />

“free writing prospectuses” after the filing of the<br />

registration statement, subject to enumerated conditions<br />

(including, in specified cases, filing with SEC).<br />

©2012 Michael K. Krebs<br />

All Rights Reserved


Session 3 – What Can Be Done During “Registration”?<br />

Overview of Restrictions on Communications<br />

7. Procedural matters, such as communications about the<br />

schedule for an offering or about account-opening<br />

procedures, are excluded from the definition of<br />

“prospectus.”<br />

8. Exemptions for research reports are exp<strong>and</strong>ed. Importantly,<br />

the JOBS Act amended the definition of “offer” in §2(3) to<br />

exclude broker-dealer research reports about any ECG.<br />

©2012 Michael K. Krebs<br />

All Rights Reserved


Session 3 – What Can Be Done During “Registration”?<br />

More about research report exemption<br />

The JOBS Act amended the definition of “offer” in §2(3) to<br />

provide:<br />

The publication or distribution by a broker or dealer of a<br />

research report about an [ECG] that is the subject of a<br />

proposed public offering of the common equity securities of<br />

such [ECG] pursuant to a registration statement that the issuer<br />

proposes to file, or has filed, or that is effective shall be<br />

deemed for purposes of §2(10) <strong>and</strong> §5(c) not to constitute an<br />

offer for sale or offer to sell a security, even if the broker or<br />

dealer is participating or will participate in the registered<br />

offering of the securities of the issuer.<br />

©2012 Michael K. Krebs<br />

All Rights Reserved


Session 3 Agenda<br />

Planning for an Initial Public Offering or IPO<br />

What is a “WKSI”? How are these rules different for a<br />

WKSI?<br />

What are the other categories of issuers under the<br />

<strong>Securities</strong> Act?<br />

Civil <strong>and</strong> Criminal Liability under the <strong>Securities</strong><br />

Act<br />

(c) 2012 Michael K. Krebs<br />

All Rights Reserved


The “Elephant in the Corner” –<br />

Liability under the <strong>Securities</strong> Act <strong>and</strong><br />

How it Shape the Registration Statement<br />

• What typically gives rise to liability? Who may be liable?<br />

• What is the “due diligence defense,” when is it available,<br />

<strong>and</strong> who may assert it?<br />

• Who is a “control person” <strong>and</strong> when might they be<br />

vicariously liable for the acts of others?<br />

• What gives rise to aiding <strong>and</strong> abetting claims? How did<br />

Dodd-Frank change scope of “aiding <strong>and</strong> abetting”<br />

liability?<br />

• When is indemnification or contribution permitted?<br />

© 2012 Michael K. Krebs<br />

All Rights Reserved


What typically gives rise to<br />

liability? Who may be liable?<br />

Three principal types of civil liability<br />

under the <strong>Securities</strong> Act:<br />

1. Rescission rights under §12(a)(1)<br />

2. Strict liability for registration<br />

statements under §11.<br />

3. Prospectus liability under §12(a)(2)<br />

© 2012 Michael K. Krebs<br />

All Rights Reserved


Rescission rights under<br />

Section 12(a)(1)<br />

Strict liability: No scienter, reliance, causation<br />

Sales of unregistered securities; illegal offer<br />

Consideration paid (i.e., rescission) or damages if<br />

security previously sold<br />

Rescission right is effectively a “put” right<br />

1. Investor may recover only if in privity with person<br />

(i.e., “seller”) who violated §12(a)(1) BUT Pinter<br />

case defines seller broadly.<br />

2. Statute of limitations – three years. §13<br />

© 2012 Michael K. Krebs<br />

All Rights Reserved


Rescission rights under<br />

Section 12(a)(1)<br />

Persons liable:<br />

Party who passed title, or<br />

Any person who solicited the purchaser if<br />

person was motivated by<br />

his own financial interests or<br />

those of the securities owner<br />

Pinter v. Dahl<br />

© 2012 Michael K. Krebs<br />

All Rights Reserved


Strict liability under Section 11<br />

Strict liability for materially false or misleading<br />

statements in registration statement:<br />

Strict liability: Plaintiff does not have to prove<br />

Reliance (some exceptions)<br />

Scienter (some exceptions)<br />

Causation<br />

Joint <strong>and</strong> several liability<br />

Scope?<br />

© 2012 Michael K. Krebs<br />

All Rights Reserved


Section 11 Liability (cont’d)<br />

What statements are covered?<br />

Any materially false or misleading statement included<br />

(or deemed to be included) in an effective registration<br />

statement<br />

Includes definitive prospectus filed after registration<br />

statement is declared effective<br />

Does not include “free writing prospectus” (See SEC<br />

Rule 433(d)(1) – “The free writing prospectus filed<br />

for purposes of this section will not be filed as part of<br />

the registration statement . . . .”)<br />

© 2012 Michael K. Krebs<br />

All Rights Reserved


Section 11 Plaintiffs<br />

Who may sue under § 11:<br />

Anyone who purchased part of securities covered by<br />

registration statement<br />

Whether or not purchased in initial distribution or<br />

“after-market”<br />

But must be able to “trace” shares back to<br />

registration statement<br />

But not purchaser of shares outst<strong>and</strong>ing prior to the<br />

offering (i.e., shares that can not be traced)<br />

Not sellers who were motivated by misleadingly<br />

pessimistic information in registration statement<br />

© 2012 Michael K. Krebs<br />

All Rights Reserved


Section 11 Defendants<br />

What categories of persons are<br />

subject to § 11 strict liability?<br />

What is the public policy rationale<br />

for exposing them to strict<br />

liability?<br />

© 2012 Michael K. Krebs<br />

All Rights Reserved


Section 11 Defendants<br />

Scope of joint <strong>and</strong> several liability:<br />

Issuer<br />

CEO, CFO, CAO<br />

Directors at time of filing (whether or not<br />

signatories to registration statement)<br />

All underwriters<br />

All experts who consent to inclusion of their<br />

opinion (but only as to information certified<br />

by expert)<br />

© 2012 Michael K. Krebs<br />

All Rights Reserved


Section 11 Defenses<br />

Due diligence<br />

Not for issuer; extremely limited for executive officers.<br />

Discussed in subsequent slides.<br />

Negative causation<br />

Defendant proves that plaintiff’s damages actually resulted<br />

from factors other than the materially false or misleading<br />

statement in the registration statement<br />

Statute of limitations<br />

One year after “discovery” of materially false or misleading<br />

statement BUT not later than three years after there is a bona<br />

fide offering of the security to the public in that transaction<br />

© 2012 Michael K. Krebs<br />

All Rights Reserved


Section 11 Defenses (cont’d)<br />

Outside director is proportionately liable<br />

Unless there is a finding that director knowingly<br />

violated the securities law §11(f)(2)(A)<br />

No liability for forward-looking statement<br />

For existing SEC reporting companies only<br />

© 2012 Michael K. Krebs<br />

All Rights Reserved


Section 11 Defenses (cont’d)<br />

Reliance must be shown if security purchased<br />

after issuer releases earnings report covering<br />

a period of at least twelve months beginning<br />

after the effective date of the registration<br />

statement – § 11(a)<br />

BUT investor need not actually have read the<br />

registration statement to prove reliance. It would<br />

be sufficient if investor relied on secondary<br />

sources that repeated the materially false or<br />

misleading statement<br />

© 2012 Michael K. Krebs<br />

All Rights Reserved


Section 11 Due Diligence Defense<br />

What is the “due diligence” defense?<br />

When is it available?<br />

Who may assert it?<br />

What is the public policy rationale for<br />

the defense?<br />

© 2012 Michael K. Krebs<br />

All Rights Reserved


Section 11 Due Diligence<br />

Defense (cont’d)<br />

Rule 176 (rather vague)<br />

Two leading cases:<br />

BarChris Construction (1968)<br />

WorldCom (2004)<br />

© 2012 Michael K. Krebs<br />

All Rights Reserved


BarChris<br />

Section 11 Due Diligence<br />

Defense (cont’d)<br />

The greater the involvement of a defendant, <strong>and</strong> the more<br />

senior the defendant’s position with the issuer, the more<br />

due diligence a court expects<br />

Underwriters conducting a due diligence investigation<br />

must obtain corroborating evidence <strong>and</strong> not rely merely on<br />

statements from the issuer’s executives or counsel<br />

“Trust, but verify.” (Russian proverb famously quoted by<br />

U.S. President Ronald Regan)<br />

© 2012 Michael K. Krebs<br />

All Rights Reserved


WorldCom<br />

Section 11 Due Diligence<br />

Defense (cont’d)<br />

1. What constitutes a red flag?<br />

Question of fact<br />

For example, any information causing an<br />

underwriter to lose confidence in the<br />

accuracy of any portion of a registration<br />

statement, including “expertized” audited<br />

financials.<br />

©2012 Michael K. Krebs<br />

All Rights Reserved


Section 11 Due Diligence<br />

Defense (cont’d)<br />

WorldCom (cont’d)<br />

1. What constitutes a red flag? (cont’d)<br />

Deeper inquiry – including retention of<br />

accountants – may be warranted by discovery of<br />

“aggressive or unusual accounting strategies<br />

regarding significant issues.”<br />

In a competitive industry, any meaningful<br />

superiority of one company over another in any<br />

financial category could raise a red flag.<br />

©2012 Michael K. Krebs<br />

All Rights Reserved


Section 11 Due Diligence<br />

Defense (cont’d)<br />

WorldCom (cont’d)<br />

2. Must underwriters retain their own accounting<br />

experts to investigate the accuracy of financial<br />

statements?<br />

WorldCom opinion disclaims any such requirement,<br />

yet acknowledges that underwriters may wish to<br />

retain accountants as a matter of prudence.<br />

Underwriters may also, or alternatively, include on<br />

the due diligence team personnel with accounting<br />

backgrounds.<br />

©2012 Michael K. Krebs<br />

All Rights Reserved


Section 11 Due Diligence<br />

Defense (cont’d)<br />

WorldCom (cont’d)<br />

3. “Comfort letter” insufficient by itself to<br />

establish a due diligence defense <strong>and</strong> thus<br />

will need supplementation.<br />

Consider: if that supplementation is effectively<br />

a mini-audit, conducted on a quarterly basis,<br />

then the mini-audit may simply supplant, rather<br />

than supplement, the comfort letter.<br />

©2012 Michael K. Krebs<br />

All Rights Reserved


Section 11 Due Diligence<br />

Defense (cont’d)<br />

WorldCom (cont’d)<br />

4. How can underwriters document their<br />

diligence?<br />

If you are an underwriter, you want the<br />

document to memorialize beyond doubt<br />

that you participated fully in all phases of<br />

diligence.<br />

©2012 Michael K. Krebs<br />

All Rights Reserved


Section 11 Due Diligence<br />

Defense (cont’d)<br />

WorldCom (cont’d)<br />

5. Nature of Due Diligence Calls, Especially<br />

in Shelf Registration Context<br />

WorldCom court excoriated the underwriters<br />

for asking too few <strong>and</strong> too general questions,<br />

for passively accepting conclusory <strong>and</strong> nonresponsive<br />

answers, <strong>and</strong> for failing to ask<br />

tough follow-up questions.<br />

©2012 Michael K. Krebs<br />

All Rights Reserved


Section 11 Due Diligence<br />

Defense (cont’d)<br />

WorldCom (cont’d)<br />

6. After WorldCom, how should co-managing<br />

underwriters (i.e., non-lead underwriters)<br />

participate in diligence?<br />

Until WorldCom, non-lead members of underwriting<br />

syndicate often did not participate in diligence <strong>and</strong><br />

simply relied on diligence performed by the lead.<br />

Post-WorldCom, the non-lead underwriter who remains<br />

uninvolved in the diligence investigation – for example,<br />

by relying on the lead, who in turn relies on the auditor –<br />

has a double risk of losing its diligence defense.<br />

©2012 Michael K. Krebs<br />

All Rights Reserved


What about Section 12(a)(2)?<br />

Establishes liability for:<br />

An offer/sale of a security by means of a<br />

prospectus or oral communication, which<br />

includes a materially false or misleading<br />

statement of a material fact, if the defendant does<br />

not sustain the burden of proof that he did not<br />

know, <strong>and</strong> in the exercise of reasonable care<br />

could not have known, of such untruth or<br />

omission<br />

© 2012 Michael K. Krebs<br />

All Rights Reserved


Was Gustafson v. Alloyd Co.<br />

correctly decided?<br />

According to the dissent in Gustafson:<br />

Commentators writing shortly after passage of the <strong>Securities</strong> Act understood §12(2)<br />

to cover resales <strong>and</strong> private sales, as well as public offerings. Felix Frankfurter,<br />

organizer of the team that drafted the statute, firmly stated this view: The <strong>Securities</strong><br />

Act “seeks to terminate the facilities of the mails <strong>and</strong> of interstate commerce for<br />

dishonest or unfair dealings in the sale of all private or foreign government<br />

securities, new or old” (emphasis added).<br />

Most subsequent commentators have agreed that §12(2), like §17(a), is not confined<br />

to public offerings.<br />

“Every Court of Appeals to consider the issue ruled that private placements are<br />

subject to §12(2).” See, e.g., Pacific Dunlop Holdings Inc. v. Allen & Co. Inc., 993<br />

F. 2d 578 (1993)(the inclusion of the term "communication" in the Act's definition<br />

of prospectus meant that the term prospectus was defined "very broadly" to include<br />

all written communications that offered the sale of a security).<br />

© 2012 Michael K. Krebs<br />

All Rights Reserved


Was Gustafson v. Alloyd Co.<br />

correctly decided?<br />

513 U.S. 561 (1995) – Majority:<br />

“In light of the care that Congress took to justify the imposition of liability<br />

without proof of either fraud or reliance on "those whose moral<br />

responsibility to the public is particularly heavy” – the "originators of<br />

securities“ – we can not conclude that Congress would have extended that<br />

liability to every private or secondary sale without a whisper of<br />

explanation.”<br />

“In sum, the word ‘prospectus’ is a term of art referring to a document<br />

that describes a public offering of securities by an issuer or controlling<br />

shareholder. The contract of sale, <strong>and</strong> its recitations, were not held out<br />

to the public <strong>and</strong> were not a prospectus as the term is used in the 1933<br />

Act.”<br />

Compare with 1985 L<strong>and</strong>reth Timber decision.<br />

© 2012 Michael K. Krebs<br />

All Rights Reserved


Gustafson v. Alloyd Co. (cont’d)<br />

Dissent (Ginsburg, with Breyer joining) :<br />

“The Court presents impressive policy reasons for its construction, but<br />

drafting history <strong>and</strong> the longst<strong>and</strong>ing scholarly <strong>and</strong> judicial underst<strong>and</strong>ing of<br />

§12(2) caution against judicial resistance to the statute's defining text. I<br />

would leave any alteration to Congress.”<br />

“The House Conference Report, which explains the Act in its final form,<br />

describes §12(2) in broad terms, <strong>and</strong> nowhere suggests that the provision is<br />

limited to public offerings:<br />

‘The House bill (sec. 12) imposes civil liability for using the mails or the facilities of<br />

interstate commerce to sell securities (including securities exempt, under section 3, from<br />

other provisions of the bill) by means of representations which are untrue or are<br />

misleading by reason of omissions of material facts.’<br />

“In light of the text, drafting history, <strong>and</strong> longst<strong>and</strong>ing scholarly <strong>and</strong> judicial<br />

underst<strong>and</strong>ing of §12(2), I conclude that §12(2) applies to a private resale of<br />

securities.”<br />

© 2012 Michael K. Krebs<br />

All Rights Reserved


When might control persons be<br />

vicariously liable for acts of others?<br />

Affiliates = Control Persons<br />

See § 15 of <strong>Securities</strong> Act<br />

See p. 117 of Soderquist<br />

© 2012 Michael K. Krebs<br />

All Rights Reserved


“Aiding <strong>and</strong> Abetting”<br />

Liability under <strong>Securities</strong> Act<br />

Evolution of theories of liability for<br />

secondary parties (accountants,<br />

lawyers, etc.)<br />

Central Bank of Denver (1994)<br />

Stoneridge Investment Partners<br />

(2008)<br />

Pacific Investment Co. v. Mayer<br />

Brown LLP (7 th Cir. April 27, 2010)<br />

© 2012 Michael K. Krebs<br />

All Rights Reserved


“Aiding <strong>and</strong> Abetting” (cont’d)<br />

Central Bank of Denver (1994)<br />

Private plaintiff may not maintain aiding <strong>and</strong><br />

abetting suit under Exchange Act 10(b)<br />

Per Supreme Court: 10(b) prohibits only<br />

making of a material misstatement (or<br />

omission) or commission of a manipulative<br />

act, <strong>and</strong> does not reach those who aid <strong>and</strong> abet<br />

a violation.<br />

©2012 Michael K. Krebs<br />

All Rights Reserved


“Aiding <strong>and</strong> Abetting” (cont’d)<br />

Stoneridge Investment Partners (2008)<br />

Vendors <strong>and</strong> customers could not be<br />

liable as primary actors under 10(b)<br />

under so-called “scheme” liability<br />

theory.<br />

©2012 Michael K. Krebs<br />

All Rights Reserved


“Aiding <strong>and</strong> Abetting” (cont’d)<br />

Pacific Investment Co. v. Mayer Brown LLP<br />

(7 th Cir. April 27, 2010)<br />

“After Stoneridge, it is somewhat unclear how . . .<br />

deceptive conduct of a secondary actor could be<br />

communicated to the public <strong>and</strong> yet remain<br />

‘deceptive.’ ”<br />

The mere fact that the ultimate result of a secondary<br />

actor's deceptive course of conduct is<br />

communicated to the public through a company's<br />

financial statements is insufficient to show reliance<br />

on the secondary actor's own deceptive conduct.<br />

©2012 Michael K. Krebs<br />

All Rights Reserved


“Aiding <strong>and</strong> Abetting” (cont’d)<br />

How did Dodd-Frank change the scope of<br />

liability for “aiding <strong>and</strong> abetting” claims?<br />

Dodd-Frank establishes a more modest<br />

“recklessness” st<strong>and</strong>ard of proof for SEC aiding<br />

<strong>and</strong> abetting claims.<br />

In 1995, Private <strong>Securities</strong> Litigation Reform<br />

Act gave SEC the right to bring claims for<br />

aiding <strong>and</strong> abetting violations of the <strong>Securities</strong><br />

Exchange Act of 1934 but required “knowing”<br />

misconduct.<br />

©-2012 Michael K. Krebs<br />

All Rights Reserved


“Aiding <strong>and</strong> Abetting” (cont’d)<br />

How did Dodd-Frank change the scope of<br />

liability for “aiding <strong>and</strong> abetting” claims?<br />

(cont’d)<br />

Since PSLRA was passed, several courts have held<br />

that actual knowledge must be shown for aiding <strong>and</strong><br />

abetting liability, <strong>and</strong> that recklessness is<br />

insufficient.<br />

With passage of Dodd-Frank Act, mere<br />

“recklessness” will be sufficient to establish the<br />

requisite state of mind for SEC aiding <strong>and</strong> abetting<br />

claims.<br />

©2012 Michael K. Krebs<br />

All Rights Reserved


Indemnification or Contribution<br />

under <strong>Securities</strong> Act<br />

SEC position against indemnification<br />

© 2012 Michael K. Krebs<br />

All Rights Reserved


Indemnification or Contribution<br />

under <strong>Securities</strong> Act<br />

SEC requires the following statement in each<br />

registration statement filed under the ’33 Act:<br />

“Insofar as indemnification for liabilities arising<br />

under the <strong>Securities</strong> Act of 1933 may be<br />

permitted to directors, officers <strong>and</strong> controlling<br />

persons of the registrant . . . , the registrant has<br />

been advised that in the opinion of the <strong>Securities</strong><br />

<strong>and</strong> Exchange Commission such indemnification<br />

is against public policy as expressed in the Act<br />

<strong>and</strong> is, therefore, unenforceable. “<br />

©2012 Michael K. Krebs<br />

All Rights Reserved


Indemnification or Contribution<br />

under <strong>Securities</strong> Act<br />

SEC position against indemnification (cont’d)<br />

“In the event that a claim for indemnification against such<br />

liabilities (other than the payment by the registrant of<br />

expenses incurred or paid by a director, officer or<br />

controlling person of the registrant in the successful<br />

defense of any action, suit or proceeding) is asserted . . . in<br />

connection with the securities being registered, the<br />

registrant will, unless in the opinion of its counsel the<br />

matter has been settled by controlling precedent, submit to<br />

a court of appropriate jurisdiction the question whether<br />

such indemnification by it is against public policy as<br />

expressed in the Act <strong>and</strong> will be governed by the final<br />

adjudication of such issue.”<br />

©2012 Michael K. Krebs<br />

All Rights Reserved


Criminal Liability<br />

Under the <strong>Securities</strong> Act<br />

Criminal liability --<br />

24:<br />

What constitutes willfulness?<br />

©2012 Michael K. Krebs<br />

All Rights Reserved


Litigation concerning violations<br />

of law in IPOs of late ’90s<br />

Please note:<br />

The following slides regarding the<br />

so-call “Initial Public Offering<br />

<strong>Securities</strong> Litigation” <strong>and</strong> related<br />

antitrust litigation are optional<br />

background material.<br />

©2012 Michael K. Krebs<br />

All Rights Reserved.


Litigation concerning violations<br />

of law in IPOs of late ’90s<br />

During the dot-com boom of the late 1990s, the stock of<br />

many technology <strong>and</strong> telecommunications companies<br />

were publicly launched in high-stakes IPOs.<br />

The so-call “Initial Public Offering <strong>Securities</strong><br />

Litigation” consisted of 309 class actions filed<br />

throughout 2001, involving more than 300 IPOs<br />

marketed between 1998 <strong>and</strong> 2000. The cases were<br />

coordinated before U.S. District Court Judge Shira A.<br />

Scheindlin in the Southern District of New York.<br />

The case is formally known as “In re Initial Public<br />

Offering <strong>Securities</strong> Litigation.”<br />

©2012 Michael K. Krebs<br />

All Rights Reserved


IPO <strong>Securities</strong> Litigation<br />

(cont’d)<br />

Plaintiffs: investors who purchased high-tech<br />

companies’ stock in after-market of IPOs<br />

Defendants: 55 IPO underwriters, 300 issuing<br />

companies, individual company directors <strong>and</strong><br />

officers<br />

Alleged misconduct<br />

Tie-in agreements/laddering<br />

Undisclosed Compensation<br />

Improper use of analysts to inflate stock prices<br />

& analyst conflicts of interest<br />

©2012 Michael K. Krebs<br />

All Rights Reserved


IPO <strong>Securities</strong> Litigation<br />

(cont’d)<br />

Specifically, plaintiff alleged three fraudulent<br />

devices used by the underwriters.<br />

First, they allege that the underwriters<br />

conditioned allocations of shares at the offer<br />

price on agreements to purchase shares in the<br />

aftermarket (the "Tie-in Agreements").<br />

©2012 Michael K. Krebs<br />

All Rights Reserved


IPO <strong>Securities</strong> Litigation<br />

(cont’d)<br />

Specifically, plaintiff alleged three fraudulent devices used<br />

by the underwriters.<br />

Second, they allege that the underwriters also required<br />

customers who received allocations of shares at the<br />

offer price to pay three forms of "Undisclosed<br />

Compensation" to the underwriters: (1) paying inflated<br />

brokerage commissions, (2) paying commissions on<br />

churned transactions in unrelated securities, <strong>and</strong> (3)<br />

purchasing other unwanted securities from the<br />

underwriters.<br />

©2012 Michael K. Krebs<br />

All Rights Reserved


IPO <strong>Securities</strong> Litigation<br />

(cont’d)<br />

Specifically, plaintiff alleged three fraudulent devices used by the<br />

underwriters.<br />

Third, Plaintiffs allege that underwriters used their analysts<br />

in several improper ways: (1) setting unrealistic price targets,<br />

(2) promising a "hot" analyst to an issuer in exchange for<br />

underwriting the IPO, (3) tying analyst compensation to<br />

performance of the investment banking division, (4) allowing<br />

analysts to own shares of stocks they were touting, <strong>and</strong> (5)<br />

failing to disclose these conflicts of interest.<br />

Plaintiffs also alleged that underwriters facilitated receipt of<br />

quick profits by insiders of defendant issuers <strong>and</strong> that the<br />

issuers "participated in <strong>and</strong> benefitted from" the underwriters'<br />

misconduct.<br />

©2012 Michael K. Krebs<br />

All Rights Reserved


IPO <strong>Securities</strong> Litigation<br />

Alleged <strong>Securities</strong> Law Violations<br />

Section 11 of the <strong>Securities</strong> Act<br />

Failure to disclose tie-in agreements <strong>and</strong> compensation<br />

arrangements in the registration statement<br />

Derivative liability under §15 for directors<br />

Section 10(b) of the Exchange Act<br />

Engaging in manipulative or deceptive practices as part<br />

of a scheme to defraud investors<br />

False or misleading statements concerning publicly<br />

traded securities<br />

Derivative liability under §20(a) for directors<br />

©2012 Michael K. Krebs<br />

All Rights Reserved


IPO <strong>Securities</strong> Litigation<br />

Refusal to Certify Plaintiffs as a Class<br />

In October 2004, Judge Scheindlin issued an<br />

order granting in part <strong>and</strong> denying in part the<br />

Plaintiffs' motions for class certification in the<br />

six focus cases.<br />

On appeal, the Second Circuit reversed, denying<br />

class certification. Miles v. Merrill Lynch & Co.<br />

(In re Initial Public Offering <strong>Securities</strong><br />

Litigation), 471 F.3d 24 (2d Cir. 2006)<br />

©2012 Michael K. Krebs<br />

All Rights Reserved


IPO <strong>Securities</strong> Litigation<br />

Refusal to Certify Plaintiffs as a Class<br />

Individual questions predominated over<br />

common questions as to:<br />

Reliance on misrepresentations<br />

Class could not rely on fraud-on-the-market doctrine<br />

because market for IPO shares is not efficient<br />

Knowledge of the misrepresentations<br />

Exclusion from class based on payment of<br />

undisclosed compensation to underwriter<br />

©2012 Michael K. Krebs<br />

All Rights Reserved


IPO <strong>Securities</strong> Litigation<br />

2009 Settlement<br />

After a long period of mediation the<br />

parties reached a $586 million cash<br />

settlement.<br />

Investment banks <strong>and</strong> issuers denied<br />

wrongdoing.<br />

Important: FINRA Rule 5131 now<br />

prohibits certain preferential<br />

allocations of “new issues”<br />

©2012 Michael K. Krebs<br />

All Rights Reserved


Please note:<br />

IPO Antitrust Case<br />

The following slides regarding the<br />

related antitrust litigation are<br />

optional background material.<br />

©2012 Michael K. Krebs<br />

All Rights Reserved.


Related Antitrust Case<br />

Contemporaneously with the In re Initial Public<br />

Offering Litigation, another putative (i.e.,<br />

proposed) class action was filed in the U.S.<br />

District Court for the Southern District of New<br />

York by investors who purchased shares of<br />

stock in certain technology related companies<br />

through IPOs or in the aftermarket immediately<br />

following IPOs during the late 1990s.<br />

©2012 Michael K. Krebs<br />

All Rights Reserved


Related Antitrust Case<br />

The complaint charged ten investment banks,<br />

including Morgan Stanley, Goldman Sachs,<br />

Lehman Brothers, Credit Suisse First Boston,<br />

<strong>and</strong> JPMorgan Chase, along with a number of<br />

institutional investors, with conspiring illegally<br />

to artificially inflate the aftermarket prices of<br />

some 900 internet <strong>and</strong> technology stocks sold in<br />

those IPOs.<br />

The plaintiffs sought treble (i.e., triple) damages<br />

under federal antitrust laws.<br />

©2012 Michael K. Krebs<br />

All Rights Reserved


Alleged Antitrust Law<br />

Violations<br />

Sherman Act, Clayton Act <strong>and</strong> Robinson-Patman<br />

Act<br />

Unlawful agreement by underwriters to refuse to<br />

sell shares unless investors agreed to:<br />

Buy additional shares at escalating prices<br />

Pay high commissions on subsequent purchases<br />

Purchase other less desirable securities from<br />

underwriter<br />

©2012 Michael K. Krebs<br />

All Rights Reserved


U.S. Supreme Court Rules<br />

<strong>Securities</strong> Laws Preclude Antitrust<br />

Claims<br />

In June 2007, the U.S. Supreme Court ruled in<br />

Credit Suisse First Boston v. Glen Billing (“IPO<br />

Antitrust Litigation”) that certain long-st<strong>and</strong>ing<br />

securities industry practices in the issuance of<br />

IPOs are impliedly immune from antitrust<br />

challenges on the ground that the regulation of<br />

such conduct is within the sole purview of the<br />

securities laws <strong>and</strong> the SEC.<br />

©2012 Michael K. Krebs<br />

All Rights Reserved


U.S. Supreme Court Rules<br />

<strong>Securities</strong> Laws Preclude Antitrust<br />

Claims<br />

The Court ruled that no antitrust liability could arise<br />

from:<br />

(1) “laddering” agreements whereby investors<br />

were required to promise to place bids in the aftermarket<br />

at prices above the IPO price;<br />

(2) “tying” arrangements whereby investors<br />

commit to purchase other, less attractive securities; <strong>and</strong><br />

(3) other allegedly excessive commissions,<br />

including for the purchase of an issuer’s shares in<br />

follow-up or secondary public offerings (for which the<br />

underwriters would earn underwriting discounts).<br />

©2012 Michael K. Krebs<br />

All Rights Reserved


U.S. Supreme Court Rules<br />

<strong>Securities</strong> Laws Preclude Antitrust<br />

Claims<br />

Court looked at 4 factors in determining “clear<br />

repugnancy” between antitrust laws <strong>and</strong> securities law:<br />

Efforts to jointly sell <strong>and</strong> market IPO securities is central to<br />

functioning of well-regulated market<br />

SEC maintained authority to enforce all challenged activity<br />

Evidence that SEC actively exercised that authority<br />

Fine line separating permissible from impermissible activity<br />

best drawn by those with expertise in securities<br />

©2012 Michael K. Krebs<br />

All Rights Reserved


U.S <strong>and</strong> <strong>Trans</strong>-<strong>Border</strong><br />

<strong>Securities</strong> <strong>Regulation</strong><br />

Boston University School of Law<br />

Executive LL.M. - International Business Law<br />

June/July 2012<br />

Michael Krebs<br />

JD, Boston University School of Law 1985<br />

Senior Partner, Nutter, McClennen & Fish, LLP, Boston, MA<br />

Tel. 617.439.2288 email: mkrebs@nutter.com<br />

© 2012 Michael K. Krebs<br />

All Rights Reserved


U.S <strong>and</strong> <strong>Trans</strong>-<strong>Border</strong><br />

<strong>Securities</strong> <strong>Regulation</strong><br />

Boston University School of Law<br />

Executive LL.M. in International Business Law<br />

Session 4<br />

July 25, 2013


Session 4 Agenda<br />

How does a company register its IPO?<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved<br />

2


Case Studies<br />

LinkedIn – November 16, 2011 IPO<br />

Facebook – May 17, 2012 IPO<br />

bluebird bio, Inc. – June 24, 2013 IPO<br />

Noodles & Company – June 28, 2013 IPO<br />

Grana y Montero Corp. – July 24, 2013 IPO<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved<br />

3


Basic Principles Underlying the<br />

<strong>Securities</strong> Act of 1933<br />

Unless an exemption is available,<br />

1. Every offer or sale of a security must be<br />

registered with the SEC under § 5 of the<br />

<strong>Securities</strong> Act, <strong>and</strong><br />

2. In the registration statement (which includes<br />

the prospectus), all information regarding<br />

the issuer <strong>and</strong> the security that is material to<br />

that investment decision must be disclosed.


Underst<strong>and</strong>ing SEC<br />

Disclosure Regime for IPOs<br />

How did Facebook <strong>and</strong> the other case<br />

study companies know what to<br />

disclose in their IPO registration<br />

statement?<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved<br />

5


Underst<strong>and</strong>ing SEC<br />

Disclosure Regime for IPOs<br />

What disclosure does the <strong>Securities</strong><br />

Act itself specify?<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved<br />

6


Underst<strong>and</strong>ing SEC<br />

Disclosure Regime for IPOs<br />

Not Important:<br />

§ 7 <strong>and</strong> Schedule A of the <strong>Securities</strong> Act<br />

EXCEPT: See § 7(a)(2) regarding financial<br />

statements<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved<br />

7


Underst<strong>and</strong>ing SEC<br />

Disclosure Regime for IPOs<br />

Very Important:<br />

SEC Form S-1 (or F-1)<br />

SEC <strong>Regulation</strong> S-K<br />

SEC <strong>Regulation</strong> S-X<br />

SEC “Industry Guides” (if applicable)<br />

SEC <strong>Regulation</strong> C (Rules 400 et seq.)<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved<br />

8


Underst<strong>and</strong>ing SEC<br />

Disclosure Regime for IPOs<br />

<strong>Regulation</strong> C (Rules 400 et seq.), especially:<br />

Rule 421(d) (“plain English” rules)<br />

Rule 408 (additional material information)<br />

Rule 418 (SEC authority to request<br />

“supplemental” information)<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved<br />

9


Underst<strong>and</strong>ing SEC<br />

Disclosure Regime for IPOs<br />

But first, some context!<br />

Prior to JOBS Act<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved<br />

10


Session 4<br />

Life Cycle of a Typical IPO<br />

1. Company tentatively decides to raise capital<br />

2. Company, after consultation with counsel,<br />

concludes than none of the exemptions from § 5<br />

registration will likely be available<br />

3. Company counsel advises management regarding<br />

compliance with “gun jumping” rules<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved<br />

11


Session 4<br />

Life Cycle of a Typical IPO<br />

4. Company contacts one or more investment<br />

banking firms to ascertain interest in acting as<br />

managing underwriter or co-managing<br />

underwriter in public offering<br />

5. Company selects one or more managing<br />

underwriters <strong>and</strong> may issue press release,<br />

especially if company is publicly traded.<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved<br />

12


Session 4<br />

Life Cycle of a Typical IPO (cont’d)<br />

6. Managing underwriter, underwriter’s counsel <strong>and</strong> company<br />

counsel conduct due diligence review of company’s<br />

business, financial condition, results of operations, <strong>and</strong><br />

prospects, including interviews with senior management<br />

7. Company <strong>and</strong> company counsel prepare registration<br />

statement (including underlying prospectus) in collaboration<br />

with managing underwriter, underwriter’s counsel<br />

NB. Company’s independent accountants are involved<br />

but typically keep their distance from the prospectus<br />

drafting but review in connection with their “comfort<br />

letter” due diligence<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved<br />

13


Session 4<br />

Life Cycle of a Typical IPO (cont’d)<br />

8. Managing underwriter has preliminary discussions with other<br />

members of underwriting “syndicate” (those underwriters who<br />

will be parties to the underwriting agreement <strong>and</strong> therefore in<br />

“privity” of contract with the company)<br />

Prior to JOBS Act, underwriters did NOT have discussions<br />

at this stage with “dealers” who often will purchase stock<br />

directly from the underwriters in the offering<br />

NB. JOBS Act – namely, §5(d) – allows written or oral<br />

“test the waters” communications with “qualified<br />

institutional buyers [QIBs] or institutions that are<br />

accredited investors”<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved<br />

14


Session 4<br />

Life Cycle of a Typical IPO (cont’d)<br />

9. Managing underwriter has preliminary discussions with<br />

company’s independent registered public accounting firm<br />

regarding scope of “comfort” letter that accounting firm will<br />

provide with respect to financial data in prospectus that is derived<br />

from company’s financial statements. The comfort letter will be a<br />

part of due diligence defense for §11 <strong>and</strong> §12(a)(2) purposes.<br />

10. Company files registration statement with SEC electronically<br />

via EDGAR system. The registration statement includes a<br />

“delaying amendment.” More about that later.<br />

11. Company typically issues a press release. If so, the Company<br />

likely would uses the safe harbor in Rule 134, so press release is<br />

not a prospectus<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved<br />

15


Session 4<br />

Life Cycle of a Typical IPO (cont’d)<br />

12. The SEC’s Division of Corporation Finance (or “Corp<br />

Fin”) reviews all IPO registration statements. Corp Fin<br />

assigns accounting <strong>and</strong> non-accounting reviewers from<br />

one of 12 Offices organized by industry. (In a non-IPO,<br />

Corp Fin makes a threshold decision whether to review<br />

registration statement.) See<br />

http://sec.gov/divisions/corpfin/cffilingreview.htm for the<br />

SEC’s summary of the review process.<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved<br />

16


Session 4<br />

Life Cycle of a Typical IPO (cont’d)<br />

13. The lead non-accountant Corp Fin reviewer assigned to<br />

the registration statement contacts Company counsel. In<br />

the case of a non-IPO registration, Corp Fin will inform<br />

Company counsel whether registration statement is being<br />

reviewed <strong>and</strong>, if so, which of the three levels of review the<br />

registration statement will receive:<br />

Full Review – a “cover-to-cover” review of the registration<br />

statement in which the staff will examine the entire filing<br />

(including exhibits) for compliance with the applicable<br />

disclosure requirements of the federal securities laws <strong>and</strong><br />

regulations – all IPO registration statements receive full<br />

review;<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved<br />

17


Session 4<br />

Life Cycle of a Typical IPO (cont’d)<br />

Financial Statement Review – The staff will examine<br />

the financial statements <strong>and</strong> related disclosure, such as<br />

MD&A, for compliance with the applicable accounting<br />

st<strong>and</strong>ards <strong>and</strong> SEC disclosure requirements; or<br />

Targeted Review – The staff will examine the filing<br />

for one or more specific items of disclosure for<br />

compliance with the applicable accounting st<strong>and</strong>ards<br />

<strong>and</strong>/or other disclosure requirements.<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved<br />

18


Session 4<br />

Life Cycle of a Typical IPO (cont’d)<br />

14. In the case of an IPO registration statement, or a non-IPO registration<br />

receiving a “full review,” the first round of staff comments likely will<br />

be received within 30 to 40 days of initial filing.<br />

15. During waiting period, underwriters begin to contact dealers <strong>and</strong><br />

customers. NB. JOBS Act allows discussions with QIBs <strong>and</strong><br />

institutions that are accredited investors<br />

16. Company receives comments from SEC staff regarding registration<br />

statement<br />

17. Company <strong>and</strong> company counsel revise registration statement<br />

(including underlying prospectus) in collaboration with managing<br />

underwriter, underwriter’s counsel <strong>and</strong> company’s independent<br />

accountants<br />

18. Company files amendment to registration statement<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved<br />

19


Session 4<br />

Life Cycle of a Typical IPO (cont’d)<br />

19. Company receives one or more additional rounds of comments<br />

from SEC regarding registration statement<br />

20. Steps 15 – 17 repeated, as necessary (often the Company will<br />

file multiple amendments)<br />

21. Company counsel <strong>and</strong> underwriter’s counsel negotiate form of<br />

underwriting agreement. NB. This often occurs before the<br />

initial registration filing.<br />

22. Underwriter’s counsel has detailed discussions with the<br />

company’s independent registered public accounting firm<br />

regarding the scope of “comfort” letter the accounting firm will<br />

provide when the offering closes. NB. This often occurs before<br />

the initial registration filing.<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved<br />

20


Session 4<br />

Life Cycle of a Typical IPO (cont’d)<br />

23. Company <strong>and</strong> managing underwriters conclude that the<br />

Company has addressed all of the SEC staff’s substantive<br />

comments, the prospectus is in substantially final form,<br />

<strong>and</strong> SEC staff would be willing to cause the registration<br />

statement to be declared “effective” upon request. A<br />

Company typically will wait until the staff informs<br />

Company counsel that the staff “has no further<br />

comments.”<br />

24. Underwriters distribute “preliminary prospectus” (which<br />

is often referred to as a “red herring” because of the red<br />

“Subject to completion” legend on the cover page of the<br />

prospectus)<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved<br />

21


Session 4<br />

Life Cycle of a Typical IPO (cont’d)<br />

25. Company (CEO <strong>and</strong> CFO) <strong>and</strong> managing underwriters<br />

go on “road show.” (Lawyers stay home.)<br />

26. Underwriters solicit offers to purchase from dealers <strong>and</strong><br />

other prospective purchasers<br />

27. Managing underwriters obtain “lock-up” agreements<br />

from Company insiders, whereby the agree not to sell<br />

stock for a specified period after the effective date<br />

(typically 90 days to one year; in the Facebook IPO,<br />

the lock-up periods ranged from 91 days to 366<br />

days with 211 days Mr. Zuckerberg<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved<br />

22


Session 4<br />

Life Cycle of a Typical IPO (cont’d)<br />

28. When managing underwriters believe the offering is<br />

sufficiently oversubscribed, the Company files “acceleration<br />

request” with SEC staff<br />

29. Company <strong>and</strong> managing underwriters have final discussions<br />

regarding offering price of securities. Per FINRA Rule 5131,<br />

book-running lead manager provides to issuer a report of<br />

indications of interest, including names of interested<br />

institutional investors <strong>and</strong> number of shares indicated by each,<br />

<strong>and</strong> a report of aggregate dem<strong>and</strong> from retail investors.<br />

30. SEC declares registration statement effective<br />

31. Company <strong>and</strong> managing underwriters execute<br />

underwriting agreement<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved<br />

23


Session 4<br />

Life Cycle of a Typical IPO (cont’d)<br />

32. Underwriters electronically send confirmations of orders<br />

to dealers <strong>and</strong> other purchaser with link to “final”<br />

prospectus, which includes pricing info (More about this<br />

later)<br />

33. Company files definitive prospectus under Rule 424(b)<br />

34. Closing or settlement usually occurs on the third business<br />

day after price (T+3) when underwriters receive funds from<br />

purchasers <strong>and</strong> deliver funds to company<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved<br />

24


Session 4<br />

Life Cycle of a Typical IPO (cont’d)<br />

35. After IPO settlement date, book-running lead manager<br />

provides to issuer, per FINRA Rule 5131, a report of the<br />

final allocation of shares<br />

36. 2 business days before release of lock-up, the book-running<br />

lead manager must announce the impending release or<br />

waiver through a major news service. Per FINRA Rule 5131<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved<br />

25


Session 4<br />

Life Cycle of A123 Systems, Inc.<br />

A very protracted IPO<br />

A123 Systems, Inc. designs, develops, manufactures <strong>and</strong> sells<br />

advanced, rechargeable lithium-ion batteries <strong>and</strong> battery<br />

systems.<br />

“Our batteries <strong>and</strong> battery systems provide a combination of<br />

power, safety <strong>and</strong> life that we believe no other commercially<br />

available battery provides.”<br />

“We believe that lithium-ion batteries will play an increasingly<br />

important role in facilitating a shift toward cleaner forms of<br />

energy. Using our innovative approach to materials science <strong>and</strong><br />

battery engineering . . . , we have developed a broad family of<br />

high-power lithium-ion batteries <strong>and</strong> battery systems.”<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved<br />

26


Timeline<br />

Session 4<br />

Life Cycle of A123 Systems IPO<br />

Filed registration statement in August ‘08 covering the<br />

offer <strong>and</strong> sale of approximately $175 million of common<br />

stock.<br />

Multiple amendments (3x) filed in fall ’08<br />

April 2009: Sells $70 million of equity in Rule 506 private<br />

placement<br />

June 2009: Files Amend. No. 4 to registration statement<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved<br />

27


Timeline (cont’d)<br />

Session 4<br />

Life Cycle of A123 Systems, Inc.<br />

2009 IPO<br />

September 23, 2009: SEC issues an order granting confidential<br />

treatment for certain portions of exhibits filed with a registration<br />

statement<br />

September 23, 2009: SEC declares registration statement effective<br />

September 24, 2009: Files definitive prospectus under Rule 424(b)<br />

$380 million offering of common stock<br />

A123 Systems, Inc. offering 27,500,000 shares of common stock<br />

“Selling stockholders” identified in prospectus, which include<br />

members of senior management, offering an additional 680,501<br />

shares<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved<br />

28


Underst<strong>and</strong>ing SEC<br />

Disclosure Regime for IPOs<br />

Now, back to case study issuers<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved<br />

29


Basic Principle Underlying the<br />

<strong>Securities</strong> Act of 1933<br />

Disclosure regime vs. merit review


What did<br />

Noodles & Company Disclose?<br />

Noodles & Company’s definitive prospectus filed under Rule 424(b)<br />

contained the following statements:<br />

The <strong>Securities</strong> <strong>and</strong> Exchange Commission <strong>and</strong> state securities regulators have<br />

not approved or disapproved these securities, or determined if this prospectus<br />

is truthful or complete. Any representation to the contrary is a criminal<br />

offense.<br />

You should rely only on the information contained in this prospectus or in any<br />

free-writing prospectus we may authorize to be delivered or made available to<br />

you. We have not, <strong>and</strong> the underwriters have not, authorized anyone to<br />

provide you with additional or different information. * * * The information<br />

in this prospectus or any free-writing prospectus is accurate only as of its date,<br />

regardless of its time of delivery or of any sale of shares of our Class A<br />

common stock. Our business, financial condition, results of operations <strong>and</strong><br />

prospects may have changed since that date.<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved<br />

31


Session 4 – Underst<strong>and</strong>ing SEC<br />

Disclosure Regime for IPOs<br />

Study Problem 4.1<br />

Within a month after the BeanTown Biosystems board authorizes the<br />

IPO, Biosystems chooses the investment banking firm Morgan<br />

Stanley to serve as the lead underwriter, <strong>and</strong> Biosystems <strong>and</strong> its<br />

counsel begin to prepare the registration statement that Biosystems<br />

expects to file with the SEC within the next 30 days for a public<br />

offering of 10,000,000 shares at a estimated offering price of<br />

$10/share.<br />

Biosystems is incorporated in Delaware. Its principal office is in<br />

Massachusetts.<br />

What registration form would Biosystems file with the SEC for<br />

its IPO?<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved<br />

32


Session 4 –Underst<strong>and</strong>ing SEC<br />

Disclosure Regime for IPOs<br />

Study Problem 4.1 – Analysis<br />

What registration form would Biosystems file with<br />

the SEC?<br />

Form S-1<br />

©2013 Michael K. Krebs<br />

All Rights Reserved


Session 4 –Underst<strong>and</strong>ing SEC<br />

Disclosure Regime for IPOs<br />

Study Problem 4.1 – Analysis<br />

Form S-1 is the “default” form for nongovernmental<br />

U.S. issuers:<br />

Eligibility Requirements for Use of Form S-1<br />

“This Form shall be used for the registration under the .<br />

. . <strong>Securities</strong> Act of securities of all registrants for<br />

which no other form is authorized or prescribed, except<br />

that this Form shall not be used for securities of foreign<br />

governments or political subdivisions thereof.”<br />

©2013 Michael K. Krebs<br />

All Rights Reserved


Session 4 – Case Studies<br />

Study Problem 4.2<br />

What registration form did the following<br />

issuers file?<br />

LinkedIn<br />

Facebook<br />

bluebird bio, Inc.<br />

Noodles & Company<br />

Grana y Montero Corp.<br />

(c) 2013 Michael K. Krebs All Rights<br />

Reserved<br />

35


Underst<strong>and</strong>ing SEC<br />

Disclosure Regime for IPOs<br />

How did Facebook know what to<br />

disclose in its IPO registration<br />

statement?<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved<br />

36


Underst<strong>and</strong>ing SEC<br />

Disclosure Regime for IPOs<br />

Form S-1 Framework<br />

II. Application of General Rules <strong>and</strong> <strong>Regulation</strong>s<br />

A. Attention is directed to the General Rules <strong>and</strong> <strong>Regulation</strong>s under<br />

the <strong>Securities</strong> Act, particularly those comprising <strong>Regulation</strong> C.<br />

That <strong>Regulation</strong> contains general requirements regarding the<br />

preparation <strong>and</strong> filing of the registration statement.<br />

B. Attention is directed to <strong>Regulation</strong> S-K for the requirements<br />

applicable to the content of the non-financial statement portions<br />

of registration statements under the <strong>Securities</strong> Act. Where this<br />

Form directs the registrant to furnish information required by<br />

<strong>Regulation</strong> S-K <strong>and</strong> the item of <strong>Regulation</strong> S-K so provides,<br />

information need only be furnished to the extent appropriate.<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved<br />

37


Underst<strong>and</strong>ing SEC<br />

Disclosure Regime for IPOs<br />

Form S-1 Framework (cont’d)<br />

Item 4. Use of Proceeds.<br />

Furnish the information required by Item 504 of<br />

<strong>Regulation</strong> S-K<br />

Item 6. Dilution.<br />

Furnish the information required by Item 506 of<br />

<strong>Regulation</strong> S-K<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved<br />

38


Underst<strong>and</strong>ing SEC<br />

Disclosure Regime for IPOs<br />

What is SEC <strong>Regulation</strong> S-K?<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved<br />

39


SEC <strong>Regulation</strong> S-K<br />

Reg. S-K, Rule 10 – The “Rosetta Stone”<br />

Reg. S-K states the requirements applicable to the content of the nonfinancial<br />

statement portions of:<br />

1. Registration statements under the <strong>Securities</strong> Act to the extent<br />

provided in the forms to be used for registration under such Act; <strong>and</strong><br />

2. Registration statements under Exchange Act (“EA”) Section 12,<br />

annual or other reports under EA Sections 13 <strong>and</strong> 15(d), goingprivate<br />

transaction statements under EA Section 13, tender offer<br />

statements under EA Sections 13 <strong>and</strong> 14, proxy <strong>and</strong> information<br />

statements under EA section 14, <strong>and</strong> any other documents required to<br />

be filed under the EA to the extent provided in the forms <strong>and</strong> rules<br />

under that Act.<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved<br />

40


SEC <strong>Regulation</strong> S-K<br />

Example of Reg. S-K Disclosure Requirements:<br />

Item 504 -- Use of Proceeds<br />

State the principal purposes for which the net<br />

proceeds to the registrant from the securities to be<br />

offered are intended to be used <strong>and</strong> the approximate<br />

amount intended to be used for each such purpose.<br />

Where registrant has no current specific plan . . . so<br />

state <strong>and</strong> discuss the principal reasons for the offering.<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved<br />

41


Don’t Forget <strong>Regulation</strong> C!<br />

For example, Rule 421(a) directs:<br />

The information required in a prospectus need not follow<br />

the order of the items or other requirements in the form.<br />

Such information shall not, however, be set forth in such<br />

fashion as to obscure any of the required information or<br />

any information necessary to keep the required<br />

information from being incomplete or misleading. Where<br />

an item requires information to be given in a prospectus in<br />

tabular form it shall be given in substantially the tabular<br />

form specified in the item.<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved<br />

42


<strong>Regulation</strong> C (cont’d)<br />

In addition, Rule 408(a) specifies:<br />

“In addition to the information expressly required to be<br />

included in a registration statement, there shall be added<br />

such further material information, if any, as may be<br />

necessary to make the required statements, in the light of<br />

the circumstances under which they are made, not<br />

misleading.”<br />

Sound familiar?<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved<br />

43


What did Facebook Disclose?<br />

USE OF PROCEEDS<br />

We estimate that our net proceeds from the sale of the Class A common stock . .<br />

. will be approximately $6.8 billion, or approximately $6.9 billion if the<br />

underwriters exercise in full their right to purchase additional shares to cover<br />

over-allotments, based on the initial public offering price of $38.00 per share,<br />

after deducting underwriting discounts <strong>and</strong> commissions <strong>and</strong> estimated offering<br />

expenses payable by us.<br />

The principal purposes of our initial public offering are to create a public market<br />

for our Class A common stock <strong>and</strong> thereby enable future access to the public<br />

equity markets by us <strong>and</strong> our employees, obtain additional capital, <strong>and</strong> facilitate<br />

an orderly distribution of shares for the selling stockholders. We intend to use<br />

the net proceeds to us from our initial public offering for working capital <strong>and</strong><br />

other general corporate purposes; however, we do not currently have any<br />

specific uses of the net proceeds planned. * * *<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved<br />

44


What did Facebook Disclose?<br />

USE OF PROCEEDS (continued)<br />

* * * Additionally, we may use a portion of the proceeds to us for<br />

acquisitions of complementary businesses, technologies, or other assets.<br />

However, we have no commitments to use the proceeds from this<br />

offering for any such acquisitions or investments at this time.<br />

Pending other uses, we intend to invest the proceeds to us in investmentgrade,<br />

interest-bearing securities * * * Our management will have<br />

broad discretion in the application of the net proceeds we receive from<br />

our initial public offering, <strong>and</strong> investors will be relying on the judgment<br />

of our management regarding the application of the net proceeds.<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved<br />

45


What did bluebird bio<br />

Disclose?<br />

USE OF PROCEEDS<br />

We estimate that the net proceeds from the sale of 5,941,176 shares of common<br />

stock in this offering will be approximately $90.9 million based on the initial public<br />

offering price of $17.00 per share, after deducting underwriting discounts <strong>and</strong><br />

commissions <strong>and</strong> estimated offering expenses payable by us. * * *<br />

We are undertaking this offering in order to access the public capital markets <strong>and</strong> to<br />

increase our liquidity. We intend to use the net proceeds of this offering as follows:<br />

Approximately $11.8 million to fund direct research <strong>and</strong> development expenses for<br />

our ALD-102 Study, a Phase II/III clinical study of Lenti-D * * *<br />

The remainder for general <strong>and</strong> administrative expenses (including personnelrelated<br />

costs), potential future development programs, early-stage research <strong>and</strong><br />

development, capital expenditures <strong>and</strong> working capital <strong>and</strong> other general corporate<br />

purposes.<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved<br />

46


What did Noodles &<br />

Company Disclose?<br />

USE OF PROCEEDS<br />

The net proceeds we receive from this offering will be approximately $87.0<br />

million based on the initial public offering price of $18.00 per share, after<br />

deducting the underwriting discounts <strong>and</strong> commissions <strong>and</strong> estimated offering<br />

expenses payable by us. If the underwriters' option to purchase additional shares<br />

in this offering from us is exercised, our net proceeds will be approximately<br />

$100.4 million after deducting the underwriting discounts <strong>and</strong> commissions <strong>and</strong><br />

estimated offering expenses payable by us.<br />

We intend to use approximately $85.9 million of the net proceeds we receive<br />

from this offering to repay borrowings under our credit facility, which has a<br />

maturity date of August 1, 2017 <strong>and</strong> had an outst<strong>and</strong>ing balance of<br />

approximately $100.3 million as of April 2, 2013. * * * We intend to use any<br />

remaining proceeds for working capital <strong>and</strong> other general corporate purposes.<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved<br />

47


Underst<strong>and</strong>ing SEC<br />

Disclosure Regime for IPOs<br />

What is SEC <strong>Regulation</strong> S-X?<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved<br />

48


SEC <strong>Regulation</strong> S-X<br />

Same concept as Reg. S-K, but applicable to financial statements<br />

Reg. S-X (together with the SEC’s Financial Reporting Releases)<br />

sets forth the form <strong>and</strong> content of <strong>and</strong> requirements for financial<br />

statements required to be filed as a part of:<br />

1. Registration statements under the <strong>Securities</strong> Act, except as<br />

otherwise specifically provided in the applicable form;<br />

2. Registration statements under EA Section 12, annual or<br />

other reports under EA Sections 13 <strong>and</strong> 15(d) <strong>and</strong> proxy<br />

<strong>and</strong> information statements under EA Section 14 except as<br />

otherwise specifically provided in the applicable form;<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved<br />

49


What did LinkedIn Disclose?<br />

LINKEDIN CORPORATION<br />

INDEX TO CONSOLIDATED FINANCIAL STATEMENTS<br />

Report of Independent Registered Public Accounting Firm (F-2 )<br />

Consolidated Balance Sheets (F-3)<br />

Consolidated Statements of Operations (F-4)<br />

Consolidated Statements of Redeemable Convertible Preferred Stock,<br />

Stockholders’ Equity <strong>and</strong> Comprehensive Income (Loss) (F-5)<br />

Consolidated Statements of Cash Flows ( F-7 )<br />

Notes to Consolidated Financial Statements (F-8)<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved<br />

50


What did LinkedIn Disclose?<br />

LINKEDIN CORPORATION<br />

Report of Independent Registered Public Accounting Firm<br />

States that Deloitte & Touche audited the accompanying consolidated<br />

financial statements of LinkedIn <strong>and</strong> subsidiaries<br />

Notes, as is customary, that the financial statements are LinkedIn’s<br />

responsibility, not Deloitte’s<br />

Opines that the consolidated financial statements present fairly, in all<br />

material respects, the financial position of LinkedIn as of December 31,<br />

2009 <strong>and</strong> 2010, <strong>and</strong> the results of operations <strong>and</strong> cash flows for each of<br />

the three years in the period ended December 31, 2010, in conformity<br />

with accounting principles generally accepted in the United States of<br />

America.<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved<br />

51


Underst<strong>and</strong>ing SEC<br />

Disclosure Regime for IPOs<br />

How did JOBS Act affect<br />

<strong>Regulation</strong> S-X?<br />

Did §7(a)(2) affect the financial<br />

statements included in the Noodles<br />

prospectus?<br />

What about the bluebird bio prospectus?<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved<br />

52


luebird bio Disclosure regarding<br />

Emerging Growth Company Status<br />

In “Risk Factors” section of definitive prospectus, bluebird bio<br />

disclosed:<br />

“We are an “emerging growth company,” <strong>and</strong> we cannot be certain if<br />

the reduced reporting requirements applicable to emerging growth<br />

companies will make our common stock less attractive to investors.<br />

“We are an “emerging growth company” * * * For as long as we continue<br />

to be an emerging growth company, we may take advantage of exemptions<br />

from various reporting requirements * * * including not being required to<br />

comply with the auditor attestation requirements of Section 404 of the<br />

Sarbanes-Oxley Act of 2002 * * * We cannot predict if investors will find<br />

our common stock less attractive because we may rely on these<br />

exemptions.”<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved<br />

53


luebird bio Disclosure regarding<br />

Emerging Growth Company Status<br />

Risk Factor disclosure (cont’d):<br />

“Under the JOBS Act, emerging growth companies can also delay<br />

adopting new or revised accounting st<strong>and</strong>ards until such time as<br />

those st<strong>and</strong>ards apply to private companies. We have irrevocably<br />

elected not to avail ourselves of this exemption from new or revised<br />

accounting st<strong>and</strong>ards <strong>and</strong>, therefore, will be subject to the same new<br />

or revised accounting st<strong>and</strong>ards as other public companies that are<br />

not emerging growth companies.” [Emphasis added.]<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved<br />

54


Underst<strong>and</strong>ing SEC<br />

Disclosure Regime for IPOs<br />

What are the SEC “Industry Guides”?<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved<br />

55


What did Graña y Montero<br />

Disclose?<br />

What industry guide, if any, is applicable to<br />

Graña y Montero S.A.A.’s registration<br />

statement?<br />

Hint: See first page of the section of financial<br />

statements titled:<br />

“Supplementary Data (Unaudited)”<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved<br />

56


SEC Industry Guides<br />

http://www.sec.gov/about/forms/industryguides.pdf<br />

Disclosure of oil <strong>and</strong> gas operations<br />

Statistical disclosure by bank holding companies<br />

Prospectus relating to interests in oil <strong>and</strong> gas programs<br />

Registration of interests in real estate limited partnerships<br />

Disclosures concerning unpaid claims <strong>and</strong> claim adjustment<br />

expenses of property-casualty insurance underwriters<br />

Description of property by issuers engaged or to be engaged<br />

in significant mining operations<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved<br />

57


Another Overarching Principle –<br />

Integrated Disclosure Under <strong>Securities</strong><br />

Act <strong>and</strong> Exchange Act<br />

Integrated Disclosure<br />

Forms S-1, S-3, S-4, S-8, etc.<br />

Reg. S-K, Reg. S-X<br />

SEC “Industry Guides”<br />

Risk Factors<br />

MD&A or “Management’s Discussion <strong>and</strong><br />

Analysis of Financial Condition <strong>and</strong> Results of<br />

Operations”<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved<br />

58


Objectives of Integrated Disclosure<br />

System:<br />

No. 1 – St<strong>and</strong>ardize ’33 Act/’34 Act<br />

Disclosure<br />

St<strong>and</strong>ardize categories of information<br />

required in SEC filings <strong>and</strong> investor<br />

documents under both the <strong>Securities</strong> Act<br />

<strong>and</strong> the Exchange Act<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved<br />

59


“Three Amigos” of Integrated<br />

Disclosure<br />

<strong>Regulation</strong> S-K<br />

Disclosures Other Than Financial Statements<br />

<strong>Regulation</strong> S-X (supplemented by Industry Guides)<br />

Form <strong>and</strong> Content of Financial Statements<br />

Industry Guides require supplemental statistical<br />

disclosure for certain industries<br />

<strong>Regulation</strong> M-A<br />

M&A/Tender Offer Disclosure<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved<br />

60


Objectives of Integrated Disclosure<br />

System:<br />

No. 2 – Incorporation by Reference<br />

Permit various information to be<br />

incorporated by reference from the<br />

issuer’s other ‘34 Act reports or ‘33 Act<br />

registration statements<br />

previously filed, or<br />

subsequently filed<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved<br />

61


Primary ’33 Act Examples of<br />

Incorporation by Reference<br />

S-3 Registration Statement<br />

S-4 Registration Statement<br />

S-8 Registration Statement<br />

More about this in Session 5<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved<br />

62


Underst<strong>and</strong>ing SEC<br />

Disclosure Regime for IPOs<br />

What is meant by the phrase<br />

“plain English”?<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved<br />

63


What is meant by the phrase<br />

“plain English”?<br />

Rule 421(d) – known as the “Plain English Rule”<br />

Issuers must use plain English principles in the<br />

organization, language, <strong>and</strong> design of these sections<br />

of the prospectus:<br />

front <strong>and</strong> back cover pages,<br />

summary, <strong>and</strong><br />

risk factors section.<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved<br />

64


“Plain English” (cont’d)<br />

For those sections where plain English in required by Rule 421(d)<br />

[see preceding slide], the following principles apply:<br />

Short sentences;<br />

Definite, concrete, everyday words;<br />

Active voice;<br />

Tabular presentation or bullet lists for complex<br />

material, whenever possible;<br />

No legal jargon or highly technical business terms; <strong>and</strong><br />

No multiple negatives.<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved<br />

65


“Plain English” (cont’d)<br />

In designing these sections specified by Rule 421(d) (or other<br />

sections of the prospectus,) you may include pictures, logos,<br />

charts, graphs, or other design elements so long as the design is<br />

not misleading <strong>and</strong> the required information is clear.<br />

Issuers are encouraged to use tables, schedules, charts <strong>and</strong><br />

graphic illustrations of the results of operations, balance sheet,<br />

or other financial data that present the data in an<br />

underst<strong>and</strong>able manner.<br />

See generally <strong>Securities</strong> Act Release No. 33–7497 (January<br />

28, 1998) for information on plain English principles<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved<br />

66


What did LinkedIn Disclose?<br />

Risks Related to Our Business<br />

We have a short operating history in a new <strong>and</strong> unproven market, which makes it difficult to<br />

evaluate our future prospects <strong>and</strong> may increase the risk that we will not be successful.<br />

We have a short operating history in a new <strong>and</strong> unproven market that may not develop as<br />

expected, if at all. This short operating history makes it difficult to effectively assess our future<br />

prospects. You should consider our business <strong>and</strong> prospects in light of the risks <strong>and</strong> difficulties<br />

we encounter in this rapidly evolving market. These risks <strong>and</strong> difficulties include our ability to,<br />

among other things:<br />

• increase our number of registered members <strong>and</strong> member engagement;<br />

• avoid interruptions or disruptions in our service or slower than expected website load<br />

times;<br />

• develop a scalable, high-performance technology infrastructure that can efficiently<br />

<strong>and</strong> reliably h<strong>and</strong>le increased member usage globally, as well as the deployment of<br />

new features <strong>and</strong> products; * * *<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved<br />

67


Underst<strong>and</strong>ing SEC<br />

Disclosure Regime for IPOs<br />

Who must sign a registration<br />

statement?<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved<br />

68


Underst<strong>and</strong>ing SEC<br />

Disclosure Regime for IPOs<br />

Who must consent to the filing<br />

of a registration statement?<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved<br />

69


Underst<strong>and</strong>ing SEC<br />

Disclosure Regime for IPOs<br />

What is a delaying amendment?<br />

Why is it relevant?<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved<br />

70


Why Do Issuers use a<br />

Delaying Amendment?<br />

Consider § 8(a) of the<br />

<strong>Securities</strong> Act<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved<br />

71


What did Grana y Montero<br />

Corp. Do?<br />

Grana y Montero Corp.’s initial F-1 filing on June 4, 2013<br />

contains the following statement toward the bottom of the<br />

registration statement cover page:<br />

The Registrant hereby amends this Registration Statement on<br />

such date or dates as may be necessary to delay its effective date<br />

until the Registrant shall file a further amendment which<br />

specifically states that this Registration Statement shall thereafter<br />

become effective in accordance with Section 8(a) of the <strong>Securities</strong><br />

Act, or until this Registration Statement shall become effective on<br />

such date as the Commission, acting pursuant to said Section 8(a),<br />

may determine.<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved<br />

72


Underst<strong>and</strong>ing SEC<br />

Disclosure Regime for IPOs<br />

Must a company file an IPO<br />

registration statement electronically<br />

with the SEC?<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved<br />

73


Underst<strong>and</strong>ing SEC<br />

Disclosure Regime for IPOs<br />

May a company file an IPO registration<br />

statement confidentially with the SEC?<br />

What did the following issuers do?<br />

bluebird bio, Inc.<br />

Noodles & Company<br />

Grana y Montero Corp.<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved<br />

74


Underst<strong>and</strong>ing SEC<br />

Disclosure Regime for IPOs<br />

What is a “free writing prospectus”?<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved<br />

75


A Few Words About “Free Writing”<br />

The 2005 Offering Reforms permit the use of a category of<br />

written offering material known as “free writing prospectuses.”<br />

A free writing prospectus is any written communication that<br />

constitutes an offer to sell (or solicitation of an offer to buy)<br />

securities that are or will be the subject of a registered offering<br />

<strong>and</strong> that is not a statutory prospectus or other written<br />

communication permitted or exempted under other provisions<br />

of the securities laws.<br />

See SEC Rules 164 <strong>and</strong> 433 (<strong>and</strong> 405).<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved<br />

76


“Free Writing” (cont’d)<br />

The term “free writing” includes offering-related emails,<br />

faxes, term sheets <strong>and</strong> other written <strong>and</strong> prerecorded<br />

electronic communications.<br />

Free writing prospectuses are permitted to be used<br />

after a registration statement has been filed with the<br />

SEC upon satisfaction of certain conditions, including<br />

filing in some cases.<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved<br />

77


“Free Writing” (cont’d)<br />

In connection with IPOs <strong>and</strong> offerings by other “unseasoned<br />

issuers,”<br />

a free writing prospectus may be used only if it is<br />

accompanied or preceded by a preliminary prospectus<br />

(which, in the IPO context, must include a price range).<br />

In the case of electronic communications, a hyperlink to<br />

the preliminary prospectus would satisfy this delivery<br />

requirement.<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved<br />

78


“Free Writing” (cont’d)<br />

The free writing prospectus is subject to prospectus liability<br />

under <strong>Securities</strong> Act Section 12(a)(2) for the user.<br />

But the free writing prospectus is not deemed part of the<br />

registration statement <strong>and</strong>, accordingly, does not carry<br />

<strong>Securities</strong> Act Section 11 cross-liability for all underwriters.<br />

The rules also clarify that an underwriter generally is not<br />

liable under Section 12(a)(2) for another person’s free writing<br />

prospectuses so long as the underwriter does not use or refer to<br />

that writing.<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved<br />

79


Underst<strong>and</strong>ing SEC<br />

Disclosure Regime for IPOs<br />

What is a road show?<br />

Does it involve a “prospectus”?<br />

Is it live or recorded?<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved<br />

80


Road Shows<br />

Fidelity Investment’s IPO glossary defines a Road Show<br />

as follows:<br />

Also called the 'Dog <strong>and</strong> Pony Show'. A tour taken by a<br />

company preparing for an IPO in order to attract interest in<br />

its securities. Attended by potential buyers, including<br />

institutional investors, analysts, <strong>and</strong> money managers by<br />

invitation only. Members of the media are forbidden to<br />

attend.<br />

For non-WSKIs, occurs only after registration statement is<br />

on file, but this may change as a result of new §5(d).<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved<br />

81


Underst<strong>and</strong>ing SEC<br />

Disclosure Regime for IPOs<br />

SEC View of Electronic Communications<br />

Essentially all pre-recorded electronic communications are treated as<br />

written communications, rather than as oral communications. Therefore,<br />

they are subject to filing if prepared or used by the issuer or if they<br />

otherwise meet the criteria for filing of free writing prospectuses.<br />

Live, real-time communications to a live audience are considered oral,<br />

<strong>and</strong> thus not an illegal prospectus or subject to filing, even if<br />

communicated by electronic means.<br />

Television <strong>and</strong> radio broadcasts continue to be treated as written<br />

communications, however, as specifically required by the <strong>Securities</strong> Act.<br />

An issuer must remain as cautious about information posted to its web<br />

site or hyperlinked on its web site to a third-party web site. 2005<br />

Offering Reforms treat these links generally as free writing prospectuses<br />

of the issuer to the extent they are deemed offers.<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved<br />

82


Electronic Road Shows<br />

A road show, graphically transmitted in real-time to a live audience,<br />

including “live” conferences with investors, live road shows, <strong>and</strong> road<br />

shows webcast in real-time, as well as any slides or other visual aids<br />

provided or transmitted as part of the road show, will not be a written<br />

communication or a free writing prospectus, although it is subject to the<br />

liability provisions of the federal securities laws.<br />

Electronic road shows that are neither live nor transmitted in real time are<br />

considered free writing prospectuses, although permitted if the rules for free<br />

writing prospectuses are satisfied.<br />

Electronic road shows that qualify as free writing prospectuses that are<br />

used in an initial public offering of common or convertible equity securities<br />

must comply with the filing conditions unless the issuer makes a version<br />

readily available without restriction electronically to any potential investor.<br />

Electronic road shows for other offerings generally do not need to be<br />

filed.<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved<br />

83


After the Road Show . . .<br />

Do underwriters have a “market out”<br />

under the typical underwriting<br />

agreement?<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved<br />

84


After the Road Show . . .<br />

What is the “Green Shoe”?<br />

(Also known as the underwriters’<br />

over-allotment option)<br />

Why is it necessary?<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved<br />

85


After the Road Show . . .<br />

The “Green Shoe” or “over-allotment” option<br />

is an option in the typical underwriting<br />

agreement that grants the underwriters a 30-day<br />

option to purchase up to 15% more of the<br />

securities being underwritten.<br />

Term is derived from an offering by the Green<br />

Shoe Company (predecessor of Stride Rite) in<br />

which the over-allotment option first was used.<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved<br />

86


What did LinkedIn Do?<br />

LinkedIn’s definitive prospectus filed under Rule 424(b)<br />

contained the following statement under the caption<br />

“Underwriting”:<br />

“We have granted to the underwriters an option, exercisable for 30<br />

days from the date of this prospectus, to purchase up to 1,176,000<br />

additional shares of Class A common stock at the public offering<br />

price listed on the cover page of this prospectus, less underwriting<br />

discounts <strong>and</strong> commissions. The underwriters may exercise this<br />

option solely for the purpose of covering over-allotments, if any,<br />

made in connection with the offering of the shares of Class A<br />

common stock offered by this prospectus. * * * ”<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved<br />

87


Underst<strong>and</strong>ing SEC<br />

Disclosure Regime for IPOs<br />

When <strong>and</strong> how must a<br />

prospectus be delivered?<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved<br />

88


Section 5 Framework<br />

After effective date of the registration statement, a<br />

written communication that confirms the sale of a<br />

security may be provided only if a final prospectus is<br />

sent or given previously or at the same time.<br />

Otherwise, such a communication is a prospectus <strong>and</strong><br />

may not be provided unless it meets the requirements<br />

of Section 10(a).<br />

As written confirmations are not designed to meet<br />

those requirements, a final prospectus must<br />

accompany or precede a written confirmation.<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved<br />

89


When/how must a prospectus be<br />

delivered?<br />

How must a prospectus be delivered?<br />

Rules 172 <strong>and</strong> 173: Access = Delivery<br />

SEC concluded, as part of 2005 Offering Reforms, that Internet<br />

usage then was sufficiently broad to allow adoption of a<br />

prospectus delivery model that relies on timely access to filed<br />

information <strong>and</strong> documents.<br />

This generally is referred to as the “access equals delivery”<br />

model, which enables issuers, brokers, <strong>and</strong> dealers to satisfy<br />

their final prospectus delivery obligations if a final prospectus<br />

is or will be on file within the time required by the new rules,<br />

including a cure period.<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved<br />

90


When/how must a prospectus<br />

be delivered? (cont’d)<br />

Rules 172 <strong>and</strong> 173: Access = Delivery<br />

Final prospectus will be deemed to precede or<br />

accompany a security for sale as long as final<br />

prospectus meeting requirements of <strong>Securities</strong> Act<br />

Section 10(a) is filed, or issuer makes a good faith <strong>and</strong><br />

reasonable effort to timely file final prospectus with<br />

SEC.<br />

Delivery of preliminary prospectus in IPOs continues<br />

to be required.<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved<br />

91


When/how must a prospectus<br />

be delivered?<br />

Rule 173: Access = Delivery<br />

Sales by an issuer or underwriter to a purchaser<br />

Purchaser must be provided, not later than two<br />

business days after completion of the sale, either a<br />

copy of the final prospectus or a notice providing that<br />

the sale was made pursuant to a registration statement<br />

or in a transaction in which a final prospectus would<br />

have been required to have been delivered in the<br />

absence of the Rule 172.<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved<br />

92


When/how must a prospectus<br />

be delivered?<br />

Rule 173: Access = Delivery<br />

For sales by an issuer or underwriter to a purchaser<br />

The investor may request a final prospectus, but the<br />

issuer <strong>and</strong> underwriter need not provide before<br />

settlement.<br />

Written confirmations <strong>and</strong> notices of allocation,<br />

including e-mail notifications to inform investors of<br />

their allocations, may be sent after effectiveness of the<br />

registration statement without being accompanied by a<br />

final prospectus.<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved<br />

93


When/how must a prospectus<br />

be delivered?<br />

For how long after the effective date of the<br />

registration statement does a “dealer” have an<br />

obligation to deliver a prospectus?<br />

Rule 174 (whereby SEC shortened timeframe<br />

under Section 4(a)(3))<br />

25 days for “dealers” in typical IPO (see Rule<br />

174(d))<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved<br />

94


What did LinkedIn Disclose?<br />

LinkedIn’s definitive prospectus filed under Rule 424(b)<br />

contained the following statements after the table of contents:<br />

“Through <strong>and</strong> including June 12, 2012 (the 25th day after the date of<br />

this prospectus), all dealers that effect transactions in these securities,<br />

whether or not participating in this offering, may be required to<br />

deliver a prospectus. This is in addition to the dealers’ obligation to<br />

deliver a prospectus when acting as underwriters <strong>and</strong> with respect to<br />

their unsold allotments or subscriptions. ”<br />

“The information contained in this prospectus is accurate only as of<br />

the date of this prospectus, regardless of the time of delivery of this<br />

prospectus, or of any sale of our Class A common stock.”<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved<br />

95


U.S <strong>and</strong> <strong>Trans</strong>-<strong>Border</strong><br />

<strong>Securities</strong> <strong>Regulation</strong><br />

Boston University School of Law<br />

Executive LL.M. - International Business Law<br />

July/August 2013<br />

Michael Krebs<br />

JD, Boston University School of Law 1985<br />

Senior Partner, Nutter, McClennen & Fish, LLP, Boston, MA<br />

Tel. 617.439.2288 email: mkrebs@nutter.com


U.S <strong>and</strong> <strong>Trans</strong>-<strong>Border</strong><br />

<strong>Securities</strong> <strong>Regulation</strong><br />

Boston University School of Law<br />

Executive LL.M. in International Business Law<br />

Session 5 – July 26, 2013<br />

Preview Slides<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Session 5 Agenda<br />

How does a company register securities<br />

after its IPO?<br />

(c) 2013 Michael K. Krebs All Rights<br />

Reserved<br />

2


Basic Principle Underlying the<br />

<strong>Securities</strong> Act of 1933<br />

Unless an exemption is available,<br />

1. Every offer or sale of a security must be<br />

registered with the SEC under § 5 of the<br />

<strong>Securities</strong> Act, <strong>and</strong><br />

2. In the registration statement (which<br />

includes the prospectus), all information<br />

material to that investment decision must<br />

be disclosed.


Session 5 – Underst<strong>and</strong>ing SEC Registration<br />

Regime for Reporting Companies<br />

Study Problem 5.1<br />

Jumbo Corp., a NYSE-listed company that has been<br />

publicly traded for the past 15 years, seeks to raise $300<br />

million in debt financing by selling ten-year senior notes<br />

in an underwritten offering primarily to institutional<br />

investors. The notes would not be “investment grade.”<br />

Jumbo’s common equity float is $50 million.<br />

What form of registration statement would Jumbo Corp<br />

file with the SEC?<br />

What if Jumbo’s common equity float is $500 million?<br />

(c) 2013 Michael K. Krebs All Rights<br />

Reserved<br />

4


Underst<strong>and</strong>ing SEC Registration<br />

Regime for Reporting Companies<br />

How does an “S-3 registration<br />

statement” differ from an “S-1<br />

registration statement”?<br />

(c) 2013 Michael K. Krebs All Rights<br />

Reserved<br />

5


Review of S-3 Eligibility<br />

Why does S-3 eligibility matter?<br />

(c) 2013 Michael K. Krebs All Rights<br />

Reserved<br />

6


S-3 Eligibility (cont’d)<br />

General Instruction I.A. of Form S–3 requires:<br />

1. Registrant is organized under laws of U.S. or any<br />

state, etc. <strong>and</strong> has its principal business operations in<br />

U.S. or its territories.<br />

2. Registrant has a class of securities registered pursuant<br />

to Section 12(b) of the Exchange Act or a class of<br />

equity securities registered pursuant to Section 12(g)<br />

of the Exchange Act or is required to file reports<br />

pursuant to Section 15(d) of the Exchange Act.<br />

(c) 2013 Michael K. Krebs All Rights<br />

Reserved<br />

7


S-3 Eligibility (cont’d)<br />

3. Registrant has been subject to the requirements of Section<br />

12 or 15(d) of the Exchange Act <strong>and</strong> has filed all the<br />

material required to be filed pursuant to Section 13, 14 or<br />

15(d) for a period of at least twelve calendar months<br />

immediately preceding the filing of the registration<br />

statement.<br />

4. Registrant has filed in a timely manner all reports<br />

required to be filed during the twelve calendar months<br />

<strong>and</strong> any portion of a month immediately preceding<br />

filing of registration statement, other than certain 8-K<br />

filings.<br />

(c) 2013 Michael K. Krebs All Rights<br />

Reserved<br />

8


S-3 Eligibility (cont’d)<br />

5. Neither the registrant nor any of its consolidated or<br />

unconsolidated subsidiaries has, since the end of the last<br />

fiscal year for which certified financial statements of the<br />

registrant <strong>and</strong> its consolidated subsidiaries were included<br />

in a report filed pursuant to Section 13(a) or 15(d) of the<br />

Exchange Act: (a) failed to pay any dividend or sinking<br />

fund installment on preferred stock; or (b) defaulted (i)<br />

on any installment or installments on indebtedness for<br />

borrowed money, or (ii) on any rental on one or more<br />

long term leases, which defaults in the aggregate are<br />

material to the financial position of the registrant.<br />

(c) 2013 Michael K. Krebs All Rights<br />

Reserved<br />

9


S-3 Eligibility (cont’d)<br />

Current S-3 Eligibility: If Float < $75 million<br />

If issuer has a “float” of less than $75 million, the issuer<br />

can use S-3 if the issuer:<br />

1. Satisfies the other S-3 eligibility criteria;<br />

2. Has a class of common equity securities listed on a<br />

national securities exchange; <strong>and</strong><br />

3. Does not sell more than the equivalent of one-third<br />

of its public float in primary offerings during any<br />

12-month period.<br />

(c) 2013 Michael K. Krebs All Rights<br />

Reserved<br />

10


S-3 Eligibility (cont’d)<br />

Current S-3 Eligibility: If Float ≥ $75 million<br />

If issuer has a “float” of $75 million or more<br />

<strong>and</strong> satisfies other S-3 eligibility criteria:<br />

Issuer can sell an unlimited amount of<br />

securities under an S-3 registration statement.<br />

(c) 2013 Michael K. Krebs All Rights<br />

Reserved<br />

11


Underst<strong>and</strong>ing SEC Registration<br />

Regime for Reporting Companies<br />

What is meant by “incorporation<br />

by reference”?<br />

(c) 2013 Michael K. Krebs All Rights<br />

Reserved<br />

12


Review of Overarching Principle –<br />

Integrated Disclosure Under <strong>Securities</strong><br />

Act <strong>and</strong> Exchange Act<br />

Integrated Disclosure<br />

Forms S-1, S-3, S-4, S-8, etc.<br />

Reg. S-K, Reg. S-X<br />

SEC “Industry Guides”<br />

Risk Factors<br />

MD&A or “Management’s Discussion <strong>and</strong><br />

Analysis of Financial Condition <strong>and</strong> Results of<br />

Operations”<br />

(c) 2013 Michael K. Krebs All Rights<br />

Reserved<br />

13


Objectives of Integrated Disclosure<br />

System:<br />

No. 1 – St<strong>and</strong>ardize ’33 Act/’34 Act<br />

Disclosure<br />

St<strong>and</strong>ardize categories of information<br />

required in SEC filings <strong>and</strong> investor<br />

documents under both the <strong>Securities</strong> Act<br />

<strong>and</strong> the Exchange Act<br />

(c) 2013 Michael K. Krebs All Rights<br />

Reserved<br />

14


“Three Amigos” of Integrated<br />

Disclosure<br />

<strong>Regulation</strong> S-K<br />

Disclosures Other Than Financial Statements<br />

<strong>Regulation</strong> S-X (supplemented by Industry Guides)<br />

Form <strong>and</strong> Content of Financial Statements<br />

Industry Guides require supplemental statistical<br />

disclosure certain industries<br />

<strong>Regulation</strong> M-A<br />

M&A/Tender Offer Disclosure<br />

(c) 2013 Michael K. Krebs All Rights<br />

Reserved<br />

15


Review of <strong>Regulation</strong> S-K<br />

Reg. S-K, Rule 10 – The “Rosetta Stone”<br />

Reg. S-K states the requirements applicable to the content of the nonfinancial<br />

statement portions of:<br />

1. Registration statements under the <strong>Securities</strong> Act to the extent<br />

provided in the forms to be used for registration under such Act; <strong>and</strong><br />

2. Registration statements under Exchange Act (“EA”) Section 12,<br />

annual or other reports under EA Sections 13 <strong>and</strong> 15(d), goingprivate<br />

transaction statements under EA Section 13, tender offer<br />

statements under EA Sections 13 <strong>and</strong> 14, proxy <strong>and</strong> information<br />

statements under EA section 14, <strong>and</strong> any other documents required to<br />

be filed under the EA to the extent provided in the forms <strong>and</strong> rules<br />

under that Act.<br />

(c) 2013 Michael K. Krebs All Rights<br />

Reserved<br />

16


Review of <strong>Regulation</strong> S-X<br />

Same concept as Reg. S-K, but applicable to financial statements<br />

Reg. S-X (together with the SEC’s Financial Reporting Releases)<br />

sets forth the form <strong>and</strong> content of <strong>and</strong> requirements for financial<br />

statements required to be filed as a part of:<br />

1. Registration statements under the <strong>Securities</strong> Act, except as<br />

otherwise specifically provided in the applicable form;<br />

2. Registration statements under EA Section 12, annual or<br />

other reports under EA Sections 13 <strong>and</strong> 15(d) <strong>and</strong> proxy<br />

<strong>and</strong> information statements under EA Section 14 except as<br />

otherwise specifically provided in the applicable form;<br />

(c) 2013 Michael K. Krebs All Rights<br />

Reserved<br />

17


Objectives of Integrated Disclosure<br />

System:<br />

No. 2 – Incorporation by Reference<br />

Permit various information to be<br />

incorporated by reference from the<br />

issuer’s other ‘34 Act reports or ‘33 Act<br />

registration statements<br />

previously filed, or<br />

subsequently filed<br />

(c) 2013 Michael K. Krebs All Rights<br />

Reserved<br />

18


Primary ’33 Act Examples of<br />

Incorporation by Reference<br />

S-3 Registration Statement<br />

S-4 Registration Statement<br />

S-8 Registration Statement<br />

(c) 2013 Michael K. Krebs All Rights<br />

Reserved<br />

19


Primary ’33 Act Examples of<br />

Incorporation by Reference<br />

S-3 Registration Statement<br />

Item 12. Incorporation of Certain<br />

Information<br />

(a) The documents listed . . . below shall be<br />

specifically incorporated by reference<br />

into the prospectus . . . :<br />

(1) annual report on Form 10-K . . . which<br />

contains financial statements for the latest<br />

fiscal year . . . .<br />

(c) 2013 Michael K. Krebs All Rights<br />

Reserved<br />

20


Primary ’33 Act Examples of<br />

Incorporation by Reference<br />

S-3 Registration Statement<br />

Item 12. Incorporation of Certain<br />

Information<br />

(b) “[a]ll documents subsequently filed . . .<br />

pursuant to Sections 13(a), 13(c), 14 or<br />

15(d) of the Exchange Act, prior to the<br />

termination of the offering, shall be<br />

deemed to be incorporated by reference<br />

into the prospectus.”<br />

(c) 2013 Michael K. Krebs All Rights<br />

Reserved<br />

21


10-K Disclosure: Geography<br />

Part I: Business Info<br />

Form 10-K Filing<br />

Part II: Financial Statements <strong>and</strong> Related Info<br />

Form 10-K or Annual Report to Stockholders<br />

Part III: Insider Info<br />

Proxy Statement (<strong>and</strong> 10-K)<br />

Part IV: Exhibits, Etc.<br />

Form 10-K Filing<br />

(c) 2013 Michael K. Krebs All Rights<br />

Reserved<br />

22


10-K Disclosure: Geography<br />

Part II: MD&A (Item 303 of Reg. S-K)<br />

Liquidity<br />

Capital resources<br />

Operating results, including<br />

o Unusual/infrequent events, transactions<br />

o Known trends/uncertainties that registrant<br />

reasonably expects will have a material<br />

favorable or unfavorable impact<br />

(c) 2013 Michael K. Krebs All Rights<br />

Reserved<br />

23


10-K Disclosure: MD&A<br />

Objective of MD&A:<br />

“To provide, in one section of a filing,<br />

material historical <strong>and</strong> prospective textual<br />

disclosure enabling investors . . . to assess<br />

the financial condition <strong>and</strong> results of<br />

operations of the registrant, with particular<br />

emphasis on the registrant's prospects for the<br />

future.” (SEC 1989 Release)<br />

(c) 2013 Michael K. Krebs All Rights<br />

Reserved<br />

24


10-K Disclosure: MD&A<br />

MD&A will be addressed in more<br />

detail in Session 7<br />

(c) 2013 Michael K. Krebs All Rights<br />

Reserved<br />

25


Underst<strong>and</strong>ing SEC Registration Regime<br />

for Reporting Companies<br />

What form of registration statement<br />

would a publicly traded company file<br />

when it grants stock options or<br />

restricted stock?<br />

(c) 2013 Michael K. Krebs All Rights<br />

Reserved<br />

26


Session 5 – Underst<strong>and</strong>ing SEC Registration<br />

Regime for Reporting Companies<br />

Study Problem 5.2<br />

Biosystems completed its IPO two years ago <strong>and</strong> now would<br />

like to grant stock options to all of its approximately 1,000<br />

employees, as well as its non-employee directors.<br />

Each option will entitle the recipient to purchase shares of<br />

Biosystems common stock at price equal to the market value<br />

of Biosystems common stock on the date of grant. Each<br />

option will vest in four annual installments beginning on the<br />

first anniversary of the grant date.<br />

Must Biosystems file a registration statement to register<br />

the common stock issuable upon exercise of the option?<br />

What did bluebird bio do?<br />

If so, when must the registration be filed?<br />

(c) 2013 Michael K. Krebs All Rights<br />

Reserved<br />

27


Underst<strong>and</strong>ing SEC Registration<br />

Regime for Reporting Companies<br />

S-8 Registration Statement<br />

For securities to be issued to its employees or employees of its<br />

subsidiaries or parents<br />

Equity Benefit Plans, include<br />

Stock Option Plans<br />

Employee Stock Purchase Plans, etc.<br />

“Employee” is defined to include<br />

Any employee, director, or officer, <strong>and</strong> certain consultants or<br />

advisors.<br />

Form S-8 is available for the issuance of securities to<br />

consultants or advisors only if services are not in connection<br />

with the offer or sale of securities in a capital-raising<br />

transaction, <strong>and</strong> do not directly or indirectly promote or<br />

maintain a market for the registrant’s securities. (Similar to<br />

Rule 701.)<br />

(c) 2013 Michael K. Krebs All Rights<br />

Reserved<br />

28


Underst<strong>and</strong>ing SEC Registration Regime<br />

for Reporting Companies<br />

What form of registration statement<br />

would a company file when it acquires<br />

another publicly traded company?<br />

(c) 2013 Michael K. Krebs All Rights<br />

Reserved<br />

29


Session 5 – Underst<strong>and</strong>ing SEC Registration<br />

Regime for Reporting Companies<br />

Study Problem 5.3<br />

Two years after Gee Whiz completes its IPO, Gee Whiz<br />

decides it wants to acquire the technology of the Next Big<br />

Thing Corp. (NBT). Gee Whiz is willing to acquire NBT by<br />

merger. NBT shareholders will receive $5.00 in cash <strong>and</strong> 0.25<br />

shares of Gee Whiz common stock for each share of NBT<br />

stock.<br />

NBT is a corporation organized under Delaware law that has its<br />

only office <strong>and</strong> facility in Massachusetts. NBT completed its<br />

IPO four years ago <strong>and</strong> has 600 stockholders.<br />

Will Gee Whiz have to file a registration under the <strong>Securities</strong><br />

Act? If so, what form of registration statement will it file?<br />

(c) 2013 Michael K. Krebs All Rights<br />

Reserved<br />

30


Underst<strong>and</strong>ing SEC Registration<br />

Regime for Reporting Companies<br />

S-4 Registration Statement<br />

M&A <strong>Trans</strong>actions<br />

Incorporation by reference for S-3<br />

eligible issuers<br />

(c) 2013 Michael K. Krebs All Rights<br />

Reserved<br />

31


Underst<strong>and</strong>ing SEC Registration Regime<br />

for Reporting Companies<br />

What is a “shelf registration statement”?<br />

(c) 2013 Michael K. Krebs All Rights<br />

Reserved<br />

32


Shelf Registrations under Rule 415<br />

“Shelf registration” or “shelf offering” are terms used<br />

for offerings under SEC Rule 415, which allows<br />

permits companies to file a registration statement<br />

covering one or more types of financings that it<br />

expects to complete within two years.<br />

For non-WKSIs, having a registration “on the shelf”<br />

allows the issuer to market quickly when conditions<br />

become favorable.<br />

[See web site for “Primer on Shelf Registrations”<br />

under Session 5 reading material.]<br />

(c) 2013 Michael K. Krebs All Rights<br />

Reserved<br />

33


Shelf Registrations <strong>and</strong> Due<br />

Diligence after Worldcom<br />

What are the implications of the<br />

WorldCom decision [Session 3]<br />

for shelf registration statements?<br />

(c) 2013 Michael K. Krebs All Rights<br />

Reserved<br />

34


Shelf Registrations <strong>and</strong> Due Diligence<br />

after Worldcom<br />

Interplay between ’34 Act Filings <strong>and</strong><br />

“Due Diligence” review for ’33 Act<br />

registration statement<br />

Lessons from WorldCom shareholder<br />

litigation<br />

(c) 2013 Michael K. Krebs All Rights<br />

Reserved<br />

35


Shelf Registrations <strong>and</strong> Due Diligence<br />

after Worldcom<br />

Lessons from WorldCom litigation:<br />

Under a short-form registration (i.e., S-<br />

3), the time needed to prepare the<br />

registration statement is reduced<br />

sharply because of issuer’s ability to<br />

incorporate by reference prior ’34 Act<br />

disclosures.<br />

(c) 2013 Michael K. Krebs All Rights<br />

Reserved<br />

36


Shelf Registrations <strong>and</strong> Due Diligence<br />

after Worldcom<br />

Lessons from WorldCom litigation:<br />

SEC has acknowledged that different<br />

due diligence methods are necessary<br />

"in view of the compressed preparation<br />

time <strong>and</strong> the volatile nature of the<br />

capital markets."<br />

Nonetheless, such techniques must be<br />

"equally thorough."<br />

(c) 2013 Michael K. Krebs All Rights<br />

Reserved<br />

37


Shelf Registrations <strong>and</strong> Due Diligence<br />

after Worldcom<br />

Lessons from WorldCom litigation:<br />

Among the strategies recommended by the SEC were<br />

the development of a "reservoir of knowledge about<br />

the companies that may select the underwriter to<br />

distribute their securities registered on short form<br />

registration statements" through a "careful review of<br />

[periodic Exchange Act] filings on an ongoing basis,"<br />

consultation of analysts' reports, <strong>and</strong> active<br />

participation in the issuer's investor relations<br />

program, especially analysts <strong>and</strong> brokers meetings.<br />

(c) 2013 Michael K. Krebs All Rights<br />

Reserved<br />

38


Shelf Registrations <strong>and</strong> Due Diligence<br />

after Worldcom<br />

Lessons from WorldCom litigation:<br />

The SEC also approvingly noted the following practices:<br />

designating of one law firm to act as underwriters' counsel,<br />

which "facilitates continuous due diligence by ensuring ongoing<br />

access to the registrant on the underwriters' behalf";<br />

holding "Exchange Act report 'drafting sessions,' " which<br />

allow underwriters "to participate in the drafting <strong>and</strong> review<br />

of periodic disclosure documents before they are filed"; <strong>and</strong><br />

conducting "periodic due diligence sessions," such as<br />

meetings between prospective underwriters, their counsel,<br />

<strong>and</strong> management shortly after the release of quarterly<br />

earnings.<br />

(c) 2013 Michael K. Krebs All Rights<br />

Reserved<br />

39


Shelf Registrations <strong>and</strong> Due Diligence<br />

after Worldcom<br />

Lessons from WorldCom litigation (cont’d):<br />

While an underwriter is not "expected to possess<br />

the intimate knowledge of corporate affairs of<br />

inside directors," his obligation is to conduct a<br />

meaningful investigation, not merely to listen to<br />

management's explanations of the company's<br />

affairs.<br />

“Tacit reliance on management assertions is<br />

unacceptable; the underwriters must play devil's<br />

advocate.”<br />

(c) 2013 Michael K. Krebs All Rights<br />

Reserved<br />

40


Shelf Registrations <strong>and</strong> Due Diligence<br />

after Worldcom<br />

Lessons from WorldCom litigation (cont’d):<br />

There are questions of fact as to whether the Underwriter<br />

Defendants conducted a reasonable investigation:<br />

the limited number of conversations with the WorldCom<br />

or its auditor,<br />

the cursory nature of the inquiries,<br />

the failure to go behind any of the almost formulaic<br />

answers given to questions,<br />

<strong>and</strong> the failure to inquire into issues of particular<br />

prominence in the Underwriter Defendants’ own internal<br />

evaluations of the financial condition of the WorldCom or<br />

in the financial press.<br />

(c) 2013 Michael K. Krebs All Rights<br />

Reserved<br />

41


Shelf Registrations <strong>and</strong> Due Diligence<br />

after Worldcom<br />

Lessons from WorldCom litigation (cont’d):<br />

In particular with respect to 2001, having<br />

internally downgraded WorldCom's credit rating<br />

<strong>and</strong> having taken steps to limit their exposure as<br />

WorldCom creditors, the Underwriter Defendants<br />

were well aware that WorldCom was in a<br />

deteriorating financial position in a troubled<br />

industry<br />

A reasonable investigation would have entailed a<br />

more searching inquiry than that undertaken by<br />

the Underwriter Defendants.<br />

(c) 2013 Michael K. Krebs All Rights<br />

Reserved<br />

42


Shelf Registrations <strong>and</strong> Due Diligence<br />

after Worldcom<br />

Lessons from WorldCom litigation (cont’d):<br />

To succeed with a due diligence defense, the<br />

Underwriter Defendants will have to show that they<br />

conducted a reasonable investigation of the nonexpertised<br />

portions of the Registration Statements <strong>and</strong><br />

thereafter had reasonable ground to believe that the<br />

interim financial statements were true.<br />

In assessing the reasonableness of the investigation,<br />

the Underwriter Defendants’ receipt of “comfort<br />

letters” from WorldCom’s auditors will be important<br />

evidence, BUT it is insufficient by itself to establish<br />

the defense.<br />

(c) 2013 Michael K. Krebs All Rights<br />

Reserved<br />

43


Underst<strong>and</strong>ing SEC Registration Regime<br />

for Reporting Companies<br />

The 2005 Offering Reforms<br />

Establish automatically effective shelf<br />

registration for WKSIs – or “Well Known<br />

Seasoned Issuers”, <strong>and</strong><br />

Significantly modify shelf registration<br />

procedures for WKSIs<br />

[Refer to Session 3 slides for more details.]<br />

(c) 2013 Michael K. Krebs All Rights<br />

Reserved<br />

44


Underst<strong>and</strong>ing SEC Registration<br />

Regime for Reporting Companies<br />

S-3 Registration Statement for WKSIs allows<br />

“On-Dem<strong>and</strong>” SEC registration through an<br />

“automatic shelf registration statement.”<br />

Guarantees no SEC review<br />

Effectiveness upon filing<br />

(c) 2013 Michael K. Krebs All Rights<br />

Reserved<br />

45


A Few Words About the Automatic<br />

Shelf Registration Statement<br />

Automatic shelf registration provides WKSIs with<br />

significant flexibility beyond that provided to non-<br />

WKSI seasoned issuers, permitting WKSIs:<br />

To take advantage of market windows,<br />

To structure terms of securities on a real-time basis<br />

to accommodate investor dem<strong>and</strong>, <strong>and</strong><br />

To determine or change the plan of distribution in<br />

response to changing market conditions.<br />

(c) 2013 Michael K. Krebs All Rights<br />

Reserved<br />

46


Underst<strong>and</strong>ing SEC Registration<br />

Regime for Reporting Companies<br />

Are there offering techniques<br />

available to non-WKSI publicly<br />

traded issuers that approximate the<br />

advantages of an automatic shelf<br />

registration statement?<br />

(c) 2013 Michael K. Krebs All Rights<br />

Reserved<br />

47


Underst<strong>and</strong>ing SEC Registration<br />

Regime for Reporting Companies<br />

Increasingly, public offerings are becoming<br />

less “public”<br />

Due to market developments, such as<br />

heightened volatility <strong>and</strong> concerns about<br />

investor front-running, fewer public offerings<br />

involve traditional marketing<br />

Most public offerings begin as confidentially<br />

marketed public offerings<br />

(c) 2013 Michael K. Krebs All Rights<br />

Reserved<br />

48


Underst<strong>and</strong>ing SEC Registration<br />

Regime for Reporting Companies<br />

“Registered direct offering”<br />

“Confidentially marketed public offering”<br />

“At-the-market offering”<br />

(c) 2013 Michael K. Krebs All Rights<br />

Reserved<br />

49


“Registered Direct Offering”<br />

A registered direct offering is a public offering that is<br />

sold by a placement agent on an agency, or “best<br />

efforts,” basis (rather than a firm commitment<br />

underwriting).<br />

Much like a PIPE (private investment in publicly traded<br />

equity – to be discussed in Session 6), a registered direct<br />

offering is marketed <strong>and</strong> sold to a selected number of<br />

accredited <strong>and</strong> institutional investors.<br />

They often are referred to as “registered PIPEs.”<br />

(c) 2013 Michael K. Krebs All Rights<br />

Reserved<br />

50


What are the advantages of a<br />

“registered direct offering”?<br />

There are two principal advantages:<br />

1. Confidential marketing is<br />

permitted;<br />

2. Pricing for the issuer will likely be<br />

better than a PIPE<br />

(c) 2013 Michael K. Krebs All Rights<br />

Reserved<br />

51


Advantages of a<br />

“registered direct offering” (cont’d)<br />

Confidentiality<br />

Issuers that want to test the market or conduct an offering without<br />

attracting publicity find that a registered direct offering is a good choice.<br />

When an issuer has an effective shelf registration statement, the<br />

placement agent may market a potential registered direct offering<br />

as it would a PIPE transaction — by obtaining confidentiality<br />

undertakings until such time as an actual transaction is announced.<br />

This permits an issuer to “test” the market for a potential offering,<br />

without a public announcement that might affect the issuer’s stock price,<br />

while complying with Reg. FD [to be discussed in Session 7]. The issuer<br />

typically announces the transaction immediately prior to pricing or at<br />

pricing.<br />

(c) 2013 Michael K. Krebs All Rights<br />

Reserved<br />

52


Advantages of a<br />

“registered direct offering”? (cont’d)<br />

Pricing<br />

An issuer that is deciding between a PIPE<br />

transaction <strong>and</strong> a registered direct offering may<br />

choose a registered direct offering for pricing<br />

reasons.<br />

Typically, a PIPE offering will be subject to some<br />

liquidity discount that will not affect a registered<br />

public offering. [More about this in Session 6.]<br />

(c) 2013 Michael K. Krebs All Rights<br />

Reserved<br />

53


“Confidentially Marketed Public<br />

Offering”<br />

Confidentially marketed public offerings – or “CMPOs”<br />

– primarily are marketed to a targeted group of<br />

institutional investors without public announcement.<br />

The advantages of CMPOs over traditionally marketed<br />

public offerings are similar to the registered direct<br />

offerings:<br />

1) Targeted <strong>and</strong> streamlined marketing efforts allow<br />

companies to complete CMPOs relatively quickly<br />

(c) 2013 Michael K. Krebs All Rights<br />

Reserved<br />

54


Advantages of CMPOs (cont’d)<br />

2) CMPOs allow companies to test the market for an offering without<br />

automatically subjecting the company's stock price to the downward<br />

market pressure typically associated with the announcement of a<br />

material equity offering.<br />

In a fully marketed underwritten offering, the market has advance notice<br />

of the potential offering, <strong>and</strong> market participants may begin shorting the<br />

issuer’s common stock in anticipation of the offering that might dilute<br />

the market price of the issuer’s stock.<br />

By comparison, CMPOs typically involve a very short interval<br />

(typically no more than one evening) or none at all between publicly<br />

announcing the offering <strong>and</strong> pricing it, <strong>and</strong> consequently the market<br />

price for the company's stock is not affected by the offering<br />

announcement.<br />

(c) 2013 Michael K. Krebs All Rights<br />

Reserved<br />

55


Elements of CMPOs (cont’d)<br />

Confidentiality considerations<br />

In order to avoid Reg. FD <strong>and</strong> insider trading issues <strong>and</strong> to ensure that a CMPO<br />

actually remains confidential, issuers <strong>and</strong> their financial advisors must carefully<br />

implement procedures to avoid public disclosure of a potential offering until after a<br />

prospective investor has agreed to keep information regarding the offering<br />

confidential.<br />

After a potential investor is "brought over the wall" by agreeing to keep information<br />

about the offering confidential, issuers <strong>and</strong> underwriters can disclose material nonpublic<br />

information about the offering, including the identity of the issuer, to that<br />

investor.<br />

Investors typically request that the issuer file a Form 8-K disclosing the financing<br />

within a certain period of time. Once a press release is issued, the investors <strong>and</strong><br />

other potential investors contacted by the underwriter are released from their<br />

confidentiality undertakings <strong>and</strong> accompanying trading restrictions.<br />

(c) 2013 Michael K. Krebs All Rights<br />

Reserved<br />

56


Elements of CMPOs (cont’d)<br />

Due diligence considerations<br />

Underwriters of a CMPO still should conduct<br />

their customary due diligence, including<br />

obtaining accountants' comfort letters <strong>and</strong><br />

opinions of counsel <strong>and</strong> conducting calls with<br />

the company's auditors <strong>and</strong> important<br />

customers <strong>and</strong> suppliers.<br />

(c) 2013 Michael K. Krebs All Rights<br />

Reserved<br />

57


Underst<strong>and</strong>ing SEC Registration<br />

Regime for Reporting Companies<br />

What is an “at-the-market” offering?<br />

(c) 2013 Michael K. Krebs All Rights<br />

Reserved<br />

58


“At the Market Offerings”<br />

An “at the market”, or ATM, offering allows a company to tap<br />

into the existing secondary market for its shares on an as-<strong>and</strong>when-needed<br />

basis.<br />

Under an ATM offering program, an exchange-listed company<br />

sells newly issued shares into the trading market through a<br />

designated broker-dealer at prevailing market prices, rather than<br />

via a traditional underwritten offering of a fixed number of shares<br />

at a fixed price all at once.<br />

The use <strong>and</strong> attractiveness of ATMs have increased significantly<br />

since the SEC’s 2005 Offering Reforms, which streamlined the<br />

procedural hurdles for conducting an ATM offering.<br />

(c) 2013 Michael K. Krebs All Rights<br />

Reserved<br />

59


Elements of<br />

an “at the Market Offering”<br />

Registration Statement. The company files a shelf registration statement<br />

on Form S-3. The base prospectus included in the registration statement<br />

includes disclosure to the effect that sales of common stock may be made<br />

from time to time at prevailing market prices by the issuer directly or<br />

through a designated agent.<br />

Sales Agreement. The company enters into a sales agreement with a<br />

broker-dealer that has agreed to serve as placement agent for the shares<br />

to be sold under the ATM offering program.<br />

The placement agent may be deemed an “underwriter” under the<br />

<strong>Securities</strong> Act, <strong>and</strong> therefore the placement agent will typically conduct<br />

pre-offering due diligence substantially similar to that performed by<br />

underwriters in firm commitment public offerings.<br />

(c) 2013 Michael K. Krebs All Rights<br />

Reserved<br />

60


Elements of an<br />

“at the Market Offering” (cont’d)<br />

Program Prospectus Supplement. The company files a prospectus supplement<br />

with the SEC that describes the general terms of the proposed ATM offering<br />

program, including the plan of distribution <strong>and</strong> the maximum number of shares to be<br />

sold, <strong>and</strong> names the designated placement agent as required by SEC guidance.<br />

Sales Orders. After the S-3 is declared effective <strong>and</strong> once all required<br />

documentation has been executed, filed <strong>and</strong> delivered, the company may send sales<br />

orders to the placement agent based on volume or other relevant trading information<br />

available to the company to assess likely dem<strong>and</strong> <strong>and</strong>/or the placement agent may<br />

bring to the attention of the company instances where dem<strong>and</strong> may exist in the<br />

market.<br />

The timing, frequency <strong>and</strong> terms of sales orders (such as minimum required pricing,<br />

volume limitations, etc.) are entirely at the discretion of the company <strong>and</strong> can be<br />

altered (or sales orders revoked before they are executed) by the company at any<br />

time.<br />

(c) 2013 Michael K. Krebs All Rights<br />

Reserved<br />

61


Elements of an<br />

“at the Market Offering” (cont’d)<br />

Settlement. Some sales agreements provide the option for a single<br />

settlement at the end of a designated selling period rather than on a<br />

rolling T+3 basis.<br />

Ongoing Disclosure. The company typically will disclose aggregate<br />

sales <strong>and</strong> commission amounts paid on a quarterly basis. Disclosure<br />

can take the form of a very brief prospectus supplement filed under<br />

Rule 424(b) to update the base prospectus <strong>and</strong>/or disclosure as part<br />

of the company’s quarterly report on Form 10-Q.<br />

In some cases, the volume of sales or the terms may be individually<br />

material <strong>and</strong> therefore require prompt disclosure following such<br />

sales.<br />

(c) 2013 Michael K. Krebs All Rights<br />

Reserved<br />

62


U.S <strong>and</strong> <strong>Trans</strong>-<strong>Border</strong><br />

<strong>Securities</strong> <strong>Regulation</strong><br />

Boston University School of Law<br />

Executive LL.M. - International Business Law<br />

July/August 2013<br />

Michael Krebs<br />

JD, Boston University School of Law 1985<br />

Senior Partner, Nutter, McClennen & Fish, LLP, Boston, MA<br />

Tel. 617.439.2288 email: mkrebs@nutter.com<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved<br />

63


U.S <strong>and</strong> <strong>Trans</strong>-<strong>Border</strong><br />

<strong>Securities</strong> <strong>Regulation</strong><br />

Boston University School of Law<br />

Executive LL.M. in International Business Law<br />

Session 6<br />

July 27, 2013<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Review of Core Principles<br />

1. “<strong>Securities</strong>” broadly defined<br />

2. Investor autonomy (sort of)<br />

3. Every offer/sale must be<br />

registered with SEC if security or<br />

transaction is not exempt<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved<br />

2


Core Principles (cont’d)<br />

4. Disclosure of all information about<br />

the issuer <strong>and</strong> the security material to<br />

an investment decision (or access to<br />

all material information) is imperative<br />

5. Financial statements (<strong>and</strong> MD&A)<br />

are essential disclosure elements in<br />

registered offering<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved<br />

3


Core Principles (cont’d)<br />

6. “Degree of difficulty” in<br />

registering a sale of securities<br />

varies depending primarily on the<br />

issuer’s market cap <strong>and</strong> reporting<br />

history<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved<br />

4


Core Principles (cont’d)<br />

7. Issuers, “control persons” <strong>and</strong>, when<br />

applicable, underwriters <strong>and</strong> “experts”<br />

will have accountability for materially<br />

false or misleading statements<br />

8. Control persons – executive officers,<br />

directors <strong>and</strong> >10% holders – are<br />

subject to extra constraints<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved<br />

5


Session 6 Agenda<br />

Part 1<br />

How do investors resell securities?<br />

Part 2<br />

How do publicly traded companies<br />

conduct private placements?<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved<br />

6


Basic Principle Underlying the<br />

<strong>Securities</strong> Act of 1933<br />

Unless an exemption is available,<br />

1. Every offer or sale of a security must be<br />

registered with the SEC under § 5 of the<br />

<strong>Securities</strong> Act, <strong>and</strong><br />

2. In the registration statement (which<br />

includes the prospectus), all information<br />

material to that investment decision must<br />

be disclosed.<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved<br />

7


Basic Principle Underlying the<br />

<strong>Securities</strong> Act of 1933<br />

Restated:<br />

If any person sells a non-exempt<br />

security to any other person, the<br />

sale must be registered unless an<br />

exemption can be found for the<br />

transaction.<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved<br />

8


Resale of <strong>Securities</strong><br />

• How do investors resell securities in the<br />

ordinary course?<br />

• How do investors resell securities purchased<br />

in a private placement?<br />

• How do “insiders” resell securities?<br />

• What is a registration rights agreement?<br />

• What is a “piggyback offering”?<br />

• What is a QIB?<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved<br />

9


Basic Principle Underlying the<br />

<strong>Securities</strong> Act of 1933<br />

“Unless an exemption is available, . . .”<br />

* * *<br />

Some exemptions focus on the type of<br />

security being offered.<br />

Other exemptions focus on the nature of the<br />

transaction in which the offering is made.<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved<br />

10


Exempt <strong>Trans</strong>actions –<br />

Key Principle #1<br />

<strong>Securities</strong> offered in exempt<br />

transactions do not become exempt<br />

securities.<br />

For every subsequent offer/sale, the<br />

seller must find an exemption or cause<br />

this issuer to register that offer/sale with<br />

the SEC.<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved<br />

11


Exempt <strong>Trans</strong>actions - Resales<br />

How do investors resell<br />

securities in the ordinary<br />

course?<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved<br />

12


Session 6 – Resale of <strong>Securities</strong><br />

Study Problem 6.1<br />

Beantown Biosystems raises $100 million by selling 5 million shares<br />

of common stock at $20 per share in an underwritten initial public<br />

offering (“IPO”) covered by an effective registration statement.<br />

Professor Pennypincher, who has no relationship to Biosystems or<br />

any of its affiliates, purchases 1,000 shares of stock in the IPO<br />

through her trusted brokerage firm Merry Brothers, a brokerage firm<br />

that was not part of the underwriting syndicate.<br />

One month after the IPO, Biosystems’s stock is trading at $30 per<br />

share. Pennypincher’s accountant encourages her to sell one-third of<br />

her Biosystems shares through Merry Brothers.<br />

May Pennypincher do so without causing Biosystems to file with<br />

the SEC a registration statement that registers that sale of<br />

Pennypincher’s stock under §5 of the <strong>Securities</strong> Act?<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved<br />

13


Primary Resale Exemptions<br />

§ 4(a)(1) – Sales not by an Issuer or<br />

Underwriter or Dealer<br />

Resales under Rule 144 – Safe harbor for nonunderwriter<br />

status<br />

“§ 4(a)(1½)” – Resales of private placement<br />

securities (“restricted securities”) outside of<br />

Rule 144 safe harbor<br />

Resales under Rule 144A – Safe harbor for<br />

non-underwriter status for “QIBs”<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved<br />

14


Primary Ordinary Course<br />

Trading Exemption<br />

§ 4(a)(1) – transactions by any person other<br />

than<br />

issuer,<br />

underwriter,<br />

or dealer<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved<br />

15


Definitions Critical to §<br />

4(a)(1)<br />

Issuer – § 2(a)(4)<br />

Underwriter – § 2(a)(11)<br />

Dealer – § 2(a)(12)<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved<br />

16


Pivotal Role of “Underwriter”<br />

Concept in § 4(a)(1)<br />

§ 2(a)(11) – "underwriter" means any person who has<br />

purchased from an issuer with a view to, or<br />

offers or sells for an issuer in connection with,<br />

the distribution of any security . . . .<br />

As used in this paragraph . . . "issuer" shall include, in<br />

addition to an issuer, any person . . . controlling or<br />

controlled by the issuer, or any person under . . .<br />

common control with the issuer.<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved<br />

17


Session 6 – Resale of <strong>Securities</strong><br />

Study Problem 6.1 – Analysis<br />

Pennypincher may sell those shares<br />

without registering the sale under §5 of<br />

the <strong>Securities</strong> Act, because<br />

Pennypincher may rely on the §4(a)(1)<br />

exemption<br />

She is neither an issuer, underwriter,<br />

nor dealer<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved<br />

18


Resale of <strong>Securities</strong><br />

How do investors resell securities<br />

purchased in a private<br />

placement?<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved<br />

19


Session 6 – Resale of <strong>Securities</strong><br />

Study Problem 6.2<br />

One month after the Biosystems IPO, its stock is trading at<br />

$50 per share. Biosystems then has 12 million shares<br />

outst<strong>and</strong>ing.<br />

Faith Frugal, one of the founders’ friends, would like to sell<br />

500 of the Biosystems shares that she acquired 17 months<br />

earlier in a “506” transaction. Neither Faith nor any member<br />

of her family is a Biosystems director or executive officer,<br />

or owns more than 1% of Biosystem stock.<br />

May Faith sell the 500 shares without registration under<br />

§5 of the <strong>Securities</strong> Act?<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved<br />

20


Pivotal Role of “Underwriter”<br />

Concept in § 4(a)(1)<br />

§ 2(a)(11) – "underwriter" means any<br />

person who has<br />

purchased from an issuer with a view<br />

to . . .<br />

the distribution of any security . . . .<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved<br />

21


Pivotal Role of “Underwriter”<br />

Concept in § 4(a)(1)<br />

What’s a “distribution” for<br />

purposes of § 2(a)(11)?<br />

* * *<br />

See pp. 99-100 of course book.<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved<br />

22


Resale of <strong>Securities</strong><br />

Rule 144 – “Underwriter” Safe Harbor<br />

Restricted <strong>Securities</strong> – Rule 144 Preamble<br />

Any person who sells restricted securities<br />

shall be deemed not to be engaged in a<br />

distribution of such securities <strong>and</strong> therefore<br />

not an underwriter thereof, if sale is made in<br />

accordance with Rule 144.<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved<br />

23


Resale of <strong>Securities</strong><br />

What is a “restricted” security?<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved<br />

24


Resale of <strong>Securities</strong><br />

Rule 144(a)(3) – “Restricted <strong>Securities</strong>”<br />

Defined<br />

<strong>Securities</strong> acquired directly or indirectly from the issuer, or<br />

from an affiliate of the issuer, in a transaction or chain of<br />

transactions not involving any public offering;<br />

<strong>Securities</strong> acquired from the issuer that are subject to the resale<br />

limitations of Rule 502(d) under <strong>Regulation</strong> D or Rule 701(g);<br />

<strong>Securities</strong> acquired in a transaction or chain of transactions<br />

meeting the requirements of Rule 144A;<br />

Equity securities of domestic issuers acquired in a transaction<br />

or chain of transactions subject to the conditions of Rule 901<br />

or Rule 903 under <strong>Regulation</strong> S (Rules 901 through 905 <strong>and</strong><br />

Preliminary Notes)<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved<br />

25


Resale of <strong>Securities</strong><br />

How do “insiders” resell securities?<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved<br />

26


Session 6 – Resale of <strong>Securities</strong><br />

Study Problem 6.3<br />

Assume that Very Confident purchased Series A preferred stock from<br />

Biosystems six months before the IPO.<br />

Immediately prior to the closing of Biosystems’s IPO, Very Confident’s<br />

Series A preferred stock was converted into Biosystems common stock.<br />

Five months after the Biosystems IPO (<strong>and</strong> 11 months after Very<br />

Confident’s initial investment), Biosystems is trading at $55 per share.<br />

Very Confident wants to sell 500,000 shares, including all 100,000<br />

shares that it purchased in the IPO. Biosystems then has 12 million<br />

shares outst<strong>and</strong>ing. Very Confident owns approximately 15% of<br />

Biosystems common stock. A managing director of Very Confident is a<br />

Biosystems director.<br />

May Very Confident sell all 500,000 shares without registration<br />

under §5 of the <strong>Securities</strong> Act?<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved<br />

27


Pivotal Role of “Underwriter”<br />

Concept in § 4(a)(1)<br />

§ 2(a)(11) – "underwriter" means any person who has<br />

purchased from an issuer with a view to, or<br />

offers or sells for an issuer in connection with,<br />

the distribution of any security . . . .<br />

IMPORTANT: As used in § 2(a)(11), the definition<br />

of "issuer" includes, “in addition to an issuer, any<br />

person . . . controlling or controlled by the issuer, or<br />

any person under . . . common control with the<br />

issuer.”<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved<br />

28


Pivotal Role of “Underwriter”<br />

Concept in § 4(a)(1)<br />

Who is a “control person” for<br />

purposes of § 2(a)(11)?<br />

When does a “control person”<br />

engage in a “distribution” for<br />

purposes of § 2(a)(11)?<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved<br />

29


Resale of <strong>Securities</strong><br />

Rule 144 – “Underwriter” Safe Harbor<br />

Control Person – Rule 144 Preamble<br />

Any person who sells . . . other securities<br />

[i.e., non-restricted securities] on behalf of a<br />

person in a control relationship with the<br />

issuer shall be deemed not to be engaged in a<br />

distribution of such securities <strong>and</strong> therefore<br />

not to be an underwriter thereof, if the sale is<br />

made in accordance with Rule 144.<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved<br />

30


Who are Control Persons?<br />

Control Persons = Affiliates<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved<br />

31


Resale of <strong>Securities</strong><br />

Rule 144 – Who is an Affiliate?<br />

Technical definition of “affiliate” -- Rule 144(a)<br />

An affiliate of an issuer is a person or entity that directly, or<br />

indirectly through one or more intermediaries, controls, or is<br />

controlled by, or is under common control with, such issuer.<br />

Practical definition of affiliate -- The following categories<br />

generally are presumed to be affiliates:<br />

Executive officers of the issuer<br />

Directors of the issuer<br />

Principal shareholders (holders of more than 10 percent<br />

of a class of equity securities)<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved<br />

32


Control Persons/Affiliates<br />

Rules of Thumb:<br />

Executive officers<br />

Directors<br />

> 10% shareholders<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved<br />

33


Resale of <strong>Securities</strong><br />

Rule 144<br />

Safe Harbor – “Underwriter” Status<br />

Two important concepts:<br />

Restricted securities<br />

Control securities<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved<br />

34


Resale of <strong>Securities</strong><br />

Rule 144 – Effect of Safe Harbor<br />

If a sale of securities complies with all of the applicable conditions<br />

of Rule 144:<br />

1. Any affiliate or other person who sells restricted securities will<br />

be deemed not to be engaged in a distribution <strong>and</strong> therefore not<br />

an underwriter for that transaction;<br />

2. Any person who sells restricted or other securities on behalf of<br />

an affiliate of the issuer will be deemed not to be engaged in a<br />

distribution <strong>and</strong> therefore not an underwriter for that transaction;<br />

<strong>and</strong><br />

3. The purchaser in such transaction will receive securities that<br />

are not restricted securities.<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved<br />

35


Resale of <strong>Securities</strong><br />

What are the Rule 144 Conditions?<br />

Holding Period (restricted securities only)<br />

Current public information (sometimes not applicable<br />

to restricted securities)<br />

Volume limitation (i.e., limit on amount of securities<br />

sold during any three month period) (control securities<br />

only)<br />

Manner of sale (securities must be sold through a<br />

broker or to a market maker)<br />

Notice of proposed sale (Form 144 filed with SEC)<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved<br />

36


Session 6 – Resale of <strong>Securities</strong><br />

Rule 144 – Important 2007 Amendments<br />

“Restricted <strong>Securities</strong>”<br />

Six-month holding period for “restricted securities” of<br />

issuers subject to Exchange Act reporting requirements for at<br />

least 90 days before the Rule 144 sale<br />

After applicable holding period requirement is met, resale of<br />

restricted securities by a non-affiliate is no longer be subject<br />

to any other conditions of Rule 144<br />

Exception: “Current public information” requirement in<br />

Rule 144(c) will apply for an additional six months after<br />

the six-month holding period requirement is met for<br />

resale of securities of a reporting issuer.<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved<br />

37


Session 6 – Resale of <strong>Securities</strong><br />

Rule 144 – Matrix<br />

Refer to website<br />

Session 6 Reading Materials<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved<br />

38


Session 6 – Resale of <strong>Securities</strong><br />

Back to Study Problem 6.2<br />

One month after the Biosystems IPO, its stock is trading at<br />

$50 per share. Biosystems then has 12 million shares<br />

outst<strong>and</strong>ing.<br />

Faith Frugal, one of the founders’ friends, would like to sell<br />

500 of the Biosystems shares that she acquired 17 months<br />

earlier in a “506” transaction. Neither Faith nor any member<br />

of her family is a Biosystems director or executive officer,<br />

or owns more than 1% of Biosystem stock.<br />

May Faith sell the 500 shares without registration under<br />

§5 of the <strong>Securities</strong> Act?<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved<br />

39


Session 6 – Resale of <strong>Securities</strong><br />

Study Problem 6.2 – Analysis<br />

Faith’s shares are “restricted securities.”<br />

Biosystems’s IPO occurred one month ago <strong>and</strong> therefore it has<br />

not been subject to the reporting requirements of Section 13 or<br />

15(d) of the Exchange Act for at least 90 days, so the one-year<br />

holding period applies<br />

Faith has held the shares for more than one year <strong>and</strong> is not now<br />

<strong>and</strong> never has been an affiliate of Biosystems.<br />

Therefore, the Rule 144 safe harbor is available <strong>and</strong> Faith may<br />

sell the 500 shares in reliance on § 4(a)(1) without complying<br />

with any other provision of Rule 144.<br />

See Rule 144(b)(1)(ii) <strong>and</strong> (d)(1)(ii)<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved<br />

40


Session 6 – Resale of <strong>Securities</strong><br />

Back to Study Problem 6.3<br />

Assume that Very Confident purchased Series A preferred stock from<br />

Biosystems eight months before the IPO.<br />

Immediately prior to the closing of Biosystems’s IPO, Very Confident’s<br />

Series A preferred stock was converted into Biosystems common stock.<br />

Five months after the Biosystems IPO (<strong>and</strong> 11 months after Very<br />

Confident’s initial investment), Biosystems is trading at $55 per share.<br />

Very Confident wants to sell 500,000 shares, including all 100,000<br />

shares that it purchased in the IPO. Biosystems then has 12 million<br />

shares outst<strong>and</strong>ing. Very Confident owns approximately 15% of<br />

Biosystems common stock. A managing director of Very Confident is a<br />

Biosystems director.<br />

May Very Confident sell all 500,000 shares without registration<br />

under §5 of the <strong>Securities</strong> Act?<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved<br />

41


Restricted vs. Control <strong>Securities</strong><br />

Session 6 – Resale of <strong>Securities</strong><br />

Study Problem 6.3 – Analysis<br />

Very Confident will likely be deemed to be “affiliate” for purposes of Rule 144.<br />

Holding Period:<br />

Net Effect:<br />

Very Confident affiliate is a director on the Biosystems board<br />

Very Confident owns more than 10 percent of Biosystems stock<br />

Biosystems has been a reporting company for at least 90 days before the proposed Rule 144<br />

sale, so the relevant holding period is 6 months.<br />

Very Confident has held its investment in Biosystems for more 13 months. The 8-month<br />

holding period for the preferred stock is “tacked” onto the 5-month holding period for the<br />

common stock.<br />

Very Confident’s shares purchased in Biosystems’s IPO are not restricted securities <strong>and</strong><br />

therefore the holding period does not apply (SEC allows holder to segregate “restricted” <strong>and</strong><br />

“control” securities.)<br />

As long as Very Confident remains an affiliate of Biosystems, all Very Confident shares will<br />

be subject to “control securities” provisions under Rule 144, even those that have been held<br />

(or are deemed to have been held) for more than six months.<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved<br />

42


Resale of <strong>Securities</strong><br />

What if Rule 144 is not available?<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved<br />

43


Session 6 – Resale of <strong>Securities</strong><br />

Study Problem 6.4<br />

George is the President <strong>and</strong> CEO of We Can Do It, Inc. (We Can) <strong>and</strong> one of<br />

the company’s largest shareholders, owning 20 percent of We Can’s outst<strong>and</strong>ing<br />

common stock. Among his holdings are 500,000 shares of We Can Series B<br />

Preferred Stock, which he purchased four months ago as part of an offering<br />

under Rule 506 to accredited investors, including some mutual funds <strong>and</strong> other<br />

large financial institutions. The Series B Preferred Stock is convertible into<br />

common stock.<br />

We Can has been listed on Nasdaq for at least the past ten years.<br />

George tells you that his twin daughters have just turned 18 <strong>and</strong> each is about to<br />

head off to a prestigious (<strong>and</strong> very expensive) private university on the banks of<br />

the Charles River. George would like to sell some or all of his Series B shares<br />

in order to pay the tuition bills.<br />

Can he do so without We Can filing a registration statement registering the<br />

transaction under the <strong>Securities</strong> Act? How? Can he sell all of his shares or<br />

just a portion? What if George has held the Series B for seven months?<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved<br />

44


Resale of <strong>Securities</strong><br />

Rule 144 – “Underwriter” Safe Harbor<br />

Rule 144 is a nonexclusive safe harbor!<br />

See Rule 144 Preamble<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved<br />

45


Session 6 – Resales of <strong>Securities</strong><br />

Study Problem 6.4 – Analysis<br />

Shares of Series B stock are “restricted securities” but are not<br />

“debt securities”<br />

George is an affiliate of We Can<br />

We Can is “listed” <strong>and</strong> therefore likely is a “reporting<br />

company”<br />

George has held the Series B only for four months <strong>and</strong><br />

therefore may not rely on Rule 144<br />

If George held the Series B for seven months, he might be<br />

able to sell under Rule 144 if other conditions are satisfied.<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved<br />

46


Session 6 – Resale of <strong>Securities</strong><br />

Study Problem 6.5<br />

Same facts as Study Problem 6.4.<br />

Three months later, Thomas, who is George’s college<br />

roommate but has no other relation to We Can, decides<br />

to sell the 250,000 shares of Series B Preferred Stock<br />

that he bought in the same offering. He doesn’t like the<br />

direction that We Can is taking <strong>and</strong> wants out!<br />

Can Thomas sell without We Can filing a registration<br />

statement registering the transaction? Can he use a<br />

brokerage firm?<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved<br />

47


Session 6 – Resales of <strong>Securities</strong><br />

Study Problem 6.5 – Analysis<br />

Thomas may rely on Rule 144<br />

The shares of Series B Preferred Stock are “restricted<br />

securities” but not “debt securities”<br />

We Can is “listed” <strong>and</strong> therefore likely is a “reporting<br />

company”<br />

Thomas has held the Series B for seven months, <strong>and</strong><br />

therefore can rely on Rule 144 BUT ONLY if there is<br />

“current information” about We Can<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved<br />

48


Session 6 – Resale of <strong>Securities</strong><br />

Study Problem 6.6<br />

Same facts as Study Problem 6.5, except assume that<br />

Thomas gave We Can a non-recourse personal note<br />

to finance his purchase of the shares of We Can<br />

preferred stock.<br />

Last month Thomas paid off the note <strong>and</strong> wants to<br />

sell his shares immediately without registration.<br />

Can he?<br />

Do you need to know any additional information?<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved<br />

49


Session 6 – Resales of <strong>Securities</strong><br />

Study Problem 6.6 – Analysis<br />

Under Rule 144(d), holding period does not begin until the<br />

full purchase price or other consideration is paid<br />

When a promissory note is given to the issuer (or an<br />

affiliate) to pay all or a portion of the purchase price of the<br />

security, the purchaser is not deemed to have paid full<br />

purchase price unless the note:<br />

provides for full recourse against the purchaser; <strong>and</strong><br />

is secured by collateral, other than the securities<br />

purchased, having a fair market value at least equal to<br />

the purchase price of securities purchased; <strong>and</strong><br />

the note is discharged by payment in full prior to sale of<br />

the securities.<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved<br />

50


Session 6 – Resale of <strong>Securities</strong><br />

Study Problem 6.7<br />

Same facts as Study Problem 6.6, except assume that<br />

Thomas paid We Can cash to purchase the Series B<br />

but borrowed the purchase price from Shadyside<br />

Bank <strong>and</strong> Trust Company. Thomas gave Shadyside<br />

a note for the purchase price, collateralized by a<br />

pledge to the bank of those shares of We Can<br />

preferred stock.<br />

If Thomas defaults on the note seven months after<br />

Thomas purchased the stock, can the bank sell the<br />

preferred stock immediately without registration?<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved<br />

51


Session 6 – Resales of <strong>Securities</strong><br />

Study Problem 6.7 – Analysis<br />

We Can has been “listed” on Nasdaq for the past 10 years, <strong>and</strong><br />

therefore likely is a “reporting company” at the time of the<br />

proposed Rule 144 sale <strong>and</strong> has been such for the preceding 90<br />

days, <strong>and</strong> therefore the six month holding period applies. Rule<br />

144(d)(1)(i).<br />

Under Rule 144(d)(3)(iv), Shadyside will be able to tack – or add –<br />

Thomas’s holding period to its own, <strong>and</strong> therefore Shadyside<br />

would have a seven month holding period:<br />

If Thomas’s pledge of restricted securities is “bona fide”, <strong>and</strong><br />

If Thomas was personally liable to Shadyside (i.e., there is<br />

“recourse” to Thomas).<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved<br />

52


Session 6 – Resales of <strong>Securities</strong><br />

Study Problem 6.7 – Analysis<br />

Let’s continue to assume that We Can is a “reporting company” at the time of the<br />

proposed Rule 144 sale <strong>and</strong> has been such for the preceding 90 days, <strong>and</strong> that<br />

therefore the six month holding period applies. Rule 144(d)(1)(i).<br />

Rule 144(b)(1) states that if the issuer of the securities is, <strong>and</strong> has been for a<br />

period of at least 90 days immediately before the proposed Rule 144 sale, subject<br />

to SEC reporting requirements under the Exchange Act, a seller under Rule 144<br />

who is not an affiliate, <strong>and</strong> has not been an affiliate during the preceding three<br />

months, who sells restricted securities of that issuer for the seller’s own account<br />

shall be deemed not to be an underwriter if:<br />

The seller has held the securities for at least six months (see Rule<br />

144(d)(1)(i));<br />

AND, when the holding period is at least six months but less than one year,<br />

the condition in Rule 144(c)(1) also must be satisfied (i.e., there must be<br />

“adequate current public information with respect to the issuer” as defined<br />

in (c)(1))<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved<br />

53


Session 6 – Resales of <strong>Securities</strong><br />

More About Pledges of <strong>Securities</strong><br />

The 1981 Supreme Court decision in Rubin v.<br />

United States held that a pledge may be a sale<br />

for determining application of the anti-fraud<br />

provisions of the federal securities laws.<br />

The SEC’s Division of Corporation finance<br />

continues to take the view that the provisions<br />

of Rule 144(d) expressly permitting the tacking<br />

of holding periods of a pledgor <strong>and</strong> pledgee<br />

continue to apply.<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved<br />

54


Resale of <strong>Securities</strong><br />

May Rule 144 be used in<br />

conjunction with other<br />

exemptions?<br />

[NOTE: THERE IS NO STUDY<br />

PROBLEM 6.8]<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved<br />

55


Session 6 – Exempt <strong>Trans</strong>actions<br />

Study Problem 6.9<br />

Nine months after Biosystems’s IPO, its stock is trading at $50 per<br />

share.<br />

Gary Grateful is one of Great Genome’s founders who acquired a<br />

warrant in lending $1 million to Biosystems. Assume the warrant was<br />

issued five months before the IPO.<br />

Grateful now would like to exercise his Biosystems warrant <strong>and</strong><br />

immediately sell the underlying shares. (As you may recall from Study<br />

Problem 2.6, the warrant includes a customary “net exercise”<br />

provision.)<br />

Grateful is not an officer or director of Biosystems <strong>and</strong> owns less than 5<br />

percent of its common stock.<br />

How could Grateful structure the transaction to accomplish his<br />

objective?<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved<br />

56


Session 6 – Exempt <strong>Trans</strong>actions<br />

Study Problem 6.9 – Analysis<br />

Grateful would utilize the “net exercise” feature of the warrant<br />

In issuing its shares of common stock to Grateful upon exercise of<br />

the warrant, Biosystems would rely on the §3(a)(9) exemption:<br />

§ 3(a)(9) – Exchanges by the issuer<br />

any security exchanged by the issuer with its existing security<br />

holders exclusively where no commission or other remuneration is<br />

paid or given directly or indirectly for soliciting such exchange<br />

Grateful then could sell shares immediately under §4(a)(1) if he<br />

were not deemed to be an “underwriter”.<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved<br />

57


Session 6 – Exempt <strong>Trans</strong>actions<br />

Study Problem 6.9 – Analysis (cont’d)<br />

Grateful would utilize the “net exercise” feature of the warrant as follows:<br />

Warrant has exercise price of $10 per share<br />

Therefore, for 100,000 shares, Grateful’s aggregate exercise price is $1<br />

million<br />

With the market price of Biosystems stock at $50 per share, Grateful would<br />

have to deliver 20,000 shares to satisfy the exercise price<br />

On a net exercise basis, Biosystems would withhold (i.e., not issue) 20,000<br />

shares, <strong>and</strong> Grateful would receive 80,000 shares upon exercise without<br />

providing any other consideration to Biosystems . . . so the exchange of<br />

Biosystems common stock would be<br />

exclusively for the warrant, <strong>and</strong><br />

without any commission or other remuneration<br />

<strong>and</strong> therefore would satisfy the criteria for the exemption under §3(a)(9)<br />

Most important, the net exercise will be helpful in allowing Grateful to utilize the<br />

Rule 144 “safe harbor” to avoid the risk that he might be characterized as an<br />

underwriter.<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved<br />

58


Session 6 – Resales of <strong>Securities</strong><br />

Study Problem 6.9 – Analysis (cont’d)<br />

The warrants are “restricted securities.”<br />

Biosystems has been a “reporting company” for nine months <strong>and</strong><br />

therefore, the relevant holding period is six months. Rule 144(d)(1)(i).<br />

Grateful can “tack” holding period of the warrant (i.e., common stock to<br />

be sold was acquired from Biosystems solely in exchange for the warrant<br />

or “other securities of same issuer” <strong>and</strong> therefore the shares of common<br />

stock or “newly acquired securities” are deemed to have been acquired at<br />

the same time as the warrant. (See Rule 144(d)(3)(ii) & (x).) NB. The<br />

result is the same even if even if the options or warrants exercised<br />

originally did not provide for cashless exercise by their terms.<br />

Grateful held the warrant for 14 months, <strong>and</strong> therefore can rely on Rule<br />

144 without satisfying the other Rule 144 conditions<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved<br />

59


Resale of <strong>Securities</strong><br />

Enough about Rule 144!<br />

What if Rule 144 is not available?<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved<br />

60


Session 6 – Resale of <strong>Securities</strong><br />

Study Problem 6.10<br />

Gee Whiz, Inc. believes that it has developed the “next generation” cell phone. It will take two years<br />

<strong>and</strong> $10 million for the phone to reach the prototype stage. Gee Whiz is not listed on an exchange<br />

<strong>and</strong> its shares are not otherwise publicly traded.<br />

Gee Whiz sells $12 million of convertible preferred stock to its existing VC investors <strong>and</strong> members of<br />

its board of directors <strong>and</strong> advisory board. Sally, one of these advisory directors, invests $500,000.<br />

Three months later Sally learns that she has a potentially life threatening medical condition. Her<br />

doctors recommend that she seek the treatment of a specialist in Australia. The course of treatment<br />

will range from two to three years in Australia, <strong>and</strong> she will not be able to continue teaching or<br />

consulting while “down under.”<br />

Ricardo, a neighbor of Sally’s, hears about her condition <strong>and</strong> wants to help. While speaking with one<br />

of Sally’s children, Riccardo learns that Sally stretched her financial resources to invest in Gee Whiz,<br />

expecting to be able to replenish her savings quickly with income from several new consulting<br />

assignments, which she now must decline. Ricardo teaches art at the local elementary school, but<br />

inherited significant assets from his late wife, a successful entrepreneur who died a year ago. Ricardo<br />

underst<strong>and</strong>s from Sally’s children that the Gee Whiz convertible preferred is “restricted.” He asks<br />

you if he may legally purchase the Gee Whiz preferred stock from Sally to help her fund her medical<br />

<strong>and</strong> relocation expenses.<br />

What is your advice? What additional facts, if any, would you like to know?<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved<br />

61


Session 6 – Resales of <strong>Securities</strong><br />

Study Problem 6.10 – Analysis<br />

Sally might consider relying on the<br />

so-called § 4(a)(1½) exemption,<br />

which is essentially a secondary<br />

private placement by her to<br />

Ricardo.<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved<br />

62


Session 6 – Resale of <strong>Securities</strong><br />

So-called § 4(a)(1½) Exemption<br />

§4(a)(2) technically is available only for issuers:<br />

“transactions by an issuer not involving any<br />

public offering.”<br />

§4(a)(1) may not be completely safe because<br />

analysis of “underwriter” status depends on a<br />

subjective assessment of facts <strong>and</strong> the holding<br />

period<br />

In concept, § 4(a)(1½) falls between §4(a)(1) <strong>and</strong><br />

§4(a)(2).<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved<br />

63


Session 6 – Resales of <strong>Securities</strong><br />

Study Problem 6.10 – Analysis (cont’d)<br />

Sally would structure the sale as if it were a 506 offering:<br />

Is Ricardo is an accredited investor?<br />

Is Ricardo sophisticated (either alone or with a<br />

purchaser representative)?<br />

Has Sally provided Ricardo with access to information<br />

that she has (or has the right to obtain) about Gee Whiz?<br />

Will Ricardo accept the same restrictions on the resale<br />

of the securities that apply to Sally?<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved<br />

64


Session 6 – Resale of <strong>Securities</strong><br />

Study Problem 6.11<br />

[Same facts as Study Problem 6.10.]<br />

Eight months after Ricardo acquires the<br />

preferred stock from Sally, he would like to<br />

resell it in a Rule 144 transaction.<br />

May Ricardo rely on Rule 144?<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved<br />

65


Session 6 – Resale of <strong>Securities</strong><br />

Study Problem 6.11 – Analysis<br />

Rule 144 is a safe harbor both for "restricted securities" <strong>and</strong> securities<br />

sold by affiliates (i.e., control securities).<br />

The SEC takes the position that "individual investors who are not<br />

professionals in the securities business also may be 'underwriters' if they<br />

act as links in a chain of transactions through which securities move<br />

from an issuer to the public." (See Note 2 to preamble to Rule 144.)<br />

Therefore, Rule 144 defines restricted securities as "securities<br />

acquired directly or indirectly from the issuer, or from an affiliate of the<br />

issuer, in a transaction or chain of transactions not involving any public<br />

offering" (Rule 144(a)(3)(i)).<br />

Ricardo's acquisition of securities from Sally would be viewed as part<br />

of a chain of transactions not involving a public offering.<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved<br />

66


Session 6 – Resale of <strong>Securities</strong><br />

Study Problem 6.11 – Analysis (cont’d)<br />

Remember in Study Problem 6.10 that Ricardo<br />

would accept the same restrictions on the resale of<br />

the securities that applied to Sally.<br />

Under Rule 144(d)(1), Riccardo may “tack”<br />

Sally’s holding period to his own, because Sally is<br />

not an affiliate of Gee Whiz<br />

The holding period began when Sally paid the<br />

full purchase price to Gee Whiz<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved<br />

67


Session 6 – Resale of <strong>Securities</strong><br />

Study Problem 6.11 – Analysis (cont’d)<br />

As the combined holding period is less than one year<br />

(three months plus eight months = eleven months),<br />

Ricardo may NOT rely on Rule 144 because Gee Whiz<br />

is not a reporting company.<br />

After Ricardo has held the securities for at least nine<br />

months he will be able to rely on Rule 144.<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved<br />

68


Session 6 – Resale of <strong>Securities</strong><br />

Study Problem 6.11 – Analysis (cont’d)<br />

What if Gee Whiz was a reporting company at the time of the<br />

proposed Rule 144 sale?<br />

As the combined holding period is greater than six months but less<br />

than one year (three months plus eight months), Ricardo may rely on<br />

Rule 144, provided that Gee Whiz<br />

filed all required reports under section 13 or 15(d) of the<br />

Exchange Act, as applicable, during the 12 months preceding<br />

such sale, other than Form 8–K reports; <strong>and</strong><br />

submitted electronically <strong>and</strong> posted on its corporate Web site<br />

every “Interactive Data File” required to be submitted <strong>and</strong> posted<br />

pursuant to Rule 405 of <strong>Regulation</strong> S–T, during the 12 months<br />

preceding such sale. [NB. This criterion will be discussed in the<br />

second half of the course.]<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved<br />

69


Session 6 – Resale of <strong>Securities</strong><br />

More About “Tacking”<br />

Rule 144(d)(1)(i) <strong>and</strong> (ii) indicate generally<br />

that the holding period for restricted securities<br />

acquired from a nonaffiliate may be tacked to<br />

the acquiror’s holding period<br />

BUT the same is not true for securities<br />

purchased from an affiliate.<br />

Other tacking situations are specifically<br />

addressed in Rule 144(d)(3).<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved<br />

70


Resale of <strong>Securities</strong><br />

Are there special rules for large<br />

institutional investors?<br />

* * *<br />

What is a “QIB”?<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved<br />

71


Session 6 – Resale of <strong>Securities</strong><br />

Study Problem 6.12<br />

Three years after the Biosystems IPO, it issues $200 million of<br />

senior unsecured notes in a private placement exempt under<br />

Rule 506. The notes mature <strong>and</strong> are payable in full on the 10 th<br />

anniversary of issuance. Mutual funds <strong>and</strong> other large financial<br />

institutions, including Kinder Gentler Insurance Co., purchase<br />

the notes.<br />

Four months after the placement, Kinder Gentler decides to<br />

change its investment portfolio strategy <strong>and</strong> wishes to sell the<br />

notes.<br />

May it do so without Biosystems filing a registration<br />

statement to register the offer/sale under § 5 of the<br />

<strong>Securities</strong> Act?<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved<br />

72


Resale of <strong>Securities</strong><br />

Rule 144(a)(3) – “Restricted <strong>Securities</strong>”<br />

Defined<br />

Reminder:<br />

Restricted <strong>Securities</strong> include:<br />

<strong>Securities</strong> acquired in a transaction<br />

or chain of transactions meeting<br />

the requirements of Rule 144A;<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved<br />

73


Resale of <strong>Securities</strong><br />

Rule 144A<br />

Private Resales of <strong>Securities</strong> to Institutions<br />

Rule 144A(b):<br />

Any person, other than the issuer or a dealer, who<br />

offers or sells securities in compliance with the<br />

conditions set forth in paragraph (d) of this section<br />

shall be deemed not to be engaged in a<br />

distribution of such securities <strong>and</strong> therefore not<br />

to be an underwriter of such securities within the<br />

meaning of sections 2(a)(11) <strong>and</strong> 4(a)(1) of the Act.<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved<br />

74


Session 6 – Resales of <strong>Securities</strong><br />

Study Problem 6.12 – Analysis<br />

Kinder Gentler may rely on Rule 144A -- a close relative of<br />

§4(a)(1½) -- if :<br />

Notes are resold only to a qualified institutional buyer or<br />

“QIB”<br />

Biosystems takes reasonable steps to ensure that QIB is<br />

aware that the seller may rely on Rule 144A;<br />

Notes were not, when issued, of the same class as securities<br />

listed on a national securities exchange;<br />

In the case of securities of an issuer that does not file periodic<br />

reports with the SEC, holder <strong>and</strong> a prospective purchaser<br />

have the right to obtain certain information from the issuer,<br />

upon request.<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved<br />

75


Session 6 – Resale of <strong>Securities</strong><br />

Rule 144A – Elements<br />

Rule 144A -- a close relative of § 4(a)(1½)<br />

Conditions to be met:<br />

<strong>Securities</strong> are offered or sold only to a “qualified<br />

institutional buyer” (“QIB”)<br />

Seller <strong>and</strong> any person acting on its behalf takes<br />

reasonable steps to ensure that purchaser is aware that<br />

seller may rely on exemption from Section 5 provided<br />

by Rule 144A<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved<br />

76


Session 6 – Resale of <strong>Securities</strong><br />

Rule 144A – Elements (cont’d)<br />

Conditions to be met (continued):<br />

The securities offered or sold:<br />

Were not, when issued, of the same class as securities listed on a national<br />

securities exchange or quoted in a U.S. automated inter-dealer quotation<br />

system<br />

<strong>Securities</strong> convertible or exchangeable into securities so listed or quoted at<br />

the time of issuance <strong>and</strong> that had an effective conversion premium of less<br />

than 10 percent, treated as securities of the class into which they are<br />

convertible or exchangeable.<br />

Warrants that may be exercised for securities so listed or quoted at the<br />

time of issuance, for a period of less than 3 years from the date of<br />

issuance, or that had an effective exercise premium of less than 10 percent,<br />

shall be treated as securities of the class to be issued upon exercise.<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved<br />

77


Conditions to be met (continued):<br />

The securities offered or sold:<br />

Session 6 – Resale of <strong>Securities</strong><br />

Rule 144A – Elements (cont’d)<br />

Are not securities of an open-end investment company, unit investment trust<br />

or face-amount certificate company that is or is required to be registered<br />

under the Investment Company Act; <strong>and</strong><br />

In the case of securities of an issuer that is neither subject to section 13 or 15(d) of the<br />

Exchange Act . . . , the holder <strong>and</strong> a prospective purchaser designated by the holder<br />

have the right to obtain from the issuer, upon request of the holder, <strong>and</strong> the<br />

prospective purchaser has received . . . at or prior to the time of sale . . . , the<br />

following information (which shall be reasonably current in relation to the date of<br />

resale under this section): a very brief statement of the nature of the [issuer’s] business<br />

<strong>and</strong> the products <strong>and</strong> services it offers; <strong>and</strong> the issuer's most recent balance sheet <strong>and</strong><br />

profit <strong>and</strong> loss <strong>and</strong> retained earnings statements, <strong>and</strong> similar financial statements for<br />

such part of the two preceding fiscal years as the issuer has been in operation (the<br />

financial statements should be audited to the extent reasonably available).<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved<br />

78


Session 6 – Resale of <strong>Securities</strong><br />

Rule 144A – Elements (cont’d)<br />

Fact that purchasers of securities from issuer thereof<br />

may purchase with a view to reselling such<br />

securities pursuant to Rule 144A will not affect<br />

availability to such issuer of an exemption under<br />

§4(a)(2) or <strong>Regulation</strong> D.<br />

<strong>Securities</strong> acquired in a transaction that complies<br />

with Rule 144A are deemed to be restricted<br />

securities within the meaning of Rule 144(a)(3).<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved<br />

79


Session 6 – Resale of <strong>Securities</strong><br />

Rule 144A – Recent Changes<br />

How did the 2012 JOBS Act <strong>and</strong><br />

regulations adopted by the SEC<br />

in July 2013 change Rule 144A?<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved<br />

80


Session 6 Agenda<br />

Part 1<br />

How do investors resell securities?<br />

Part 2<br />

How do publicly traded companies<br />

conduct private placements?<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved<br />

81


Private Placements by<br />

Publicly Traded Companies<br />

• What is a “PIPE”<br />

• What is an “A/B Exchange<br />

Offer”?<br />

• What is a Reg. S offering?<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved<br />

82


Basic Principle Underlying the<br />

<strong>Securities</strong> Act of 1933<br />

“Unless an exemption is available, . . .”<br />

* * *<br />

Some exemptions focus on the type of<br />

security being offered.<br />

Other exemptions focus on the nature of the<br />

transaction in which the offering is made.<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved<br />

83


Session 6 (Part 2) – Private Placements by Publicly<br />

Traded Companies<br />

Study Problem 6.13<br />

2008 Buffet Investment in Goldman Sachs<br />

On September 23, 2008, The Goldman Sachs Group, Inc. announced that in<br />

exchange for a $5 billion cash investment by Berkshire Hathaway, Inc., a<br />

company controlled by Warren Buffet, Goldman Sachs agreed to sell to Berkshire<br />

Hathaway:<br />

Shares of 10% cumulative perpetual Goldman Sachs preferred stock, having<br />

a liquidation preference of $5 billion <strong>and</strong> being “callable” (i.e., subject to<br />

repurchase by Goldman Sachs) at any time at a 10 percent premium;<br />

A warrant to purchase 43.5 million shares of Goldman Sachs common stock<br />

at a price of $115 per share<br />

On September 24, 2008, Goldman Sachs entered into an underwriting agreement<br />

for the sale of 40.65 million shares of Goldman Sachs common stock at a price of<br />

$115 per share (the “Goldman Common Stock Offering”). The Goldman<br />

Common Stock Offering was completed on September 29, 2006.<br />

How would you structure these financings to comply with the <strong>Securities</strong> Act<br />

of 1933?<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved<br />

84


Session 6 (Part 2) – Private Placements by<br />

Publicly Traded Companies<br />

Study Problem 6.13 — Analysis<br />

Neither the sale of preferred stock or the warrant to Berkshire<br />

Hathaway Sale was registered under the <strong>Securities</strong> Act of 1933.<br />

Instead, they were sold in a private placement pursuant to Section<br />

4(a)(2) of the Act.<br />

Goldman Sachs <strong>and</strong> Berkshire Hathaway entered into a<br />

registration rights agreement<br />

The Common Stock Offering was registered under the Act pursuant<br />

to a “shelf” registration statement on Form S-3ASR (automatic shelf<br />

registration statement of securities of well-known seasoned issuers),<br />

which was originally filed on December 2, 2005.<br />

Goldman Sachs filed a prospectus supplement dated September<br />

25, 2008 related to the Common Stock Offering that describes<br />

the specific terms of the Common Stock Offering <strong>and</strong> adds to <strong>and</strong><br />

updates information contained in a prospectus dated July 16,<br />

2006.<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved<br />

85


Session 6 (Part 2) – Private Placements by<br />

Publicly Traded Companies<br />

Study Problem 6.14<br />

BeanTown Biosystems completed its IPO five years ago <strong>and</strong> has<br />

timely filed all periodic reports subsequently due under the<br />

Exchange Act.<br />

Biosystems decides to raise additional common equity to fund a<br />

cash acquisition. Biosystems needs to obtain the commitments<br />

relatively quickly (within a few weeks), so it may enter into the<br />

acquisition agreement, but the acquisition will not close for at<br />

least six months.<br />

Biosystems would prefer not to sell its stock at a substantial<br />

discount from the current market price, so it wants to avoid selling<br />

stock that would be subject to material resale restrictions.<br />

Biosystems has a common equity float of $300 million.<br />

What do you recommend?<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved<br />

86


PIPE—Private Investment in<br />

Public Equities<br />

Step 1 – Investors agree to purchase securities in a<br />

private placement – typically under Rule 506.<br />

Step 2 – Closing of private placement, <strong>and</strong> payment of<br />

funds to issuer, typically is contingent upon<br />

effectiveness of registration statement covering<br />

resales of the privately placed securities.<br />

Alternative Step 2 – Issuer agrees to file registration<br />

promptly after the closing<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved<br />

87


PIPE—Private Investment in<br />

Public Equities (cont’d)<br />

Why is this not deemed to be a public<br />

offering under the integration doctrine?<br />

Rule 152: the §4(a)(2) exemption “shall be<br />

deemed to apply to transactions not involving<br />

any public offering at the time of said<br />

transactions although subsequently thereto the<br />

issuer decides to . . . [file] . . . a registration<br />

statement.”<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved<br />

88


PIPE—Private Investment in<br />

Public Equities (cont’d)<br />

Private placement must be “completed” prior to filing registration<br />

statement, otherwise Rule 152 will not be available.<br />

Private placement is completed when the issuer has commitments<br />

from all investors subject only to conditions outside the investors’<br />

control<br />

The effectiveness of resale registration statement is considered to<br />

be a condition outside the investors’ control<br />

Investors typically are at market risk from the time the private<br />

placement is completed until the registration statement is effective.<br />

Renegotiation of material terms of purchase after registration<br />

statement filing may jeopardize availability of Rule 152 (as it may<br />

constitute a new offering).<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved<br />

89


PIPE—Private Investment in<br />

Public Equities (cont’d)<br />

Watch for “toxic convertibles” or “death spirals”!<br />

If a PIPE deal is not structured properly, an issuer may throw the<br />

issuer’s stock into an irreversible “death spiral.”<br />

For example, a small percentage of structured PIPEs involve<br />

convertible securities with floorless reset conversion features.<br />

The floorless price reset features create an incentive for<br />

investors of toxic convertibles to short-sell the stock, driving<br />

the stock price down <strong>and</strong> allowing them to obtain more shares<br />

upon conversion of the toxic convertibles. These potential<br />

issuances of additional shares cause further downward<br />

pressure on stock price, throwing the issuer’s stock into a tailspin.<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved<br />

90


Session 6 (Part 2) – Private Placements by<br />

Publicly Traded Companies<br />

Nasdaq Rule 5635(d)<br />

Be mindful of Nasdaq Rule 5635(d) – The “20% Rule”<br />

Shareholder approval required prior to issuance of securities in<br />

connection with a transaction other than a public offering if:<br />

issuance or potential issuance of common stock (or securities<br />

convertible into or exercisable for common stock), together with<br />

sales by officers, directors or “Substantial Shareholders,” are ≥ 20%<br />

of common stock or ≥ 20% of voting power outst<strong>and</strong>ing before<br />

issuance; <strong>and</strong><br />

price per share in private placement is < than greater of book or<br />

“market” value<br />

Note also that Nasdaq often will question whether offering registered<br />

with SEC – such as a “registered direct” offering – in fact is a bona fide<br />

“public offering”<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved<br />

91


Session 6 (Part 2) – Private Placements by<br />

Publicly Traded Companies<br />

Study Problem 6.15<br />

Jumbo Corp., a NYSE-listed company that has been publicly traded for<br />

the past 15 years, seeks to raise $300 million in debt financing by<br />

selling ten-year notes to institutional investors to fund a cash<br />

acquisition.<br />

Jumbo needs to obtain the commitments relatively quickly (within two<br />

weeks), so it may enter into the acquisition agreement. Jumbo will not<br />

be able to file a registration statement for several months while<br />

negotiations for another material acquisition are pending.<br />

Jumbo would prefer not to issue the debt in a Rule 506/Rule 144A<br />

structure, because it believes the illiquidity discount on account of the<br />

resale restrictions would be too great.<br />

Jumbo has a common equity public float of $500 million.<br />

What do you recommend?<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved<br />

92


Session 6 (Part 2) – Private Placements by<br />

Publicly Traded Companies<br />

Study Problem 6.15 – Analysis<br />

Jumbo does not qualify as a WKSI.<br />

Jumbo’s negotiations for another material<br />

acquisition preclude filing a registration statement<br />

immediately, thus making a traditional PIPE<br />

structure undesirable.<br />

If Jumbo would prefer not to issue the debt in a Rule<br />

506/Rule 144A structure, another approach would<br />

be a transaction known as an “A/B exchange<br />

offer.”<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved<br />

93


Session 6 (Part 2) – Private Placements by<br />

Publicly Traded Companies<br />

“Exxon Capital” A/B Exchange Offers<br />

In an A/B exchange offer transaction, the issuer sells securities in a<br />

private placement <strong>and</strong>, shortly thereafter, effects a registered<br />

exchange offer for those securities.<br />

The result is that the purchasers of the restricted securities hold<br />

freely tradable securities after the exchange—they can sell them<br />

in the secondary market <strong>and</strong> will not be deemed to be<br />

underwriters.<br />

The transaction may only be used with non-convertible debt<br />

securities, certain types of preferred stock <strong>and</strong> initial public<br />

offerings of common stock of foreign issuers to eliminate a<br />

Rule 144A facility.<br />

The rationale for A/B exchange offers is set forth in the “Exxon<br />

Capital” line of SEC no-action letters.<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved<br />

94


Session 6 (Part 2) – Private Placements by<br />

Publicly Traded Companies<br />

“Exxon Capital” A/B Exchange Offers<br />

Step 1 – Debt securities are sold in private placement<br />

under an exemption from registration requirements of<br />

the <strong>Securities</strong> Act (e.g., under Rule 506 to accredited<br />

investors – typically QIBs for purposes of Rule 144A).<br />

Step 2 –Issuer registers an exchange offer (on Form S-4)<br />

of debt securities having identical terms <strong>and</strong> conditions<br />

Step 3 – After the S-4 is effective, issuer exchanges the<br />

registered debt securities (i.e., the “B” tranche) for the<br />

privately placed debt securities (i.e., the “A” tranche).<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved<br />

95


Session 6 (Part 2) – Private Placements by<br />

Publicly Traded Companies<br />

“Exxon Capital” A/B Exchange Offers<br />

Implications of the Exchange:<br />

Investors now hold registered debt securities that<br />

are freely tradable in the secondary market without<br />

compliance with the <strong>Securities</strong> Act’s registration<br />

<strong>and</strong> prospectus delivery requirements applicable to<br />

underwriters, as long as the securities were acquired<br />

in the ordinary course of business <strong>and</strong> the private<br />

placee has no arrangement with any person for the<br />

distribution of the securities.<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved<br />

96


Session 6 (Part 2) – Private Placements by<br />

Publicly Traded Companies<br />

“Exxon Capital” A/B Exchange Offers<br />

Reasoning:<br />

SEC has previously opined that an institutional<br />

investor who purchases a large quantity of<br />

securities from an issuer will not be deemed to be<br />

an underwriter when selling the securities in the<br />

secondary market provided that the securities were<br />

acquired in the ordinary course of business <strong>and</strong> the<br />

investor has no arrangement with any person for the<br />

distribution of the securities.<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved<br />

97


Session 6 (Part 2) – Private Placements by<br />

Publicly Traded Companies<br />

“Exxon Capital” A/B Exchange Offers<br />

Query:<br />

How did the 2007 changes to Rule 144 affect<br />

the role of the A/B exchange offer?<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved<br />

98


Session 6 (Part 2) – Reg. S<br />

Study Problem 6.16<br />

Five years ago BeanTown Biosystems raised $200 million in<br />

an underwritten IPO. The lead underwriter was the<br />

investment banking firm Gold, Bull & Bear (“GBB”).<br />

GBB now advises Biosystems that there is growing interest<br />

in Europe for Biosystem <strong>and</strong> that an issuance of debt<br />

securities in Europe would enhance Biosystems’s reputation<br />

among institutional money managers in Europe.<br />

Biosystems would like to raise $75 million in Europe, but<br />

does not want to wait for a registration statement to be<br />

declared effective. What is your advice?<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved<br />

99


Session 6 (Part 2) –<br />

Basic Principle Underlying <strong>Securities</strong> Act of 1933<br />

(Refined)<br />

Unless an exemption is available, it is<br />

unlawful to use any means of interstate<br />

commerce to make any offer or sale of a<br />

security unless the transaction is<br />

registered with the SEC <strong>and</strong> all material<br />

information has been disclosed.<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved<br />

100


Session 6 (Part 2) – Reg. S<br />

<strong>Regulation</strong> S (Rules 901 – 905)<br />

Rule 901: “offer” <strong>and</strong> “sale” does not<br />

include offers <strong>and</strong> sales solely outside<br />

of United States<br />

Preliminary Notes: A non-exclusive<br />

safe harbor<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved<br />

101


Session 6 (Part 2) – Reg. S<br />

<strong>Regulation</strong> S – Rule 903(a):<br />

Offer <strong>and</strong> sale is made in an “offshore”<br />

transaction<br />

No “directed selling efforts” are made in<br />

the U.S.<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved<br />

102


Session 6 (Part 2) – Reg. S<br />

<strong>Regulation</strong> S – Rule 903(a):<br />

Additional conditions depending on the type of offering:<br />

“Category 1” includes<br />

Foreign issuer reasonably believes at the<br />

commencement of the offering that there is no<br />

substantial U.S. market interest); <strong>and</strong><br />

The securities are offered <strong>and</strong> sold to employees of<br />

issuer or its affiliates pursuant to employee benefit<br />

plan established <strong>and</strong> administered in accordance with<br />

the law of a country other than the United States, <strong>and</strong><br />

customary practices <strong>and</strong> documentation of such<br />

country, provided several other conditions are<br />

satisfied.<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved<br />

103


Session 6 (Part 2) – Reg. S<br />

<strong>Regulation</strong> S – Rule 903(a):<br />

“Category 2” which includes<br />

Debt securities of a reporting U.S. issuer<br />

Equity securities of a reporting foreign<br />

issuer<br />

Additional conditions<br />

Offering restrictions are implemented<br />

40-day “distribution compliance” period<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved<br />

104


Session 6 (Part 2) – Reg. S<br />

<strong>Regulation</strong> S – Rule 903(a):<br />

“Category 3” which applies to any class of securities<br />

not eligible for either category 1 or 2, including<br />

Equity securities of a reporting U.S. issuer<br />

Additional conditions<br />

Offering restrictions are implemented<br />

40-day “distribution compliance” period for debt<br />

six month “distribution compliance” period for<br />

equity for “reporting issuers” (one year period<br />

for non-reporting issuers)<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved<br />

105


Reg. S<br />

<strong>Regulation</strong> S – Rule 903(a):<br />

Additional conditions for Category 3 equity offerings:<br />

Purchaser (other than a distributor) must certify that it<br />

is not a U.S. person <strong>and</strong> is not acquiring the securities<br />

for the account or benefit of any U.S. person;<br />

Purchaser agrees to resell such securities only in<br />

accordance with <strong>Regulation</strong> S, or pursuant to<br />

registration under the Act, or pursuant to an available<br />

exemption from registration; <strong>and</strong> agrees not to engage<br />

in hedging transactions with regard to such securities<br />

unless in compliance with the Act;<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved<br />

106


<strong>Regulation</strong> S – Rule 903(a):<br />

Reg. S<br />

Additional conditions for Category 3 equity<br />

offerings:<br />

<strong>Securities</strong> of a domestic issuer contain restrictive<br />

legend;<br />

The issuer is required, either by contract or a<br />

provision in its bylaws, articles, charter or<br />

comparable document, to refuse to register any<br />

transfer of the securities that does not comply<br />

with the transfer restrictions<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved<br />

107


<strong>Regulation</strong> S – Rule 903(a):<br />

Reg. S<br />

Additional conditions for Category 3 equity offerings:<br />

Each distributor, dealer (as defined in section<br />

2(a)(12) of the Act), or a person receiving a selling<br />

concession, fee or other remuneration, prior to the<br />

expiration of the “distribution compliance period”,<br />

sends a confirmation or other notice to the purchaser<br />

stating that the purchaser is subject to the same<br />

restrictions on offers <strong>and</strong> sales that apply to a<br />

distributor.<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved<br />

108


Reg. S<br />

<strong>Regulation</strong> S – Rules 904 <strong>and</strong> 905:<br />

Resale Restrictions under 904 – Offshore<br />

Similar to basic Reg. S conditions<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved<br />

109


Reg. S<br />

<strong>Regulation</strong> S – Rules 904 <strong>and</strong> 905:<br />

Resale Restrictions under 905 – U.S.<br />

Equity securities of domestic issuers<br />

acquired from the issuer, a distributor, or<br />

any of their respective affiliates in a<br />

transaction subject to the conditions of Rule<br />

901 or Rule 903 are deemed to be<br />

"restricted securities" as defined in Rule<br />

144.<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved<br />

110


Session 6 (Part 2) – Reg. S<br />

<strong>Regulation</strong> S – Rules 904 <strong>and</strong> 905:<br />

Resale Restrictions under 905 – U.S. (cont’d)<br />

Resales of such restricted securities must be made in<br />

accordance with<br />

<strong>Regulation</strong> S, or<br />

the registration requirements of the <strong>Securities</strong> Act, or<br />

an exemption therefrom.<br />

Any "restricted securities," as defined in Rule 144, that are<br />

equity securities of a domestic issuer will continue to be<br />

deemed to be restricted securities, notwithst<strong>and</strong>ing that they<br />

were acquired in a resale transaction made pursuant to Rule<br />

901 or Rule 904.<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved<br />

111


Same facts as 6.16<br />

Session 6 (Part 2) – Reg. S<br />

Study Problem 6.17<br />

May BioSystems sell $75 million of debt securities<br />

in Europe <strong>and</strong> concurrently sell $50 million of the<br />

same debt securities in the US?<br />

What is your advice?<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved<br />

112


Session 6 (Part 2) – Reg. S<br />

Study Problem 6.17 Analysis<br />

Yes, Biosystems may sell the debt securities<br />

offshore in reliance on Reg. S <strong>and</strong> concurrently<br />

conduct a private placement of the same securities in<br />

the United States.<br />

According to one source, a majority of international<br />

offerings are concurrent Reg. S offerings <strong>and</strong> Rule<br />

506 private placements in the United States to QIBs<br />

that may resell the securities under Rule 144A.<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved<br />

113


Session 6 (Part 2) – Reg. S<br />

Study Problem 6.17 Analysis (cont’d)<br />

In determining whether the requirements for an exempt<br />

private placement under Section 4(a)(2) (including Rule<br />

506) have been satisfied, offshore transactions made in<br />

compliance with Reg S will not be integrated with<br />

domestic offerings that are otherwise exempt from<br />

registration under the <strong>Securities</strong> Act. See Preliminary<br />

Note 7 to <strong>Regulation</strong> D.<br />

For Reg. S purposes, it is essential that the issuer not<br />

engage in conduct that could constitute “directed selling<br />

efforts” in the United States.<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved<br />

114


Note about JOBS Act <strong>and</strong><br />

Foreign Private Issuers<br />

Foreign Private Issuers will be discussed in a<br />

later session.<br />

The JOBS Act contains a number of key<br />

changes that will facilitate U.S. IPOs by<br />

foreign private issuers that are emerging<br />

growth companies.<br />

These changes are relevant to both SECregistered<br />

<strong>and</strong> non-SEC-registered deals.<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved<br />

115


Note about JOBS Act <strong>and</strong><br />

Foreign Private Issuers<br />

For a client advisory focusing on JOBS Act<br />

changes relevant to foreign private issuers<br />

that are emerging growth companies, see<br />

http://www.davispolk.com/files/Publication/69e8a705a654-486b-b313-<br />

29763590e278/Presentation/PublicationAttachment/6f4c<br />

dcd1-4d3a-41c3-90df-<br />

29801fd8bd2b/042612_finaljobsact.pdf<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved<br />

116


U.S <strong>and</strong> <strong>Trans</strong>-<strong>Border</strong><br />

<strong>Securities</strong> <strong>Regulation</strong><br />

Boston University School of Law<br />

Executive LL.M. - International Business Law<br />

July/August 2013<br />

Michael Krebs<br />

JD, Boston University School of Law 1985<br />

Senior Partner, Nutter, McClennen & Fish, LLP, Boston, MA<br />

Tel. 617.439.2288 email: mkrebs@nutter.com<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved 117


U.S <strong>and</strong> <strong>Trans</strong>-<strong>Border</strong><br />

<strong>Securities</strong> <strong>Regulation</strong><br />

Boston University School of Law<br />

Executive LL.M. in International Business Law<br />

Session 6 – Study Problem<br />

July 27, 2013<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Session 6 – Resale of <strong>Securities</strong><br />

Study Problem 6.1<br />

Beantown Biosystems raises $100 million by selling 5 million shares<br />

of common stock at $20 per share in an underwritten initial public<br />

offering (“IPO”) covered by an effective registration statement.<br />

Professor Pennypincher, who has no relationship to Biosystems or<br />

any of its affiliates, purchases 1,000 shares of stock in the IPO<br />

through her trusted brokerage firm Merry Brothers, a brokerage firm<br />

that was not part of the underwriting syndicate.<br />

One month after the IPO, Biosystems’s stock is trading at $30 per<br />

share. Pennypincher’s accountant encourages her to sell one-third of<br />

her Biosystems shares through Merry Brothers.<br />

May Pennypincher do so without causing Biosystems to file with<br />

the SEC a registration statement that registers that sale of<br />

Pennypincher’s stock under §5 of the <strong>Securities</strong> Act?<br />

(c) 2013 Michael K. Krebs All Rights<br />

Reserved<br />

2


Session 6 – Resale of <strong>Securities</strong><br />

Study Problem 6.2<br />

One month after the Biosystems IPO, its stock is trading at<br />

$50 per share. Biosystems then has 12 million shares<br />

outst<strong>and</strong>ing.<br />

Faith Frugal, one of founders’ friends, would like to sell 500<br />

of the Biosystems shares that she acquired 17 months earlier<br />

in a “506” transaction. Neither Faith nor any member of her<br />

family is a Biosystems director or executive officer, or owns<br />

more than 1% of Biosystem stock.<br />

May Faith sell the 500 shares without registration under<br />

§5 of the <strong>Securities</strong> Act?<br />

(c) 2013 Michael K. Krebs All Rights<br />

Reserved<br />

3


Session 6 – Resale of <strong>Securities</strong><br />

Study Problem 6.3<br />

Assume that Very Confident purchased Series A preferred stock from<br />

Biosystems six months before the IPO.<br />

Immediately prior to the closing of Biosystems’s IPO, Very Confident’s<br />

Series A preferred stock was converted into Biosystems common stock.<br />

Five months after the Biosystems IPO (<strong>and</strong> 11 months after Very<br />

Confident’s initial investment), Biosystems is trading at $55 per share.<br />

Very Confident wants to sell 500,000 shares, including all 100,000<br />

shares that it purchased in the IPO. Biosystems then has 12 million<br />

shares outst<strong>and</strong>ing. Very Confident owns approximately 15% of<br />

Biosystems common stock. A managing director of Very Confident is a<br />

Biosystems director.<br />

May Very Confident sell all 500,000 shares without registration<br />

under §5 of the <strong>Securities</strong> Act?<br />

(c) 2013 Michael K. Krebs All Rights<br />

Reserved<br />

4


Session 6 – Resale of <strong>Securities</strong><br />

Study Problem 6.4<br />

George is the President <strong>and</strong> CEO of We Can Do It, Inc. (We Can) <strong>and</strong> one of<br />

the company’s largest shareholders, owning 20 percent of We Can’s outst<strong>and</strong>ing<br />

common stock. Among his holdings are 500,000 shares of We Can Series B<br />

Preferred Stock, which he purchased four months ago as part of an offering<br />

under Rule 506 to accredited investors, including some mutual funds <strong>and</strong> other<br />

large financial institutions. The Series B Preferred Stock is convertible into<br />

common stock.<br />

We Can has been listed on Nasdaq for at least the past ten years.<br />

George tells you that his twin daughters have just turned 18 <strong>and</strong> each is about to<br />

head off to a prestigious (<strong>and</strong> very expensive) private university on the banks of<br />

the Charles River. George would like to sell some or all of his Series B shares<br />

in order to pay the tuition bills.<br />

Can he do so without We Can filing a registration statement registering the<br />

transaction under the <strong>Securities</strong> Act? How? Can he sell all of his shares or<br />

just a portion? What if George held the Series B for seven months?<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved<br />

5


Session 6 – Resale of <strong>Securities</strong><br />

Study Problem 6.5<br />

Same facts as Study Problem 6.4.<br />

Three months later, Thomas, who is George’s old<br />

college roommate <strong>and</strong> has no other relation to We Can,<br />

decides to sell the 250,000 shares of Series B Preferred<br />

Stock that he bought in the same offering. He doesn’t<br />

like the direction that We Can is taking <strong>and</strong> wants out!<br />

Can Thomas sell without We Can filing a registration<br />

statement registering the transaction? Can he use a<br />

brokerage firm?<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved<br />

6


Session 6 – Resale of <strong>Securities</strong><br />

Study Problem 6.6<br />

Same facts as Study Problem 6.5, except assume that<br />

Thomas gave We Can a non-recourse personal note<br />

to finance his purchase of the shares of We Can<br />

preferred stock.<br />

Last month Thomas paid off the note <strong>and</strong> wants to<br />

sell his shares immediately without registration.<br />

Can he?<br />

Do you need to know any additional information?<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved<br />

7


Session 6 – Resale of <strong>Securities</strong><br />

Study Problem 6.7<br />

Same facts as Study Problem 6.6, except assume that<br />

Thomas borrowed money from Shadyside Bank <strong>and</strong><br />

Trust Company to fund the purchase of the shares of<br />

We Can preferred stock. He gave Shadyside a note<br />

for the purchase price, collateralized by a pledge to<br />

the bank of those shares of We Can preferred stock.<br />

If Thomas defaults on the note seven months after<br />

Thomas purchased the stock, can the bank sell the<br />

preferred stock immediately without registration?<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved<br />

8


Resale of <strong>Securities</strong><br />

THERE IS NO 6.8<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved<br />

9


Session 6 – Exempt <strong>Trans</strong>actions<br />

Study Problem 6.9<br />

Nine months after Biosystems’s IPO, its stock is trading at $50<br />

per share.<br />

Gary Grateful is one of Great Genome’s founders who acquired a<br />

warrant in lending $1 million to Biosystems. Assume the warrant<br />

was issued five months before the IPO.<br />

Grateful now would like to exercise his Biosystems warrant <strong>and</strong><br />

immediately sell the underlying shares.<br />

Grateful is not an officer or director of Biosystems <strong>and</strong> owns less<br />

than 5 percent of its common stock.<br />

How could Grateful structure the transaction to accomplish<br />

his objective?<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved<br />

10


Session 6 – Resale of <strong>Securities</strong><br />

Study Problem 6.10<br />

Gee Whiz, Inc. believes that it has developed the “next generation” cell phone. It will take two years<br />

<strong>and</strong> $10 million for the phone to reach the prototype stage. Gee Whiz is not listed on an exchange<br />

<strong>and</strong> its shares are not otherwise publicly traded.<br />

Gee Whiz sells $12 million of convertible preferred stock to its existing VC investors <strong>and</strong> members of<br />

its board of directors <strong>and</strong> advisory board. Sally, one of these advisory directors, invests $500,000.<br />

Three months later Sally learns that she has a potentially life threatening medical condition. Her<br />

doctors recommend that she seek the treatment of a specialist in Australia. The course of treatment<br />

will range from two to three years in Australia, <strong>and</strong> she will not be able to continue teaching or<br />

consulting while “down under.”<br />

Ricardo, a neighbor of Sally’s, hears about her condition <strong>and</strong> wants to help. While speaking with one<br />

of Sally’s children, Riccardo learns that Sally stretched her financial resources to invest in Gee Whiz,<br />

expecting to be able to replenish her savings quickly with income from several new consulting<br />

assignments, which she now must decline. Ricardo teaches art at the local elementary school, but<br />

inherited significant assets from his late wife, a successful entrepreneur who died a year ago. Ricardo<br />

underst<strong>and</strong>s from Sally’s children that the Gee Whiz convertible preferred is “restricted.” He asks<br />

you if he may legally purchase the Gee Whiz preferred stock from Sally to help her fund her medical<br />

<strong>and</strong> relocation expenses.<br />

What is your advice? What additional facts, if any, would you like to know?<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved<br />

11


Session 6 – Resale of <strong>Securities</strong><br />

Study Problem 6.11<br />

[Same facts as Study Problem 6.10.]<br />

Eight months after Ricardo acquires the<br />

preferred stock from Sally, he would like to<br />

resell it in a Rule 144 transaction.<br />

May Ricardo rely on Rule 144?<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved<br />

12


Session 6 – Resale of <strong>Securities</strong><br />

Study Problem 6.12<br />

Three years after the Biosystems IPO, it issues $200 million of<br />

senior unsecured notes in a private placement exempt under<br />

Rule 506. The notes mature <strong>and</strong> are payable in full on the 10 th<br />

anniversary of issuance. Mutual funds <strong>and</strong> other large financial<br />

institutions, including Kinder Gentler Insurance Co., purchase<br />

the notes.<br />

Four months after the placement, Kinder Gentler decides to<br />

change its investment portfolio strategy <strong>and</strong> wishes to sell the<br />

notes.<br />

May it do so without Biosystems filing a registration<br />

statement to register the offer/sale under § 5 of the<br />

<strong>Securities</strong> Act?<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved<br />

13


Session 6 (Part 2) – Private Placements by Publicly<br />

Traded Companies<br />

Study Problem 6.13<br />

2008 Buffet Investment in Goldman Sachs<br />

On September 23, 2008, The Goldman Sachs Group, Inc. announced that in<br />

exchange for a $5 billion cash investment by Berkshire Hathaway, Inc., a<br />

company controlled by Warren Buffet, Goldman Sachs agreed to sell to Berkshire<br />

Hathaway:<br />

Shares of 10% cumulative perpetual Goldman Sachs preferred stock, having<br />

a liquidation preference of $5 billion <strong>and</strong> being “callable” (i.e., subject to<br />

repurchase by Goldman Sachs) at any time at a 10 percent premium;<br />

A warrant to purchase 43.5 million shares of Goldman Sachs common stock<br />

at a price of $115 per share<br />

On September 24, 2008, Goldman Sachs entered into an underwriting agreement<br />

for the sale of 40.65 million shares of Goldman Sachs common stock at a price of<br />

$115 per share (the “Goldman Common Stock Offering”). The Goldman<br />

Common Stock Offering was completed on September 29, 2006.<br />

How would you structure these financings to comply with the <strong>Securities</strong> Act<br />

of 1933?<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved<br />

14


Session 6 (Part 2) – Private Placements by<br />

Publicly Traded Companies<br />

Study Problem 6.14<br />

BeanTown Biosystems completed its IPO five years ago <strong>and</strong> has<br />

timely filed all periodic reports subsequently due under the<br />

Exchange Act.<br />

Biosystems decides to raise additional common equity to fund a<br />

cash acquisition. Biosystems needs to obtain the commitments<br />

relatively quickly (within a few weeks), so it may enter into the<br />

acquisition agreement, but the acquisition will not close for at<br />

least six months.<br />

Biosystems would prefer not to sell its stock at a substantial<br />

discount from the current market price, so it wants to avoid selling<br />

stock that would be subject to resale restrictions.<br />

Biosystems has a common equity float of $300 million.<br />

What do you recommend?<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved<br />

15


Session 6 (Part 2) – Private Placements by<br />

Publicly Traded Companies<br />

Study Problem 6.15<br />

Jumbo Corp., a NYSE-listed company that has been publicly traded for<br />

the past 15 years, seeks to raise $300 million in debt financing by<br />

selling ten-year notes to institutional investors to fund a cash<br />

acquisition.<br />

Jumbo needs to obtain the commitments relatively quickly (within two<br />

weeks), so it may enter into the acquisition agreement. Jumbo will not<br />

be able to file a registration statement for several months while<br />

negotiations for another material acquisition are pending.<br />

Jumbo would prefer not to issue the debt in a Rule 506/Rule 144A<br />

structure, because it believes the illiquidity discount on account of the<br />

resale restrictions would be too great.<br />

Jumbo has a common equity public float of $500 million.<br />

What do you recommend?<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved<br />

16


Session 6 (Part 2) – Reg. S<br />

Study Problem 6.16<br />

Five years ago BeanTown Biosystems raised $200 million in<br />

an underwritten IPO. The lead underwriter was the<br />

investment banking firm Gold, Bull & Bear (“GBB”).<br />

GBB now advises Biosystems that there is growing interest<br />

in Europe for Biosystem <strong>and</strong> that an issuance of debt<br />

securities in Europe would enhance Biosystems’s reputation<br />

among institutional money managers in Europe.<br />

Biosystems would like to raise $75 million in Europe, but<br />

does not want to wait for a registration statement to be<br />

declared effective. What is your advice?<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved<br />

17


Same facts as 6.16<br />

Session 6 (Part 2) – Reg. S<br />

Study Problem 6.17<br />

May BioSystems sell $75 million of debt securities<br />

in Europe <strong>and</strong> concurrently sell $50 million of the<br />

same debt securities in the US?<br />

What is your advice?<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved<br />

18


U.S <strong>and</strong> <strong>Trans</strong>-<strong>Border</strong><br />

<strong>Securities</strong> <strong>Regulation</strong><br />

Boston University School of Law<br />

Executive LL.M. - International Business Law<br />

July/August 2013<br />

Michael Krebs<br />

JD, Boston University School of Law 1985<br />

Senior Partner, Nutter, McClennen & Fish, LLP, Boston, MA<br />

Tel. 617.439.2288 email: mkrebs@nutter.com<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved 19


U.S <strong>and</strong> <strong>Trans</strong>-<strong>Border</strong><br />

<strong>Securities</strong> <strong>Regulation</strong><br />

Boston University School of Law<br />

Executive LL.M. in International Business Law<br />

Session 7 – July 29, 2013<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Session 7 Agenda<br />

Periodic reporting under the<br />

Exchange Act<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Registration <strong>and</strong> Reporting<br />

Under <strong>Securities</strong> Exchange Act of 1934<br />

Primary Objective:<br />

Maintain integrity of<br />

securities markets<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Exchange Act Overview<br />

Establish SEC (§4 et seq.)<br />

Regulate securities trading markets, including<br />

broker-dealers<br />

Require disclosure of material information<br />

regarding “reporting companies”<br />

Prohibit deceptive <strong>and</strong> manipulative practices<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


<strong>Securities</strong> Exchange Act<br />

Overview (cont’d)<br />

<strong>Regulation</strong> of securities trading markets<br />

The Exchange Act empowers the SEC with broad authority over<br />

all aspects of the securities industry, including the power to<br />

register, regulate, <strong>and</strong> oversee:<br />

brokerage firms,<br />

transfer agents,<br />

clearing agencies<br />

securities self-regulatory organizations (SROs)<br />

various stock exchanges, such as the New York Stock<br />

Exchange, The NASDAQ Stock Market, <strong>and</strong> the American<br />

Stock Exchange are SROs.<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


<strong>Securities</strong> Exchange Act<br />

Overview (cont’d)<br />

<strong>Securities</strong> exchanges, Nasdaq <strong>and</strong> SROs -<br />

§§ 5, 6, 15A, 19<br />

Limits on securities related borrowing:<br />

Margin requirements - §7<br />

Limits on borrowing by members, brokers, dealers - §8<br />

Swap agreements (express exclusion thereof) - §3A<br />

“<strong>Securities</strong> information processors” - §11A<br />

<strong>Securities</strong> settlement procedures - §17A<br />

Including DTC<br />

<strong>Regulation</strong> of brokers <strong>and</strong> dealers - §15<br />

<strong>Regulation</strong> of municipal securities dealers - §15B<br />

<strong>Regulation</strong> of government securities brokers <strong>and</strong> dealers - §15C<br />

<strong>Regulation</strong> of securities analysts, research reports - §15D<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


<strong>Securities</strong> Exchange Act<br />

Overview (cont’d)<br />

Disclosure of material information regarding<br />

“reporting companies”, including<br />

Periodic <strong>and</strong> other reports - §§13 <strong>and</strong> 15(d)<br />

Forms 10-K (annual), 10-Q (quarterly)<br />

Form 8-K (episodic)<br />

Schedules 13D <strong>and</strong> 13G (certain shareholders)<br />

Audit <strong>and</strong> non-audit services - §10A<br />

Proxy statements - §14<br />

<strong>Regulation</strong> of trading by “insiders” - §16<br />

Liability for misleading statements - §§ 18, 32<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


<strong>Securities</strong> Exchange Act<br />

Overview (cont’d)<br />

Prohibition of deceptive <strong>and</strong> manipulative<br />

practices, including<br />

Fraud prohibition - §10(b)<br />

Rule 10b-5<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Registration <strong>and</strong> Reporting<br />

Under <strong>Securities</strong> Exchange Act<br />

How does a company become a<br />

“reporting company”?<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Session 7 – Registration <strong>and</strong> Reporting<br />

Under <strong>Securities</strong> Exchange Act<br />

Study Problem 7.1<br />

Global Yearbook was organized under Delaware<br />

law in 2006 <strong>and</strong> now has its headquarters outside<br />

of San Francisco, California.<br />

As of June 30, 2013, the end of Global's most<br />

recent fiscal year, it had total assets of $15 million.<br />

For FY 2013, it $100 million of revenue.<br />

Global has had three rounds of venture capital<br />

investments, each structured as an exempt private<br />

placement under the Rule 506 safe harbor.<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Session 7 – Registration <strong>and</strong> Reporting<br />

Under <strong>Securities</strong> Exchange Act<br />

Study Problem 7.1 (cont’d)<br />

Global has been reluctant to issue stock in a public<br />

offering, because it has been able to fund growth<br />

through earnings <strong>and</strong> did not need additional capital. In<br />

the judgment of Global's board of directors, the pricing<br />

in an IPO would result in unacceptable dilution to<br />

existing shareholders.<br />

Global's practice has been to grant stock options to<br />

all employees.<br />

At the end of FY ’13, Global had 300 holders of<br />

common stock, <strong>and</strong> 355 current or former employees<br />

held options to acquire Global common stock.<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Session 7 – Registration <strong>and</strong> Reporting<br />

Under the <strong>Securities</strong> Exchange Act<br />

Study Problem 7.1 (cont’d)<br />

Global's accounting firm asks whether<br />

Global must begin filing reports with the<br />

SEC during its fiscal year ending June 30,<br />

2014.<br />

What is your advice?<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Registration <strong>and</strong> Reporting<br />

Under <strong>Securities</strong> Exchange Act<br />

§12(g)(1)(B)<br />

Prior to JOBS Act:<br />

$10 million of assets (Rule 12g-1)<br />

500 “holders of record” of a class<br />

of equity security (see Rule 3a-11)<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Underst<strong>and</strong>ing §12(g)<br />

Prior to JOBS Act:<br />

Section 12(g), as modified by Rule 12g-1,<br />

requires a company to register its class of<br />

equity securities with the SEC under the<br />

Exchange Act, within 120 days after the last<br />

day of its fiscal year, if, at the end of the fiscal<br />

year, that class of equity securities is "held of<br />

record" by 500 or more persons <strong>and</strong> the<br />

company has "total assets" exceeding $10<br />

million.<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


A few words about “holders of record”<br />

<strong>and</strong> “street name” ownership<br />

Generally speaking, the SEC’s definition of "held of<br />

record" counts as holders of record only persons<br />

identified as owners on records of security holders<br />

maintained by the company in accordance with accepted<br />

practice.<br />

The SEC uses this definition to simplify the process of<br />

determining the applicability of Section 12(g) by allowing<br />

a company to look to the holders of its securities as shown<br />

on records maintained by it or on its behalf, such as<br />

records maintained by the company's transfer agent.<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


A few words about “holders of record”<br />

<strong>and</strong> “street name” ownership (cont’d)<br />

But a fundamental shift has occurred in how securities are<br />

held in the United States since the enactment of Section<br />

12(g) in 1964. Today, the vast majority of securities of<br />

publicly-traded companies are held in nominee or “street<br />

name” form.<br />

A security is said to be held in “street name” when the<br />

security is owned by an institutional custodian. The most<br />

prominent custodian in the U.S. is the Depository Trust<br />

Company (DTC), which holds securities through its<br />

nominee Cede & Co.<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


A few words about “holders of record”<br />

<strong>and</strong> “street name” ownership (cont’d)<br />

DTC is a central repository or clearinghouse facility through<br />

which members transfer stock <strong>and</strong> bond certificates<br />

electronically (i.e., through a “book entry” system). DTC was<br />

set up to provide an infrastructure for settling trades in<br />

municipal, mortgage-backed <strong>and</strong> corporate securities in a costefficient<br />

<strong>and</strong> timely manner.<br />

DTC is owned indirectly by numerous banks, brokerages,<br />

trading houses <strong>and</strong> trading exchanges (the “Participants”).<br />

For example, one Participant brokerage firm may own a large<br />

position in a publicly traded company on behalf of thous<strong>and</strong>s<br />

of beneficial owners.<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


A few words about “holders of record”<br />

<strong>and</strong> “street name” ownership (cont’d)<br />

“Holders of record” Defined<br />

A clearinghouse facility such as DTC is not a single<br />

“holder of record” for purposes of Exchange Act<br />

registration, even though the company’s stock records<br />

will show a single position held by Cede & Co.<br />

Instead, each DTC “participant” (i.e., the banks <strong>and</strong><br />

brokerage firms that own DTC) is a treated as a<br />

single record holder.<br />

Source: Rule 12g5-1(b)(1) <strong>and</strong> SEC Compliance <strong>and</strong><br />

Disclosure Interpretations<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


JOBS Act Change:<br />

Holder of Record Threshold Increased<br />

Section 501 of JOBS Act amends §12(g)(1)(A) of the<br />

Exchange Act to increase “holder of record” threshold for<br />

ALL companies (other than banks <strong>and</strong> bank holding<br />

companies) to<br />

(i) 2,000 persons, or<br />

(ii) 500 persons who are not accredited investors (as<br />

such term is defined by the Commission).<br />

Applies to both EGCs <strong>and</strong> non-EGCs.<br />

Question: How will a company know who is an<br />

accredited investor?<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


JOBS Act Change:<br />

Special Rule for Banks <strong>and</strong> Bank<br />

Holding Companies<br />

Section 601 of JOBS Act amends §12(g)(1)(B) of the<br />

Exchange Act to increase “holder of record” threshold<br />

for banks <strong>and</strong> bank holding companies only to<br />

2,000 persons<br />

Whether or not accredited investors.<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


JOBS Act Change:<br />

“Holder of Record” Excludes <strong>Securities</strong><br />

issued under Rule 701, etc.<br />

Section 502 of JOBS Act amended §12(g)(5) of the<br />

Exchange Act to provide:<br />

Definition of ‘held of record’ shall not include securities<br />

held by persons who receive securities pursuant to an<br />

employee compensation plan in transactions exempted<br />

from §5 registration.<br />

Examples: Awards under Rule 701. The JOBS Act<br />

directs the SEC to adopt safe harbor rules.<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


JOBS Act Change:<br />

“Crowdfunding” <strong>Securities</strong> to be<br />

Excluded for Holder of Record Test<br />

Section 303 of JOBS Act added §12(g)(6) to<br />

the Exchange Act directing SEC to adopt a<br />

rule:<br />

Exempting, conditionally or unconditionally,<br />

securities acquired pursuant to a<br />

“crowdfunding” offering made under §4(6)<br />

SEC rulemaking has not occurred<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Session 7 – Registration <strong>and</strong> Reporting<br />

Under the <strong>Securities</strong> Exchange Act<br />

Study Problem 7.1<br />

Back to Study Problem 7.1!<br />

Global's accounting firm asks whether<br />

Global must begin filing reports with the<br />

SEC during its current fiscal year ending<br />

June 30, 2014.<br />

Do the option holders count as “holders of<br />

record” of the common stock?<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Registration <strong>and</strong> Reporting<br />

Under <strong>Securities</strong> Exchange Act<br />

First, consider Rule 3a-11:<br />

The term equity security is hereby defined to<br />

include any . . . security convertible, with or<br />

without consideration into such a security . . .; or<br />

any . . . warrant or right; or any put, call,<br />

straddle, or other option or privilege of buying<br />

such a security from or selling such a security to<br />

another without being bound to do so.<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Registration <strong>and</strong> Reporting<br />

Under <strong>Securities</strong> Exchange Act<br />

Next consider Rule 12h-1(f):<br />

In 2007 (i.e., after Google’s IPO), the SEC adopted Rule<br />

12h-1(f), which provides an exemption from the holder<br />

of record threshold for compensatory stock options.<br />

This rule decreased the odds that compensatory stock<br />

options granted by pre-IPO companies to employees,<br />

officers, directors, consultants <strong>and</strong> advisors will cause<br />

the company to have to register a class of equity<br />

securities under the Exchange Act.<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


More about Rule 12h-1(f)<br />

Application to Restricted Stock Units<br />

In 2008, in response to a request by<br />

Facebook, Corp Fin issued a “no-action<br />

letter” extending the relief in Rule 12h-<br />

1(f) to restricted stock units. See<br />

Facebook, Inc. (October 14, 2008 no<br />

action letter).<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Registration <strong>and</strong> Reporting<br />

Under <strong>Securities</strong> Exchange Act<br />

But then consider §502 of JOBS Act:<br />

Definition of ‘held of record’ shall not<br />

include securities held by persons who<br />

receive securities pursuant to an employee<br />

compensation plan in transactions exempted<br />

from §5 registration (i.e., equity awards<br />

exempt under Rule 701)<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Session 7 – Registration <strong>and</strong> Reporting<br />

Under the <strong>Securities</strong> Exchange Act<br />

Study Problem 7.1 – Analysis<br />

Global will not have to register under<br />

Section 12(g) in FY 2014.<br />

Per Rule 12h-1(f), Global did not have<br />

more than 500 “holders of record” as of<br />

June 30, 2013 <strong>and</strong> therefore could not<br />

have had more than 500 holders who were<br />

not accredited investors.<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Session 7 – Registration <strong>and</strong> Reporting<br />

Under the <strong>Securities</strong> Exchange Act<br />

Study Problem 7.2<br />

Same facts as Study Problem 7.1<br />

Global plans to raise $500 million by selling shares of its common<br />

stock in a 506 transaction to a so-called “special-purpose vehicle” in<br />

which approximately 250 accredited investors would invest.<br />

Global’s CEO tells you that Global’s investment banking firm, Hook<br />

Line & Sinker, told the CEO that the investors who invest indirectly<br />

through the “special-purpose vehicle” would not be considered<br />

Global “holders of record” for SEC purposes.<br />

The CEO asks you whether this structure presents any<br />

compliance risks for Global. What is your advice.<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Session 7 – Registration <strong>and</strong> Reporting<br />

Under the <strong>Securities</strong> Exchange Act<br />

Study Problem 7.2 – Analysis<br />

It is conceivable the SEC might assert that the structure<br />

proposed by Hook Line & Sinker could raise compliance issues<br />

under Section 12(g).<br />

Consider 12g5-1:<br />

If the issuer knows or has reason to know that the form of<br />

holding securities of record is used primarily to<br />

circumvent the provisions of section 12(g) or 15(d) of the<br />

Act, the beneficial owners of such securities shall be<br />

deemed to be the record owners thereof.<br />

Is the special purpose vehicle being used primarily for another<br />

reason?<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Registration <strong>and</strong> Reporting<br />

Under <strong>Securities</strong> Exchange Act<br />

How does “registration” under<br />

the Exchange Act differ from<br />

registration under the<br />

<strong>Securities</strong> Act?<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Registration <strong>and</strong> Reporting<br />

Under <strong>Securities</strong> Exchange Act<br />

§12(g)(1)(B) <strong>and</strong> Rule 12g-1<br />

One-time registration of the class of an<br />

equity security (Rule 12d-1)<br />

Registration of a class of equity<br />

securities is effectively registration of<br />

“the company.”<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Registration <strong>and</strong> Reporting<br />

Under <strong>Securities</strong> Exchange Act<br />

In addition to Section 12(g), how else<br />

might a company become a<br />

“reporting company”?<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Registration <strong>and</strong> Reporting<br />

Under <strong>Securities</strong> Exchange Act<br />

§12(b) – Listing on an Exchange<br />

Registration required to list a security on<br />

an exchange, such as<br />

New York Stock Exchange<br />

The NASDAQ Stock Market<br />

Same effect as Section 12(g) registration<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Registration <strong>and</strong> Reporting<br />

Under <strong>Securities</strong> Exchange Act<br />

§15(d) <strong>and</strong> Rules 15d-1 to 15d-16<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Registration <strong>and</strong> Reporting<br />

Under <strong>Securities</strong> Exchange Act<br />

§15(d)<br />

Each issuer which has filed a registration<br />

statement . . . which has become effective<br />

pursuant to the <strong>Securities</strong> Act . . . shall file with<br />

the [SEC] . . . , such supplementary <strong>and</strong><br />

periodic information, documents, <strong>and</strong><br />

reports as may be required pursuant to § 13<br />

in respect of a security registered pursuant<br />

to § 12.<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Registration <strong>and</strong> Reporting<br />

Under <strong>Securities</strong> Exchange Act<br />

§15(d) (continued)<br />

The duty to file under §15(d)<br />

automatically suspended if <strong>and</strong> so long<br />

as any issue of securities of such issuer<br />

is registered pursuant to §12<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Registration <strong>and</strong> Reporting<br />

Under <strong>Securities</strong> Exchange Act<br />

Voluntary Registration under §12(g)(1)(B)<br />

Any issuer may register any class of equity<br />

security not required to be registered by filing<br />

a registration statement on Form 10.<br />

See GM’s filing in early 2010.<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Registration <strong>and</strong> Reporting<br />

Under <strong>Securities</strong> Exchange Act<br />

§12(g)(2) –§12(g) Registration Exemptions:<br />

security issued by any investment co.<br />

security issued by a mutual or cooperative<br />

organization which supplies a commodity or<br />

service primarily for the benefit of its members<br />

<strong>and</strong> operates not for pecuniary profit<br />

security issued by certain insurance companies<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Registration <strong>and</strong> Reporting<br />

Under <strong>Securities</strong> Exchange Act<br />

§12(g)(2) –§12(g) Registration Exemptions:<br />

collective trust funds maintained by a bank or in a<br />

separate account maintained by an insurance<br />

company which interest or participation is issued<br />

in connection with<br />

a stock bonus, pension, or profit-sharing plan which<br />

meets the requirements for qualification under section<br />

401 of Internal Revenue Code or<br />

an annuity plan which meets the requirements for<br />

deduction of the employer's contribution under section<br />

404(a)(2) of the Internal Revenue Code<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Registration <strong>and</strong> Reporting<br />

Under <strong>Securities</strong> Exchange Act<br />

How does a company cease to be a<br />

“reporting company”?<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Registration <strong>and</strong> Reporting<br />

Under <strong>Securities</strong> Exchange Act<br />

Termination of registration (Rule 12g-4)<br />

“Going Private”<br />

1) Fewer than 300 holders of record; or<br />

2) Fewer than 500 holders of record <strong>and</strong><br />

less than $10 million of assets<br />

Which test is likely to be more relevant?<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Registration <strong>and</strong> Reporting<br />

Under <strong>Securities</strong> Exchange Act<br />

Termination of reporting<br />

Don’t forget §15(d)<br />

The duty to file under §15(d)<br />

automatically is reinstated if the issuer<br />

no longer has any securities registered<br />

pursuant to §12<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


§15(d)<br />

Registration <strong>and</strong> Reporting<br />

Under <strong>Securities</strong> Exchange Act<br />

The duty to file . . . shall also be automatically<br />

suspended as to any fiscal year, other than the fiscal<br />

year within which such registration statement<br />

became effective, if, at the beginning of such fiscal<br />

year, the securities of each class to which the<br />

registration statement relates are held of record by<br />

less than three hundred persons.<br />

See Rule 12h-3 for details.<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Registration <strong>and</strong> Reporting<br />

Under <strong>Securities</strong> Exchange Act<br />

How does the disclosure in a “registration”<br />

under Section 12 compare to the<br />

disclosure in an S-1 for an IPO?<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Registration <strong>and</strong> Reporting<br />

Under <strong>Securities</strong> Exchange Act<br />

§12(b) <strong>and</strong> §12(g) Registration<br />

Form 10:<br />

www.sec.gov/about/forms/form10.pdf<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Registration <strong>and</strong> Reporting<br />

Under <strong>Securities</strong> Exchange Act<br />

What reports must a reporting<br />

company file?<br />

How are the reports filed?<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Registration <strong>and</strong> Reporting<br />

Under <strong>Securities</strong> Exchange Act<br />

Periodic Reports:<br />

Form 10-K<br />

Form 10-Q<br />

Form 8-K<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Registration <strong>and</strong> Reporting<br />

Under <strong>Securities</strong> Exchange Act<br />

How Do Investors Access Periodic<br />

Reports?<br />

EDGAR<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Registration <strong>and</strong> Reporting<br />

Importance of EDGAR System<br />

Electronic Data Gathering<br />

Analysis <strong>and</strong> Retrieval (EDGAR)<br />

All companies, foreign <strong>and</strong> domestic,<br />

are required to file registration<br />

statements, periodic reports, <strong>and</strong><br />

other forms electronically through<br />

EDGAR.<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Registration <strong>and</strong> Reporting<br />

EDGAR (Cont’d)<br />

Not all documents filed with the SEC by public<br />

companies will be available on EDGAR.<br />

Companies were phased in to EDGAR filing over<br />

a three-year period ended May 6, 1996.<br />

As of that date, all public domestic companies<br />

generally were required to make their filings on<br />

EDGAR.<br />

Third-party filings with respect to these<br />

companies, such as tender offers <strong>and</strong> Schedules<br />

13D, are also filed on EDGAR<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Registration <strong>and</strong> Reporting<br />

EDGAR (Cont’d)<br />

Practice point:<br />

All EDGAR filers must have EDGAR codes<br />

issued by the SEC.<br />

For example, a principal shareholder filing a<br />

13D or a Form 3 under Section 16 will<br />

require her own EDGAR codes. (Application<br />

must be made to the SEC for EDGAR codes.)<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Registration <strong>and</strong> Reporting<br />

Under <strong>Securities</strong> Exchange Act<br />

When are periodic reports due?<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Registration <strong>and</strong> Reporting<br />

Under <strong>Securities</strong> Exchange Act<br />

Due date for periodic reports:<br />

Form 10-K<br />

Form 10-Q<br />

Form 8-K Generally 4 business<br />

days after trigger event<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Registration <strong>and</strong> Reporting<br />

Under <strong>Securities</strong> Exchange Act<br />

Due date for periodic reports:<br />

Form 10-K Depends upon size of<br />

Form 10-Q<br />

Form 8-K<br />

reporting companies<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Registration <strong>and</strong> Reporting<br />

Under <strong>Securities</strong> Exchange Act<br />

Categories of reporting companies:<br />

Large accelerated filer<br />

Accelerated filer<br />

Non-accelerated filer<br />

Smaller reporting company<br />

Emerging growth company<br />

See definitions in Rule 12b-2<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Registration <strong>and</strong> Reporting<br />

Under <strong>Securities</strong> Exchange Act<br />

Large accelerated filer<br />

(Similar to WKSI definition)<br />

Criteria include:<br />

Aggregate worldwide “float” ≥ $700 million, as<br />

of the last business day of the issuer's most<br />

recently completed second fiscal quarter;<br />

Subject to section 13(a) or 15(d) reporting for a<br />

period of at least twelve calendar months<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Registration <strong>and</strong> Reporting<br />

Under <strong>Securities</strong> Exchange Act<br />

Large accelerated filer<br />

10-K Due 60 days after the end of the<br />

fiscal year covered by the report<br />

10-Q Due 40 days after the end of the<br />

fiscal quarter<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Registration <strong>and</strong> Reporting<br />

Under <strong>Securities</strong> Exchange Act<br />

Accelerated filer<br />

(Similar to non-WKSI S-3 issuer)<br />

Criteria include:<br />

Aggregate worldwide “float” ≥ $75 million (but<br />


Registration <strong>and</strong> Reporting<br />

Under <strong>Securities</strong> Exchange Act<br />

Accelerated filer<br />

10-K Due 75 days after the end of the<br />

fiscal year covered by the report<br />

10-Q Due 40 days after the end of the<br />

fiscal quarter<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Registration <strong>and</strong> Reporting<br />

Under <strong>Securities</strong> Exchange Act<br />

Smaller Reporting Company<br />

Criteria include:<br />

Public “float” < $75 million, as of the last<br />

business day of the issuer's most recently<br />

completed second fiscal quarter<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Registration <strong>and</strong> Reporting<br />

Under <strong>Securities</strong> Exchange Act<br />

Non-accelerated filer <strong>and</strong> Smaller<br />

Reporting Company<br />

10-K Due 90 days after the end of the<br />

fiscal year covered by the report<br />

10-Q Due 45 days after the end of the<br />

fiscal quarter<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Registration <strong>and</strong> Reporting<br />

Under <strong>Securities</strong> Exchange Act<br />

Emerging Growth Company<br />

Section 101(b) of JOBS Act adds to definitions in Exchange Act<br />

(§3(a)(80)) “emerging growth company” or EGC.<br />

A company ceases to be an EGC upon the earlier of:<br />

1. Becoming a “Large Accelerated Filer” which could occur as early as<br />

approximately one year after IPO;<br />

2. Last day of FY during which 5 th anniversary of IPO (common<br />

equity) occurred pursuant to an effective registration statement;<br />

3. Last day of FY during which it had total annual gross revenues of<br />

≥$1 billion (indexed for inflation);<br />

4. Date on which the company has, during previous 3-year period,<br />

issued >$1 billion in non-convertible debt.<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Special Exchange Act Rules for<br />

Emerging Growth Companies<br />

Title II of the JOBS Act exempts Emerging Growth<br />

Companies from various requirements of Exchange<br />

Act reporting.<br />

Please refer to Goodwin Procter matrix distributed<br />

in class.<br />

http://www.goodwinprocter.com/~/media/E7463DA<br />

9940544CF83D8715CC1E67A98.pdf<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Registration <strong>and</strong> Reporting<br />

Under <strong>Securities</strong> Exchange Act<br />

What are the implications of a<br />

filing under Rule 12b-25<br />

(Notice of Late Filing)?<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Registration <strong>and</strong> Reporting<br />

Under <strong>Securities</strong> Exchange Act<br />

Rule 12b-25 – Notice of Late Filing<br />

With respect to any report . . . which is not<br />

timely filed because the registrant is unable to<br />

do so without unreasonable effort or expense,<br />

such report shall be deemed to be filed on the<br />

prescribed due date for such report if:<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Registration <strong>and</strong> Reporting<br />

Under <strong>Securities</strong> Exchange Act<br />

Rule 12b-25 – Notice of Late Filing (cont’d)<br />

1. The registrant files Form 12b-25 in compliance with<br />

paragraph (a);<br />

2. The registrant represents . . . that the reason(s)<br />

causing the inability to file timely could not be<br />

eliminated by the registrant without unreasonable<br />

effort or expense; <strong>and</strong><br />

3. Form 10-K is filed no later than the fifteenth<br />

calendar day following the prescribed due date; or<br />

Form 10-Q is filed no later than the fifth calendar<br />

day following the prescribed due date<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Registration <strong>and</strong> Reporting<br />

Under <strong>Securities</strong> Exchange Act<br />

Rule 12b-25 – Notice of Late Filing (cont’d)<br />

A registrant will not be eligible to use any<br />

registration statement form under the<br />

<strong>Securities</strong> Act of 1933 the use of which is<br />

predicated on timely filed reports (e.g.,<br />

Form S-3) until the subject report is<br />

actually filed pursuant to paragraph (b)(3)<br />

of this section<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Registration <strong>and</strong> Reporting<br />

Under <strong>Securities</strong> Exchange Act<br />

What are the key MD&A<br />

disclosure principals?<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


MD&A Overview<br />

Practical Guidance<br />

Past <strong>Trans</strong>gressions<br />

[SEE SEPARATE SLIDE DECK]<br />

Michael Krebs<br />

Nutter, McClennen & Fish, LLP<br />

November 2009<br />

© 2003-2009 Nutter, McClennen & Fish, LLP All Rights Reserved<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Registration <strong>and</strong> Reporting<br />

Under <strong>Securities</strong> Exchange Act<br />

“Forward Looking Statements”<br />

The Private <strong>Securities</strong> Litigation Reform Act (PSLRA),<br />

codified at Section 27A of the <strong>Securities</strong> Act <strong>and</strong> 21E of the<br />

Exchange Act, provides a safe harbor from liability for<br />

forward-looking statements, which immunizes an issuer’s<br />

forward-looking statements from securities law liability if:<br />

(1) the statement is identified as forward-looking <strong>and</strong><br />

is accompanied by meaningful cautionary language; or<br />

(2) plaintiffs fail to establish that defendants that<br />

defendants had actual knowledge of the falsity of the<br />

statement.<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Registration <strong>and</strong> Reporting<br />

Under <strong>Securities</strong> Exchange Act<br />

Section 21E (<strong>and</strong> 27A) – Safe Harbor<br />

“Forward Looking Statements”<br />

(conceptually related to “bespeaks<br />

caution” doctrine)<br />

(c) 2013 Michael K. Krebs All Rights<br />

Reserved


Registration <strong>and</strong> Reporting<br />

Under <strong>Securities</strong> Exchange Act<br />

What is a “Forward Looking Statement”?<br />

What steps are necessary to achieve the<br />

benefit of the safe harbor for forward<br />

looking statements?<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Registration <strong>and</strong> Reporting<br />

Under <strong>Securities</strong> Exchange Act<br />

Forward Looking Statement:<br />

A statement containing or regarding<br />

Projection of revenues, income, etc.<br />

Plans <strong>and</strong> objectives of management for<br />

future operations<br />

Future economic performance, including<br />

any such statement contained in MD&A<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Registration <strong>and</strong> Reporting<br />

Under <strong>Securities</strong> Exchange Act<br />

Section 21E<br />

in any private action . . . based on an untrue<br />

statement of a material fact or omission of a<br />

material fact necessary to make the statement<br />

not misleading . . . a person . . . shall not be<br />

liable with respect to any “forward-looking<br />

statement” if <strong>and</strong> to the extent that –<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Registration <strong>and</strong> Reporting<br />

Under <strong>Securities</strong> Exchange Act<br />

Section 21E (cont’d)<br />

the forward-looking statement is--<br />

identified as a forward-looking statement, <strong>and</strong><br />

accompanied by meaningful cautionary<br />

statements identifying important factors that<br />

could cause actual results to differ materially<br />

from those in the forward looking statement; or<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Registration <strong>and</strong> Reporting<br />

Under <strong>Securities</strong> Exchange Act<br />

Section 21E (cont’d)<br />

the plaintiff fails to prove that the forward-looking<br />

statement—<br />

If made by a natural person, was made with actual<br />

knowledge by that person that the statement was<br />

false or misleading; or<br />

If made by a business entity, was made by or with<br />

the approval of an executive officer with actual<br />

knowledge by that officer that the statement was<br />

false or misleading.<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Registration <strong>and</strong> Reporting<br />

Under <strong>Securities</strong> Exchange Act<br />

Section 21E (cont’d)<br />

Oral forward-looking statements:<br />

Oral forward-looking statement must be<br />

accompanied by a cautionary statement<br />

that the particular oral statement is a forwardlooking<br />

statement; <strong>and</strong><br />

that the actual results might differ materially;<br />

<strong>and</strong><br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Registration <strong>and</strong> Reporting<br />

Under <strong>Securities</strong> Exchange Act<br />

Section 21E (cont’d)<br />

The oral forward-looking statement is<br />

accompanied by an oral statement that<br />

additional information concerning factors<br />

that could cause actual results to materially<br />

differ is contained in a “readily available<br />

written document,” or portion thereof;<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Registration <strong>and</strong> Reporting<br />

Under <strong>Securities</strong> Exchange Act<br />

Section 21E (cont’d)<br />

The accompanying oral statement referred to<br />

identifies the document, or portion thereof, that<br />

contains the additional information about those<br />

factors relating to the forward-looking statement;<br />

<strong>and</strong><br />

The information contained in that written<br />

document is a cautionary statement that satisfies<br />

the st<strong>and</strong>ard for written forward looking<br />

statements<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Registration <strong>and</strong> Reporting<br />

Under <strong>Securities</strong> Exchange Act<br />

Forward Looking Statements in the Courts<br />

Can defendant prevail before discovery?<br />

Outside the Seventh Circuit, the prevailing rule is that<br />

the adequacy of defendant’s ‘‘cautionary language’’ can<br />

be resolved at the pleading stage, without discovery, so<br />

long as the language identifies important factors that<br />

could cause results to differ materially from those in the<br />

forward-looking statement.<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Registration <strong>and</strong> Reporting<br />

Under <strong>Securities</strong> Exchange Act<br />

Forward Looking Statements in the Courts<br />

Can defendant prevail before discovery?<br />

In the Seventh Circuit, if the defendant’s cautionary<br />

language does not identify the negative events that<br />

ultimately occurred, discovery is required to determine if<br />

defendant’s cautionary language was sufficiently<br />

meaningful.<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Registration <strong>and</strong> Reporting<br />

Under <strong>Securities</strong> Exchange Act<br />

Forward Looking Statements in the Courts<br />

(cont’d)<br />

How specific must cautionary statements be?<br />

Courts generally agree that cautionary language is sufficient if it<br />

warns investors of risks similar in scope to that actually realized so<br />

that the investor is on notice of the danger of the investment<br />

Courts struggle, however, with how specific an issuer’s risk<br />

disclosure must be to avoid the fatal charge that its cautionary<br />

language is mere boilerplate.<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Registration <strong>and</strong> Reporting<br />

Under <strong>Securities</strong> Exchange Act<br />

Forward Looking Statements in the Courts<br />

(cont’d)<br />

How specific must cautionary statements be?<br />

Courts are especially unlikely to find the safe harbor applicable where the<br />

language is so broad that it could be applied to any business.<br />

For example, a court analyzing a telecommunications company warning that:<br />

‘‘Actual results may differ from the results discussed in the forward-looking<br />

statements. Factors that might cause such a difference include . . . risks associated<br />

with introducing new products, entering new markets, availability of resources,<br />

competitive response, . . . .”<br />

The court rejected this warning as “useless caveat emptor boilerplate,” holding<br />

that the “breadth of these warnings makes it impossible to determine if it<br />

meaningfully described the principal or important risks facing [the defendant].”<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Registration <strong>and</strong> Reporting<br />

Under <strong>Securities</strong> Exchange Act<br />

Forward Looking Statements in the Courts<br />

(cont’d)<br />

How to draft effective cautionary statements?<br />

First, every issuer should reconsider, on a quarterly basis, whether new<br />

developments in its business or in the markets in which it operates<br />

warrant an update of the cautionary language to reflect any changes to the<br />

description of the nature of the risks facing the company.<br />

Second, in crafting risk disclosures it will often be helpful for the issuer’s<br />

counsel to review the risk disclosures of competitors, suppliers <strong>and</strong><br />

customers.<br />

Third, reviewing recent analyst reports on the company <strong>and</strong> the industry<br />

will often help identify appropriate risk factors to highlight.<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Registration <strong>and</strong> Reporting<br />

Under <strong>Securities</strong> Exchange Act<br />

Forward Looking Statements in the Courts<br />

(cont’d)<br />

Does the phrase “accompanied by” permit allow<br />

the Company to cross reference to cautionary<br />

statements in another SEC filing?<br />

Recent decisions have found that an issuer does not lose its<br />

safe harbor protection by simply cross referencing, in one<br />

written statement, to cautionary language in one of its SEC<br />

filings.<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Registration <strong>and</strong> Reporting<br />

Under <strong>Securities</strong> Exchange Act<br />

What is the Sarbanes-Oxley Act?<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Decades Later . . . More<br />

Dramatic Legislation Required!<br />

Nearly 70 years after the adoption of the<br />

<strong>Securities</strong> Act of 1933, Congress again reacted<br />

to a major crisis in the capital markets – this<br />

time resulting from corporate fraud <strong>and</strong><br />

accounting sc<strong>and</strong>als revealed in 2000 <strong>and</strong><br />

2001 – by passing the Sarbanes-Oxley Act of<br />

2002.<br />

SOX has had a HUGE impact on Exchange<br />

Act Reporting.<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Origins of Sarbanes-Oxley Act<br />

Intentional misstating of revenue <strong>and</strong>/or expense<br />

WorldCom (n/k/a MCI):<br />

Reduced operating expenses by improperly releasing certain reserves<br />

held against operating expenses<br />

Improperly reduced operating expenses by recharacterizing certain<br />

expenses as capital assets<br />

Tyco: Accused of “Spring-Loading” – Padding earnings growth by<br />

acquiring companies after making them prepay expenses <strong>and</strong> forgo<br />

new revenue<br />

Global Crossing: Accumulated $12.4 billion in debt building a<br />

worldwide fiber optic network. Global Crossing leased space on its<br />

27-nation network to rivals from which it rented capacity at the same<br />

time, helping both parties boost reported revenue.<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Origins of Sarbanes-Oxley Act<br />

(cont’d)<br />

Deceptive Related-Party <strong>Trans</strong>actions<br />

Enron: Limited partnerships used as “off-balance sheet”<br />

special purpose entities<br />

Aggressively boosted profits <strong>and</strong> hid debts totaling over $1<br />

billion by using off-the-books partnerships<br />

Adelphia Communications: Fraudulently excluded<br />

billions of dollars in liabilities from its consolidated<br />

financial statements by hiding them on the books of offbalance<br />

sheet affiliates<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Origins of Sarbanes-Oxley Act<br />

(cont’d)<br />

Abuse of Insider Loans<br />

Tyco: $121.1 million -- Including $61 million to CEO<br />

for “relocation costs”<br />

WorldCom: $160.8 million to former CEO<br />

Adelphia Communication: $3.1 billion to Rigas Family<br />

– used money for private purchases <strong>and</strong> investments<br />

including a golf course <strong>and</strong> dealings with a NHL hockey<br />

team<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Origins of Sarbanes-Oxley Act<br />

(cont’d)<br />

Ineffective Corporate Governance<br />

Ineffective oversight by senior-most management <strong>and</strong><br />

especially audit committees of financial reporting <strong>and</strong><br />

internal controls<br />

Enron, WorldCom, etc.<br />

Accounting firms perceived to be insufficiently independent<br />

of management<br />

Enron, WorldCom, etc.<br />

Lawyers perceived to view management <strong>and</strong> not the board<br />

of directors as their client<br />

Enron, Tyco<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Origins of Sarbanes-Oxley Act<br />

(cont’d)<br />

Economic impact of corporate sc<strong>and</strong>als – in the<br />

nine months from early October 2001 to late June<br />

2002<br />

WorldCom stock fell 95% ~ $42 billion decline!<br />

Enron stock declined 99% ~ $25 billion decline!<br />

Adelphia stock fell 99% ~ $3 billion decline!<br />

Tyco stock fell 70% ~ $63 billion decline!<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Sarbanes-Oxley Act of 2002<br />

Overview<br />

Accounting St<strong>and</strong>ards <strong>and</strong> Oversight<br />

Auditor Independence<br />

Management Accountability<br />

CEO/CFO Certifications Under Sections 302 <strong>and</strong> 906<br />

Internal Control Requirements<br />

Ethics Policies Required<br />

Whistle-blower Protection<br />

Limitations on use of Non-GAAP Disclosures<br />

Prohibition on Personal Loans to Executives<br />

Obligation of Lawyers to Report “Up-the-Ladder”<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Impact of Sarbanes-Oxley<br />

Certifications under 302 <strong>and</strong> 906<br />

Each CEO <strong>and</strong> CFO of a reporting company must certify the<br />

accuracy of all periodic reports (i.e., 10-Ks <strong>and</strong> 10-Qs) filed<br />

with the SEC.<br />

Each CEO <strong>and</strong> CFO must certify that she has reviewed the<br />

report, <strong>and</strong> to her knowledge the report does not contain any<br />

material misstatements or omissions, <strong>and</strong> the financial<br />

statements <strong>and</strong> other information contained in the report fairly<br />

represent in all material respects the company’s financial<br />

condition <strong>and</strong> results of operations of the issuer for the periods<br />

presented in the reports.<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Internal Control Certifications<br />

The CEO <strong>and</strong> CFO must also certify in every quarterly <strong>and</strong> annual report (i.e., 10-Ks <strong>and</strong> 10-<br />

Qs):<br />

that they are responsible for establishing <strong>and</strong> maintaining internal controls <strong>and</strong> have<br />

designed such internal controls to ensure that material information relating to the<br />

company <strong>and</strong> its consolidated subsidiaries is made known to such officers by others<br />

within those entities;<br />

that they have evaluated the effectiveness of the company’s internal controls within<br />

the past 90 days;<br />

that they have presented in the report their conclusions about the effectiveness of their<br />

controls;<br />

that they have disclosed to the company’s auditors <strong>and</strong> the audit committee all<br />

significant deficiencies in the design or operation of internal controls which could<br />

adversely affect the company’s ability to record, process, summarize <strong>and</strong> report financial<br />

data <strong>and</strong> have identified for the auditors any material weaknesses in internal controls <strong>and</strong><br />

any fraud, whether material or not, that involves management or other employees who<br />

have a significant role in the issuer’s internal controls.<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


CEO/CFO Certifications – Penalties<br />

Whoever certifies one of the above statements<br />

knowing that the periodic report does not<br />

comport with all the requirements can be fined<br />

up to $1,000,000 <strong>and</strong> imprisoned up to 10 years.<br />

Whoever willfully certifies such a statement<br />

knowing it does not comport with the statute’s<br />

requirements can be fined up to $5,000,000 <strong>and</strong><br />

imprisoned up to 20 years.<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


CEO/CFO Certifications<br />

SEC Enforcement Actions<br />

There have been at least eight SEC enforcement actions involving a<br />

CEO or CFO certification under SOX.<br />

In one, the SEC charged that the CEO "signed [the annual report]<br />

<strong>and</strong> the Sarbanes-Oxley certification without having read either<br />

document <strong>and</strong> without having taken any steps to determine their<br />

accuracy or truthfulness,” relying instead on nothing more than a 27year<br />

old EVP’s assurances.<br />

In another, the SEC alleged that the CFO ignored “red flags” of<br />

improper revenue recognition <strong>and</strong> participated in preparing<br />

backdated documentation that was provided to the company’s<br />

auditors to support fictitious fiscal 2006 year-end sales.<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Impact of Sarbanes-Oxley (cont’d)<br />

Audit Integrity<br />

Section 303<br />

Section 401<br />

PCAOB<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Impact of Sarbanes-Oxley (cont’d)<br />

Corporate Governance Practices<br />

Section 402 – No Loans to Insiders<br />

Section 404 – Internal Control Certifications<br />

Section 406 – Code of Ethics<br />

Section 409 – “Real Time” Disclosure<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Impact of Sarbanes-Oxley (cont’d)<br />

404 Internal Control Certifications<br />

Section 404 of SOX requires a company’s independent<br />

accounting firm to satisfactorily complete an audit of the<br />

company’s “internal control over financial reporting” (ICOFR).<br />

Effectiveness of a company’s ICOFR is evaluated using<br />

suitable control criteria, such as the COSO (Committee of<br />

Sponsoring Organizations of the Treadway Commission)<br />

criteria.<br />

This is a relatively expensive process, especially for most<br />

companies that are not large accelerated filers.<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


404 Internal Control Certifications<br />

Special Rule for EGCs<br />

Section 103 of the JOBS Act amends<br />

Section 404(b) of SOX:<br />

The 404 requirement for audit of the<br />

company’s “internal control over<br />

financial reporting” does not apply to<br />

emerging growth companies<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Registration <strong>and</strong> Reporting<br />

Under <strong>Securities</strong> Exchange Act<br />

Trend Toward “Real Time” Disclosure<br />

August 2004 SEC Amends Form 8-K:<br />

Dramatically shortened filing<br />

deadlines:<br />

4 business days for most events<br />

Significantly exp<strong>and</strong>ed scope of<br />

events triggering disclosure<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Registration <strong>and</strong> Reporting<br />

Under <strong>Securities</strong> Exchange Act<br />

2004 Amendment of Form 8-K (cont’d)<br />

Item 1.01 Entry into a Material<br />

Definitive Agreement<br />

Item 1.02 Termination of a Material<br />

Definitive Agreement<br />

(c) 2013 Michael K. Krebs All Rights<br />

Reserved


Registration <strong>and</strong> Reporting<br />

Under <strong>Securities</strong> Exchange Act<br />

2004 Amendment of Form 8-K (cont’d)<br />

Item 2.03 Creation of a Direct Financial<br />

Obligation or an Obligation under an Off-<br />

Balance Sheet Arrangement of a Registrant.<br />

Item 2.04 Triggering Events That Accelerate<br />

or Increase a Direct Financial Obligation or<br />

an Obligation under an Off-Balance Sheet<br />

Arrangement.<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Registration <strong>and</strong> Reporting<br />

Under <strong>Securities</strong> Exchange Act<br />

2004 Amendment of Form 8-K (cont’d)<br />

Item 2.05 Costs Associated with Exit<br />

or Disposal Activities<br />

Item 2.06 Material Impairments<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Registration <strong>and</strong> Reporting<br />

Under <strong>Securities</strong> Exchange Act<br />

2004 Amendment of Form 8-K (cont’d)<br />

Item 2.06 Material Impairments.<br />

No filing is required under this Item 2.06 if the<br />

conclusion is made in connection with the<br />

preparation, review or audit of financial statements<br />

required to be included in the next periodic report due<br />

to be filed under the Exchange Act, the periodic<br />

report is filed on a timely basis, <strong>and</strong> such conclusion<br />

is disclosed in the report.<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Registration <strong>and</strong> Reporting<br />

Under <strong>Securities</strong> Exchange Act<br />

2004 Amendment of Form 8-K (cont’d)<br />

Item 3.01 Notice of Delisting or Failure to<br />

Satisfy a Continued Listing Rule or<br />

St<strong>and</strong>ard; <strong>Trans</strong>fer of Listing.<br />

Item 3.02 Unregistered Sales of Equity<br />

<strong>Securities</strong>.<br />

Item 3.03 Material Modification to Rights<br />

of Security Holders.<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Registration <strong>and</strong> Reporting<br />

Under <strong>Securities</strong> Exchange Act<br />

2004 Amendment of Form 8-K (cont’d)<br />

Item 4.02 Non-Reliance on Previously<br />

Issued Financial Statements or a<br />

Related Audit Report or Completed<br />

Interim Review.<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Registration <strong>and</strong> Reporting<br />

Under <strong>Securities</strong> Exchange Act<br />

2004 Amendment of Form 8-K (cont’d)<br />

Item 5.02 Departure of Directors or<br />

Principal Officers; Election of<br />

Directors; Appointment of Principal<br />

Officers.<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Registration <strong>and</strong> Reporting<br />

Under <strong>Securities</strong> Exchange Act<br />

<strong>Regulation</strong> G – Non-GAAP Disclosure<br />

Pursuant to Section 401(b) of Sarbanes-Oxley:<br />

SEC adopted new <strong>Regulation</strong> G <strong>and</strong> new Item 10<br />

of <strong>Regulation</strong> S-K, governing the use of non-<br />

GAAP financial information in public<br />

communications by SEC registrants <strong>and</strong> filings<br />

made with the SEC.<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Registration <strong>and</strong> Reporting<br />

Under <strong>Securities</strong> Exchange Act<br />

<strong>Regulation</strong> G – Non-GAAP Disclosure<br />

(cont’d)<br />

"Non-GAAP financial measure" is defined as a numerical measure of a<br />

company's historical or future financial performance, financial position or<br />

cash flows that:<br />

1) excludes amounts, or is subject to adjustments that have the effect<br />

of excluding amounts, that are included in the most directly<br />

comparable GAAP measure in the statement of income, balance<br />

sheet or statement of cash flows of the company; or<br />

2) includes amounts, or is subject to adjustments that have the effect<br />

of including amounts, that are excluded from the most directly<br />

comparable measure so calculated <strong>and</strong> presented.<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Registration <strong>and</strong> Reporting<br />

Under <strong>Securities</strong> Exchange Act<br />

<strong>Regulation</strong> G – Non-GAAP Disclosure<br />

(cont’d)<br />

<strong>Regulation</strong> G requires a company to provide the following<br />

information as part of the disclosure or release of non-GAAP<br />

financial information:<br />

a presentation of the most directly comparable financial<br />

measure calculated <strong>and</strong> presented in accordance with<br />

GAAP; <strong>and</strong><br />

a reconciliation (by schedule or other clearly<br />

underst<strong>and</strong>able method) of the differences between the non-<br />

GAAP measure <strong>and</strong> the most directly comparable GAAP<br />

measure or measures.<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Registration <strong>and</strong> Reporting<br />

Under <strong>Securities</strong> Exchange Act<br />

Foreign Corrupt Practices Act<br />

What is scope of FCPA?<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Foreign Corrupt Practices Act<br />

Enacted in 1977 in the wake of a series of overseas <strong>and</strong><br />

domestic bribery sc<strong>and</strong>als, the FCPA originally<br />

prohibited U.S. corporations <strong>and</strong> nationals from making<br />

improper payments to foreign officials, parties or<br />

c<strong>and</strong>idates, in order to assist a company in obtaining,<br />

retaining or directing business to any person.<br />

The FCPA also imposes record-keeping <strong>and</strong> internal<br />

controls requirements on all SEC reporting<br />

companies.<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Foreign Corrupt Practices Act (cont’d)<br />

The U.S. Department of Justice (“DOJ”) has primary responsibility<br />

for enforcing the anti-bribery provisions of FCPA.<br />

The SEC typically takes the lead in enforcing the accounting<br />

provisions (e.g., books <strong>and</strong> records, internal controls).<br />

Both the SEC <strong>and</strong> DOJ have authority to seek permanent injunctions<br />

against present <strong>and</strong> future violations. Criminal <strong>and</strong> civil penalties for<br />

violating the FCPA can be severe for corporations as well as<br />

individual officers, employees <strong>and</strong> agents.<br />

In addition to large DOJ <strong>and</strong> SEC monetary sanctions, FCPA<br />

violations can provoke shareholder litigation, as well as government<br />

debarment <strong>and</strong> suspension proceedings <strong>and</strong> parallel investigations in<br />

foreign jurisdictions.<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Foreign Corrupt Practices Act (cont’d)<br />

Record-keeping Provisions – See p. 127 of Soderquist<br />

Codified in § 13(b)(2) <strong>and</strong> (3) of the Exchange Act, the FCPA record-keeping provisions<br />

state:<br />

Every issuer which has a class of securities registered pursuant to section 12 <strong>and</strong> every<br />

issuer which is required to file reports pursuant to section 15(d) shall—<br />

(A) make <strong>and</strong> keep books, records, <strong>and</strong> accounts, which, in reasonable detail, accurately<br />

<strong>and</strong> fairly reflect the transactions <strong>and</strong> dispositions of the assets of the issuer;<br />

(B) devise <strong>and</strong> maintain a system of internal accounting controls sufficient to provide<br />

reasonable assurances that—<br />

(i) transactions are executed in accordance with management's general or<br />

specific authorization;<br />

(ii) transactions are recorded as necessary (I) to permit preparation of financial<br />

statements in conformity with generally accepted accounting principles or any<br />

other criteria applicable to such statements, <strong>and</strong> (II) to maintain accountability<br />

for assets;<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Foreign Corrupt Practices Act (cont’d)<br />

Record-keeping Provisions (cont’d)<br />

FCPA record-keeping <strong>and</strong> internal controls provisions apply<br />

to all reporting companies, whether or not they have any<br />

foreign operations.<br />

FCPA recording keeping <strong>and</strong> internal control rules also<br />

apply to companies with ADRs traded on a U.S. stock<br />

exchange.<br />

FPCA record-keeping nor internal control provisions are not<br />

limited to transactions above a certain amount <strong>and</strong> do not<br />

impose a materiality requirement.<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Foreign Corrupt Practices Act (cont’d)<br />

Record-keeping Provisions (cont’d)<br />

Inadvertent mistakes will not give rise to<br />

enforcement actions or prosecutions.<br />

An issuer can violate the books <strong>and</strong> records<br />

provisions if a foreign subsidiary creates false<br />

records to conceal an illicit payment, <strong>and</strong> the<br />

issuer parent then incorporates the subsidiary’s<br />

information into its books <strong>and</strong> records.<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Foreign Corrupt Practices Act (cont’d)<br />

Record-keeping Provisions (cont’d)<br />

Examples of transactions which accounting records may fail to<br />

adequately or accurately disclose:<br />

payments to foreign government officials;<br />

commercial bribes or kickbacks;<br />

political contributions;<br />

smuggling activities;<br />

income tax violations;<br />

customs or currency violations; <strong>and</strong><br />

extraordinary gifts<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Foreign Corrupt Practices Act (cont’d)<br />

Bribery Provisions<br />

A U.S. company or issuer can be liable under<br />

the FCPA as amended for the conduct of<br />

overseas employees or agents, even if no<br />

money was transferred from the U.S. <strong>and</strong> no<br />

U.S. person participated in any way in the<br />

foreign bribery.<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Foreign Corrupt Practices Act (cont’d)<br />

Bribery Provisions<br />

The 1998 amendments exp<strong>and</strong>ed the FCPA’s jurisdiction to cover<br />

corrupt foreign payments outside the U.S. by U.S. persons without any<br />

link to interstate commerce.<br />

The FCPA amendments make it illegal for any U.S. person to violate<br />

the FCPA “irrespective of whether such U.S. person makes use of<br />

interstate commerce in furtherance of the illegal foreign activity.<br />

Until 1998, foreign persons were not subject to the anti-bribery<br />

provisions unless they were issuers or domestic concerns. The 1998<br />

amendments exp<strong>and</strong>ed the FCPA to allow for the prosecution of any<br />

foreign person, whether or not a U.S. resident, who takes any act in<br />

furtherance of a corrupt payment while in the territory of the U.S.<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Foreign Corrupt Practices Act (cont’d)<br />

What about the ‘Bribery is Accepted <strong>and</strong> Routine There’ Defense<br />

“The argument that a client “conducted business in a foreign country<br />

where corrupt practices are routine <strong>and</strong> long established” <strong>and</strong> “there was<br />

no other practical way to do business <strong>and</strong> compete” is highly unlikely to<br />

succeed, with either the DOJ or the SEC. The uniform government<br />

response is that Congress was fully aware of foreign customs <strong>and</strong><br />

practices where bribery payments were the norm when it enacted the<br />

FCPA three decades ago, <strong>and</strong> it sought to establish ethical business<br />

practices for U.S. companies doing business overseas.”<br />

The Foreign Corrupt Practices Act:<br />

A Primer For Multinational General Counsel<br />

By: Robert W. Tarun<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Foreign Corrupt Practices Act (cont’d)<br />

Two noteworthy FCPA enforcement actions during the paste decade:<br />

1. In April 2007, the DOJ <strong>and</strong> SEC entered into an FCPA record setting<br />

$44 million settlement – the largest monetary sanction ever imposed<br />

in an FCPA case – with Baker Hughes Inc. for a subsidiary’s<br />

payment of bribes totaling $4.1 million over a two-year period to<br />

a Kazakh official in order to obtain an oil field services contract.<br />

2. In March 2005, defense contractor Titan Corporation entered into a<br />

$28.5 million settlement with the DOJ <strong>and</strong> SEC for FCPA bribery<br />

violations involving the president of Benin’s reelection campaign.<br />

Titan was required to plead guilty as a result of its submission of<br />

false invoices for consulting services <strong>and</strong> payment of $3.5 million<br />

to an agent, who was in fact the Benin president’s business<br />

advisor.<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Registration <strong>and</strong> Reporting<br />

Under <strong>Securities</strong> Exchange Act<br />

What is Reg. FD?<br />

What are the practical<br />

implications?<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Reg. FD Overview<br />

Reg. FD – Fair Disclosure<br />

Perceived Abuse:<br />

Selective disclosure of material,<br />

nonpublic information to “Wall<br />

Street” professionals at the expense of<br />

individual investors<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Reg. FD Overview (cont’d)<br />

Reg. FD – Key Elements<br />

1. Disclosure covered by rule:<br />

Statements by issuer or a person<br />

acting on its behalf<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Reg. FD Overview (cont’d)<br />

2. Activity covered:<br />

Selective disclosure of material,<br />

nonpublic information to securities<br />

market professionals or holders of<br />

issuer’s securities, when it is reasonably<br />

foreseeable that recipient will trade on<br />

basis of the material, non-public<br />

information<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Reg. FD Overview (cont’d)<br />

Examples of covered activities:<br />

“Guidance” re: earnings results<br />

One-on-one sessions involving<br />

senior management <strong>and</strong> analysts or<br />

investors<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Reg. FD Overview (cont’d)<br />

Speeches, interviews <strong>and</strong> conferences<br />

Responding to market rumors<br />

Reviewing analyst reports <strong>and</strong> similar<br />

materials<br />

Referring to or distributing analyst<br />

reports about the company<br />

Postings on company website<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Reg. FD Overview (cont’d)<br />

3. Required Disclosure:<br />

Issuer must make public disclosure of<br />

the information –<br />

(1) simultaneously, if the disclosure was<br />

intentional (like a press release), or<br />

(2) promptly thereafter, if the<br />

disclosure was unintentional<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Reg. FD Overview (cont’d)<br />

Public disclosure of the information –<br />

by “furnishing to” or “filing with” the<br />

Commission a Form 8-K disclosing that<br />

information<br />

See Item 7.01 of Form 8-K <strong>and</strong> related<br />

Instruction B.1 regarding “furnishing”<br />

vs. “filing” under Item 8.01 of Form 8-K<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Reg. FD Overview (cont’d)<br />

4. Exceptions:<br />

a. Broad Advance Notice<br />

Issuer exempt from requirement to furnish or file a<br />

Form 8-K if instead it disseminates information<br />

through another method of disclosure that is<br />

reasonably designed to provide broad, nonexclusionary<br />

distribution of the information to the<br />

public<br />

Typically, the alternative scenario is a publicized<br />

conference call in which any party can listen<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Reg. FD Overview (cont’d)<br />

4. Exceptions:<br />

b. “Breach of trust”<br />

Any officer, director, employee, or agent<br />

of an issuer who discloses material,<br />

nonpublic information in breach of a duty<br />

of trust or confidence to the issuer shall<br />

not be considered to be “acting on behalf<br />

of the issuer”<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Reg. FD Overview (cont’d)<br />

Examples involving “trust”<br />

(1) a lawyer or an investment banker<br />

engaged by the issuer, or<br />

(2) a party to a confidentiality<br />

agreement<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Reg. FD Overview (cont’d)<br />

4. Exceptions:<br />

c. Violation of Company Policy<br />

If issuer adopts policy that limits which<br />

senior officials are authorized to speak to<br />

securities market professionals, a selective<br />

disclosure by a senior official who is not<br />

authorized to speak under the policy will not<br />

violate <strong>Regulation</strong> FD (but may subject the<br />

person to insider trading liability)<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Reg. FD Compliance Programs<br />

Elements of Sample FD Policy:<br />

1. Limit authorize spokespersons<br />

CEO<br />

CFO<br />

Investor Relations Officer<br />

Other persons designated by<br />

“Disclosure Committee”<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Reg. FD Compliance Programs<br />

2. Example of Disclosure Committee<br />

Investors Relations<br />

CFO<br />

General Counsel<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Reg. FD Compliance Programs<br />

3. Dissemination of Information<br />

Press release through widely circulated<br />

news <strong>and</strong> wire services<br />

Advance public notice <strong>and</strong> public access<br />

information for each scheduled conference<br />

call<br />

Anyone may listen to call by telephone or<br />

webcast.<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Reg. FD Compliance Programs<br />

3. Dissemination of Information (cont’d)<br />

Permissible to allow only a limited group<br />

to ask questions on the conference call, as<br />

long as all listeners can hear the questions<br />

<strong>and</strong> answers<br />

Make an audio recording of the conference<br />

call publicly available through our website<br />

or an outside service for limited period<br />

(e.g., one week following the call)<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Reg. FD Enforcement<br />

Who may bring a claim for a<br />

violation of Reg. FD?<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Reg. FD Enforcement<br />

Only the SEC may bring a claim for<br />

violation of Reg. FD<br />

Recognizing that private liability could<br />

contribute to a chilling effect on issuer<br />

communications, the SEC has emphasized<br />

that <strong>Regulation</strong> FD contains no private<br />

right of action.<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Reg. FD Enforcement<br />

SEC has been viewed as enforcing Reg. FD<br />

zealously.<br />

Most companies <strong>and</strong> insiders against whom<br />

enforcement actions have been brought<br />

have agreed to settle.<br />

BUT the SEC lost decisively in its only<br />

litigated Reg. FD case<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Reg. FD Enforcement – Siebel Case<br />

In September 2005, in SEC v. Siebel<br />

Systems Inc., a federal district court<br />

decisively dismissed the SEC.<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Reg. FD Enforcement – Siebel Case<br />

SEC alleged that<br />

1) Siebel’s CFO had commented positively on the<br />

company’s business activity <strong>and</strong> sales transaction<br />

pipeline in a private meeting with an institutional<br />

investor, <strong>and</strong><br />

2) CFO’s statements “materially contrasted” with<br />

allegedly more cautious public statements made by<br />

Siebel’s chairman in a conference calls earlier the<br />

same month<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Reg. FD Enforcement – Siebel Case<br />

Court concluded that Reg. FD does not require that<br />

corporate officials “only utter verbatim statements<br />

that were previously publicly made.” So long as the<br />

private statement communicates the same material<br />

information that the public statement conveyed, the<br />

court concluded that <strong>Regulation</strong> FD is not implicated.<br />

Court ruled that, when viewed in context, the<br />

defendants’ public <strong>and</strong> private disclosures “did not<br />

add, contradict, or significantly alter” the material<br />

information available to the general public.<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Reg. FD Enforcement – Siebel Case<br />

Court rejected the SEC’s syntactic parsing of<br />

the Siebel disclosures: “Fair accuracy, not<br />

perfection, is the appropriate st<strong>and</strong>ard.”<br />

Court admonished the SEC for “scrutiniz[ing],<br />

at an extremely heightened level, every<br />

particular word used in [the Siebel statements],<br />

including the tense of verbs <strong>and</strong> the general<br />

syntax of each sentence.”<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Attorney Conduct Rules<br />

Under Federal <strong>Securities</strong> Laws<br />

Attorney Conduct Rules –17 CFR Part 205<br />

(pursuant to §307 of Sarbanes-Oxley Act of 2002)<br />

Applies to attorneys who are “appearing<br />

<strong>and</strong> practicing before the Commission in<br />

the representation of an issuer”<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Attorney Conduct Rules<br />

Under Federal <strong>Securities</strong> Laws<br />

“Appearing <strong>and</strong> practicing before the<br />

Commission . . . ” is broadly defined to<br />

include<br />

<strong>Trans</strong>acting any business with SEC or otherwise<br />

communicating with SEC;<br />

Representing an issuer in an SEC administrative<br />

proceeding or in connection with any SEC<br />

investigation, inquiry, information request or<br />

subpoena;<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Attorney Conduct Rules<br />

Under Federal <strong>Securities</strong> Laws<br />

Providing advice in respect of federal securities laws<br />

<strong>and</strong> regulations concerning any document that the<br />

attorney has notice will be filed with or submitted to<br />

SEC by a client-issuer, including customary SEC filings<br />

as well documents filed as exhibits or otherwise; <strong>and</strong><br />

Advising an issuer as to whether information,<br />

statements, opinions or other writings are required to<br />

be filed with or submitted to the SEC under the federal<br />

securities laws <strong>and</strong> regulations<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Attorney Conduct Rules<br />

Under Federal <strong>Securities</strong> Laws<br />

Foreign Attorneys:<br />

Foreign attorneys who are not admitted in the United<br />

States, <strong>and</strong> who do not advise clients regarding U.S.<br />

law, are not be covered by the rule<br />

Foreign attorneys who provide legal advice regarding<br />

U.S. law would be covered to the extent they are<br />

appearing <strong>and</strong> practicing before the SEC, unless they<br />

provide such advice in consultation with U.S. counsel<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Attorney Conduct Rules<br />

Under Federal <strong>Securities</strong> Laws<br />

Attorney subject to m<strong>and</strong>atory<br />

“up-the-ladder” reporting<br />

Must report any evidence of<br />

any material violation of federal or state<br />

securities law,<br />

any material breach of a fiduciary duty arising<br />

under federal or state law, or<br />

any other “similar” violation of federal or state<br />

law.<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Attorney Conduct Rules<br />

Under Federal <strong>Securities</strong> Laws<br />

Trigger for attorney’s reporting obligation:<br />

“Evidence of a material violation means<br />

credible evidence, based upon which it would<br />

be unreasonable, under the circumstances, for<br />

a prudent <strong>and</strong> competent attorney not to<br />

conclude that it is reasonably likely that a<br />

material violation has occurred, is ongoing, or<br />

is about to occur” (emphasis added).<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Attorney Conduct Rules<br />

Under Federal <strong>Securities</strong> Laws<br />

“Under the circumstances”<br />

Determined at time attorney decides whether he<br />

or she is obligated to report the information.<br />

May include, among others, attorney's<br />

professional skills, background <strong>and</strong> experience,<br />

the time constraints under which attorney is<br />

acting, attorney's previous experience <strong>and</strong><br />

familiarity with client, <strong>and</strong> availability of other<br />

attorneys for consultation.<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Attorney Conduct Rules<br />

Under Federal <strong>Securities</strong> Laws<br />

“Reasonably Likely”<br />

To be "reasonably likely" a material<br />

violation must be more than a mere<br />

possibility, but it need not be "more likely<br />

than not."<br />

(c) 2013 Michael K. Krebs All Rights<br />

Reserved


Attorney Conduct Rules<br />

Under Federal <strong>Securities</strong> Laws<br />

“Up-the-ladder” reporting<br />

Disclosure first to<br />

Chief Legal Officer, or<br />

Chief Legal Officer <strong>and</strong> Chief<br />

Executive Officer<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Attorney Conduct Rules<br />

Under Federal <strong>Securities</strong> Laws<br />

“Up-the-ladder” reporting (cont’d)<br />

Unless attorney believes CLO or CEO has made an<br />

“appropriate response”, the attorney must report the<br />

evidence of a material violation further up-the-ladder<br />

to:<br />

the audit committee of the board of directors,<br />

another independent committee of the board,<br />

or<br />

if no such committees exist, to the entire board.<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Attorney Conduct Rules<br />

Under Federal <strong>Securities</strong> Laws<br />

SEC perspective on CLOs:<br />

CLO can play an essential leadership role in assuring an appropriate "tone"<br />

<strong>and</strong> corporate culture that support rigorous compliance with all laws.<br />

CLO generally can "push back" on senior management more forcefully than<br />

other employees when difficult legal issues arise, especially in light of the<br />

greatly heightened awareness among officers <strong>and</strong> directors today of the price<br />

of corporate malfeasance.<br />

CLO can serve as a bridge to the board on difficult legal matters.<br />

CLO also can best assure an appropriate level of protection for<br />

whistleblowers <strong>and</strong> others who identify potential legal problems at the<br />

company, especially given the sometimes difficult task of sorting out<br />

potential cases of whistleblower retaliation from ordinary personnel disputes.<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Attorney Conduct Rules<br />

Under Federal <strong>Securities</strong> Laws<br />

In addition to the straight up-the-ladder<br />

reporting, the SEC rules also permit companies<br />

to establish a “qualified legal compliance<br />

committee” (“QLCC”).<br />

Once an attorney reports evidence of a material<br />

violation to pre-existing QLCC, then that<br />

committee is responsible for investigating the<br />

evidence of a material violation <strong>and</strong> formulating<br />

an appropriate <strong>and</strong> timely response.<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


U.S <strong>and</strong> <strong>Trans</strong>-<strong>Border</strong><br />

<strong>Securities</strong> <strong>Regulation</strong><br />

Boston University School of Law<br />

Executive LL.M. - International Business Law<br />

July/August 2013<br />

Michael Krebs<br />

JD, Boston University School of Law 1985<br />

Senior Partner, Nutter, McClennen & Fish, LLP, Boston, MA<br />

Tel. 616.439.2288 email: mkrebs@nutter.com<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


MD&A Overview<br />

Practical Guidance<br />

Past <strong>Trans</strong>gressions<br />

Michael Krebs<br />

Nutter, McClennen & Fish, LLP<br />

November 2009<br />

© 2003-2009 Nutter, McClennen & Fish, LLP All Rights Reserved


MD&A Overview<br />

MD&A:<br />

Management’s Discussion <strong>and</strong> Analysis of<br />

Financial Condition, <strong>and</strong><br />

Results of Operations


MD&A Overview<br />

Objective:<br />

“To provide, in one section of a filing,<br />

material historical <strong>and</strong> prospective textual<br />

disclosure enabling investors . . . to assess<br />

the financial condition <strong>and</strong> results of<br />

operations of the registrant, with particular<br />

emphasis on the registrant's prospects for the<br />

future.” (SEC 1989 Release)


MD&A Overview<br />

Key Elements of MD&A<br />

(Item 303 of Reg. S-K <strong>and</strong> Supplemental SEC Guidance)<br />

Executive summary<br />

Critical accounting policies<br />

Liquidity<br />

Capital resources<br />

Off-balance sheet arrangements; contractual<br />

obligations <strong>and</strong> commitments<br />

Operating results


MD&A Overview<br />

Overview of Item 303:<br />

“MD&A is intended to give the investor an<br />

opportunity to look at the company through<br />

the eyes of management by providing both a<br />

short <strong>and</strong> long-term analysis of the business<br />

of the company. [Item 303] asks<br />

management to discuss the dynamics of the<br />

business <strong>and</strong> to analyze the financials.”<br />

(SEC 1989 Release, emphasis added.)


MD&A Overview<br />

Overview of Item 303 (cont’d):<br />

“It is the responsibility of management to<br />

identify <strong>and</strong> address those key variables <strong>and</strong><br />

other qualitative <strong>and</strong> quantitative factors<br />

which are peculiar to <strong>and</strong> necessary for an<br />

underst<strong>and</strong>ing <strong>and</strong> evaluation of the<br />

individual company.” (SEC 1981 Release.)


MD&A Overview<br />

Overview of Item 303 (cont’d):<br />

Several specific provisions in Item 303 require<br />

disclosure of forward-looking information.<br />

MD&A requires discussion of “known trends or<br />

any known dem<strong>and</strong>s, commitments, events or<br />

uncertainties that will result in or that are<br />

reasonably likely to result in the registrant's<br />

liquidity increasing or decreasing in any material<br />

way.”


MD&A Overview<br />

Overview of Item 303 (cont’d):<br />

MD&A also requires discussion of<br />

known material trends in the registrant's capital<br />

resources <strong>and</strong> expected changes in the mix <strong>and</strong> cost<br />

of such resources; <strong>and</strong><br />

known trends or uncertainties that the registrant<br />

reasonably expects will have a material impact on<br />

net sales, revenues, or income from continuing<br />

operations.


MD&A Overview<br />

Overview of Item 303 (cont’d):<br />

Finally, MD&A requires a discussion of<br />

material events <strong>and</strong> uncertainties known to<br />

management that would cause reported financial<br />

information not to be necessarily indicative of<br />

future operating results or of future financial<br />

condition.


MD&A Overview<br />

Elements of MD&A – In Detail<br />

Executive summary (best practice)<br />

Summary identifying what management considers the<br />

most important factors in determining its financial<br />

results <strong>and</strong> conditions, including the principal factors<br />

driving them, the principal trends on which<br />

management focuses <strong>and</strong> the principal risks to the<br />

business<br />

Summary must be balanced <strong>and</strong> include all issues, <strong>and</strong><br />

details must be included in body of MD&A.


MD&A Overview<br />

Elements of MD&A – In Detail<br />

Critical accounting policies<br />

In December 2001, SEC issued "cautionary advice" to<br />

issuers regarding MD&A disclosure of critical accounting<br />

policies.<br />

SEC stated that companies should include in their MD&A<br />

clear, balanced explanations of the effects of “critical<br />

accounting policies,” the judgments made in their<br />

application, <strong>and</strong> the likelihood of materially different<br />

reported results under different assumptions or conditions.


MD&A Overview<br />

Elements of MD&A – In Detail<br />

Critical accounting policies (cont’d)<br />

Working Definition:<br />

A critical accounting policy as one that is both very<br />

important to the portrayal of the company's financial<br />

condition <strong>and</strong> results, <strong>and</strong> requires management's most<br />

difficult, subjective or complex judgments.<br />

(Based upon 2002 remarks by SEC Chief Accountant)


MD&A Overview<br />

Elements of MD&A – In Detail<br />

Critical accounting policies (cont’d)<br />

SEC Objective:<br />

To provide investors with an underst<strong>and</strong>ing about how<br />

management forms its judgments about future events,<br />

including the variables <strong>and</strong> assumptions underlying the<br />

estimates, <strong>and</strong> the sensitivity of those judgments to different<br />

circumstances.<br />

As the complexity <strong>and</strong> subjectivity of judgments increase,<br />

the inherent level of precision in the financial statements<br />

decreases, which is a fact that investors should be told.


MD&A Overview<br />

Elements of MD&A – In Detail<br />

Critical accounting policies (cont’d)<br />

Prior to filing annual reports, the audit committee should<br />

review <strong>and</strong> discuss with senior management <strong>and</strong> outside<br />

auditors the selection, application <strong>and</strong> disclosure of critical<br />

accounting policies.<br />

SEC officials have also advised that critical accounting<br />

policy disclosures be reviewed every quarter.


MD&A Overview<br />

Elements of MD&A – In Detail<br />

Liquidity<br />

Liquidity is defined in Instruction 5 to Item 303(a) as "the<br />

ability of an enterprise to generate adequate amounts of cash<br />

to meet the enterprise's needs for cash."<br />

Item 303(a)(1) requires that the discussion identify "any<br />

known trends or any known dem<strong>and</strong>s, commitments, events<br />

or uncertainties that will result in or that are reasonably likely<br />

to result in the company's liquidity increasing or decreasing in<br />

any material way."


MD&A Overview<br />

Elements of MD&A – In Detail<br />

Liquidity (cont’d)<br />

The scope of the discussion should address liquidity in the<br />

broadest sense, evaluating the amounts <strong>and</strong> certainty of cash<br />

flows from internal operations <strong>and</strong> from outside sources,<br />

current conditions as well as future commitments, known<br />

trends, <strong>and</strong> changes in circumstances <strong>and</strong> uncertainties.


MD&A Overview<br />

Elements of MD&A – In Detail<br />

Liquidity (cont’d)<br />

The scope of the discussion should address liquidity in the broadest<br />

sense, evaluating the amounts <strong>and</strong> certainty of cash flows from<br />

internal operations <strong>and</strong> from outside sources, current conditions as<br />

well as future commitments, known trends, <strong>and</strong> changes in<br />

circumstances <strong>and</strong> uncertainties.<br />

For example, if liquidity is dependent on off-balance sheet<br />

financing, such as securitization of receivables or obtaining access<br />

to assets through special purpose entities, disclosure of factors that<br />

may affect continued use of material off-balance sheet<br />

arrangements is likely to be necessary.


MD&A Overview<br />

Elements of MD&A – In Detail<br />

Liquidity (cont’d)<br />

SEC has identified various items to be considered in preparing the liquidity<br />

section:<br />

(1) Provisions in financial guarantees or commitments, debt or lease<br />

agreements or other arrangements that could trigger a requirement for an<br />

early payment, additional collateral support, changes in terms,<br />

acceleration of maturity, or the creation of an additional financial<br />

obligation, such as adverse changes in the registrant's credit rating,<br />

financial ratios, earnings, cash flows, or stock price, or changes in the<br />

value of underlying, linked or indexed assets;


MD&A Overview<br />

Elements of MD&A – In Detail<br />

Liquidity (cont’d)<br />

(2) Circumstances that could impair the registrant's ability to continue to<br />

engage in transactions that have been integral to historical operations or<br />

are financially or operationally essential, or that could render that activity<br />

commercially impracticable, such as the inability to maintain a specified<br />

investment grade credit rating, level of earnings, earnings per share,<br />

financial ratios, or collateral;<br />

(3) Factors specific to the company <strong>and</strong> its markets that the registrant expects<br />

to be given significant weight in the determination of the registrant's credit<br />

rating or will otherwise affect the registrant's ability to raise short-term<br />

<strong>and</strong> long-term financing;


MD&A Overview<br />

Elements of MD&A – In Detail<br />

Liquidity (cont’d)<br />

(4) Guarantees of debt or other commitments to third parties;<br />

(5) Written options on nonfinancial assets (for example, real estate puts)<br />

(6) Material deficiencies in liquidity <strong>and</strong> any proposed remedies<br />

contemplated, e.g., (i) past due payables to trade <strong>and</strong> other creditors,<br />

negotiations with such creditors <strong>and</strong> steps contemplated to fund<br />

delinquent balances <strong>and</strong> meet ongoing trade obligations <strong>and</strong> (ii) violations<br />

of restrictive maintenance covenants in debt agreements (minimum ratios,<br />

working capital or stockholders' equity) <strong>and</strong> negotiations with lenders to<br />

cure any defaults.


MD&A Overview<br />

Elements of MD&A – In Detail<br />

Liquidity (cont’d)<br />

(7) Cash flows from (i) investing <strong>and</strong> financing activities (e.g., debt<br />

refinancings <strong>and</strong> redemptions <strong>and</strong> financing from customers or suppliers)<br />

<strong>and</strong> (ii) operations (e.g., discretionary operating expenses such as<br />

advertising, research <strong>and</strong> development), including how operating cash<br />

flows may be affected by trends or significant events.<br />

(8) Any limitation on the ability of subsidiaries to upstream funds to the<br />

parent company in the form of cash dividends, loans or advances, or if any<br />

of the parent's debt instruments contain such restrictions, a discussion of<br />

such limitations <strong>and</strong> the expected effect on the ability of the parent to<br />

meet its cash requirements.


MD&A Overview<br />

Elements of MD&A – In Detail<br />

Capital resources<br />

(Companies are permitted to <strong>and</strong> often do combine the discussion of liquidity <strong>and</strong><br />

capital resources whenever the two topics are interrelated. For clarity, this<br />

presentation separately addresses Capital Resources.)<br />

Item 303(a)(2) requires that MD&A describe "the company's material<br />

commitments for capital expenditures" <strong>and</strong> "the general purpose of such<br />

commitments <strong>and</strong> the anticipated source of funds needed to fulfill such<br />

commitments."<br />

Commitments in this context should be construed as planned expenditures, not<br />

simply legal obligations. The discussion should indicate any known material<br />

trends, favorable or unfavorable, in capital resources <strong>and</strong> expected material<br />

changes in the mix <strong>and</strong> relative cost of such resources, such as the mix between<br />

equity, debt, <strong>and</strong> off-balance sheet arrangements.


MD&A Overview<br />

Elements of MD&A – In Detail<br />

Off-Balance Sheet Arrangements; Contractual<br />

Obligations <strong>and</strong> Commitments<br />

As directed by Section 401(a) of the Sarbanes-Oxley Act,<br />

the SEC amended the MD&A requirements to include<br />

specific disclosure m<strong>and</strong>ates with respect to off-balance<br />

sheet arrangements <strong>and</strong> contractual obligations <strong>and</strong><br />

commitments.


MD&A Overview<br />

Elements of MD&A – In Detail<br />

Off-Balance Sheet Arrangements; Contractual<br />

Obligations <strong>and</strong> Commitments (cont’d)<br />

Disclosure of off-balance sheet transactions must be in a<br />

separately-captioned section of MD&A.<br />

Cross-referencing to information in the notes to the financial<br />

statements is allowed if the notes are written in a clear <strong>and</strong><br />

informative manner.<br />

Off-balance sheet arrangements should be aggregated in<br />

categories or groups in a manner that allows investors to<br />

underst<strong>and</strong> the circumstances that would have common effects<br />

with respect to a number of off-balance sheet arrangements.


MD&A Overview<br />

Elements of MD&A – In Detail<br />

Operating results<br />

Companies are required, pursuant to Item 303(a)(3), to<br />

Describe any unusual or infrequent events or transactions . . . that<br />

materially affected the amount of reported income from continuing<br />

operations <strong>and</strong>, in each case, indicate the extent to which income<br />

was so affected; <strong>and</strong><br />

Describe any known trends or uncertainties that have had or that<br />

the company reasonably expects will have a material favorable or<br />

unfavorable impact on net sales or revenues or income from<br />

continuing operations.


MD&A Overview<br />

Elements of MD&A – In Detail<br />

Operating results (cont’d)<br />

Discussion should include a description of matters that might have<br />

an impact on future operating results even if they have not had an<br />

impact in the past, <strong>and</strong> vice versa.<br />

Discussion should include the impact of inflation, if material. In<br />

that case, management need only present its views textually; no<br />

numerical financial data is required.


MD&A Overview<br />

Item 303 of Reg. S-K:<br />

Known Trends, Dem<strong>and</strong>s, Commitments,<br />

Events or Uncertainties<br />

Distinct Three-Step Test<br />

per SEC ’89 Release<br />

Not Probability/Magnitude Assessment<br />

per Basic, Inc. v. Levinson


MD&A Overview<br />

Item 303 of Reg. S-K:<br />

Three-Step Test:<br />

1. Is management aware of any<br />

potential trend, dem<strong>and</strong>,<br />

commitment, event or uncertainty?


MD&A Overview<br />

Item 303 of Reg. S-K:<br />

Three-Step Test:<br />

1. Is there a potential trend, dem<strong>and</strong>, commitment or<br />

uncertainty?<br />

2. If so, is the potential trend,<br />

uncertainty, etc. reasonably unlikely<br />

to occur?


MD&A Overview<br />

Item 303 of Reg. S-K:<br />

Three-Step Test:<br />

1. Is there a known trend, dem<strong>and</strong>, commitment or<br />

uncertainty?<br />

2. Is the known uncertainty, etc.<br />

reasonably unlikely to occur?<br />

If unlikely to occur, no disclosure<br />

required


MD&A Overview<br />

Three-Step Test:<br />

1. Is there a potential trend, dem<strong>and</strong>, commitment or<br />

uncertainty?<br />

2. Is the known uncertainty, etc. reasonably unlikely to<br />

occur?<br />

3. Is it reasonably unlikely that the<br />

occurrence of the known uncertainty,<br />

etc. would have material effect<br />

(negative or positive) on financial<br />

condition or operating results?


MD&A Overview<br />

Three-Step Test:<br />

3. Is it reasonably unlikely that the<br />

occurrence of the known uncertainty,<br />

etc. would have material effect<br />

(negative or positive) on financial<br />

condition or operating results?<br />

If unlikely, no disclosure required


MD&A Overview<br />

When is an effect “material”?<br />

TSC v. Northway:<br />

o Is there a substantial likelihood . . .<br />

o that the . . . fact would have been<br />

viewed by the reasonable investor . . .<br />

o as having significantly altered the<br />

"total mix" of information made<br />

available.


MD&A Overview<br />

When is an effect “material”?<br />

o Reasonable investor test<br />

o No rote percentage test<br />

(i.e., “But it’s less than 5 percent of net<br />

income!”)<br />

Cf. Staff Accounting Bulletin 99<br />

(8.13.99)


MD&A Overview<br />

When is an effect “material”?<br />

o Significant to investors<br />

o No rote %<br />

SAB 99: “exclusive reliance on certain<br />

quantitative benchmarks to assess<br />

materiality in preparing financial<br />

statements <strong>and</strong> performing audits . . . is<br />

inappropriate”


MD&A Overview<br />

More about SAB 99:<br />

To illustrate that a percentage test alone is never defensible, SAB 99<br />

lists qualitative factors that could render material a quantitatively<br />

small misstatement of a financial statement item.<br />

These include:<br />

Whether the misstatement arises from an item capable of precise<br />

measurement or whether it arises from an estimate <strong>and</strong>, if so, the<br />

degree of imprecision inherent in the estimate;<br />

Whether the misstatement masks a change in earnings or other trends;<br />

Whether the misstatement hides a failure to meet analysts' consensus<br />

expectations for the enterprise;


MD&A Overview<br />

More about SAB 99 (cont’d):<br />

Whether the misstatement changes a loss into income or vice versa;<br />

Whether the misstatement concerns a segment or other portion of the<br />

registrant's business that has been identified as playing a<br />

significant role in the registrant's operations or profitability;<br />

Whether the misstatement affects the registrant's compliance with<br />

regulatory requirements;<br />

Whether the misstatement affects the registrant's compliance with loan<br />

covenants or other contractual requirements;


MD&A Overview<br />

More about SAB 99 (cont’d):<br />

Whether the misstatement has the effect of increasing management's<br />

compensation ? for example, by satisfying requirements for the<br />

award of bonuses or other forms of incentive compensation; or<br />

Whether the misstatement involves concealment of an unlawful<br />

transaction.<br />

Other factors that the SEC staff suggests be taken into account include<br />

the volatility of the stock price in response to certain types of<br />

disclosures – a possible indicator of the importance of small<br />

misstatements to investors.


MD&A Overview<br />

Cautionary Tales<br />

Or


MD&A Overview<br />

What You Say (or Choose Not to Say)<br />

Can (<strong>and</strong> Will) Be Used Against You!


MD&A Overview<br />

Cautionary Tale No. 1<br />

• 1990 SEC Enforcement Action re<br />

Bank of New Engl<strong>and</strong><br />

MD&A - Failure to Disclosure Adverse Trends in<br />

Real Estate Market <strong>and</strong> Future Loan Loss Impact<br />

SEC alleged that BNE failed to disclose certain adverse trends<br />

indicating a deterioration in the New Engl<strong>and</strong> real estate market<br />

as well as in BNE's loan portfolio that were reasonably likely to<br />

have material adverse effects on BNE's future loan loss reserve<br />

<strong>and</strong> net income in early 1990.<br />

(SEC brought a similar case against Bank of Boston based upon<br />

its 1989 loan related disclosures.)


MD&A Overview<br />

Cautionary Tale No. 2<br />

• 1992 SEC Enforcement Action re Caterpillar<br />

MD&A - Failure to Disclosure Possible Material<br />

Future Impact of Brazilian Hyperinflation <strong>and</strong><br />

Currency Exchange Issues<br />

SEC alleged that in early ‘90 (before CAT filed ‘89<br />

10-K), CAT management became aware that<br />

Brazilian subsidiary might be significantly less<br />

profitable than in ‘89 <strong>and</strong> this was likely to reduce<br />

materially CAT’s overall ‘90 operating results.


MD&A Overview<br />

Cautionary Tale No. 3<br />

• 1997 re BankAmerica Corp.<br />

Market Risk Disclosure - Disclosure of<br />

securities <strong>and</strong> derivatives trading through joint<br />

venture did not comply with Item 305 (Market<br />

Risk).<br />

SEC alleged that BAC did not disclose the<br />

market risks to which the venture exposed BAC<br />

<strong>and</strong> the potential losses arising from those risks.


MD&A Overview<br />

Cautionary Tale No. 4<br />

• 1998 Sony Corporation<br />

MD&A Disclosure (Prior to Significant<br />

Goodwill Charge) <strong>and</strong> Segment Report for<br />

Foreign Registrant<br />

SEC alleged inadequate disclosures in 6-K <strong>and</strong><br />

MD&A.<br />

SEC also questioned Sony’s “segment<br />

reporting.”


MD&A Overview<br />

Cautionary Tale No. 4 (cont’d)<br />

• 1998 Sony Corporation<br />

SEC alleged that Sony "made inadequate disclosures about the<br />

nature <strong>and</strong> extent of Sony Pictures' net losses <strong>and</strong> their impact<br />

on the consolidated results Sony was reporting."<br />

Sony selectively noted positive developments such as box<br />

office share or the success of individual motion pictures.<br />

SEC took specific issue with MD&A disclosure in Sony's<br />

Annual Report to Shareholders filed with SEC four months<br />

prior to Sony’s November 1994 write-down of approximately<br />

$2.7 billion of goodwill associated with the acquisition of its<br />

motion picture operations.


MD&A Overview<br />

Cautionary Tale No. 4 (cont’d)<br />

• 1998 Sony Corporation<br />

SEC found that Sony’s 1994 Annual Report painted a<br />

generally positive picture of the 1994 results for Sony's<br />

entertainment segment <strong>and</strong> failed to disclose that Sony<br />

Pictures had incurred its first ever operating loss <strong>and</strong> a net loss<br />

of nearly a half billion dollars.<br />

Instead, the MD&A section of that Annual Report discussed<br />

positive results achieved by Sony Pictures – box office share,<br />

Academy Award nominations <strong>and</strong> gross box office receipts –<br />

but simultaneously failed to disclose known negative results<br />

<strong>and</strong> trends in operating income before amortization, net<br />

income <strong>and</strong> operating cash flow.


MD&A Overview<br />

Cautionary Tale No. 4 (cont’d)<br />

• 1998 Sony Corporation<br />

SEC also expressed concerns over the lack of transparency<br />

concerning Sony's motion picture operations.<br />

While not citing Sony for improper accounting, the<br />

Commission specifically noted that "over the expressed<br />

preference of its outside accountants <strong>and</strong> its own U.S.-based<br />

financial officers for separate reporting of Sony's music <strong>and</strong><br />

picture businesses," Sony chose to report the combined results<br />

of these two businesses as a single "entertainment" industry<br />

segment, which resulted in the obscuring of the significant<br />

losses Sony experienced in its motion picture business.


MD&A Overview<br />

Cautionary Tales Nos. 5, 6, 7 Etc.<br />

• 2001-2002: The Corporate Sc<strong>and</strong>al Sheet


MD&A Overview<br />

• Revenue Recognition<br />

Global Crossing: Boosted its reported profits by<br />

“swapping” network capacity with another carrier<br />

Tyco: Accused of “Spring-Loading” -- Padding<br />

earnings growth by acquiring companies after<br />

making them prepay expenses <strong>and</strong> forgo new<br />

revenue<br />

Bristol-Myers Squibb: Inflated 2001 revenue by<br />

$1.5 billion by “channel stuffing” (forcing<br />

wholesalers to accept inventory to get it off the<br />

manufacturer’s books)


MD&A Overview<br />

• Off Balance Sheet <strong>Trans</strong>actions<br />

Enron: Aggressively boosted profits <strong>and</strong> hid<br />

debts totaling over $1 billion by using off-thebooks<br />

partnerships<br />

Adelphia Communications: Fraudulently<br />

excluded billions of dollars in liabilities from its<br />

consolidated financial statements by hiding them<br />

on the books of off-balance sheet affiliates


MD&A Overview<br />

• Operating Expenses vs. Capital Expenses<br />

WorldCom:<br />

• Reduced its operating expenses by improperly<br />

releasing certain reserves held against<br />

operating expenses<br />

• Improperly reduced its operating expenses by<br />

recharacterizing certain expenses as capital<br />

assets<br />

• SEC complaint against WorldCom:<br />

http://www.sec.gov/litigation/complaints/com<br />

p17829.htm


MD&A Overview<br />

Concluding observations:<br />

The MD&A requirements are intentionally flexible<br />

<strong>and</strong> general.<br />

No two companies are identical, <strong>and</strong> therefore<br />

good MD&A disclosure for one company is not<br />

necessarily good for another.<br />

The same is true for MD&A disclosure of the same<br />

registrant in different years.


MD&A Overview<br />

Concluding observations (cont’d):<br />

The Caterpillar <strong>and</strong> Sony decisions highlight SEC's<br />

emphasis on the importance of establishing internal<br />

procedures to ensure compliance with Item 303.<br />

MD&A’s accuracy depends on an effective system for<br />

gathering <strong>and</strong> disseminating information.<br />

The process of MD&A preparation should not be driven by<br />

fixed rules or static checklists, or by simply marking up last<br />

year’s MD&A disclosure.


U.S <strong>and</strong> <strong>Trans</strong>-<strong>Border</strong><br />

<strong>Securities</strong> <strong>Regulation</strong><br />

Boston University School of Law<br />

Executive LL.M. in International Business Law<br />

Session 8 – July 30, 2013<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Session 8 Agenda<br />

Part 1<br />

Woe to be an insider of a reporting company<br />

Part 2<br />

Proxy Statement <strong>Regulation</strong><br />

Part 3<br />

<strong>Regulation</strong> of Foreign Private Issuers under <strong>Securities</strong> Act <strong>and</strong><br />

Exchange Act<br />

Part 4<br />

Comparative differences between U.S. securities law regime <strong>and</strong> that of<br />

UK, EU <strong>and</strong> Hong Kong<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Rule 10b-5<br />

<strong>and</strong> Insider Trading Policies<br />

Limited Trading Windows for Insiders<br />

Role of 10b5-1 Trading Plans<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Rule 10b-5<br />

<strong>and</strong> Insider Trading Policies<br />

Reason for policy<br />

Typical elements of policy<br />

Waiting period – 48 to 72 hours – after<br />

release of material information<br />

Blackout period prior to earnings release<br />

Clearance procedures<br />

Section 16 compliance<br />

Acknowledgement of policy by insiders<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Rules 10b5-1<br />

Rule 10b5-1(a):<br />

“Manipulative <strong>and</strong> deceptive devices" prohibited by<br />

Section 10(b) <strong>and</strong> Rule 10b-5 include, among other<br />

things, purchase or sale of security of any issuer, on<br />

the basis of material nonpublic information about<br />

that security or issuer, in breach of duty of trust or<br />

confidence owed directly, indirectly, or derivatively,<br />

to issuer of that security or shareholders of that<br />

issuer, or to any other person who is source of<br />

material nonpublic information<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Rule 10b5-1(b):<br />

Rules 10b5-1 <strong>and</strong> 10b5-2<br />

Trading is "on the basis of" material nonpublic<br />

information if<br />

the person making the purchase or sale was<br />

aware of the material nonpublic information<br />

when the person made the purchase or sale.<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Rules 10b5-1 <strong>and</strong> 10b5-2<br />

Rule 10b5-2:<br />

Provides a non-exclusive definition of<br />

circumstances in which a person has a duty of<br />

trust or confidence for purposes of the<br />

"misappropriation" theory of insider trading<br />

under Section 10(b) of the Act <strong>and</strong> Rule 10b-5.<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Rule 10b5-1 Plans<br />

Reason for plans –<br />

Rule 10b5-1 establishes affirmative defense<br />

A purchase or sale is not "on the basis of"<br />

material nonpublic information if<br />

the person making the purchase or sale<br />

demonstrates that he or she had adopted a<br />

written plan for trading securities at a time when<br />

he or she was not in possession of material nonpublic<br />

information.<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


The plan must either:<br />

1. Specify<br />

Rule 10b5-1 Plans<br />

Amount of securities to be purchased or sold<br />

Price at which <strong>and</strong> date on which securities are to<br />

be purchased or sold; or<br />

2. Include a written formula or algorithm, etc.,<br />

In addition, plan must not permit insider to exercise<br />

any subsequent influence over how, when, or whether<br />

to effect purchases or sales<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Section 16<br />

Reporting <strong>and</strong> Short-Swing Liability<br />

Section 16(a): Reporting<br />

Forms 3, 4 <strong>and</strong> 5<br />

Section 16(b): Liability<br />

Strict Liability<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Section 16<br />

Reporting <strong>and</strong> Short-Swing Liability<br />

Persons covered:<br />

Directors <strong>and</strong> executive officers<br />

Function over form (i.e., title does not<br />

control)<br />

> 10% holders<br />

(c) 2013 Michael K. Krebs All Rights<br />

Reserved


Section 16<br />

Reporting <strong>and</strong> Short-Swing Liability<br />

Beneficial ownership<br />

Broadly defined<br />

“Pecuniary interest” test<br />

Note: Different than beneficial ownership test<br />

for Schedule 13D/13G purposes<br />

“Presumption” of beneficial ownership of securities<br />

held by immediate family members living at home<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Section 16<br />

Reporting <strong>and</strong> Short-Swing Liability<br />

Any matching Purchase/Sale or<br />

Sale/Purchase within less than 6 months<br />

Regardless of actual inside info.<br />

Matching calculated to yield greatest<br />

profit disgorgement<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Section 16<br />

Reporting <strong>and</strong> Short-Swing Liability<br />

Status at Purchase/Sale or Sale/Purchase<br />

>10% holder – must be > 10% at each stage<br />

Directors <strong>and</strong> officers<br />

<strong>Trans</strong>action before generally not matched<br />

Post-tenure transaction are matched<br />

See Rule 16a-2(c)<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Section 16<br />

Reporting <strong>and</strong> Short-Swing Liability<br />

Exemptions – Rule 16b-3<br />

Exercise of option is typically neither<br />

purchase nor sale<br />

Typically employee stock option will be<br />

structured to be exempt from Section 16<br />

liability<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Section 16<br />

Reporting <strong>and</strong> Short-Swing Liability<br />

Reporting on Form 4<br />

Post Sarbanes-Oxley, Form 4 must be filed by<br />

end of second business day after day on which<br />

transaction occurred<br />

Close coordination between company <strong>and</strong><br />

insider required<br />

Filing occurs via EDGAR<br />

Filings closely monitored by “§ 16 Bar”<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Section 402 (a/k/a 13(k))<br />

Prohibited Loans<br />

Applicable to companies registered under section 12<br />

or required to file reports under section 15(d), <strong>and</strong><br />

any company that files or has filed a registration<br />

statement that has not yet become effective under the<br />

<strong>Securities</strong> Act of 1933, <strong>and</strong> that it has not withdrawn.<br />

Company may not make personal loans (including<br />

the extension of credit or the arrangement of the<br />

extension of credit) to any of its directors or<br />

executive officers, subject to very limited<br />

exceptions.<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Section 402 (a/k/a 13(k))<br />

Prohibited Loans<br />

Two categories of exceptions to the general<br />

prohibition against loans to insiders:<br />

1. Loans by consumer lenders in the ordinary<br />

course of business; <strong>and</strong><br />

2. Loans by banks <strong>and</strong> thrifts that are insured by<br />

the U.S. FDIC (by rule SEC has extended this<br />

exception to apply to foreign banks).<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Section 402 (a/k/a §13(k))<br />

Prohibited Loans<br />

SEC still has not issued guidance in response to questions about<br />

whether certain arrangements between issuers <strong>and</strong> their officers may<br />

violate Section 402.<br />

For example, consider whether the following may violate<br />

Section 402:<br />

Split-dollar life insurance for a director or executive officer<br />

401(k) Plan loans (made by the plan, but “arranged” by the<br />

issuer?)<br />

(See memor<strong>and</strong>um authored by group of 25 law firms for<br />

additional background.)<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Section 306 of Sarbanes Oxley<br />

Blackout Period<br />

Insider Trades During Pension Fund Blackout Periods<br />

Unlawful for any director or executive officer of an<br />

issuer of any equity security to purchase, sell, or<br />

otherwise acquire or transfer any equity security of the<br />

issuer during any blackout period with respect to<br />

such equity security if such director or officer acquires<br />

such equity security in connection with his or her<br />

service or employment as a director or executive<br />

officer.<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Section 306 of Sarbanes Oxley<br />

Blackout Period (cont’d)<br />

Blackout Period Defined<br />

Any period of more than 3 consecutive business days<br />

during which the ability of not fewer than 50 percent<br />

of the participants or beneficiaries under all<br />

individual account plans maintained by the issuer<br />

to purchase, sell, or otherwise acquire or transfer an<br />

interest in any equity of such issuer held in such an<br />

individual account plan is temporarily suspended by<br />

the issuer or by a fiduciary of the plan<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Session 8 Agenda<br />

Part 1<br />

Woe to be an insider of a reporting company<br />

Part 2<br />

Proxy Statement <strong>Regulation</strong><br />

Part 3<br />

<strong>Regulation</strong> of Foreign Private Issuers under <strong>Securities</strong> Act <strong>and</strong><br />

Exchange Act<br />

Part 4<br />

Comparative differences between the U.S. securities law regime <strong>and</strong><br />

that of UK, EU <strong>and</strong> Hong Kong<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Proxy <strong>Regulation</strong><br />

Under <strong>Securities</strong> Exchange Act<br />

Proxy regulation: Mix of<br />

State law (jurisdiction of incorporation)<br />

Federal securities law<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Proxy <strong>Regulation</strong><br />

Under <strong>Securities</strong> Exchange Act<br />

Federal proxy regulation applies<br />

only to<br />

“§12 companies”<br />

(i.e., companies with a class of equity<br />

securities registered under §12 of the<br />

Exchange Act)<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Proxy <strong>Regulation</strong><br />

Under <strong>Securities</strong> Exchange Act<br />

Caution regarding text on page 132 of Soderquist:<br />

Delaware law is NOT “generally silent”<br />

regarding disclosure in proxy solicitations<br />

Delaware cases have confirmed that corporations<br />

organized under Delaware law must disclose all<br />

material facts when soliciting shareholder approval,<br />

even if the corporation is not registered under §12 of<br />

the Exchange Act.<br />

See, e.g., Stroud v. Grace, Del. Supr., 606 A.2d 75, 84<br />

(1992).<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Proxy <strong>Regulation</strong><br />

Under <strong>Securities</strong> Exchange Act<br />

What is the meaning of the phrase<br />

“solicitation of proxies” under Section<br />

14(a)?<br />

Are some solicitations exempt?<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Proxy <strong>Regulation</strong><br />

Under <strong>Securities</strong> Exchange Act<br />

“Proxy Solicitation” Broadly Defined:<br />

Any communication reasonably<br />

calculated to result in the<br />

procurement, withholding or<br />

revocation of a proxy<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Proxy <strong>Regulation</strong><br />

Under <strong>Securities</strong> Exchange Act<br />

Two Key Exemptions: Rule 14a-1(l)(2)(iv)<br />

1. Communication by a security holder stating how the security<br />

holder intends to vote <strong>and</strong> the reasons therefor, if the holder<br />

does not otherwise engage in proxy solicitation (other than a<br />

solicitation exempt under Rule 14a-2), <strong>and</strong> if such<br />

communication is:<br />

made by means of speeches in public forums, press<br />

releases, published or broadcast opinions, etc., or<br />

directed to persons to whom the security holder owes a<br />

fiduciary duty in connection with the voting of securities,<br />

or<br />

made in response to unsolicited requests for additional<br />

information with respect to a prior exempt communication.<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Proxy <strong>Regulation</strong><br />

Under <strong>Securities</strong> Exchange Act<br />

2. Rule 14a-2(b)<br />

Various exemptions, including<br />

(2) Any solicitation made otherwise than on behalf of<br />

the registrant where the total number of persons<br />

solicited is not more than ten<br />

(c) 2013 Michael K. Krebs All Rights<br />

Reserved


Proxy statement as vehicle for social<br />

policy:<br />

Extensive executive compensation disclosure<br />

Exp<strong>and</strong>ed effective for proxy statements after<br />

December 15, 2006<br />

Disclosure of late Form 4s (§16 insiders)<br />

Compensation Disclosure & Analysis (“CD&A”)<br />

Audit Committee/Compensation Committee Reports<br />

Audit Committee/Compensation Committee Charters<br />

Nominating Committee Process<br />

Shareholder Access to Director Nomination (on hold)<br />

Nonbinding “Say-On-Pay”/ “Say-On-Parachute” Votes<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Proxy <strong>Regulation</strong><br />

Under <strong>Securities</strong> Exchange Act<br />

Who controls the proxy mechanism?<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Proxy <strong>Regulation</strong><br />

Under <strong>Securities</strong> Exchange Act<br />

Rule 14a-8 –<br />

Security Holder Proposals<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Proxy <strong>Regulation</strong><br />

Under <strong>Securities</strong> Exchange Act<br />

14a-8(c) – Grounds for exclusion:<br />

“Ordinary course of business”<br />

“Cracker Barrel” No Act<br />

Letters<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Proxy <strong>Regulation</strong><br />

Under <strong>Securities</strong> Exchange Act<br />

In 2009 the Corp Fin staff indicated in Staff Legal Bulletin<br />

No. 14E that the staff will be less likely in the future to grant<br />

no-action relief to companies seeking to exclude shareholder<br />

proposals under the ordinary business exclusion in Rule 14a-<br />

8(i)(7).<br />

Instead of allowing companies to automatically exclude<br />

any proposal that would require the company to evaluate<br />

risk, the Staff will look at the underlying subject matter<br />

to determine whether or not the proposal should be<br />

allowed.<br />

Proposals relating to CEO succession planning may also<br />

be allowed.<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Proxy <strong>Regulation</strong><br />

Under <strong>Securities</strong> Exchange Act<br />

Shareholder Access to Director Nomination<br />

Proposed June 2009<br />

SEC proposes new rules that would require, under<br />

certain circumstances, a company to include in the<br />

company’s proxy materials a shareholder’s, or group<br />

of shareholders’, nominees for director.<br />

Very controversial.<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Proxy <strong>Regulation</strong><br />

Under <strong>Securities</strong> Exchange Act<br />

Effective in early 2011,<br />

“say-on-pay”<br />

“say-on-parachute”<br />

nonbinding votes required by Dodd-Frank<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Say-on-Pay<br />

Dodd-Frank amended the <strong>Securities</strong> Exchange Act of 1934<br />

by adding Section 14A, which requires companies to obtain a<br />

separate nonbinding (a/k/a “advisory”) shareholder vote to<br />

approve compensation of executives, as disclosed pursuant<br />

SEC proxy statement disclosure rules<br />

Section 14A also requires companies to conduct a separate<br />

shareholder advisory vote to determine how often an issuer<br />

will conduct a shareholder advisory vote on executive<br />

compensation. In 2011 “proxy season” many <strong>and</strong> perhaps<br />

most companies opted for annual “say-on-pay”<br />

disclosure.<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Proxy <strong>Regulation</strong><br />

Under <strong>Securities</strong> Exchange Act<br />

Director Nominating Process:<br />

More robust disclosure of the nominating<br />

committee processes of public companies<br />

More specific disclosure of the processes by<br />

which security holders may communicate with<br />

the directors of the companies in which they<br />

invest<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Proxy <strong>Regulation</strong><br />

Under <strong>Securities</strong> Exchange Act<br />

Where are the disclosure<br />

requirements for proxy statements?<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Proxy <strong>Regulation</strong><br />

Under <strong>Securities</strong> Exchange Act<br />

Schedule 14A<br />

Plus Annual Report (if electing<br />

directors)<br />

Form 10-K<br />

(Part III – Instruction G(3))<br />

Reg. S-K<br />

Integrated Disclosure System<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Proxy <strong>Regulation</strong><br />

Under <strong>Securities</strong> Exchange Act<br />

Form 10-K (Part III – Instruction G(3))<br />

Item 10. Directors, Executive Officers <strong>and</strong> Corporate<br />

Governance<br />

Item 11. Executive Compensation<br />

Item 12. Security Ownership of Certain Beneficial Owners<br />

<strong>and</strong> Management <strong>and</strong> Related Stockholder Matters<br />

Item 13. Certain Relationships <strong>and</strong> Related <strong>Trans</strong>actions,<br />

<strong>and</strong> Director Independence<br />

Item 14. Principal Accounting Fees <strong>and</strong> Services<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Proxy <strong>Regulation</strong><br />

Under <strong>Securities</strong> Exchange Act<br />

Form 10-K (Part III – Instruction G(3))<br />

Item 11. Executive Compensation<br />

Who are the “NEOs” (or named executive officers”)?<br />

What is the “summary compensation table”?<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Named Executive Officers (NEOs)<br />

S-K Item 402(a)(3)<br />

1. All individuals serving as the registrant's principal executive officer during the last<br />

completed fiscal year ("PEO"), regardless of compensation level;<br />

2. All individuals serving as the registrant's principal financial officer during the last<br />

completed fiscal year ("PFO"), regardless of compensation level;<br />

3. Three most highly compensated executive officers other than the PEO <strong>and</strong> PFO who<br />

were serving as executive officers at the end of the last completed fiscal year; <strong>and</strong><br />

4. Up to two additional individuals for whom disclosure would have been provided<br />

pursuant to paragraph (a)(3)(iii) of this Item but for the fact that the individual was<br />

not serving as an executive officer of the registrant at the end of the last completed<br />

fiscal year.<br />

No disclosure need be provided for any executive officer, other than the PEO <strong>and</strong><br />

PFO, whose total compensation does not exceed $100,000.<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Google:<br />

Summary Compensation Table<br />

http://sec.gov/Archives/edgar/data/1288776/000119312511103<br />

802/ddef14a.htm#rom154220_62<br />

General Motors:<br />

http://sec.gov/Archives/edgar/data/1467858/000119312511104<br />

797/ddef14a.htm#toc156829_33<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Proxy <strong>Regulation</strong><br />

Under <strong>Securities</strong> Exchange Act<br />

“Compensation Discussion & Analysis”<br />

or<br />

CD&A<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Proxy <strong>Regulation</strong><br />

Under <strong>Securities</strong> Exchange Act<br />

“Compensation Discussion & Analysis”<br />

Objectives of company’s compensation programs?<br />

What is the compensation plan designed to reward?<br />

What is each element of compensation?<br />

Why does company choose to pay each element?<br />

How does company determine amount for each element?<br />

How does each element of company’s decision regarding<br />

that element fit into company’s overall compensation<br />

objectives <strong>and</strong> affect decisions regarding other elements?<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Proxy <strong>Regulation</strong><br />

Under <strong>Securities</strong> Exchange Act<br />

What role do Glass Lewis, RiskMetrics <strong>and</strong> other<br />

proxy advisory firms play in proxy solicitations?<br />

Institutional voting of portfolio stocks generally is no longer in<br />

the h<strong>and</strong>s of institutional money managers, except for votes with<br />

clear economic significance (such as mergers or election<br />

contests).<br />

Instead, the vast majority of institutional investors have delegated<br />

voting decisions to a separate internal voting function or have<br />

outsourced voting decisions to third-party proxy advisory firms.<br />

Glass Lewis <strong>and</strong> RiskMetrics are the two most prominent proxy<br />

advisory firms in the United States.<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Proxy <strong>Regulation</strong><br />

Under <strong>Securities</strong> Exchange Act<br />

Changes to exchange rules on broker non-votes<br />

A registered broker holding a customer’s shares in the<br />

name of the broker may vote on the customer’s behalf on<br />

certain routine matters (including ratification of the<br />

company’s auditors).<br />

A “broker non-vote” occurs when the broker has not<br />

received voting instructions on a matter from the<br />

customer <strong>and</strong> is barred from exercising discretionary<br />

authority to vote on the matter, which the broker<br />

indicates on the proxy.<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Proxy <strong>Regulation</strong><br />

Under <strong>Securities</strong> Exchange Act<br />

NYSE Rule 452 applies to stockholder meetings<br />

held on or after January 1, 2010<br />

Under the rule, brokers may vote a customer’s shares on<br />

any routine matter if the broker does not receive voting<br />

instructions at least 10 days prior to the election.<br />

However, election of directors, which was previously<br />

considered a routine matter if the election was<br />

uncontested, is no longer considered routine.<br />

Therefore, a broker is prohibited from voting a<br />

customer’s shares on uncontested director elections<br />

absent specific voting instructions from the customer.<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Proxy <strong>Regulation</strong><br />

Under <strong>Securities</strong> Exchange Act<br />

Rule 452 applies to all brokers registered with NYSE,<br />

regardless of whether the company holding the election is a<br />

NYSE listed company<br />

The impact on director elections may be significant.<br />

Disney’s 2004 Annual Meeting: 45% of votes cast on M.<br />

Eisner’s election were “withhold” votes. Without broker<br />

discretionary voting in Mr. Eisner’s favor, 54% of the<br />

votes cast would have been “withhold” votes.<br />

Majority vote campaigns<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Proxy <strong>Regulation</strong><br />

Under <strong>Securities</strong> Exchange Act<br />

What is difference between<br />

14a-2 // 14a-3, <strong>and</strong><br />

14c-2?<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Proxy <strong>Regulation</strong><br />

Under <strong>Securities</strong> Exchange Act<br />

How quickly can a company act<br />

following distribution of information<br />

statement?<br />

Rule 14c-2(b)<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Proxy <strong>Regulation</strong><br />

Under <strong>Securities</strong> Exchange Act<br />

Rule 14c-2(b) –<br />

Information statement shall be sent or given at<br />

least 20 calendar days prior to the meeting date<br />

or, in the case of corporate action taken<br />

pursuant to the consents or authorizations of<br />

security holders, at least 20 calendar days prior<br />

to the earliest date on which the corporate<br />

action may be taken.<br />

60 days for “Roll-ups”<br />

(c) 2013 Michael K. Krebs All Rights<br />

Reserved


Proxy <strong>Regulation</strong><br />

Under <strong>Securities</strong> Exchange Act<br />

Does a shareholder have recourse if a<br />

proxy statement is materially false or<br />

misleading?<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Proxy <strong>Regulation</strong><br />

Under <strong>Securities</strong> Exchange Act<br />

Rule 14a-9(a) – similar to Rule 10b-5<br />

Private right of action?<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Proxy <strong>Regulation</strong><br />

Under <strong>Securities</strong> Exchange Act<br />

What is definition of materiality?<br />

TSC Industries, Inc. v. Northway, Inc.<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Proxy <strong>Regulation</strong><br />

Under <strong>Securities</strong> Exchange Act<br />

Must a shareholder prove causation?<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Proxy <strong>Regulation</strong><br />

Under <strong>Securities</strong> Exchange Act<br />

Causation: Mills v. Electric Auto-Lite<br />

proxy solicitation – not the defect in<br />

the proxy materials – must be an<br />

“essential link” in the accomplishment<br />

of the transaction<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Proxy <strong>Regulation</strong><br />

Under <strong>Securities</strong> Exchange Act<br />

What are the tests?<br />

Cole (2 nd Circuit) compared to<br />

Virginia Bankshares (Supreme Court)<br />

Loss causation under §21D(b)(4)<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Proxy <strong>Regulation</strong><br />

Under <strong>Securities</strong> Exchange Act<br />

What degree of fault must be proved?<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Scienter<br />

vs.<br />

Proxy <strong>Regulation</strong><br />

Under <strong>Securities</strong> Exchange Act<br />

Negligence<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Session 8 Agenda<br />

Part 1<br />

Woe to be an insider of a reporting company<br />

Part 2<br />

Proxy Statement <strong>Regulation</strong><br />

Part 3<br />

<strong>Regulation</strong> of Foreign Private Issuers under <strong>Securities</strong> Act <strong>and</strong><br />

Exchange Act<br />

Part 4<br />

Comparative differences between U.S. securities law regime <strong>and</strong> that of<br />

UK, EU <strong>and</strong> Hong Kong<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Foreign Private Issuers –<br />

<strong>Securities</strong> Act <strong>Regulation</strong><br />

Same basic principle:<br />

Unless an exemption is available,<br />

Every offer or sale of a security [in the U.S., whether<br />

by a U.S. issuer or a foreign private issuer,] must be<br />

registered with the SEC under § 5 of the <strong>Securities</strong> Act,<br />

<strong>and</strong><br />

In the registration statement (which includes the<br />

prospectus), all information material to that investment<br />

decision must be disclosed.<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Foreign Private Issuers –<br />

<strong>Securities</strong> Act <strong>Regulation</strong> (cont’d)<br />

What exemptions are available?<br />

§ 4(2) <strong>and</strong> Private Placement Safe Harbors:<br />

Same exemptions, except Reg. A, which is<br />

available only for U.S. <strong>and</strong> Canadian issuers<br />

§ 4(1) <strong>and</strong> Resale Safe Harbors<br />

Reg. S, Rule 144A, Rule 144<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Foreign Private Issuers –<br />

<strong>Securities</strong> Act <strong>Regulation</strong> (cont’d)<br />

What about incidental offers/sales?<br />

Exemptions for Cross-<strong>Border</strong> Rights<br />

Offerings, Exchange Offers <strong>and</strong> Business<br />

Combinations<br />

Rules 800 et seq.<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Foreign Private Issuers –<br />

<strong>Securities</strong> Act <strong>Regulation</strong> (cont’d)<br />

Rules 800-802 – General Rules<br />

1. These rules exempt only the transaction in which the issuer or other person<br />

offers or sells the securities, not for the securities themselves. <strong>Securities</strong><br />

acquired in a Rule 801 or 802 transaction may be resold in the United States<br />

only if they are registered under the Act or an exemption from registration is<br />

available.<br />

2. Unregistered offers <strong>and</strong> sales made outside the United States will not affect<br />

contemporaneous offers <strong>and</strong> sales made in compliance with §230.801 or<br />

§230.802. A transaction that complies with §230.801 or §230.802 will not<br />

be integrated with offerings exempt under other provisions of the Act, even<br />

if both transactions occur at the same time.<br />

3. The rules do not affect the applicability of the anti-fraud, civil liability or<br />

other provisions of the federal securities laws.<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Rule 801 – Cross <strong>Border</strong><br />

Rights Offerings<br />

Rights offering by a foreign private issuer is exempt from Section 5 of the <strong>Securities</strong> Act if<br />

U.S. holders hold no more than 10 percent of the outst<strong>and</strong>ing class of securities that is the<br />

subject of the rights offering, <strong>and</strong> the other conditions of Rule 801 are satisfied, including<br />

Equal treatment of U.S. <strong>and</strong> foreign holders<br />

Information<br />

Any informational documents must be filed in English with the SEC<br />

Informational documents must be provided to U.S. holders in English on a<br />

comparable basis to that provided to security holders in the home jurisdiction.<br />

Eligibility of securities. The securities offered in the rights offering are equity securities<br />

of the same class as the securities held by the offerees in the United States directly or<br />

through American Depositary Receipts.<br />

Limitation on transferability of rights. The terms of the rights prohibit transfers of the<br />

rights by U.S. holders except in accordance with Reg. S<br />

Legends on information documents<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Rule 802 – Exchange Offers<br />

<strong>and</strong> Business Combinations<br />

Exchange offers <strong>and</strong> business combinations are exempt from Section 5 of the<br />

<strong>Securities</strong> Act if in the case of a business combination in which the securities are<br />

to be issued by a successor registrant, U.S. holders may hold no more than 10<br />

percent of the class of securities of the successor registrant, as if measured<br />

immediately after completion of the business combination, <strong>and</strong> the other<br />

conditions of Rule 802 are satisfied, including<br />

Equal treatment of U.S. <strong>and</strong> foreign holders<br />

Information<br />

Any informational documents must be filed in English with the SEC<br />

Informational documents must be provided to U.S. holders in English on a<br />

comparable basis to that provided to security holders in the home<br />

jurisdiction.<br />

Legends on disclosure documents<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Foreign Private Issuer<br />

Registration under <strong>Securities</strong> Act<br />

Forms:<br />

F-1, F-3, F-4 etc.<br />

Financial statements:<br />

U.S. GAAP<br />

IFRS<br />

Reconciliation to U.S. GAAP<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Foreign Private Issuer Registration<br />

under <strong>Securities</strong> Act (cont’d)<br />

More about financial statements:<br />

According to SEC staff comments in February 2011:<br />

Previously foreign companies would use home-country<br />

GAAP with a U.S. GAAP reconciliation.<br />

More recently, the SEC is seeing more U.S. GAAP<br />

filers in the foreign private issuer community – “a few<br />

hundred.”<br />

There are approximately 170 IFRS filers, <strong>and</strong> soon to<br />

be many more, as Canadians companies move to IFRS<br />

in 2012.<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Foreign Private Issuer Registration<br />

under <strong>Securities</strong> Act (cont’d)<br />

SEC Review:<br />

Office of International Corporate Finance<br />

Every foreign private issuer is in one of<br />

Corp Fin’s industry groups.<br />

The Office also reviews foreign<br />

governmental offerings<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Foreign Private Issuers –<br />

Exchange Act <strong>Regulation</strong><br />

§ 12 Registration <strong>and</strong> Rule 12g3-2<br />

Primary exemption for any foreign private issuer<br />

maintaining a listing of the subject class of<br />

securities on one or more exchanges in one or<br />

more foreign jurisdiction,<br />

Two separate tests.<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Foreign Private Issuers –<br />

Exchange Act <strong>Regulation</strong><br />

Rule 12g3-2(a)<br />

<strong>Securities</strong> of any class issued by any foreign private issuer are<br />

exempt from § 12(g) if the class has fewer than 300 holders<br />

resident in the U.S.<br />

<strong>Securities</strong> held of record by persons resident in the U.S. is<br />

determined as provided in Rule 12g5–1 except<br />

securities held of record by a broker, dealer, bank or nominee<br />

for any of them for the accounts of customers resident in the<br />

United States shall be counted as held in the United States by<br />

the number of separate accounts for which the securities are<br />

held.<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Foreign Private Issuers –<br />

Exchange Act <strong>Regulation</strong><br />

Rule 12g3-2(b)<br />

Exemption available where<br />

1. 55 percent or more of trading takes place<br />

outside of the U.S. <strong>and</strong> if traded on two or more<br />

foreign exchanges, at least must have greater<br />

volume in that security than in the U.S.<br />

2. Foreign private issuer satisfies certain<br />

information requirements.<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Foreign Private Issuers –<br />

Exchange Act <strong>Regulation</strong> (cont’d)<br />

Proxy Statement <strong>and</strong> Section 16 Exemptions<br />

Rule 3a12-3<br />

<strong>Securities</strong> for which the filing of registration statements<br />

on Form 18 are authorized shall be exempt from<br />

Sections 14 <strong>and</strong> 16 of the Exchange Act.<br />

<strong>Securities</strong> registered by a foreign private issuer are<br />

exempt from sections 14(a), 14(b), 14(c), 14(f) <strong>and</strong> 16<br />

of the Exchange Act.<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Foreign Private Issuers –<br />

Exchange Act <strong>Regulation</strong> (cont’d)<br />

Underst<strong>and</strong>ing ADRs<br />

The stocks of most foreign companies that trade in the U.S. markets<br />

are traded as American Depositary Receipts (ADRs) issued by U.S.<br />

depositary banks.<br />

Though a U.S. bank issues the ADRs by registering the ADRs on<br />

Form F-6, the foreign private issuer is responsible for Exchange Act<br />

compliance whether or not the ADR is a “sponsored” program.<br />

Exchange traded ADRs must be registered on Form 20-F.<br />

See Pre-Residency material online.<br />

See p. 201 of Soderquist.<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Underst<strong>and</strong>ing ADRs (cont’d)<br />

ADRs or ADSs?<br />

Sometimes the terms “ADR” <strong>and</strong> “ADS” (American<br />

Depositary Share) are used interchangeably.<br />

An ADR is actually the negotiable physical certificate that<br />

evidences ADSs (in much the same way a stock certificate<br />

evidences shares of stock), <strong>and</strong> an ADS is the security that<br />

represents an ownership interest in deposited securities (in<br />

much the same way a share of stock represents an ownership<br />

interest in the corporation).<br />

ADRs are the instruments actually traded in the market.<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Level I ADRs<br />

Level I ADRs - Traded in the U.S. over-the-counter (OTC) market (i.e., not on an<br />

exchange).<br />

To establish a Level I sponsored ADR program, the following three principal steps<br />

are required:<br />

1) The foreign private issuer must qualify for a Rule 12g3-2(b) exemption (see<br />

above);<br />

2) The foreign private issuer enters into a deposit agreement the depositary bank<br />

<strong>and</strong> the ADR holders that detail the rights <strong>and</strong> responsibilities of each party; <strong>and</strong><br />

3) The parties file a Form F-6 with the SEC to register the ADSs under the 1933<br />

Act.<br />

The Form F-6 is signed by the depositary bank, the issuer <strong>and</strong> its directors <strong>and</strong><br />

officers. Financial statements <strong>and</strong> a description of your business are not required to<br />

be included in a Form F-6 registration statement.<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Level II ADRs<br />

“Listing Facility”<br />

Level II ADR programs refer to a company listing its ADRs on a U.S.<br />

exchange.<br />

To qualify a foreign private issuer must comply with the registration <strong>and</strong><br />

reporting requirements of the Exchange Act as well the listing requirements<br />

of the relevant exchange.<br />

A foreign private issuer registers under § 12 of the Exchange Act by filing a<br />

Form 20-F. Annually the foreign private issuer updates its 20-F filing.<br />

The financial statements filed with the 20-F must either be prepared in<br />

accordance with U.S. GAAP or IFRS, or reconciled to U.S. GAAP.<br />

The financial statements must be audited in accordance with U.S. generally<br />

accepted auditing st<strong>and</strong>ards, <strong>and</strong> the auditor must comply with the U.S.<br />

st<strong>and</strong>ards for auditor independence.<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Level III ADRs<br />

“Offering Facility”<br />

Level III ADR programs refer to an ADR program used in connection with the<br />

raising of capital through a public offering of securities <strong>and</strong> contemporaneous listing<br />

on a U.S. exchange.<br />

Level III ADR programs require registration of the underlying shares <strong>and</strong> ADRs<br />

under the 1933 Act. The ADRs are registered on Form F-6; the underlying shares<br />

are registered on Form F-1.<br />

The foreign private issuer must register under § 12 of the Exchange Act by filing a<br />

Form 20-F. Annually the foreign private issuer updates its Form 20-F filing. The<br />

financial statements filed with the 20-F must either be prepared in accordance with<br />

U.S. GAAP or IFRS, or reconciled to U.S. GAAP. The financial statements must be<br />

audited in accordance with U.S. generally accepted auditing st<strong>and</strong>ards, <strong>and</strong> the<br />

auditor must comply with the U.S. st<strong>and</strong>ards for auditor independence.<br />

In addition, any material information given to shareholders in the home market,<br />

must be filed with the SEC through Form 6-K. See Rules 13a-16 <strong>and</strong> 15d-16.<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Form 6-K<br />

Filing required whenever the foreign private issuer:<br />

(i) makes or is required to make public pursuant to the law of the jurisdiction of its<br />

domicile or in which it is incorporated or organized, or<br />

(ii) files or is required to file with a stock exchange on which its securities are traded<br />

<strong>and</strong> which was made public by that exchange, or<br />

(iii) distributes or is required to distribute to its security holders.<br />

The information required to be furnished pursuant to (i), (ii) or (iii) above is that which is<br />

material with respect to the issuer <strong>and</strong> its subsidiaries concerning: changes in business;<br />

changes in management or control; acquisitions or dispositions of assets; bankruptcy or<br />

receivership; changes in registrant’s certifying accountants; the financial condition <strong>and</strong><br />

results of operations; material legal proceedings; changes in securities or in the security<br />

for registered securities; etc.<br />

The information <strong>and</strong> documents furnished in this report shall not be deemed to be “filed”<br />

for the purposes of Section 18 of the Act or otherwise subject to the liabilities of that<br />

section.<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Session 8 Agenda<br />

Part 1<br />

Woe to be an insider of a reporting company<br />

Part 2<br />

Proxy Statement <strong>Regulation</strong><br />

Part 3<br />

<strong>Regulation</strong> of Foreign Private Issuers under <strong>Securities</strong> Act <strong>and</strong><br />

Exchange Act<br />

Part 4<br />

Comparative differences between U.S. securities law regime <strong>and</strong><br />

that of UK, EU <strong>and</strong> Hong Kong<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Comparative Review<br />

U.S., U.K., EU & Hong Kong<br />

TO BE ADDED<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


U.S <strong>and</strong> <strong>Trans</strong>-<strong>Border</strong><br />

<strong>Securities</strong> <strong>Regulation</strong><br />

Boston University School of Law<br />

Executive LL.M. - International Business Law<br />

July/August 2013<br />

Michael Krebs<br />

JD, Boston University School of Law 1985<br />

Senior Partner, Nutter, McClennen & Fish, LLP, Boston, MA<br />

Tel. 616.439.2288 email: mkrebs@nutter.com<br />

© 2013 Michael K. Krebs<br />

All Rights Reserved


U.S <strong>and</strong> <strong>Trans</strong>-<strong>Border</strong><br />

<strong>Securities</strong> <strong>Regulation</strong><br />

Boston University School of Law<br />

Executive LL.M. in International Business Law<br />

Session 9 – July 31, 2013<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Session 9 Agenda<br />

Part 1<br />

Mergers <strong>and</strong> Acquisitions under the<br />

Exchange Act, including:<br />

Schedules 13D <strong>and</strong> 13G<br />

Tender Offers<br />

Going Private <strong>Trans</strong>actions<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Session 9 Agenda<br />

Part 2<br />

Rule 10b-5 Litigation<br />

Insider Trading Liability<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Mergers <strong>and</strong> Acquisitions under<br />

Exchange Act<br />

<strong>Securities</strong> Act vs. Exchange Act<br />

<strong>Securities</strong> Act: only business combinations<br />

that involve issuance of securities<br />

Exchange Act: most business combinations<br />

involving publicly traded companies, including<br />

Tender or Exchange Offers<br />

Mergers<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Mergers <strong>and</strong> Acquisitions under<br />

Exchange Act (cont’d)<br />

<strong>Regulation</strong> of Public Company Mergers<br />

Stockholder approval<br />

Section 14<br />

Schedule 14A, Item 14<br />

Cash deals v. stock deals<br />

<strong>Regulation</strong> M-A <strong>and</strong> Form S-4<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Mergers <strong>and</strong> Acquisitions under<br />

Exchange Act (cont’d)<br />

<strong>Regulation</strong> of Public Company Mergers<br />

Registration Statement on Form S-4<br />

Disclosure Issues<br />

S-1 Level Disclosure v. S-3 Level Disclosure<br />

SEC Review<br />

Timing Issues<br />

Prospectus Delivery<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Mergers <strong>and</strong> Acquisitions under<br />

Exchange Act (cont’d)<br />

<strong>Regulation</strong> of Public Company Mergers<br />

Shelf Registration<br />

Rule 415<br />

Must be S-3 eligible<br />

Acquisition does not require pro forma<br />

financial information<br />

Duty to update prospectus<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Mergers <strong>and</strong> Acquisitions under<br />

Exchange Act (cont’d)<br />

S-4 Merger Proxy Statement<br />

S-4 for acquiror<br />

Proxy Statement for target <strong>and</strong>/or acquiror<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Mergers <strong>and</strong> Acquisitions under<br />

Exchange Act (cont’d)<br />

Example: Proposed Acquisition of Pennichuck<br />

Philadelphia Suburban Corporation, a<br />

publicly traded water utility, enters into a<br />

definitive agreement to acquire Pennichuck<br />

Corporation, another publicly traded water<br />

utility, in exchange for PSC stock<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Mergers <strong>and</strong> Acquisitions under<br />

Exchange Act (cont’d)<br />

Philadelphia Suburban <strong>and</strong> Pennichuck<br />

execute Merger Agreement<br />

Merger Agreement provides that<br />

Pennichuck will merge into a newly<br />

formed subsidiary of Philadelphia<br />

Suburban, subject to approval of<br />

Pennichuck shareholders <strong>and</strong><br />

satisfaction of customary closing<br />

conditions<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Mergers <strong>and</strong> Acquisitions under<br />

Exchange Act (cont’d)<br />

As a result of the merger, all Pennichuck shares will be<br />

converted into shares of Philadelphia Suburban stock<br />

Philadelphia Suburban agrees to register shares with the<br />

SEC<br />

Pennichuck agrees to seek shareholder approval<br />

What SEC filing will Pennichuck need to make in<br />

order to solicit shareholder approval of the merger?<br />

What SEC filing will Philadelphia Suburban need to<br />

make in order to offer <strong>and</strong> sell its securities to<br />

Pennichuck shareholders?<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Mergers <strong>and</strong> Acquisitions under<br />

Exchange Act (cont’d)<br />

Philadelphia Suburban <strong>and</strong> Pennichuck file with<br />

SEC joint Form S-4 Merger Proxy Statement<br />

Level of disclosure: S-3 for Philadelphia<br />

Suburban<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Mergers <strong>and</strong> Acquisitions under<br />

Exchange Act (cont’d)<br />

Creeping Acquisitions, Tender Offers <strong>and</strong><br />

Exchange Offers<br />

Williams Act (1968) amends Exchange Act to close loop holes for open<br />

market purchases <strong>and</strong> tender offers<br />

Section 13(d): Acquisition of more than 5% beneficial ownership<br />

Schedule 13D – provides signal to market <strong>and</strong> issuer<br />

Short Form Schedule 13G – Institutional <strong>and</strong> other passive<br />

investors (until ownership equals or exceeds 20%)<br />

Beneficial Ownership – direct or indirect voting <strong>and</strong>/or<br />

investment power<br />

Section 13(d) “Group” – group for purposes of acquiring,<br />

holding or disposing issuer’s securities<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Mergers <strong>and</strong> Acquisitions under<br />

Exchange Act (cont’d)<br />

Example: Management Buy-Out of Uno<br />

Restaurant Company (UNO)<br />

Aaron Spencer, majority stockholder of Uno,<br />

<strong>and</strong> management team acquire Uno for cash<br />

through the merger of Uno into a new<br />

corporation owned by Spencer <strong>and</strong><br />

management team<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Mergers <strong>and</strong> Acquisitions under<br />

Exchange Act (cont’d)<br />

Aaron Spencer expresses interest in acquiring Uno from public<br />

shareholders, <strong>and</strong> Board of Uno forms Special Committee to consider<br />

offer <strong>and</strong> seek valuation of Uno<br />

Special Committee negotiates <strong>and</strong> enters into Merger Agreement with<br />

Spencer<br />

Merger Agreement provides that (contingent upon approval of a<br />

majority of the minority shareholders of Uno <strong>and</strong> satisfaction of<br />

conditions to closing, including financing) Uno will merge into a new<br />

corporation owned by Spencer <strong>and</strong> management team<br />

Minority Uno shareholders will receive cash in exchange for<br />

cancellation of Uno common stock<br />

Uno agrees to seek shareholder approval <strong>and</strong> files Merger Proxy<br />

Statement with SEC<br />

Uno, Spencer <strong>and</strong> management team file Schedule 13E-3 with SEC<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


UNITED STATES<br />

SECURITIES AND EXCHANGE COMMISSION<br />

Washington, D.C. 20549<br />

SCHEDULE 13D<br />

Under the <strong>Securities</strong> Exchange Act of 1934*<br />

(Amendment No. 6)<br />

Uno Restaurant Corporation<br />

(Name of Issuer)<br />

Common Stock, par value $.01 per share<br />

(Title of Class of <strong>Securities</strong>)<br />

914900-10-5<br />

(CUSIP Number)<br />

Constantine Alex<strong>and</strong>er, Esquire<br />

James E. Dawson, Esquire<br />

Nutter, McClennen & Fish, LLP<br />

One International Place<br />

Boston, MA 02110-2699<br />

(617) 439-2000<br />

(Name, Address <strong>and</strong> Telephone Number of Person Authorized to Receive Notices <strong>and</strong> Communications)<br />

February 28, 2001<br />

(Date of Event which Requires Filing of this Statement)<br />

If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the<br />

subject of this Schedule 13D, <strong>and</strong> is filing this schedule because of §§ 240.13d-1(b)(e), 240.13d-1(f) or<br />

240.13d-1(g), check the following box. G<br />

NOTE: Schedules filed in paper format shall include a signed original <strong>and</strong> five copies of the schedule,<br />

including all exhibits. See § 240.13d-7(b) for other parties to whom copies are to be sent.<br />

*The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with<br />

respect to the subject class of securities, <strong>and</strong> for any subsequent amendment containing information which<br />

would alter disclosures provided in a prior cover page.<br />

The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose<br />

of Section 18 of the <strong>Securities</strong> Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that<br />

section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).


Item 4. Purpose of <strong>Trans</strong>action.<br />

On October 25, 2000, the Reporting Persons submitted to a<br />

Special Committee of the Issuer’s Board of Directors a proposal to<br />

acquire all of the outst<strong>and</strong>ing shares of Common Stock currently not<br />

held by them. During the period from October 25, 2000 to February<br />

28, 2001, the Special Committee <strong>and</strong> the Reporting Persons <strong>and</strong> their<br />

respective advisors negotiated terms of a going private transaction for<br />

the Issuer by the Reporting Persons. On February 28, 2001, the Issuer<br />

announced that the Special Committee <strong>and</strong> the Reporting Persons<br />

reached a tentative agreement on the terms of the going private<br />

transaction at a price of $9.75 in cash for all shares of Common Stock<br />

not held by the Reporting Persons. The transaction will proceed as a<br />

merger <strong>and</strong> will be subject to execution of a definitive merger<br />

agreement, approval by the holders of a majority of the shares not<br />

owned or controlled by the Reporting Persons, receipt of financing <strong>and</strong><br />

customary closing conditions. The transaction has a value of<br />

approximately $41 million to the stockholders other than the Reporting<br />

Persons. The Reporting Persons beneficially own approximately 62%<br />

of the Issuer’s outst<strong>and</strong>ing shares of capital stock. The Reporting<br />

Persons have engaged the investment banking firm of Tucker Anthony<br />

to act as financial advisor in connection with the transaction.


Mergers <strong>and</strong> Acquisitions under<br />

Exchange Act (cont’d)<br />

<strong>Regulation</strong> of Tender Offers:<br />

Not Defined in Williams Act<br />

SEC generally applies 8 factor test:<br />

1. Broad solicitation of public shareholders<br />

2. Solicitation of substantial or controlling interest<br />

3. Terms are firm rather than negotiable<br />

4. Offer price provides premium to market price<br />

5. Offer contingent on tender of min. number of shares<br />

6. Solicitation provides deadline for tendering<br />

7. Offerees are subject to pressure to tender<br />

8. Solicitation is announced to the public<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Mergers <strong>and</strong> Acquisitions under<br />

Exchange Act (cont’d)<br />

<strong>Regulation</strong> of Tender Offers<br />

Tender Offer v. Exchange Offer<br />

Exchange Offer is a form of tender<br />

offer in which the type of consideration<br />

offered by bidder is securities rather<br />

than cash<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Mergers <strong>and</strong> Acquisitions under<br />

Exchange Act (cont’d)<br />

<strong>Regulation</strong> of Tender Offers<br />

REGULATION 14D v. REGULATION 14E<br />

Section 14(d): filing <strong>and</strong> disclosure<br />

requirements for tender offers for equity<br />

securities registered under Section 12 of<br />

the Exchange Act<br />

Section 14(e): anti-fraud provisions that<br />

apply to all tender offers<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Mergers <strong>and</strong> Acquisitions under<br />

Exchange Act (cont’d)<br />

<strong>Regulation</strong> of Tender Offers<br />

Section 14(d)(1) prohibits tender offer for<br />

equity securities registered under Section 12<br />

If after tender offer, person would be direct or<br />

indirect beneficial owner of more than 5% of equity<br />

securities<br />

Unless at the time of offer person has filed<br />

statement with SEC in accordance with SEC rules<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Mergers <strong>and</strong> Acquisitions under<br />

Exchange Act (cont’d)<br />

<strong>Regulation</strong> of Tender Offers<br />

Schedule TO – Tender Offer Statement<br />

Offer to Purchase vs. Schedule TO<br />

Dissemination requirement<br />

No SEC review prior to mailing<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Mergers <strong>and</strong> Acquisitions under<br />

Exchange Act (cont’d)<br />

Schedule TO incorporates requirements from Reg. M-A<br />

Summary terms sheet (Item 1001 of Reg M-A)<br />

Subject company information (Item 1002 of Reg M-A)<br />

Background about target <strong>and</strong> bidder (Item 1003 of Reg M-A)<br />

Terms of the transaction (Item 1004 of Reg M-A)<br />

Past contacts, transactions, negotiations <strong>and</strong> agreements (Item 1005<br />

of Reg M-A)<br />

Purpose of the transaction <strong>and</strong> plans or proposals (Item 1006 of Reg<br />

M-A)<br />

Sources <strong>and</strong> amount of funds (Item 1007 of Reg M-A)<br />

Interests in subject company securities (Item 1008 of Reg M-A)<br />

Persons retained or compensated (Item 1009 of Reg M-A)<br />

Financial Statements (Item 1010 of Reg M-A)<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Mergers <strong>and</strong> Acquisitions under<br />

Exchange Act (cont’d)<br />

<strong>Regulation</strong> of Tender Offers<br />

Material Changes <strong>and</strong> Extension of Offer<br />

Withdrawal Rights<br />

Pro Rata Purchase of Shares<br />

Equal Treatment of Stockholders<br />

Subsequent Offering Period<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Mergers <strong>and</strong> Acquisitions under<br />

Exchange Act (cont’d)<br />

<strong>Regulation</strong> of Tender Offers<br />

Recommendation of Target Company<br />

Rule 14D-9: applies to recommendations by<br />

directors, officers, affiliates <strong>and</strong> subsidiaries<br />

Rule 14e-2: requires target to take a position<br />

within 10 business days<br />

“Stop, look <strong>and</strong> listen” press release<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Mergers <strong>and</strong> Acquisitions under<br />

Exchange Act (cont’d)<br />

Example: Chartwell Acquisition of Carey<br />

International<br />

Chartwell Investments, a private equity<br />

firm, <strong>and</strong> senior management of Carey<br />

International acquire Carey International<br />

through a cash tender offer made to holders<br />

of publicly traded shares<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Mergers <strong>and</strong> Acquisitions under<br />

Exchange Act (cont’d)<br />

Chartwell <strong>and</strong> Carey International Management propose<br />

cash tender offer for all of the outst<strong>and</strong>ing stock of Carey<br />

to Special Committee of Board of Carey<br />

Tender offer is not hostile -- Chartwell chooses to<br />

negotiate tender offer terms with Special Committee<br />

Carey <strong>and</strong> Chartwell enter into acquisition agreement in<br />

which Chartwell agrees to make tender offer at fixed price<br />

<strong>and</strong> Carey agrees to recommend that shareholders<br />

accept tender offer<br />

Bidders <strong>and</strong> Carey put out “stop look <strong>and</strong> listen” press<br />

release regarding agreement<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


CAREY INTERNATIONAL TO BE ACQUIRED BY AN<br />

AFFILIATE OF CHARTWELL AND FORD FOR $18.25 PER SHARE<br />

Washington, D.C. – July 19, 2000 – Carey International, Inc. (Nasdaq:CARY), the world’s<br />

largest chauffeured vehicle services company, announced today that it has entered into a definitive<br />

agreement <strong>and</strong> plan of merger with an entity affiliated with both Chartwell Investments II, LLC, a New<br />

York private-equity firm, <strong>and</strong> Ford Motor Company. The Company’s Board of Directors, with a<br />

recommendation of a special committee comprised of outside directors, unanimously approved the<br />

transaction that provides for the acquisition of all outst<strong>and</strong>ing shares of Carey International stock for<br />

$18.25 per share in cash.<br />

The transaction is structured as a joint tender offer, that will commence within approximately<br />

two weeks, followed by a merger. Consummation of the transaction is subject to certain conditions,<br />

including the tender of at least 50.1 percent of the Company’s outst<strong>and</strong>ing shares <strong>and</strong> the satisfaction of<br />

customary conditions. The Company expects that the transaction will be consummated by the end of<br />

August. Of the $300 million in total financing that will be required to fund the transaction, $100<br />

million will be in equity.<br />

***<br />

This press release is intended for informational purposes only <strong>and</strong> is not an offer to buy or<br />

the solicitation of an offer to sell any shares of Carey International common stock. The<br />

solicitation of offers to sell Carey International’s common stock will only be made pursuant to the<br />

offer to purchase <strong>and</strong> related materials that will be sent out to Carey International’s stockholders<br />

shortly. Stockholders should read those materials carefully because they will contain important<br />

information, including the various terms <strong>and</strong> conditions of the offer. The tender offer documents<br />

(including the offer to purchase, the related letter of transmittal <strong>and</strong> all other offer documents to<br />

be filed with the <strong>Securities</strong> <strong>and</strong> Exchange Commission) will also be available for free at the<br />

Commission’s Web site at www.sec.gov.


Mergers <strong>and</strong> Acquisitions under<br />

Exchange Act (cont’d)<br />

Reasons for Tender Offer v. Merger<br />

Carey <strong>Trans</strong>action<br />

compared to<br />

Uno <strong>Trans</strong>action<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Mergers <strong>and</strong> Acquisitions under<br />

Exchange Act (cont’d)<br />

<strong>Regulation</strong> of Tender Offers<br />

<strong>Regulation</strong> 14E: Unlawful Tender Offer Practices<br />

Minimum offer period of 20 days <strong>and</strong> 10 days after material<br />

change<br />

Public notice of extension of tender offer<br />

Purchase of securities on the basis of nonpublic information<br />

about tender offer prohibited<br />

Prohibits short tendering <strong>and</strong> hedging tenders<br />

Prohibits purchases outside of tender offer<br />

Prohibits announcement of offer without intent to commence<br />

Recall Rule 14e-2 – position of target<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Mergers <strong>and</strong> Acquisitions under<br />

Exchange Act (cont’d)<br />

<strong>Regulation</strong> of Issuer Tender Offers<br />

Issuer Tender Offers<br />

Rule 13e-4 <strong>Trans</strong>action<br />

Disclosure requirements are similar to third party<br />

tender offers<br />

Going Private <strong>Trans</strong>actions<br />

Rule 13e-3 <strong>Trans</strong>action<br />

Schedule 13E-3: statement re: fairness of transaction<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Rule 13E-4 <strong>Trans</strong>action: Option<br />

Exchange – Microsoft Experience<br />

In October 2003, Microsoft proposed to establish a stock<br />

option transfer program for compensatory purposes to<br />

enable Microsoft employees to realize some value for their<br />

"out of the money" employee stock options.<br />

"Eligible Options" are options that were granted under<br />

certain Microsoft compensatory benefit plans for<br />

employees, had an exercise price per share ≥ $33.00 <strong>and</strong><br />

had an expiration date on or after February 29, 2004.<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Rule 13E-4 <strong>Trans</strong>action: Option Exchange<br />

– Microsoft Experience (cont’d)<br />

In requesting a no-action letter from Corp Fin,<br />

Microsoft conceded that the program is subject to<br />

those rules relating to issuer tender offers under Rule<br />

13e-4.<br />

Microsoft argued that its program was very similar to<br />

those previously addressed by the Corp Fin in the<br />

context of employee stock option exchange offers<br />

<strong>and</strong> issuer share repurchase programs for<br />

employee-owned stock.<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Rule 13E-4 <strong>Trans</strong>action: Option Exchange<br />

– Microsoft Experience (cont’d)<br />

One of the tender offer issues presented by the Microsoft<br />

program was compliance with the “all holders” requirement<br />

of Rule 13e-4(f)(8)(i), because the Program excludes (i)<br />

options issued under non-qualifying option plans, options with<br />

exercise prices < $33.00 <strong>and</strong> options with expiration dates<br />

earlier than February 29, 2004, (ii) options held by certain<br />

employees who do not meet continued employment criteria,<br />

(iii) options held by persons other than employees, including<br />

directors, advisors <strong>and</strong> consultants of Microsoft <strong>and</strong> (iv)<br />

options held by employees who are employed in certain foreign<br />

jurisdictions.<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Rule 13E-4 <strong>Trans</strong>action: Option Exchange<br />

– Microsoft Experience (cont’d)<br />

The SEC granted an exemption from Rule 13e-<br />

4(f)(8)(i) to permit Microsoft to exclude certain<br />

options <strong>and</strong> certain option holders.<br />

* * *<br />

Be mindful of complicated tender offer<br />

compliance issues with option repurchases <strong>and</strong><br />

exchange offers<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Mergers <strong>and</strong> Acquisitions under<br />

Exchange Act (cont’d)<br />

Rule 13E-3 <strong>Trans</strong>action:<br />

Key factors:<br />

Triggering <strong>Trans</strong>action<br />

Triggering Effect<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Mergers <strong>and</strong> Acquisitions under<br />

Exchange Act (cont’d)<br />

Rule 13E-3 Triggering <strong>Trans</strong>actions:<br />

purchase of security,<br />

tender offer,<br />

shareholder solicitation,<br />

sale of substantially all of assets,<br />

reverse stock split<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Mergers <strong>and</strong> Acquisitions under<br />

Exchange Act (cont’d)<br />

Rule 13E-3 Triggering Effect:<br />

Causes fewer than 300 record<br />

shareholders<br />

Causes delisting from an exchange (i.e.,<br />

NYSE, NASDAQ)<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Mergers <strong>and</strong> Acquisitions under<br />

Exchange Act (cont’d)<br />

Example: Carey Tender Offer Cont’d<br />

Carey, Chartwell, Management <strong>and</strong> Financing Sources all<br />

considered “Bidders”<br />

Bidders file Schedule TO <strong>and</strong> mail Offer to Purchase to<br />

stockholders<br />

Bidders file Schedule 13E-3<br />

Carey files Schedule 14D-9<br />

Shareholders tender shares in excess of 90% of outst<strong>and</strong>ing<br />

Bidders close tender offer <strong>and</strong> shareholders receive cash for<br />

shares tendered<br />

Carey’s common stock ceases to be traded on NASDAQ<br />

Carey merges into new corporation owned by Bidders<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Mergers <strong>and</strong> Acquisitions under<br />

Exchange Act (cont’d)<br />

Other Rule 13E-4 Considerations:<br />

“Best Price Rule” <strong>and</strong> Management Group<br />

Participation<br />

In 2006 the SEC amended the issuer <strong>and</strong> third-party best-price<br />

rules so that consideration offered <strong>and</strong> paid pursuant to<br />

employment compensation, severance or other employee<br />

benefit arrangements that are entered into with security holders<br />

of the subject company <strong>and</strong> that meet certain substantive<br />

requirements are not prohibited by the best-price rules<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Schedule 13D<br />

Treatment of Derivatives<br />

Under Rule 13d-3(d)(1)(i), beneficial ownership exists<br />

when a derivative gives a person (i) voting or<br />

investment power over the underlying security or (ii)<br />

the right to acquire the underlying security within 60<br />

days or the person holds such right to acquire with the<br />

purpose of changing or influencing control.<br />

Additionally, under anti-evasion prong included in<br />

Rule 13d-3(b), beneficial ownership is deemed to exist<br />

if a derivative is used as part of a plan or scheme to<br />

evade beneficial ownership reporting requirements.<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Schedule 13D<br />

Treatment of Derivatives (cont’d)<br />

The SEC, in a broad-ranging “Concept Release”<br />

issued in July 2010, acknowledged that its staff is<br />

in the process of reviewing current disclosure<br />

requirements relating to holdings of financial<br />

instruments, including short sale positions <strong>and</strong><br />

derivatives positions often utilized by activist<br />

investors to magnify their economic return.<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Schedule 13D<br />

Recent Developments<br />

1. Beware of “boilerplate” disclosure<br />

Tracinda, an investment fund controlled by Kirk Kerkorian, owned 9.9%<br />

of GM stock prior to its bankruptcy.<br />

Tracinda owned ~ 28.0 million shares but it could sell only 14.0 million<br />

at the price it wanted.<br />

In its 13D amendment for the sale of the 14.0 million shares, Tracinda<br />

included boilerplate disclosure that said, "We may sell additional shares,<br />

but we may also acquire additional shares." The SEC took the position,<br />

upon its investigation, that there was enough evidence to say, "No, you<br />

had a plan to sell all your shares. It was highly unlikely you would<br />

have acquired additional shares. So that disclosure wasn't good<br />

enough. You should have fully disclosed that your intent <strong>and</strong> your<br />

plan were to sell all of your holdings."<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Schedule 13D<br />

Recent Developments (cont’d)<br />

2. Can 13D disclosures go too far <strong>and</strong> constitute a proxy<br />

solicitation necessitating the filing of proxy materials?<br />

Yes. The analysis is whether the information was included<br />

only to comply with Schedule 13D disclosure rules. Of<br />

course, if it is a solicitation, you have to look at whether you<br />

have an exemption for the proxy rules.<br />

In recent years investors who are hesitant to be active but<br />

want to get their point across have used 13D as the<br />

megaphone.<br />

When the 13D starts sounding like a pitch in a sales piece, it<br />

starts sounding like a solicitation.<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Schedule 13D<br />

Recent Developments (cont’d)<br />

3. When does an affiliated person (thinking of taking a<br />

company private) need to amend their 13D?<br />

When buying shares in the open market?<br />

When retaining an investment banker to explore the<br />

possibility of taking the company private?<br />

When lining up financing for the potential transaction?<br />

When discussing with the board the possibility of taking<br />

the company private?<br />

Or only subsequently when they have actually<br />

"determined" to take the company private?<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Schedule 13D<br />

Recent Developments (cont’d)<br />

3. When does an affiliated person (thinking of taking a<br />

company private) need to amend their 13D? (cont’d)<br />

The Staff's interpretation says that a security holder is<br />

required to promptly amend its 13D to disclose the material<br />

change in the information appearing when it has<br />

“determined” to pursue a plan that would or could<br />

result in a delisting or deregistration of this company's<br />

securities.<br />

The SEC’s Office of Mergers <strong>and</strong> Acquisitions focuses on<br />

the word "determine." When does that person determine to<br />

do something?<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Schedule 13D<br />

Recent Developments (cont’d)<br />

4. Is there a “private right of action” for damages<br />

for a material false or misleading 13D or 13G<br />

filing?<br />

Section 13(d) does not explicitly provide a private<br />

right of action.<br />

Courts of Appeals have found an implied private<br />

right of action for both issuers <strong>and</strong> shareholders to<br />

bring claims for injunctive relief.<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Schedule 13D<br />

Recent Developments (cont’d)<br />

4. Is there a “private right of action” for damages for a<br />

material false or misleading 13D or 13G filing? (cont’d)<br />

2 nd Circuit has ruled that Section 13(d) also permits a tender<br />

offeror to bring a claim for injunctive relief. The court reasoned<br />

that there is no principled basis not to support a private right of<br />

action for tender offerors seeking solely injunctive relief while<br />

finding that shareholders <strong>and</strong> the issuer have such st<strong>and</strong>ing.<br />

No federal court has granted a private right of action for a<br />

damage claim. However, a Delaware state court judge has<br />

permitted a state law fraud claim based upon materially false or<br />

misleading 13Ds <strong>and</strong> 13Gs.<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Session 9 Agenda<br />

Part 2<br />

Rule 10b-5 Litigation<br />

Insider Trading Liability<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Rule 10b-5 <strong>and</strong> Related Matters<br />

Basic elements:<br />

False or misleading statement with<br />

respect to a material fact<br />

TSC Industries v. Northway<br />

“In connection with” the purchase or<br />

sale of a security<br />

includes “fraud on the market”<br />

“Scienter” – Culpability<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Rule 10b-5 <strong>and</strong> Related Matters<br />

Basic elements (cont’d):<br />

“Recklessness”<br />

Conduct that is "highly unreasonable,<br />

representing an extreme departure<br />

from the st<strong>and</strong>ards of ordinary care.”<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Rule 10b-5 <strong>and</strong> Related Matters<br />

Primarily five scenarios:<br />

misleading statement<br />

silence when duty to disclose<br />

insider trading<br />

selective disclosure – “tipping”<br />

inappropriate behavior “in connection<br />

with” sale of securities<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Rule 10b-5 <strong>and</strong> Related Matters<br />

Private Right of Action<br />

Kardon v. National Gypsum<br />

Section 21D – heightened pleading<br />

Private Litigation Reform Act of<br />

1995<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Rule 10b-5 <strong>and</strong> Related Matters<br />

Liability for misleading statements<br />

Texas Gulf Sulfur<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Rule 10b-5 <strong>and</strong> Related Matters<br />

Insider trading<br />

Not “anyone in possession of<br />

material non-public information”<br />

Scope of liability for tippees<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Rule 10b-5: Basic Elements<br />

False or misleading statement with<br />

respect to a material fact<br />

“In connection with” purchase or<br />

sale of security<br />

Reliance<br />

Loss causation<br />

“Scienter”<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Rule 10b-5: “In connection with . . .”<br />

If claim is based upon public statement,<br />

plaintiff must prove that the statement was<br />

material; <strong>and</strong><br />

disseminated in a medium upon which<br />

an investor would presumably rely.<br />

It is irrelevant that statement was not<br />

intended to influence the securities market.<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Rule 10b-5: “In connection with . . .”<br />

What if claim is NOT based upon<br />

public statement?<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Rule 10b-5: “In connection with . . .”<br />

Superintendent of Insurance (S. Ct. 1971):<br />

10b-5 claim found to be “in connection<br />

with . . .” where issuer of bonds suffered<br />

financial harm as a result of deceptive<br />

practices having a nexus with or<br />

“touching” its sale of bonds to investors<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Rule 10b-5: “In connection with . . .”<br />

Zanford (S. Ct. 2002):<br />

Broker sells securities <strong>and</strong> steals proceeds.<br />

Court finds 10b-5 claim because “it is enough<br />

that scheme to defraud <strong>and</strong> sale of securities<br />

coincide.”<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Rule 10b-5: “In connection with . . .”<br />

Ketchum (3 rd Cir. 1977):<br />

Court found dispute was an internal corporate<br />

conflict, not securities fraud, even though a<br />

consequence of the allegedly wrongful conduct<br />

was that plaintiff was required to sell stock under<br />

a pre-existing stockholder agreement.<br />

The real purpose of the internal maneuvers was<br />

to remove plaintiffs as officers <strong>and</strong> employees.<br />

Sale of stock triggered by removal was incidental.<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Rule 10b-5: “In connection with . . .”<br />

Santa Fe (S. Ct. 1977):<br />

Short-form merger under Delaware law (i.e.,<br />

cash out merger without shareholder vote)<br />

Court ruled that no 10b-5 claim exists if<br />

allegation is based solely upon a claim involving<br />

breach of a fiduciary duty under state corporate<br />

law that does not involve shareholder action in<br />

reliance upon a on material misrepresentation or<br />

material omission.<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Rule 10b-5: “In connection with . . .”<br />

Brown (5 th Cir. 1981):<br />

Allegation that defendants fraudulently induced plaintiff<br />

to enter into 1979 agreement that required plaintiff to sell<br />

stock to corporation if plaintiff were no longer employed<br />

by corporation<br />

Defendants misrepresented reason for new agreement<br />

<strong>and</strong> intent to terminate plaintiff<br />

Court concluded that 10b-5 claim existed because sale of<br />

security (pursuant to the new agreement) was “in<br />

connection with” the fraudulent inducement<br />

Compare with Ketchum<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Compare:<br />

Rule 10b-5: “Reliance . . .”<br />

Failure to Disclose<br />

Fraud on the Market<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Rule 10b-5: “Reliance . . .”<br />

“Failure to Disclose”<br />

Reliance not required<br />

Plaintiff must show<br />

Obligation to disclose<br />

Withholding of material fact<br />

Rule 10b-5 liability may exist whether<br />

counterparty to purchase or sale is known<br />

(Affiliate Ute) or anonymous (Shapiro)<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Rule 10b-5: “Reliance . . .”<br />

“Fraud on the Market”<br />

Purchaser of stock on market is<br />

presumed to rely generally on valid<br />

market price <strong>and</strong> indirectly on all<br />

material representations made by a<br />

company, including those in its SEC<br />

filings<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Rule 10b-5: “Reliance . . .”<br />

“Fraud on the Market”<br />

Basic v. Levinson (S. Ct. 1988)<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Rule 10b-5: “Reliance . . .”<br />

“Fraud on the Market”<br />

Basic v. Levinson (S. Ct. 1988)<br />

"The fraud on the market theory is based on the hypothesis<br />

that, in an open <strong>and</strong> developed securities market, the price of a<br />

company's stock is determined by the available material<br />

information regarding the company <strong>and</strong> its business. . . .<br />

Misleading statements will therefore defraud purchasers of<br />

stock even if the purchasers do not directly rely on the<br />

misstatements. . . . The causal connection between the<br />

defendants' fraud <strong>and</strong> the plaintiffs' purchase of stock in such<br />

a case is no less significant than in a case of direct reliance on<br />

misrepresentations."<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Rule 10b-5: “Reliance . . .”<br />

“Fraud on the Market”<br />

Basic v. Levinson (S. Ct. 1988) (cont’d)<br />

An investor's reliance on any public material<br />

misrepresentations may be presumed for<br />

purposes of a Rule 10b-5 action, because most<br />

publicly available information is reflected in<br />

market price.<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Rule 10b-5: “Reliance . . .”<br />

“Fraud on the Market”<br />

Basic v. Levinson (S. Ct. 1988) (cont’d)<br />

Any showing that severs the link between the alleged misrepresentation <strong>and</strong><br />

either the price received (or paid) by the plaintiff, or his decision to trade at a<br />

fair market price, will be sufficient to rebut the presumption of reliance.<br />

For example, the causal connection could be broken in Basic:<br />

if petitioners could show that the "market makers" were privy to the<br />

truth about the merger discussions here with Combustion, <strong>and</strong> thus that<br />

the market price would not have been affected by their<br />

misrepresentation; or<br />

if news of the merger discussions credibly entered the market <strong>and</strong><br />

dissipated the effects of the misstatements.<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Rule 10b-5: “Loss Causation . . .”<br />

“Loss Causation” - Section 21D(b)(4)<br />

In any private action arising under this title,<br />

plaintiff shall have the burden of proving<br />

that the act or omission of defendant<br />

alleged to violate this title caused the loss for<br />

which the plaintiff seeks to recover<br />

damages.<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


“Loss Causation . . .” (cont’d)<br />

Reliance <strong>and</strong> loss causation are wholly independent<br />

elements of a Section 10(b) claim.<br />

Fraud-on-the-market theory of reliance focuses on material<br />

misrepresentations that permeate an efficient market <strong>and</strong><br />

thereby affect all purchasers <strong>and</strong> sellers.<br />

“Loss causation, by contrast, requires a plaintiff to show<br />

that a misrepresentation that affected the integrity of the<br />

market price also caused a subsequent economic loss.”<br />

Erica P. John Fund, Inc. v. Halliburton Co., 131 S. Ct. 2179<br />

(2011)<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Rule 10b-5: “Purchaser/Seller . . .”<br />

General principle:<br />

Private plaintiff must be<br />

Purchaser or Seller<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Rule 10b-5: “Purchaser/Seller . . .”<br />

Blue Chip Stamps (S. Ct. 1975):<br />

Plaintiff alleged that defendant had intentionally caused<br />

prospectus to include material statements that were<br />

overly pessimistic about company’s prospects, because<br />

defendant wanted to discourage purchase of stock that<br />

defendant was required to offer as part of a settlement.<br />

Plaintiff did not purchase stock. S. Ct. ruled: without a<br />

purchase (or sale), there is no 10b-5 claim!<br />

Very important principle, though very uncommon facts.<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Rule 10b-5: “Purchaser/Seller . . .”<br />

Rubin v. U.S. (S. Ct. 1981):<br />

A pledge of stock constitutes a sale for purposes of 10b-5<br />

Pledgor is seller.<br />

Pledgee is purchaser<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Rule 10b-5: “Scienter or Fault”<br />

Hochfelder (S. Ct. 1976) <strong>and</strong> subsequent<br />

cases:<br />

Mere negligence is not enough<br />

Must prove intent (or recklessness??)<br />

Even SEC must show intent or recklessness<br />

Case law affected by subsequent statutory<br />

changes<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Rule 10b-5: “Scienter or Fault”<br />

Statutory Developments:<br />

Private <strong>Securities</strong> Litigation Reform Act of 1995<br />

(“PSLRA”)<br />

Plaintiff’s complaint must state “with<br />

particularity facts giving rise to a strong<br />

inference” that defendant acted with intent or<br />

recklessness (Section 21D(b)(2) of Exchange Act)<br />

<strong>Securities</strong> Litigation St<strong>and</strong>ards Act of 1998<br />

Class actions involving publicly traded<br />

companies must be brought in federal court<br />

(Section 28(f) of Exchange Act)<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Rule 10b-5: Recklessness?<br />

Post-PSLRA – Cases Split<br />

Supreme Court has not definitively addressed after the<br />

adoption of the PSLRA.<br />

2 nd Circuit – Plaintiff may plead scienter by alleging facts<br />

showing conscious misbehavior or recklessness – a<br />

st<strong>and</strong>ard requiring, “at the least, conduct which is highly<br />

unreasonable <strong>and</strong> which represents an extreme departure<br />

from the st<strong>and</strong>ards of ordinary care to the extent that the<br />

danger was either known to the defendant or so obvious that<br />

the defendant must have been aware of it.”<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Rule 10b-5: Recklessness?<br />

Post-PSLRA – Cases Split<br />

9 th Circuit – “Congress intended to elevate the pleading<br />

requirement above the 2 nd Circuit st<strong>and</strong>ard . . . .”<br />

Put simply, in a securities class action, “the plaintiffs must<br />

show that defendants engaged in ‘knowing’ or ‘intentional’<br />

conduct . . . . [R]eckless conduct can also meet this<br />

st<strong>and</strong>ard ‘to the extent that it reflects some degree of<br />

intentional or conscious misconduct,’ or what we have<br />

called ‘deliberate recklessness.’”<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Rule 10b-5: Recent Developments<br />

Recent Statutory <strong>and</strong> Regulatory Developments:<br />

Section 20A of Exchange Act<br />

Rule 10b5-2<br />

Rule 10b5-1<br />

Rule 14e-3<br />

Sections 804 <strong>and</strong> 807 of Sarbanes-Oxley Act<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Rule 10b-5: Recent Developments<br />

Section 20A of Exchange Act<br />

Rule 10b5-2<br />

Person civilly liable to anyone who<br />

“contemporaneously” trades<br />

Presumption regarding relationship of<br />

trust <strong>and</strong> confidence<br />

Non-exclusive!<br />

But consider Mark Cuban case.<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Rule 10b-5: Recent Developments<br />

Section 20A of Exchange Act<br />

Any person who violates [Rule 10b-5, etc.] by<br />

purchasing or selling a security while in possession of<br />

material, nonpublic information shall be liable . . . to<br />

any person who, contemporaneously with the<br />

purchase or sale of securities that is the subject of<br />

such violation, has purchased (where such violation is<br />

based on a sale of securities) or sold (where such<br />

violation is based on a purchase of securities)<br />

securities of the same class.<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Rule 10b-5: Recent Developments<br />

Rule 10b5-1<br />

Rule 14e-3<br />

Presumption regarding “use” of material<br />

non-public information<br />

Refer to Session 8 for more discussion<br />

of so-called “Rule 10b5-1 plans”<br />

Liability for insider trading in tender offer<br />

context; no nexus to “fiduciary duty” to<br />

issuer required<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Rule 10b-5: Recent Developments<br />

Sarbanes-Oxley<br />

Section 804<br />

Statute of Limitation: 2 years/5 years<br />

When does the limitations period begin to<br />

run?<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Rule 10b-5: Statute of Limitations<br />

When does the limitations period begin to run?<br />

Following the enactment of the Sarbanes Oxley Act, the general rule<br />

is that a securities fraud complaint is timely if filed no more than “2<br />

years after the discovery of the facts constituting the violation” or 5<br />

years after the violation.<br />

In Merck & Co., Inc. v. Reynolds, S. Ct. (April 27, 2010), the<br />

Supreme Court addressed what constitutes “discovery.”<br />

The Court unanimously held that a 10b-5 cause of action accrues<br />

“(1)when the plaintiff did in fact discover, or (2) when a<br />

reasonably diligent plaintiff would have discovered, “the facts<br />

constituting the violation”—whichever comes first.<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Rule 10b-5: Statute of Limitations<br />

Merck & Co., Inc. v. Reynolds, S. Ct. (April 27, 2010) (cont’d)<br />

The Court also held that the “facts constituting the violation” include the fact of scienter,<br />

“a mental state embracing intent to deceive, manipulate, or defraud.” In other words,<br />

the limitations period does not begin to run until the plaintiff discovers or a reasonably<br />

diligent plaintiff would have discovered “the facts constituting the violation,” including<br />

scienter—irrespective of whether the actual plaintiff undertook a reasonably diligent<br />

investigation.<br />

The Court acknowledged that “one might read the statutory words ‘after the discovery of<br />

the facts constituting the violation’ as referring to the time a plaintiff actually discovered<br />

the relevant facts. But in the statute of limitations context, the word ‘discovery’ is often<br />

used as a term of art in connection with the ‘discovery rule,’ a doctrine that delays<br />

accrual of a cause of action until the plaintiff has ‘discovered’ it” (emphasis added). The<br />

Court concluded that “[g]iven the history <strong>and</strong> precedent surrounding the use of the word<br />

‘discovery’ in the [statute of] limitations context generally as well as in this provision in<br />

particular, . . . [w]e . . . hold that “discovery” as used in this statute encompasses not only<br />

those facts the plaintiff actually knew, but also those facts a reasonably diligent plaintiff<br />

would have known” (emphasis added).<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Rule 10b-5: Issuer Duty to Disclose<br />

Affirmative Duty to Disclose in SEC Filings<br />

MD&A, Reg. FD<br />

Historical Statement – Duty to Correct<br />

Forward Looking Statement – Duty to<br />

Update?<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Rule 10b-5: Issuer Duty to Update<br />

vs. Duty to Correct<br />

Historical Statement – Duty to Correct<br />

Was statement incorrect when report was filed?<br />

Forward Looking Statement – Duty to Update?<br />

Compare<br />

Stansky v. Cummins Engine (7 th Cir. 1995)<br />

with<br />

Weiner v. Quaker Oats (3 rd Cir. 1997)<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Rule 10b-5: Issuer Duty to Disclose<br />

Role of “No Comment”<br />

Basic v. Levinson (S. Ct. 1988)<br />

“Functional equivalent of silence”<br />

Very important principle<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Session 9 – Rule 10b-5<br />

Study Problem 9.1<br />

Farmer’s Cooperative Corp. (Co-op) helps area farmers finance their farming<br />

operations <strong>and</strong> offers various farming outreach programs. Three years ago the Coop’s<br />

manager, Bill Uppin, started his own company, called Uppin Flames, Inc., to<br />

build <strong>and</strong> operate a gasohol plant that would convert corn into fuel. To fund the<br />

company’s expansion Uppin approached the Co-op board for a loan. The board<br />

approved $2 million in unsecured, low-interest loans by the Co-op to Uppin Flames,<br />

for which Uppin gave personal guarantees.<br />

Problems at the plant developed, causing Uppin Flames to approach<br />

insolvency. Uppin contrived a scheme to sell Uppin Flames to the Co-op in order to<br />

escape his personal guarantees. Uppin, with the help of complicit members of the<br />

Co-op board, convinced the rest of the Co-op board that, while having difficulty<br />

servicing its debt in the short term, Uppin Flames was on the verge of tremendous<br />

growth <strong>and</strong> would be a prudent investment. The Co-op board approved a transaction<br />

whereby the Co-op acquired the stock of Uppin Flames in return for debt<br />

forgiveness, <strong>and</strong> Bill Uppin was relieved of $2 million in personal guarantees.<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Session 9 – Rule 10b-5<br />

Study Problem 9.1 (continued)<br />

The “acquisition” of Uppin Flames, Inc. proved disastrous for the Coop.<br />

Within two years after the acquisition, the Co-op was bankrupt because<br />

of the heavy gasohol liabilities it had assumed. The bankruptcy trustee for<br />

the Co-op considers 10b-5 claims against various participants in the Co-op’s<br />

acquisition of Uppin’s interest the gasohol plant.<br />

1. The trustee begins to draw up a list of potential 10b-5 defendants. Who<br />

should be on the list?<br />

2. From the start Bill Uppin asserted his belief (perhaps naive) that the<br />

gasohol plant would turn itself around with the Co-op’s financial backing<br />

<strong>and</strong> an upturn in gasohol prices. Can Uppin be liable if he had a “clean<br />

heart <strong>and</strong> empty mind”?<br />

3. Even if the Co-op was culpably deceived, can Bill Uppin be liable if the<br />

Uppin Flames investment fizzled because of weakness in gasohol prices?<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


TO BE ADDED<br />

Session 9 – Rule 10b-5<br />

Study Problem 9.1 — Analysis<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


TO BE ADDED<br />

Session 9 – Rule 10b-5<br />

Study Problem 9.1 — Analysis (continued)<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Session 9 – Rule 10b-5<br />

Study Problem 9.2<br />

To raise money for its operations, the Co-op sells<br />

promissory notes to its members. The notes, payable on<br />

dem<strong>and</strong>, are uncollateralized <strong>and</strong> uninsured. The Co-op<br />

advertises its dem<strong>and</strong> note program promising that “your<br />

investment is safe, secure, <strong>and</strong> available when you need it.”<br />

1. Do noteholders have st<strong>and</strong>ing to bring a 10b-5 class action<br />

regarding the Co-op’s acquisition of Uppin Flames?<br />

2. Were the noteholders deceived in connection with the<br />

purchase or sale of their notes?<br />

3. Who are potential defendants in a suit by the noteholders?<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


TO BE ADDED<br />

Session 9 – Rule 10b-5<br />

Study Problem 9.2 — Analysis<br />

(c) 2013 Michael K. Krebs All Rights<br />

Reserved


Session 9 – Rule 10b-5<br />

Study Problem 9.2 — Analysis (continued)<br />

TO BE ADDED<br />

(c) 2013 Michael K. Krebs All Rights<br />

Reserved


Session 9 – Rule 10b-5<br />

Study Problem 9.3<br />

A year after acquiring Uppin Flames, the Co-op hires the well-known<br />

accounting firm Dewey Cheetum & Co. to audit its financial statements. During<br />

their review of the Co-op’s books, Dewey Cheetum accountants notice that the Coop<br />

did not properly account for its investment in Uppin Flames.<br />

In its audit report to the Co-op board, Dewey Cheetum ignores the Uppin<br />

Flames problem. The Dewey Cheetum accountants are aware that the Co-op should<br />

have a negative net worth under generally accepted accounting principals. That bad<br />

news about the Co-op’s financial condition could well trigger a disastrous run on the<br />

dem<strong>and</strong> notes. The only cautionary disclosure came in a footnote to the audit report<br />

in which Dewey Cheetum doubted the recoverability of the Co-op’s investment in<br />

Uppin Flames. Dewey Cheetum attends a meeting of noteholders at which the Coop’s<br />

financial condition is discussed.<br />

Most of the noteholders did not know of the audit report, which Dewey<br />

Cheetum provided only to the Co-op board. Can Arthur Young be liable to the<br />

noteholders despite the absence of any actual reliance?<br />

(c) 2013 Michael K. Krebs All Rights<br />

Reserved


TO BE ADDED<br />

Session 9 – Rule 10b-5<br />

Study Problem 9.3 — Analysis<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Session 9 Agenda<br />

Part 1<br />

Rule 10b-5 Litigation<br />

Part 2<br />

Insider Trading Liability<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Insider Trading Liability<br />

What is the current law?<br />

How did it evolve?<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Insider Trading Liability<br />

Statement of Current Law<br />

The purchase or sale of a security of any<br />

issuer, on the basis of material nonpublic<br />

information about that security or the issuer,<br />

in breach of a duty of trust or confidence that<br />

is owed, directly, indirectly or derivatively to<br />

the issuer of that security or the shareholders<br />

of that issuer, or any person who is the source<br />

of the material nonpublic information violates<br />

Rule 10b-5.<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Insider Trading Liability<br />

“Classical Theory”<br />

A person purchases or sells securities,<br />

with scienter, while in possession of<br />

material, nonpublic information in<br />

breach of a duty arising out of a<br />

fiduciary relationship to the issuer<br />

of the security<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Insider Trading Liability<br />

“Misappropriate Theory”<br />

A person violates Rule 10b-5 when<br />

she misappropriates <strong>and</strong> trades on the<br />

basis of confidential information in a<br />

breach of a duty of trust or<br />

confidence owed to the source of<br />

the information.<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Insider Trading Liability<br />

Evolution of Insider Trading Law<br />

In re Cady Roberts (S. Ct. 1961) (tipper/tippee)<br />

Texas Gulf Sulfur (2 nd Cir. 1971) (accepting options<br />

while in possession of material non-public<br />

information)<br />

Chiarella (S. Ct. 1980)<br />

Dirks (S. Ct. 1983)<br />

O’Hagan (S. Ct. 1997)<br />

SEC Rule 10b5-2 (2000)<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Rule 10b5-2<br />

Provides a non-exclusive<br />

definition of circumstances in<br />

which a person has a duty of trust<br />

or confidence for purposes of the<br />

"misappropriation" theory of<br />

insider trading under Section<br />

10(b) of the Act <strong>and</strong> Rule 10b-5.<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Rule 10b5-2 (cont’d)<br />

(1) A person agrees to maintain information in confidence;<br />

(2) the person communicating the material nonpublic information <strong>and</strong> the person<br />

to whom it is communicated have a history, pattern, or practice of sharing<br />

confidences, such that the recipient of the information knows or reasonably<br />

should know that the person communicating the material nonpublic information<br />

expects that the recipient will maintain its confidentiality; or<br />

(3) A person receives or obtains material nonpublic information from his or<br />

her spouse, parent, child, or sibling, unless the person receiving or obtaining the<br />

information demonstrates that no duty of trust or confidence existed with respect<br />

to the information, by establishing that he or she neither knew nor reasonably<br />

should have known that the person who was the source of the information<br />

expected that the person would keep the information confidential, because of the<br />

parties' history, pattern, or practice of sharing <strong>and</strong> maintaining confidences, <strong>and</strong><br />

because there was no agreement or underst<strong>and</strong>ing to maintain the confidentiality<br />

of the information.<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Liability is derivative<br />

Insider Trading:<br />

Tipper/Tippee Liability<br />

Tippee will be liable only if tipper is liable<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Tipper Liability:<br />

Insider Trading:<br />

Tipper/Tippee Liability<br />

(1) Tipper had a duty to keep material non-public<br />

information confidential;<br />

(2) Tipper breached that duty by intentionally or<br />

recklessly relaying the information to a tippee who<br />

could use the information in connection with<br />

securities trading; <strong>and</strong><br />

(3) Tipper received a personal benefit from the tip.<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Tippee Liability:<br />

Insider Trading:<br />

Tipper/Tippee Liability<br />

(1) Tipper breached a duty by tipping confidential<br />

information;<br />

(2) Tippee knew or had reason to know that the tippee<br />

improperly obtained the information (i.e., that the<br />

information was obtained through the tipper’s breach);<br />

<strong>and</strong><br />

(3) Tippee, while in knowing possession of the material<br />

non-public information, used the information by trading<br />

or by tipping for his own benefit.<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Tipper/Tippee Liability<br />

Study Problem 9.4<br />

Thomas is an employee of GE Capital.<br />

Peter <strong>and</strong> Nelson work at Wynnefield Capital.<br />

Peter is a college friend of Thomas.<br />

Thomas “tips” Peter about the possible acquisition of SunSource<br />

Inc. by Allied Capital Corporation that GE Capital was financing.<br />

Peter passes this information to Nelson, who purchases<br />

SunSource stock based on it.<br />

After an internal investigation, GE Capital did not consider itself<br />

to be a victim of a breach of confidentiality.<br />

Would Thomas, Peter <strong>and</strong>/or Nelson be liable for insider<br />

trading?<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


TO BE ADDED<br />

Tipper/Tippee Liability<br />

Study Problem 9.4 - Analysis<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Tipper/Tippee Liability<br />

Study Problem 9.4 – Analysis (cont’d)<br />

TO BE ADDED<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Tipper/Tippee Liability<br />

Study Problem 9.4 – Analysis (cont’d)<br />

TO BE ADDED<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Insider Trading:<br />

Non-Equity <strong>Securities</strong><br />

SEC has brought cases alleging improper<br />

trading in securities other than equities<br />

<strong>and</strong> listed options, such as<br />

credit default swaps,<br />

exchange-traded funds<br />

mutual funds.<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


Insider Trading: Tender Offers<br />

Study Problem 9.5<br />

Kate is drying her hair in the locker room of her very upscale gym.<br />

As she turns off the hair dryer, she overhears the end of a conversation between<br />

two women who Kate knows only casually by their first names – Monica <strong>and</strong><br />

Hillary.<br />

Monica: “I wish could be in the room when Meg learns that Googolplex is<br />

launching a hostile tender for her company.”<br />

Hillary: “I hope Meg can h<strong>and</strong>le the stress. With the premium that ‘Plex<br />

is offering, she will have no choice but to toss in towel.”<br />

Monica <strong>and</strong> Hillary do not know that Kate overhead their conversation.<br />

Making an educated guess regarding the identity of Meg’s company, Kate<br />

purchases shares of its stock before Googolplex launches its tender offer. Her<br />

profit on the trade is $1 million.<br />

Will Kate, Monica <strong>and</strong>/or Hillary have liability for insider trading?<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


TO BE ADDED<br />

Insider Trading:<br />

Study Problem 9.5 - Analysis<br />

(c) 2013 Michael K. Krebs<br />

All Rights Reserved


U.S <strong>and</strong> <strong>Trans</strong>-<strong>Border</strong><br />

<strong>Securities</strong> <strong>Regulation</strong><br />

THE END!!<br />

© 2013 Michael K. Krebs<br />

All Rights Reserved


U.S <strong>and</strong> <strong>Trans</strong>-<strong>Border</strong><br />

<strong>Securities</strong> <strong>Regulation</strong><br />

Boston University School of Law<br />

Executive LL.M. - International Business Law<br />

July/August 2013<br />

Michael Krebs<br />

JD, Boston University School of Law 1985<br />

Senior Partner, Nutter, McClennen & Fish, LLP, Boston, MA<br />

Tel. 616.439.2288 email: mkrebs@nutter.com<br />

© 2013 Michael K. Krebs<br />

All Rights Reserved

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!